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SUMMARY 
Staphylococcus aureus is a major pathogen, which causes a wide range of infections. 
Despite its obvious clinical importance, little is known about the mechanisms of 
pathogenesis. An in vitro model mimicking infection was developed in order to identify 
putative virulence determinants. The model involves the growth of S. aureus in serum 
under microaerobic conditions. All known virulence factors tested were shown not to be 
required for growth, or preferentially expressed, in serum. 
Tn917 transposon libraries of S. aureus were screened to identify genes preferentially 
expressed in serum, compared to a nutrient-rich growth medium. 73 clones were 
identified and the transposon insertion site was characterised for 23 of these clones. 
Analysis of sequence flanking the transposon insertion revealed the identity of the 
mutated loci. 10 out of 23 sequenced clones, contained transposons inserted within 
genes involved in the biosynthesis of the aspartate family of amino acids (lysine. 
threonine, methionine and isoleucine). These were: the two common pathway enzymes; 
aspartokinase (lysC) , and aspartate semi aldehyde dehydrogenase (asd) , along with; 
dihydrodipicolinate dehydrogenase (dapA), and cystathionine y-synthase (yjcf) , 
involved in the biosynthesis oflysine and methionine respectively. 
Analysis of methionine biosynthesis indicated that S. aureus possesses only a single 
pathway, which proceeds via cystathionine. Several genes encoding methionine 
biosynthetic enzymes were found clustered on the S. aureus chromosome. 
The genes lyse, asd and dapA were found to be encoded by the first three genes of an 
eight gene operon, which also contains three other genes involved in lysine 
biosynthesis. This operon named the dap operon, is the major lysine biosynthetic 
operon of S. aureus. lysC, asd and dapA were all found to be repressed at the 
transcriptional level primarily by lysine, although factors other than the availability of 
lysine may be responsible for the regulation of lysine biosynthetic gene expression in 
serum. lysC, asd and dapA were all found to be expressed in vivo, in a murine 
pyelonephritis model using both RT-PCR and TaqMan techniques. However, these 
genes were not found to be important in three murine pathogenicity models. 
Finally, in addition to the development of a model mimicking infection, and the 
identification of genes with a potentially important role in vivo, this thesis has enhanced 
our understanding of both methionine and lysine biosynthesis in S. aureus. 
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CHAPTER 1 
INTRODUCTION 
1.1 The staphylococci 
Staphylococci are Gram-positive cocci of 0.5-1.5 !lm diameter that characteristically 
divide in more than one plane to form irregular or grape-like clusters. It was due to this 
clustering that Ogston in the late nineteenth century, named a group of micrococci, 
causing inflammation and suppuration Staphylococcus, from staphyle' meaning bunch 
of grapes (Kloos and Lambe, 1991). Currently the genus Staphylococcus is comprised 
of 32 species and eight subspecies, many of whose natural hosts include humans (Kloos 
and Bannerman, 1994; Kloos and Lambe, 1991). The genus Staphylococcus is well 
defined and phylogenetically belongs to the Bacillus-Lactobacillus-Streptococcus 
cluster of Gram-positive bacteria, with a low G + C content (Woese, 1987). 
The staphylococci are non-motile non-spore forming bacteria that are not generally 
encapsulated. The cell wall peptidoglycan is unique owing to multiple glycine residues 
in the interpeptide bridge, rendering them susceptible to lysostaphin. Members of the 
genus are commonly catalase-positive but oxidase-negative, and are generally 
facultative anaerobes, capable of generating energy by respiration or fermentative 
pathways. Most species have relatively complex nutritional requirements, and it is not 
possible to specify a defined medium for all staphylococcal strains, as nutritional 
requirements vary between strains. However, in general, staphylococci require 5-12 
essential amino acids and 2 or 3, B-group vitamins (Wilkinson, 1997). 
Staphylococci are typically found on the skin, skin glands and mucus membranes of 
warm blooded animals. They are sometimes found at other sites including, the mouth, 
blood, mammary glands and upper respiratory tracts of hosts. The staphylococci are 
also wide-spread in the environment for example, soil, air and water. They are some of 
the hardiest of the non-spore-forming bacteria, having the ability to survive for long 
periods on dry inanimate objects. Staphylococci also demonstrate resistance to heat 
(withstanding 50°C for 30 minutes) and tolerance to high concentrations of salt, with 
most species capable of growth in the presence of 1.7 M (10 % w/v) NaCI (Kloos and 
Lambe, 1991; Kloos and Bannerman, 1994). 
The identification of pathogenic staphylococci is most commonly by the ability to 
produce coagulase and thus clot plasma (Kloos and Lambe, 1991). The vast majority of 
staphylococci are coagulase-negative and do not cause disease. A few coagulase-
negative strains do however cause disease, but are generally considered to be 
opportunistic pathogens, causing infection following trauma, pre-disposing disease, or 
due to indwelling foreign bodies. To date only three species of staphylococci have been 
found to be coagUlase-positive; S. intermedius and S. hyicus, which are found in 
animals (Deveriese et al., 1978; Hajek, 1976) and S. aureus, which causes infections in 
humans. 
1.2 Staphylococcus aureus 
Staphylococcus aureus is the second most common species In the genus 
Staphylococcus, but the best known and by far the most studied staphylococcal species, 
on account of its frequency and highly versatile pathogenicity. The accolade of the most 
common staphylococci goes to S. epidermidis, which lives on the skin of many people 
but rarely causes disease. The species name aureus ('golden') refers to the fact that on 
agar, its colonies are pigmented with a bronze colour, while other species form white 
colonies. S. aureus however is probably best distinguished from other species of the 
genus using the coagulase test (Chapter 1.1). Strains of S. aureus are alkaline 
phosphatase-positive and usefully show no ~-galactosidase activity. The acidic amino 
acids, aspartate and glutamate; and K+, represent the major amino acids and cation in 
terms of concentration in the cytoplasmic pool (Wilkinson, 1997). The chromosome of 
S. aureus (strain 8325) has been mapped by a variety of methods including SmaI 
digestion (Pattee et al., 1990) and has been shown to be approximately 2.78 megabase 
pairs in size. Using the assumption of a I kb average gene size, this suggests that S. 
aureus encodes approximately 3,000 genes (Coulter et al., 1998). 
1.3 Diseases and infections caused by S. aureus 
S. aureus is a virulent and frequent pathogen that is probably the most common cause 
of bacterial infection in humans, although the majority are minor and superficial skin 
infections. S. aureus has been reported as the fourth most frequently isolated pathogen 
in hospital environments (Kloos and Bannerman, 1994), but is also isolated from 
community acquired infections. Infections caused by S. aureus range from the 
insignificant, to the life threatening and can be viewed as three general types: 
superficial lesions such as small skin abscesses and wound infections; systemic and life 
threatening conditions such as bacteraemia, endocarditis, osteomyelitis, pneumonia and 
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sepSIS; and toxinoses such as toxic shock, toxic epidermal necrolysis, and food 
poisoning. 
S. aureus is also a particular problem following invasive hospital techniques. For 
example, 20 % of infections involving long-term intravascular canulae (Bluhm, 1985) 
and prosthetic joint infections, in up to 1 % of patients undergoing hip replacement 
(Fitzgerald, 1989) are caused by S. aureus. 
S. aureus produces a range of heat-stable extracellular toxins (Table 1.1) that on 
ingestion causes food-poisoning. Food poisoning is characterised by nausea, vomiting, 
abdominal pains and diarrhoea, with symptoms generally presenting within 2-6 hours of 
consuming contaminated food (Bergdoll, 1989). The foods most regularly implicated 
include; cooked meat, fish, poultry, and dairy produce. Importantly, death from 
staphylococcal induced food poisoning is rare. 
A more important toxin related disease associated with infection or colonization with S. 
aureus is toxic shock syndrome (TSS). However this disease is only attributed to strains 
of S. aureus containing the gene for toxic shock syndrome toxin-l (TSST -1). 
Symptoms of this syndrome include shock, high fever, vomiting, diarrhoea, renal and 
hepatic dysfunction and a scarlatiniform rash. Menstrual tampons have been shown to 
be an important accessory factor in the development of TSS (Arbuthnott et al., 1990). 
Serious S. aureus infections generally occur in association with a predisposing 
condition. Entry into the body is enhanced by skin damage, as S. aureus does not 
usually penetrate into deep tissues unless the skin or mucosal membranes are damaged 
or actually cut. This may come about for example by bums, accidental wounds, surgical 
intervention or associated skin disease. Susceptibility is also caused by chronic 
debilitating disorders such as acquired immune deficiency or cancer. Thus it is not 
surprising that S. aureus is a pathogen commonly associated with nosocomial infections 
(Kloos and Bannerman, 1994). Life-threatening diseases of S. aureus include 
bacteraemia, septicaemia, endocarditis, pneumonia and meningitis. Staphylococcal 
bacteraemia is generally as a result of a local infection with dissemination into the 
blood stream, but also due to direct inoculation as a result of intravenous drug abuse. 
Septicaemia differs from bacteraemia, in that it is the result of the multiplication of 
bacteria in the blood. This often results in secondary site infections for example 
endocarditis. 
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Problematically, for both food preparation and hospital workers, is that 25-50 % of 
healthy individuals are carriers of S. aureus, with the mucous membrane of the nose 
being the main site of carriage. S. aureus however, is also found on the skin and in 
faeces (Novick, 1990; Kloos and Bannerman, 1994). 
1.4 Treatment of S. aureus infections 
The introduction of penicillin in the 1940's, for the treatment of severe S. aureus 
infections allowed control of these infections, and had a great effect on morbidity and 
mortality. However, resistance due to the presence of a penicillinase emerged almost 
immediately and by the late 1940's approximately 60 % of hospital-acquired strains 
were resistant to penicillin (Barber and Rozwadow-Dowzenko, 1948). Furthermore the 
staphylococci have proved to be extremely capable in developing resistance to the 
commonly used antimicrobial agents with resistant strains to streptomycin, tetracycline 
and erythromycin emerging shortly after their introduction into clinical practice 
(Demerec, 1948; Haight and Finland, 1952). The resistance to antibiotics in most cases 
is coded for by genes carried on plasmids, this probably accounts for the rapid spread of 
resistant organisms. The early widespread arrival of antibiotic resistant strains by the 
1950's caused grave therapeutic problems and sent a shock wave through the medical 
community. Although it seems entirely in character, that among the earliest organisms 
to accommodate to these powerful drugs should have been the adaptable 
Staphylococcus. In the 1960's p-Iactamase resistant antibiotics, such as methicillin were 
introduced, but methicillin-resistant S. aureus (MRS A) were reported soon after 
(levons, 1961) and they currently account for a large proportion of clinical isolates of S. 
aureus worldwide. Methicillin resistance is due primarily to a novel form of a penicillin 
binding protein (PBP2a (MecA» that has reduced affinity for methicillin (Hartman and 
Tomasz, 1984). Vancomycin is often the last line of defence antibiotic, in the treatment 
of multiple antibiotic resistant strains, in particular MRSA. Unfortunately intermediate 
level vancomycin-resistant S. aureus (VRSA) have now been detected. These resistant 
strains were first reported in Japan (Kremery et al., 1996), but have since been reported 
in both the United States and France. Concemingly it has been reported that up to 20 % 
of MRSA isolated from hospitals throughout Japan are heterogeneously resistant to 
vancomycin, and that this resistance develops into VRSA upon exposure to vancomycin 
(Hiramatsu et al., 1997). The global spread of resistance to this antibiotic is now almost 
inevitable and could potentially lead to a return to the pre-antibiotic age. 
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1.5 Virulence factors of S. aureus 
S. aureus elaborates a great variety of extracellular proteins, many of which are 
potential virulence factors, although only a few have actually been implicated in 
virulence (Arvidson, 1983). Several definitions of a virulence factor exist, however for 
the purpose of this study a virulence factor is described as a factor, for which there is at 
least a hypothetical involvement in the causation of disease. A list of putative and 
proven virulence factors is shown in Table 1.1, although it is not comprehensive. 
Furthermore, many of the genes for these factors have yet to be identified. The 
virulence factors listed in Table 1.1 have been divided into four broad categories: 1) 
Attachment; factors involved in attaching the bacteria to cells or extracellular matrices. 
2) Evasion of host defence; factors that prevent or reduce phagocytosis, or that interfere 
with the function of specific anti staphylococcal antibodies or other specific host-
defence mechanisms. 3) Invasion/tissue penetration; factors that specifically attack host 
cells and factors that specifically degrade components of the extracellular matrices. 4) 
Antibiotic inactivation; factors that destroy/inactivate antibiotics administered against 
S. aureus or other infections (Projan and Novick, 1997). 
Importantly, the purpose of a given virulence factor is thought not to be to cause disease 
but to enhance survival of the bacterium. This is because S. aureus are not inherently 
pathogenic organisms (unlike for example the influenzae virus which must cause 
disease to propagate). Thus for every illness caused by S. aureus, many more 
individuals are benignly colonized with no sign of disease. In these terms, the infected 
host should really be viewed as the environment to which the bacterium must adapt in 
order to survive. Within the context of the ability to grow and divide, few if any of the 
virulence factors are essential, and thus these factors are best viewed as a subset of 
accessory gene products, which are advantageous in particular environments. 
Furthermore, with the exception of toxinoses, no single factor is responsible for 
staphylococcal infections but is instead due to the coordinate action of multiple 
different factors (Projan and Novick, 1997). 
1.6 Control of production of virulence determinants 
1.6.1 Coordinate regulation of virulence 
Bacterial growth and survival is competitive and is largely dependent on a cell's 
ability to adapt to environmental changes. Infections caused by S. aureus are at least in 
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Factor Role Gene Expressed? 
Clumping factor Attachment cJfA Log phase 
Fibrinogen-binding protein Attachment jbpA Log phase 
Fibronectin-binding protein A Attachment fnbA Log phase 
Fibronectin-binding protein B Attachment fnbB Log phase 
Collagen-binding protein Attachment cna 
Coagulase Attachment cga/coa Log phase 
Polysaccharide / adhesin (PS/A) Attachment 
Polysaccharide intracellular adhesin Attachment 
Enterotoxin A Evasion of host defences sea Constitutive 
Enterotoxins B, CI-3, D, E, H Evasion of host defences seb-h Post-exponential 
Toxic shock syndrome toxin-l Evasion of host defences tst Post-exponential 
Exfoliative toxins A, B Evasion of host defences eta, etb Post-exponential 
Protein A Evasion of host defences spa Log phase 
Lipase Evasion of host defences geh Post-exponential 
V8 protease Evasion of host defences ssP Post-exponential 
Fatty acid modifying enzyme (FAME) Evasion of host defences 
Panton-Valentine leukocidin Evasion of host defences lukPV, Post-exponential 
lukS-PV 
Leukocidin R Evasion of host defences lukF-R, 
lukS-R 
Capsular polysaccharide type 1 Evasion of host defences cap] locus Post-exponential 
Capsular polysaccharide type 5 Evasion of host defences Post-exponential 
Capsular polysaccharide type 8 Evasion of host defences capBlocus Post-exponential 
Staphylokinase Evasion of host defences sak 
Catalase Evasion of host defences kalA 
a-Toxin Invasion/tissue penetration hla Post-exponential 
~- Haemolysin Invasion/tissue penetration hlb Post-exponential 
y- Haemolysin Invasion/tissue penetration hlgA, B, C Post-exponential 
5- Haemolysin Invasion/tissue penetration hid Post-exponential 
Phospholipase C Invasion/tissue penetration pic 
Metalloprotease (elastase) Invasion/tissue penetration sepA 
Hyaluronidase, hyaluronate lyase Invasion/tissue penetration hysA Post-exponential 
~-lactamase Antibiotic inactivation bla 
Table 1.1 
Putative and proven virulence factors of S. aureus 
Adapted from Projan and Novick (1997). 
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part related to the organisms' striking ability to react to changing environments during 
the infection process. All bacteria express their genetic information in a regulated 
manner, with relatively few genes being continuously expressed ('housekeeping' 
genes). The remainder of the genes, are deemed non-essential for growth and are often 
referred to as accessory genes (Chapter 1.5). The constitutive production of accessory 
factors rather than on a needs only basis would be energetically unfavourable. As a 
result bacteria have evolved control systems that coordinately regulate groups of genes 
and operons. This modulation occurs by the expression of appropriate genes via signal 
transduction pathways, so that accessory factors are only produced when needed (Miller 
et al., 1989). 
Several characteristics of a host environment are known to induce the production of 
virulence factors and toxins, such as temperature and nutrient availability (Bliska et al., 
1993). Sensing of these signals leads to a change in the control of the transcription of a 
wide variety of unlinked genes, many of which are involved in pathogenesis. 
1.6.2 Bacterial signal transduction 
Adaptive gene expression necessitates that the cell be able to detect and respond to 
environmental changes. As the majority of stimuli to which cells are required to 
respond, do not generally penetrate the cytoplasm, signalling systems have evolved in 
all cells. These signal transduction systems in bacteria often share a significant degree 
of structural similarity with one an other, despite the signals detected being quite 
diverse (Stock et ai., 1989). A common mechanism for the transduction of 
environmental stimuli to bring about changes in gene expression are the two-component 
sensor regulators, these have been identified in eukaryotes as well as in many bacteria 
(Parkinson and Kofoid, 1992; Kavanaugh and Williams, 1996). Two-component 
systems generally consist of two proteins, which are often encoded in a single operon. 
Commonly one of the proteins is a transmembrane sensor, and the other a transcription 
factor known as a response regulator. In general the transmembrane protein (sensor) 
binds to a specific ligand, the signal, and autophosphorylates. The phosphorylated 
sensor then relays the phosphate to the response regulator. The regulator is now in its 
active conformation and can stimulate or repress target genes at the trancriptionallevel. 
A further method of global regulation of gene expression involves a process of 
intercellular communication that enables cells to sense population levels. This 
signalling mechanism is known as quorum sensing and has been described in many 
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bacteria, including several Gram-positive species. This mechanism of communication 
uses a diffusible signalling molecule (pheromone) to regulate physiological processes in 
a cell density dependent manner (Kleerebezem et al., 1997). 
1.6.3 Expression of virulence factors in S. aureus 
The majority of information on this important subject has been gained from the study of 
bacterial cells in culture. A classical growth curve of S. aureus, grown in nutrient 
medium is divided into four phases; lag, log, post-exponential and stationary, and is 
represented diagrammatically in Figure 1.1. During exponential growth, bacterial 
metabolism is rapid and efficient and can be regarded as a steady state in which cells 
are geared to ensure constancy of growth. As a culture ages and growth stops (post-
exponential), there is a reorganization of cellular metabolism for long-term survival 
under unfavourable conditions. A striking feature of this reorganization is the rapid 
synthesis of exoproteins, of which many are virulence factors. In fact it has been 
observed that almost all the exoproteins produced by S. aureus are produced post 
exponentially (Novick and Projan, 1997). There are two exceptions to this, enterotoxin 
A, which is produced constitutively (Tremaine et al., 1993), and coagulase, which is 
produced during logarithmic growth (Duthie, 1954). At the same time the production of 
many proteins essential for growth and cell division, along with a wide range of cell 
wall associated proteins including protein A, clumping factor and the fibronectin-
binding proteins, ceases. Therefore it is clear that there is a complex regulatory system 
governing this change over, which can be regarded as a metabolic 'toggle switch' that is 
set at the end of exponential phase for exoprotein synthesis. Table 1.1 shows a list of 
virulence factors, and indicates where possible, during which growth phase they are 
expressed. 
1.7 Regulators of virulence determinant production of S. aureus 
Several regulatory loci have been discovered in S. aureus by transposon mutagenesis. 
Each mutation results in pleiotropic differences in the expression of exoproteins and/or 
virulence factors. These loci have been termed global regulators and include: agr 
(Recsei et al., 1986; Morfeldt et al., 1988), sar (Cheung et al., 1992), and sae (Girauldo 
et al., 1994). A further global regulator, xpr (extracellular protein regulator) was 
thought to have been identified (Smeltzer et al., 1992), but this was later shown to 
contain an additional mutation within the agr locus (McNamara and Iandolo, 1998). It 
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Figure 1.1 
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Synthesis of 
surface proteins 
Exponential 
I Synthesis of 
toxins and 
exoenzyrnes 
PXP 
Spread to new sites 
Hypothetical role of virulence factors in staphylococcal infection 
STA 
Abscess 
In this model, bacteria in lag phase initiate the infection and would enter exponential 
phase, where multiplication would begin, accompanied by synthesis of surface proteins. 
Crowding during post-exponential phase (PXP) would activate a density sensing 
mechanism that would stimulate toxic exoprotein production. This enables the 
organism to escape from the localised infection (abscess) during stationary phase (STA) 
and spread to new sites, where the cycle would be repeated. 
Reproduced from Projan and Novick (1997). 
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is via these global regulators, along with many other unknown regulatory components 
that S. aureus coordinates production of a wide range of virulence factors (Table 1.1). 
These regulatory loci, which act either independently or coordinately, bring about the 
sophisticated control of both exo- and cell wall associated proteins. Three loci encoding 
the global regulators; agr, sar, and sae, have been cloned and studied in some detail. 
1.7.1 agr (accessory gene regulator) 
The agr locus was originally isolated as a a-haemolysin mutant (Mallonee et al., 1982), 
but was later demonstrated to be the site of a transposon insertion affecting the 
expression of several exoproteins/virulence factors (Recsei et al., 1986; Morfeldt et al., 
1988). Interestingly, at approximately the same time, a class of pleiotropic mutants 
were isolated, designated exp with an almost identical phenotype to agr (Bjorklind and 
Arvidson, 1980; Morfeldt et al., 1988). Analysis of agr and exp by Northern blot 
showed that exp and agr were identical (Morfeldt et al., 1988). Since virulence factors 
are also known as accessory factors, the locus was designated agr, for accessory gene 
regulator. Studies have shown that agr up regulates the production of many proteins 
including: the haemolysins (a, p, 0, y); toxic shock syndrome toxin-1 (TSST -1); 
enterotoxin B and C; V8 protease; and lipase. Additionally agr represses production of 
certain other exo- and cell wall associated proteins, including: protein A; fibronectin 
binding proteins; and clumping factor. This regulation by agr has been shown to occur 
in a growth phase dependent manner (Bjorklind and Arvidson 1980; Recsei et al., 
1986). The agr locus was cloned and the complete sequence determined (Peng et al., 
1988; Kornblum et al 1990; Arvidson et al., 1990). The agr operon is shown 
diagrammatically in Figure 1.2. 
The agr locus consists of two divergent transcriptional units, whose transcripts RNAII 
and RNAIII are transcribed from promoters P2 and P3 respectively (Kornblum et al., 
1990; Novick et al., 1995). A third transcript RNAI has also been detected and is 
transcribed from promoter Pl. The role of PI is unclear, and has been shown to be weak 
and constitutive, occurring throughout the growth cycle and independently of agr 
function (Peng et al., 1988). The P2 operon produces a transcript, RNAII of 
approximately 3.5 kb long which encompasses four genes, designated agrA, agrE, agre 
and agrD (Novick et al., 1995). The final agr transcript is RNAIII, which is a transcript 
of approximately 0.5 kb and is transcribed in the opposite direction to RNAII (P2) 
(Kornblum et al., 1990) (Figure 1.2). 
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Figure 1.2 
The agr locus of S. aureus 
Map of the agr locus showing the positions of the three agr promoters, PI, P2 and P3, 
together with the extent of their transcripts. The agrC and agrA genes encode a sensor 
and response regulator, respectively of a two-component signal transduction system. 
The agrD gene product is modified by the product of the agrB gene to give an 
octapeptide know as AlP (auto inducing peptide). The hid gene encodes o-haemolysin. 
Adapted from Kornblum et al. (1990). 
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1.7.1.1 RNAIII 
The P3 operon produces a 512 base RNAIII transcript, containing three putative open 
reading frames (ORFs). The first encodes the 26 amino acid, 8-haemolysin protein 
(hid). The second and third ORFs, potentially encode 21 and 19 amino acid 
polypeptides respectively, however only the second ORF has a putative ribosome 
binding site. 
Therefore it would appear that the 3' portion of RNAIII is not translated. However 
studies have shown that the 3' portion of RNAIII is required for agr activity. 
Mutagenesis studies have shown than none of the ORFs can be responsible for RNAIII 
activity, thus indicating that RNAIII itself is the effector molecule of the positive and 
negative regulation by agr, of genes at the end of exponential growth (Novick el al., 
1993). The role of RNAIII as the molecule regulating exoprotein gene expression was 
also supported by the finding that an insertion in the RNAIII 3' region, did not impair 
8-haemolysin production, but resulted in a typical agr - phenotype (Arvidson el al., 
1990). 
The manner in which RNAIII regulates target genes has been the subject of much study 
and is not fully understood. Transcriptional fusions to hla, spa and lsI have determined 
that RNAIII acts at the transcriptional level (Novick et al., 1993). However a series of 
experiments using an exogenous inducer to regulate RNAIII expression showed that 
while induction of RNAIII at virtually any point in the growth of S. aureus resulted in 
an immediate inhibition of spa transcription, transcription of hla while dependent on 
RNAIII, did not always immediately follow induction of RNAIII, but instead occurred 
at a later point in growth (Vandenesch et al., 1991). From this result it was concluded 
that another 'temporal factor' must exist in addition to agr, that is required for the 
expression of a-haemolysin and thus probably other exoproteins produced by S. aureus. 
There is also evidence demonstrating that RNAIII acts as a translational activator, 
stimulating translation of a-haemolysin mRNA (Novick et al., 1993). The mechanism 
for this translational control, was determined by Morfeldt et al. (1995), who 
demonstrated that, RNAIII functions as an antisense RNA to complex with sequences 
on the a-haemolysin mRNA upstream from the translational start site. This prevents a 
stem-loop from forming and frees the ribosome binding site and start codon, thus 
allowing translation of the hla mRNA. Therefore RNAIII has two likely regulatory 
roles, functioning at both the transcriptional and translational levels. 
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1.7.1.2 RNAII 
Studies established that there are four ORFs within the P2 transcript, all of which have 
been shown to be essential for complete agr function. These ORFs are designated agrA, 
agrB, agrC and agrD (Novick et at., 1995). Studies have demonstrated that AgrA 
shows N-terminal similarity to the response regulatory component, and that AgrC has 
C-terminal amino acid sequence homology to the sensory component of a two-
component sensor regulator system (Novick, 1990). The primary role of the 
AgrAfAgrC signalling pathway is to up regulate both of the major agr promoters, P2 
and P3. It has not however been demonstrated that AgrA binds directly to DNA. Instead 
AgrA is thought to work in conjunction with a second transcription factor SarA 
(Chapter 1.7.2) (Morfeldt et at., 1996a/b) (Figure 1.3). The remaining two ORFs, AgrB 
and AgrD are involved in the generation of a small autoinducing peptide (AlP), (Ji et at 
1995) which is involved in cell density signalling. 
1.7.3 Cell density control of virulence determinants by AlP 
Transcription of the P2 operon of agr, has been found to be auto-regulated in a density 
dependent manner by a signalling pheromone system (Ji et at., 1995). Two genes of the 
P2 operon, agrB and agrD are responsible for this auto-regulation and combine to 
produce the autoinducer. The auto inducer is a small peptide, which is the ligand that 
binds to and activates AgrC. agrD encodes the auto inducer as a 46 amino acid 
propeptide, which is subsequently processed to giving an octapeptide known as AlP 
(auto inducing peptide). agrB encodes a protein that is required for this processing and 
possibly for the secretion of AlP (li et at., 1997). AlP functions as an extracellular 
signal that stimulates the coordinated virulence response in S. aureus. This autocrine 
regulation suggests that the S. aureus agr operon is a quorum sensing regulon, detecting 
the presence of a critical cell density (1.6.2), analogous to density-sensing regulatory 
systems in other bacteria that utilize homoserine lac tones as auto inducers. Achievement 
of the threshold concentration of AlP causes activation of both the P2 and P3 promoters 
of agr (li et at., 1995). 
A survey of some 400 strains of S. aureus and other staphylococci revealed that the vast 
majority synthesize and secrete a soluble autoinducer of RNAIII transcription. 
Interestingly, this study also revealed that the peptides of some strains inhibit the 
expression of agr in other strains (Ji et at., 1997). In total four different groups of 
S. aureus have been identified with AlP from one group inhibiting agr expression of the 
13 
RNAll RNAIll 
t 
14 
Figure 1.3 
Model of the interaction between the agr and sar gene products (depicted in bold type) 
which mediate changes in expression from the P2 and P3 promoters of agr 
AgrC and AgrA represent the sensor and regulator, respectively of a two-component 
signal transduction system. AlP (Autoinducing peptide) is encoded within the agrD 
gene, and is modified from a 46 amino acid propeptide to an octapeptide, by the gene 
product of the agrB gene. AlP has been proposed as a signalling pheromone that, 
probably via AgrC, leads to increased transcription from the P2 and P3 promoters of 
agr, in a density dependent manner. The RNAIII transcript has been shown to both up 
and down regulate production of some exoproteins, as indicated (not to scale). 
Adapted from Fairhead (1998). 
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other groups. This finding represents a novel type of bacterial interference, which could 
be correlated with the ability of one strain to exclude others from infection and/or 
colonization sites (Ji et al., 1997). The sequence of agrD, which encodes AlP, and the 
two flanking genes agrB (AlP processor) and agrC (sensor), is highly variable among 
different strains of S. aureus. Thus these three genes must have co-evolved in order to 
retain the specificity of autoinducer processing and receptor interaction (Ji et al., 1997). 
1.7.2 sar (staphylococcal accessory regulator) 
A second regulatory locus, was identified in S. aureus by Cheung and colleagues 
(1992), once again using transposon mutagenesis. This mutation resulted in a 
pleiotropic effect on the expression of several virulence factors. This locus was 
designated sar (staphylococcal accessory regulator), and was shown to be distinct from 
agr (Cheung et al., 1992). A mutation in the sar locus was found to result in decreased 
production of several extracellular enzymes including; a., p and 8-haemolysin, along 
with an increase in serine protease (V8), and metalloprotease (Cheung and Ying, 1994; 
Chan and Foster, 1998a). Finally studies have shown that the sar gene products are 
necessary for the optimal transcription of RNAIII, suggesting that sar is essential for 
agr-dependent regulation (Heinrichs et al 1996). The sar locus has been cloned and 
mapped (Bayer et al., 1996), and is shown diagrammatically in Figure 1.4. 
The entire sar locus encompasses 1.2 kb and studies have demonstrated there to be 
three overlapping transcripts in a parallel array, each transcribed from a distinct 
promoter (Bayer et al., 1996; Heinrichs et al 1996). The three sar transcripts designated 
sarA, sare and sarB, have common 3' ends and are initiated from a triple-promoter 
system, designated PI, P3 and P2, respectively (Figure 1.4). Interestingly, multiple 
promoters directing the transcription of environmentally regulated genes are a common 
architectural feature in the control of transcription (Projan and Novick, 1997). All three 
sar transcripts encode an ORF (sarA) of 372 bp which in complementation experiments 
has been show to be necessary for a.-haemolysin production (Cheung and Ying, 1994). 
However all three transcripts have been shown to be required for wildtype levels of 0.-
haemolysin. This indicates a role for the two small upstream ORFs (ORF3 and ORF4) 
of 39 and 18, amino acids respectively (Bayer et al., 1996), which together are only 
present on the sarB (P2) transcript. All three promoters, have been shown to be 
regulated in a growth phase dependent manner, with expression of sarA (PI) and sarB 
(P2) greatest during mid-exponential phase, and sare (P3) expression maximal at the 
end of stationary phase (Bayer et al., 1996). This links well with the fact that promoters 
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Figure 1.4 
The sar locus of S. aureus 
The location of the three sar promoters and the approximate extent of their transcripts 
are marked. 
Adapted from Bayer et al. (1996). 
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PI and P2 show sequence similarity to sigma70 dependent promoters, whilst P3 showed 
a high degree of similarity to a B. subtiUs sigmaB «(iB) dependent promoter (Deora et al., 
1997), which are known to be induced by (iB (Chapter 1.7.4.1) during stationary phase 
(Boyland et al., 1993). However, further analysis of these promoters has revealed that 
transcription from PI is stronger than that from P2 or P3 (Cheung et al., 1998). 
From comparison of sar with the virF gene of Shigella flexneri, it was hypothesized 
that sar may control the expression of a range of exoproteins by positively controlling 
RNAIII levels (Cheung and Projan, 1994). Subsequently it has been shown that levels 
of RNAII and RNAIII, the agr transcripts, are markedly diminished in sar mutants, but 
are partially restored in mutants complemented with the smallest of the sar transcripts, 
sarA. However, when a sar mutant is complemented with sequences encompassing all 
three sar transcripts, wild type levels of RNAII and RNAIII are restored. Secondly both 
a- and p-haemolysin levels are depressed in sar mutants along with RNAIII 
transcription. However restoration of wild type levels of RNAIII, restores the ability of 
cells to produce a- and p-haemolysins, and probably that of other agr regulated 
exoproteins (Cheung and Projan, 1994; Projan and Novick, 1997). 
The SarA protein encoded by all three transcripts, has recently been purified and found 
to be dimeric in nature, consisting mostly of a-helices (Rechtin et al., 1999). The 
function of the SarA protein has been studied and shown to be a DNA-binding protein. 
Two recent reports (Morfeldt et al., 1996a; Chein and Cheung, 1998) have shown SarA 
binds to cis-regulating elements upstream of both the P2 and P3 promoters of agr 
activating the expression of both agr operons. However there are significant 
discrepancies between the two studies regarding the binding sites for SarA in the agr 
locus. The situation however has recently been clarified by Rechtin et al. (1999), who 
showed that neither of the earlier reports were wholly accurate. DNase I footprint 
analysis revealed three high-affinity binding sites for SarA in the putative regulatory 
region cis to the agr promoters. Each of these binding sites consists of two half sites, 
each of approximately 18 bp. Thus the current model of SarA interactions with the agr 
region involves a stable SarA dimer binding to three specific sites, each containing two 
half sites, upstream of the regulated P2 and P3 promoters (Rechtin et al., 1999). 
Therefore it appears that sar and agr do interact at some level and increased SarA levels 
have been shown to correlate with greater agr activation (Cheung et al., 1998). 
However, the fact that a agr, sar double mutant is more impaired in virulence factor 
production, than either agr or sar single mutants implies that sar also has a role in 
expression of virulence factors, independent of agr (Cheung et al., 1994; Booth et al., 
1997). 
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SarA is also known to directly regulate collagen adhesin (ena), although definitive SarA 
binding sites upstream of this gene have yet to be identified. Furthermore significant 
homology has been observed among sequences eis to genes with altered expression in 
SarA mutants, for example tst, spa, hla and hlb, to the SarA binding sites of agr (Chan 
and Foster 1998a). However, none of these genes have been shown to be regulated 
directly by SarA. 
Several models exist for the mechanism by which SarA affects gene expression 
(reviewed by Rechtin et ai., 1999). The most interesting model was originally proposed 
by Morfeldt et al. (1996a). This model centres around SarA inducing changes in the 
superhelicity of DNA. Several pieces of evidence support this model including: i) the 
spacing between the -10 and -35 regions of the P2 and P3 promoters of agr is 
approximately 3 bp too far (Morfeldt et ai., 1996a), thus one function of SarA may be 
to overcome this spacing; and ii) the gene encoding the collagen adhesin (ena) is 
repressed by SarA in late-stage cultures, at the same time as SarA activates P2 and P3 
(Gillaspy et ai., 1997; Blevins et ai., 1999). The spacing of the -10 and -35 regions is 
near optimal and thus SarA binding may serve to overwind regulatory promoters, thus 
acting as both a repressor and an activator (Rechtin et ai., 1999). 
1.7.3 sae (S. aureus exoprotein expression) 
A third global regulator of virulence determinant production, designated sae (S. aureus 
exoprotein expression), has been identified (Giraudo et ai., 1994), and subsequently 
shown to be different from both agr and sar (Giraudo et al., 1999). Inactivation of sae 
leads to the diminished production of a- and ~-haemolysins, DNase, coagulase and 
protein A. However, production of proteases, staphylokinase and lipase remained 
constant (Giraudo et al., 1994). Northern blot analysis revealed that sae affects 
exoprotein expression at the transcriptional level (Giraudo et al., 1997). 
The sae locus has recently been cloned, and sequencing revealed the presence of two 
genes that are potentially co-transcribed, designated saeR and saeS, encoding a 
response regulator and a histidine protein kinase, respectively (Figure 1.5). These genes 
show high homology to other bacterial two-component regulatory systems, including 
the PhoPlPhoR system of B. subtilis (Giraudo et ai., 1999). Interestingly, while sae is 
required for the transcription of hla, hlb and eoa genes, its inactivation appears to have 
no effect on agr or sar transcription (Giraudo et al., 1997). Therefore it is believed that 
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The sae locus of S. aureus 
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Schematic drawing indicating the location and orientation of the saeR-saeS operon and 
part of an incomplete ORF, represented by dotted lines, with homology to cbsB of 
B. subtilis. 
Adapted from Giraudo et al. (1999). 
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SaeR exerts its effects by direct interaction with target genes, which are also subject to 
regulation by agr (Giraudo et al., 1999). 
However, a direct interaction between sae and agr presently cannot be ruled out as 
reduced levels of exoproteins are found in a sae, agr double mutant, as compared to 
their already diminished levels in either single mutant. This suggests that there may be a 
synergistic interaction between the two loci. Furthermore the sae agr double mutant 
showed further decreased virulence (Giraudo et al., 1996). Importantly in the same 
double mutant, the low levels of protein A found in the sae mutant, are raised to the 
high levels characteristic of an agr mutant, while the high coagulase levels of an agr 
mutant, are reduced to the very low levels of an sae mutant. Thus there is a difference 
in the regulation of these two exoenzymes, which are both repressed by agr (Giraudo et 
al., 1996). 
1.7.4 Other putative regulatory loci of S. aureus 
A further putative regulatory locus was identified following the screening of transposon 
mutants, for fibrinogen binding protein mutants (Cheung et ai., 1995). One such mutant 
displayed nil levels of surface protein A, and increased haemolysin production, in 
addition to a decreased fibrinogen binding capacity. Importantly, this locus has been 
shown to be distinct from other regulatory loci, including agr and sar (Cheung et al., 
1995). 
Several other two-component regulatory systems, in addition to agrA/agrC and saeSI 
saeR have been identified in S. aureus. These include: lytSllytR which effect the 
expression of murein hydrolases and thus influencing control over the rate of autolysis 
(Brunskill and Bayles, 1996); and phoRiphoP which in E. coli up regulates the 
expression of at least 30 genes (Lammers et al., 2000; Wanner et al., 1993). However it 
is predicted that many more two-component regulatory systems will be discovered in S. 
aureus, some of which will potentially be involved in pathogenesis and in the 
regulation of virulence determinants. 
Finally sigma factors (0'), which are proteins that bind to core RNA polymerase to form 
the holoenzyme that binds to, specific promoters (Moran, 1993), may have a role in the 
regulation of virulence determinant production. There are two broad groups of sigma 
factors: primary sigma factors that are responsible for the expression of housekeeping 
genes, whose products are necessary for exponential growth (Deora et al., 1997); and 
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the alternative sigma factors, that control the expression of a wide range of genes 
involved in many cellular functions. It is this latter class of sigma factors that have been 
proposed to playa role in virulence determinant production (Cheung et 01., 1999; 
Nicholas et ai., 1999). 
1.7.4.1 The role of sigma factor aD in the regulation of virulence 
determinant production 
aD encoded by sigB, is an example of an alternative sigma factor (Haldenwang and 
Losick, 1980) and has been proposed to control the expression of genes involved in the 
environmental stress response of S. aureus (Chan et 01., 1998). The sar P3 promoter 
was identified as having a aD-like consensus sequence and studies confirmed that aD 
initiated transcription from the sar P3 promoter (Deora et 01., 1997), which like most aD 
dependent promoters, is most active during stationary phase (Cheung et 01., 1997). A 
sigB mutant has been found to be deficient in clumping factor, coagulase and a pigment 
(Nicholas et 01., 1999). However aD has been shown not to have a major role in 
virulence (Chan et 01., 1998; Nicholas et 01., 1999), although the aD mutant has been 
reported to lead to an alteration in hla transcription (Cheung et 01., 1999). 
1.8 The role of environmental stimuli in the expression of virulence 
determinants 
S. aureus is a successful pathogen that is capable of colonizing a diverse range of 
environments in the human host. This is substantially aided by the fact that S. aureus 
has evolved a range of sophisticated mechanisms to rapidly respond and adapt to 
environmental changes. This is important as the interaction between S. aureus and the 
human host during infection, involves both survival and multiplication of the pathogen 
in the presence of the host immune system. Thus it is essential for the bacterium to be 
able to sense from environmental signals, its association with a host. These signals 
probably include temperature, osmolarity, oxygen concentration, pH and the 
concentration of metal ions such as iron, calcium and magnesium (Mekalanos, 1992). 
Some of these environmental factors have been found to modulate virulence 
determinant production, in both agr/sar dependent and independent ways. For example, 
it was discovered that ex.-haemolysin is specifically induced under microaerobic 
conditions. This induction was found to be independent of agr, but dependent on sarA, 
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and to occur at the transcriptional level (Chan and Foster, 1998a). Whereas high NaCI 
levels have been shown to repress transcription of spa, hla and lsI expression. This 
appears to be independent of agr and sarA. Thus additional regulatory mechanisms are 
also involved in the control of the transcription of these agr-dependent genes (Chan and 
Foster, 1998b). 
Further studies have also revealed both pH and glucose to have an effect on sec, hla and 
agr expression. It was observed that the agr transcripts, RNAII and RNAIII, were 
poorly expressed when the pH of the culture was maintained at 6.5 or higher (Regassa 
el al., 1992). Therefore agr expression is to some extent dependent on a drop in pH that 
is usually observed as a culture grows. Finally the presence of glucose in the growth 
medium has also been shown to repress transcription of RNAII and RNAIII, in addition 
to sec and hla (Regassa et al., 1992). The fact that the expression of agr, and thus that 
of virulence factors of S. aureus are subjected to catabolite repression is interesting, as 
it may imply that agr plays a role in nutrition, as well as virulence and thus, these two 
roles may be at least in part linked. 
Therefore it can be seen that S. aureus is capable of detecting a wide range of 
environmental stimuli and modulating their production of virulence factors accordingly. 
The majority of these mechanisms involved here however remain to be elucidated. 
1.9 The expression of virulence factors and their regulators in vivo 
The vast majority of work conducted on the expression of virulence factors and their 
regulators has been carried out in vitro, primarily in nutrient-rich growth media. 
Recently however, several studies have been conducted, aimed at analyzing the 
expression of virulence factors (for example, protein A and a-haemolysin) and their 
regulators (agr and sar) in vivo. 
1.9.1 In vivo expression of agr, spa and hla 
In order to gain insight into the regulatory response of S. aureus during infection, a 
system has recently been described allowing bacterial gene expression to be monitored 
in the host (Goerke et al., 2000). This study developed a method for the direct analysis 
of gene expression during bacterial infections, and allowed for the first time the activity 
of the global regulator agr (via RNAIII expression), controlling the expression of major 
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virulence factors to be analysed during infection. Additionally, the transcription of spa 
(encoding protein A, a gene repressed by agr), and of hla (encoding a-haemolysin, a 
gene activated by agr), was monitored. This method enabled direct transcriptional 
analysis from clinical specimens of S. aureus and quantification of specific transcripts 
was performed by competitive reverse transcription-PCR (RT-PCR). Analysis was 
performed on ex vivo material, namely sputum from cystic fibrosis (CF) patients, 
infected with S. aureus. Interestingly, the bacteria expressed RNAIII poorly, indicating 
an inactive agr, in vivo. This is thought, to be linked to the fact that in sputum samples, 
the bacterial density is below the threshold for agr activation in vitro (109 cfu ml- l 
(Balaban and Novick, 1995)). Furthermore, this study revealed that agr-deficient strains 
were able to infect CF airways (Goerke et al., 2000), therefore showing that agr is not 
activated or essential for chronic lung infection in CF patients. This result however, is 
in contrast to other animal models were agr mutants have been shown to be less 
virulent than the corresponding wild type (Abdelnour et al., 1993). Therefore it is 
possible that the agr operon is only activated during particular types, and/or at certain 
stages, of a given infection. 
Despite the observed low levels of RNAIII expression, spa was greatly diminished 
compared to its transcription in vitro. This was even true of agr-deficient strains, thus 
indicates agr-independent regulatory mechanisms of spa in vivo. Finally the 
transcription of a-haemolysin was detectable in sputum samples, but its levels were 
found not to correlate with RNAIII expression, Once more indicating the presence of 
signals and additional regulators not linked to agr (Goerke et al., 2000). 
1.9.2 In vivo expression analysis of sar 
Studies on the three transcripts of sar showed these to be expressed temporally (Bayer 
et al., 1996; Blevins et al., 1999) (Chapter 1.7.2). In an attempt to determine if the 
individual sar promoters were differentially expressed in vitro and in vivo, green 
fluorescent protein (gfp) transcriptional fusions were constructed (Cheung et al., 1998). 
In vitro findings showed PI (sarA) to be the only active promoter as determined, by 
fluorescence microscopy. In vivo activity was determined in the rabbit endocarditis 
model 24 h after infection. This once more showed PI to be active and P3 to be 
inactive. However, P2 (sarE) which was inactive in vitro, became highly activated in 
vivo. Thus in vivo promoter activation of sar, differed from that in vitro. Finally gfp 
studies showed that, the sar P2 promoter was activated on the surface, but not in the 
centre of the lesions. Therefore the individual sar promoters may be differentially 
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expressed within the host, presumably reflecting the physiological response to distinct 
host micro-environments (Cheung et al., 1998). 
1.10 Virulence factors and disease 
The important question remains as to how do the concerted action of the virulence 
determinants and their global regulators lead to disease? Results suggest that attachment 
and growth are precursors to the production of most exotoxins. The fact that the 
attachment proteins require on going cell wall assembly to become anchored to the cell 
wall, is good reason for cells to only produce these under conditions which support cell 
division, and not post-exponentially. Likewise to have an optimum effect in the 
immediate environment of the bacterium, extracellular proteins would be best produced 
when the cells are localised and in sufficient quantity to produce enough material to 
have a 'beneficial effect' for the organism. This schaem suggests that sepsis due to 
staphylococcal infection is not the result of a generally disseminated contamination of 
the bloodstream. Rather it is the focal infection in which growing bacteria reach a cell 
density sufficient to lower the local pH, deplete available nutrients, and then produce 
degrading enzymes, pore-forming invasins, and immunomodulators that produce the 
symptoms associated with the disease (Projan and Novick, 1997). 
Finally, despite the obvious central role played by the global regulators, agr, sar and 
sae, mutations at these loci, while demonstrating reduced virulence in virtually all 
models used (Abdelnour et al., 1993; Cheung et al., 1994; Booth et al., 1995), did not 
render the bacteria avirulent. This is an important consideration for the design of 
antimicrobial substances, as a therapeutic approach designed against these targets might 
well fail. 
1.11 In vitro and in vivo screens for bacterial genes potentially important 
in pathogenicity 
Many techniques have been developed over the years, that have increased our 
knowledge and understanding of the mechanisms employed by bacteria to enable them 
to survive and proliferate inside the host, causing disease. Our current level of 
knowledge is however by no means complete, but has been greatly increased by the 
development of a succession of ingenious techniques, designed to identify key 
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components and determine their role in pathogenesis. Some of these techniques are 
described in the following sections. 
1.11.1 In vitro analysis of pathogenicity 
A variety of in vitro systems have been developed that recreate certain aspects of 
infection, enabling the study of bacterial gene expression, along with the behaviour of 
mutant strains in physiological conditions that reflect the situation in vivo (DiRita and 
Mekalanos, 1989). These include the use of specific culture conditions to mimic the 
host environment, as well as tissue culture assays for adhesion, invasion or cytotoxicity 
studies. These in vitro assays mimicking the infectious process have been immensely 
useful and continue to provide much information into the mechanisms of bacterial 
pathogenesis. 
1.11.1.1 Plate-based screens 
1.11.1.1.1 Screens for genes important in starvation-survival 
Nutrient limitation of S. aureus has been shown to induce a starvation-survival state, 
which enables the bacterium to survive until sufficient nutrients become available to 
support growth (Watson et al., 1998a). A library of Tn917 mutants of S. aureus was 
screened for strains defective in their starvation-survival response, using a simple 
technique based on their ability to survive on nutrient limiting agar plates. 20 mutants 
were isolated displaying approximately 10- to 1 DO-fold lowered survival potential under 
amino acid limiting conditions (Watson, 1997). These included sodA, encoding the 
major superoxide dismutase of S. aureus, and a gene with homology to ctaA of B. 
subtilis, which encodes a haem A synthase. Interestingly the ctaA mutant demonstrated 
a decreased production of both a-haemolysin and toxic shock syndrome toxin-l 
(Clements et al., 1 999a). Despite the apparent importance of these two genes in vitro, 
later studies showed that neither of these mutants were defective in the ability to form 
lesions in a subcutaneous mouse infection model (Clements et al., 1999a1b). 
Interestingly a further screen for starvation-survival mutants under glucose limiting 
conditions (as described by Watson, 1997) identified the gene in S. aureus encoding 
catalase (katA). A defective katA was found not only to be impaired in its ability to 
enter the starvation-survival state, but importantly was also found to be attenuated in a 
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mouse subcutaneous lesion model (Horsburgh and Foster, unpublished data). This 
demonstrates that simple in vitro screens can identify genes that are both expressed and 
important in vivo. 
1.11.1.1.2 Screens for genes expressed during growth in milk 
Recently a study was undertaken to identify S. aureus genes expressed during growth in 
milk, in an attempt to gain an insight into the genes important for bovine mastitis, of 
which S. aureus is the major cause (Lammers et al., 2000). In this study a Tn917 
transposon library was screened during growth on bovine milk and mutants were 
selected which expressed p-galactosidase in milk, but not in a nutrient-rich growth 
medium. This screen identified 28 genes, including those involved in cell wall 
synthesis, carbohydrate metabolism and transcriptional regulation (Lammers et al., 
2000). Furthermore many of the genes identified in this approach were also identified 
from S. aureus by in vivo approaches in various murine models of infection (Mei et al., 
1997; Coulter et al., 1998; Lowe et al., 1998) (Chapter 1.11.2). 
1.11.1.2 In vitro studies using tissue culture for the identifications of in vivo 
induced genes 
Several studies have been undertaken aimed at looking at the expression of genes on 
interaction with a variety of mammalian cell lines in vitro. 
1.11.1.2.1 Screening for L. monoeytogenes genes preferentially expressed in 
mammalian cells 
A method for the identification of genes preferentially expressed in mammalian cells 
has been used with some success on the facultative intracellular pathogen Listeria 
monocytogenes. Listeria genes, with preferentially intracellular expression (pic genes), 
were identified using a library of Tn917::/acZ insertional mutants, by screening for 
transcriptional fusions with greater lacZ expression inside a macrophage like cell line, 
than in a nutrient-rich growth medium (Klarsfeld et al., 1994). This screen identified 
five genes with as much as lOO-fold induction within macrophages, including the 
isolation of a gene encoding a phosphatidylinositol-phospholipase C (PIcA), which has 
been identified as a virulence factor (Camilli et al., 1993). Importantly, the picA 
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promoter drives the majority of transcription of prfA, the major virulence gene regulator 
of L. monocytogenes (Mengaud et al., 1991). Furthermore a mutation within picA led to 
a 25-fold increase in LDso (Mengaud et al., 1991). 
A more recent screen has been conducted on L. monocytogenes in an attempt to further 
study the response of the interaction of bacterial cells with a variety of mammalian 
cells. This work showed that PrfA is induced upon adherence to mammalian cells. 
Additionally, it was also discovered that PrfA was up regulated by mammalian cell 
extracts, (Renzoni et al., 1999) in the same manner as by whole cells, via the pic 
promoter (Klarsfeld et al., 1994). This result strongly argues the role of host cellular 
component(s) in the activation of PrfA, either directly or indirectly (Renzoni et ai., 
1999). However, the identity of the host signal and the sensory mechanism leading to 
increased prfA transcription remains unknown. 
1.11.1.2.2 Screening for S. aureus genes preferentially expressed in 
mammalian cells 
A similar study to the one described above (Chapter 1.11.1.2.1) has recently been 
conducted in S. aureus, in an attempt to assess its response to the cellular environment. 
In this study an expression library of S. aureus was used to identify genes whose 
expression was induced after exposure to human umbilical vein endothelial cells 
(HUVEC) (Vriesema et ai., 2000). This screen identified 33 different clones, containing 
transposons that had integrated into a gene showing preferential expression under the 
selective conditions. 19 of these clones showed homology at the protein level to entries 
in the database, while the remainder, were novel genes. The genes identified could be 
divided into different categories based on function of the encoded proteins: transport, 
catabolism, biosynthesis, and DNA repair. Finally a subset of five of these clones were 
analysed further, and showed that human serum, in addition to HUVEC were capable of 
triggering gene expression in S. aureus (Vriesema et al., 2000). 
Importantly these in vitro studies show that cell extractslhuman serum induce the same 
genes respectively as whole cells, which are presumed to be the same as those induced 
in vivo. Therefore simple in vitro assays can produce credible results for the analysis of 
in vivo expressed genes. 
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1.11.1.3 Other in vitro screens 
1.11.1.3.1 Two-dimensional gel electrophoresis (2DGE) 
An alternative to studying differential gene expression is the analysis of differential 
protein production. Two-dimensional gel electrophoresis (2DGE) is a powerful method 
with high resolution and sensitivity and has been shown to be useful for the 
comparative analysis and detection of proteins from bacterial cells. The 2DGE system 
has been used to compare proteins from S. typhimurium, grown in laboratory broth and 
macrophages. This demonstrated that a number of proteins were, induced by host 
tissues, including the stress proteins GroEL and DnaK (Buchrneier and Heffron, 1990). 
1.11.1.3.2 Subtractive and differential hybridization 
Several strategies for the identification of genes preferentially induced by host tissues 
have been described, which involve the study of either mRNA or cDNA for differences 
in gene expression under different conditions. Differential subtractive hybridization 
systems have recently been developed for use in prokaryotes and are particularly useful 
for organisms that do not have a well-defined background. These techniques allow the 
identification of genes, transcriptionally induced under different conditions, for 
example in response to different external stimuli (reviewed by Handfield and Levesque, 
1999). Differential and subtractive hybridization techniques are variations on a thaem, 
with both systems based on mRNA expression levels. However, rather than relying on 
specific probes, as other mRNA based studies do (for example, Northern blotting), 
differential subtractive hybridization systems rely on random isolations of unknown and 
differently expressed genes. An example of the application of this technique was in the 
analysis of gene expression of Mycobacterium avium following phagocytosis by human 
macrophages (Plum and Clarck-Curtiss, 1994). In this study total RNA was isolated 
from M avium grown in parallel in human-derived macrophages and nutrient-rich 
broth. Bacterial mRNA was then converted to cDNA, and biotin-labeled cDNA 
prepared from broth grown M avium was used to subtract housekeeping genes. After 
each round of subtraction, a sample of the unsubtracted eDNA was amplified, labeled 
and hybridized to a cosmid library under stringent conditions. This study identified one 
gene as specifically induced in M avium grown in cell culture, although this gene was 
shown to have no significant homologue in the database (Plum and Clarck-Curtiss, 
1994). Interestingly all other cell culture induced genes were also expressed in broth 
grown bacteria. 
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1.11.1.3.3 Oligonucleotide arrays 
A panoramic view of bacterial transcription can also be obtained with the use of high-
density oligonucleotide probe arrays to monitor gene expression. Bacterial transcript 
imaging was studied on a chip containing probes for 106 H inj/uenzae and 100 S. 
pneumoniae genes which demonstrated the applicability of oligo arrays for monitoring 
global gene expression (de Saizieu et al., 1998). As well as allowing simultaneous 
quantification of the transcript level, the technique was found to be very sensitive 
(range of 1-5 transcripts per cell). It has been stated that with the increasing number of 
fully sequenced bacterial genomes, parallel methods for monitoring gene expression 
should provide information for understanding the bacterial response in an infection and 
studying virulence gene induction in vivo (Handfield and Levesque, 1999). 
1.11.2 In vivo genetic analysis of bacterial virulence 
Upon entering the host, pathogenic organisms find themselves in a situation that must 
differ significantly from any encountered in the environmental reservoir. Bacteria are 
able to respond to this change in circumstance by modulating their pattern of gene 
expression accordingly, down regulating genes that are no longer necessary, and up 
regulating the expression of those that are specifically required for survival within the 
host (Chapter 1.6.3). It is therefore postulated that the majority of these up regulated 
components will be virulence factors and that at least some will play a critical role in 
pathogenesis. 
Many potential virulence factors of S. aureus have been studied in great detail in vitro 
over the last few decades, and these in vitro assays continue to contribute a great deal to 
the understanding of bacterial pathogenesis. However, generally they cannot replicate 
the complex environment encountered by pathogens during infection. For example, a 
pathogen may encounter several radically different environments within the host, and it 
may therefore have very different requirements at various points during infection, 
particularly in terms of a developing immune response. Thus the information gained 
from such in vitro studies is of limited use. Therefore, in vivo experimental models are 
highly desirable as they permit direct assessment of a pathogen's ability to colonize, 
survive and cause disease, or damage, in a living host. 
In vivo models allow the analysis of bacterial pathogenesis in situ, however despite 
their obvious advantages they have their own limitations being generally expensive, and 
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often laborious. This has to some extent, reduced the inclination to conduct studies in 
living animals especially on a large-scale. As a result until recently, very little has been 
determined about the role of virulence factors and their expression in vivo. This is true 
for almost all pathogenic bacteria, although some screening of individual mutant strains 
for altered virulence has been carried out on a limited scale with both plant and animal 
infection models, using either randomly selected transposon mutants (Bowe et al., 
1998; Osbourne et al., 1987) or strains affected in cell surface or extracellular protein 
production (Miller et ai., 1989). 
Recently however, steps have been taken to address the abyss in our knowledge, with 
the development of several methods that greatly simplify in vivo analysis, allowing the 
simultaneous analysis of large numbers of strains. This is important as the discovery 
and characterisation of genes preferentially induced in vivo during infection is 
important, as it will comprise the next phase in the study of bacterial virulence at the 
molecular level. 
Most of these in vivo methods fall into two broad groups: in vivo expression 
technology, and signature-tagged mutagenesis. In vivo expression technology (lVET) is 
a promoter trap strategy designed to identify promoters that are specifically activated 
within the host. Signature-tagged mutagenesis (STM) is the alternative method and uses 
comparative hybridisation to isolate mutants unable to survive specified environmental 
conditions, and has been used to identify genes critical for survival in the host. These 
methods and their major findings are outlined in the following sections. 
1.11.2.1 In vivo expression technology (IVET) 
In vivo expression technology (IVET) was initially designed to identify putative 
virulence genes in Salmonella typhimurium (Mahan et al., 1993), but has since been 
adapted for use in many bacterial species. This method for the first time allowed the 
study of the bacterial response to the host environment using a gene expression system 
within the animal host itself, for the selection of genes that are specifically expressed 
during infection. The IVET system functions as a promoter trap for genes that are 
specifically induced in host tissues. Four variants of IVET have been designed to date, 
all enabling the isolation of in vivo induced (ivi) genes. These use: auxotrophic 
selection, antibiotic selection, genetic recombination and green fluorescent protein, as 
the reporter to detect in vivo promoter activity. 
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1.11.2.1.1 Auxotrophic complementation as a reporter for in vivo gene 
expression 
The original S. typhimurium IVET system required the availability of a bacterial 
auxotroph (Mahan et al., 1993). This nutritional deficiency needed to be supplemented 
in vitro and complemented in vivo by expression from the ivi promoter fused to the 
gene used for selection. Transcriptional fusions were created by inserting fragments of 
chromosomal DNA into a suicide delivery plasmid, upstream of a promoterless operon 
fusion of the lacZY genes, fused to purA (purine metabolism). This library was then 
introduced via homologous recombination into S. typhimurium (purA- strain). 
Importantly the integration of fusions by homologous recombination into the host 
bacterium chromosome generates a duplication of the cloned DNA, leaving a functional 
copy of the wild type gene, in addition to the partial copy fused to the reporter operon. 
This is important as it allows the analysis of genes essential for growth in vivo and 
assured that no polar effects were present (Mahan et al., 1993). 
Bacteria representing the pool of chromosomal fusions were injected intraperitoneally 
into mice, and the surviving bacteria (those able to overcome the purine deficiency), 
were recovered following three days infection. These were screened on laboratory 
medium for clones with low promoter activity, via ~-galactosidase activity. Clones 
containing fusions to genes specifically induced in the animal model showed little lacZ 
expression in synthetic laboratory media, although clearly these clones had sufficient 
transcription levels to survive within the mouse (Mahan et al., 1993). This led to the 
identification of 15 strains carrying promoters specifically induced in vivo. Analysis of 
mutations of some of these ivi genes, were found to have attenuated virulence, thereby 
validating the ability ofIVET to isolate virulence genes. 
A slight variation on the auxotrophy thaem has been described (Wang et al., 1996a), in 
which the products of purEK (purine metabolism) were used as selection in an adenine 
auxotrophic background. This system relied solely on colony size, rather than 
expression from a reporter gene, to measure in vitro activities of gene fusions. The 
rational here was that a lower activity would result in smaller colony size on minimal 
medium containing limiting amounts of adenine. Application of this strategy identified 
ivi genes in Pseudomonas aeruginosa induced in both mice (Wang et al., 1996a) and in 
respiratory mucus collected from cystic fibrosis (CF) patients (Wang et al., 1996b). 
These studies identified novel loci specifically induced under their respective 
conditions. Additionally two loci were identified by both methods one of which lead to 
an approximately IOO-fold increase in LDso. 
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This IVET method, although successful in some bacteria, requires the existence of an 
attenuating and complementary auxotrophy, which is not available in all bacterial 
systems. 
1.11.2.1.2 Antibiotic selection as a reporter for in vivo gene expression 
An alternative to the above auxotrophic complementation method, has been developed 
that uses a selection based on antibiotic resistance in the host, rather than alleviation of 
nutritional deficiencies. This was originally carried out using the gene encoding 
chloramphenicol acetyltransferase (cat) as a selection marker fused to lacZY. The 
antibiotic based IVET was developed for S. typhimurium (Mahan et al., 1995), and was 
used for the identification of ivi genes in both cultured macrophages as well as in mice. 
In this system, ivi genes were identified, by host induced chloramphenicol resistance in 
vivo and low promoter activity in vitro (~-galactosidase). Screens of this nature in S. 
typhimurium have lead to the identification of several genes that were known virulence 
determinants. For example, phoP was identified which induces the expression of 
multiple virulence genes following invasion of macrophages (Heithoff et al., 1997). 
However a large proportion had either no known homologues or none with known 
function (reviewed by Chiang et al., 1999). Antibiotic based IVET has also been used 
successfully to identify host responsive elements (hre) in Yersinia entrocolitica. 
Disruption of four of these hre genes lead to increased LDso, decreased persistence in 
host tissues, or both (Young and Miller, 1997). 
Significantly, adjustment of the antibiotic dosage or timing of its administration may 
permit the isolation of ivi promoters with different levels of activity, or expressed 
differentially during the infection cycle. This is a major advantage of this system since 
gene activation and expression is not an all or nothing phenomenon. This system could 
however present problems in systemic distribution of chloramphenicol and limitations 
for selection of chloramphenicol resistance in certain animal models. 
1.11.2.1.3 Genetic recombination as a reporter for in vivo gene expression 
The previous IVET variations (auxotrophic complementation or antibiotic selection) 
both favour the identification of genes that are highly expressed throughout infection, as 
fusions to genes that are transiently or lowly expressed during infection, generally 
would be unable to survive. To allow the identification of promoters that are only lowly 
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or transiently expressed during infection, an alternative IVET system was designed that 
relies on the use of tnpR operon fusions encoding a site-specific resolvase (y l) 
resolvase), as the selection gene and lacZY as reporter genes. Resolvase is an enzyme 
that catalyses the irreversible recombination between specific DNA sequences, termed 
res sites (Camilli et al., 1994). 
In this system resolvase activity results in the permanent excision from the chromosome 
of a tetracycline resistant cassette flanked by res sites. This in vivo activity can be 
detected by screening, following the recovery of bacteria from the animal (Camilli et 
al., 1994). As the action of resolvase is permanent this IVET system permits the 
detection of promoter activity even if the promoter is only briefly active in vivo. 
Unfortunately this method does not have the benefits of positive selection, as 
auxotrophic complementation or antibiotic selection both do, although this technique 
should be significantly more sensitive. 
An early application of resolvase IVET was for the identification of ivi genes in Vibrio 
cholerae. Credibility of this technique was confirmed on the determination that three of 
the ivi loci showed colonization defects in infant mouse competition assays (Camilli 
and Mekalanos, 1995). 
Resolvase IVET technology has also been conducted without homologous 
recombination, in S. aureus, using the murine renal abscess model to identify ivi genes 
(Lowe et al., 1998). A collection of 45 ivi genes, were isolated of which, only 17 had 
homology to known genes. Interestingly, one of these included agrA, part of the 
accessory gene regulator of S. aureus (Chapter 1.7.1). However, the majority of the ivi 
genes identified were not classical virulence factors but were involved in adaptation to 
the in vivo environment. Notably, a selection of 12 ivi genes, were insertionally 
inactivated, of which 7, were found to be attenuated in virulence, in a murine renal 
abscess model (Lowe et al., 1998). 
1.11.2.1.4 Differential fluorescence induction using green fluorescent protein 
as a reporter for in vivo gene expression 
The final and most sophisticated IVET technique for the identification of ivi is based on 
differential fluorescence induction (DFI) (Valdivia and Falkow, 1996), which allows 
the rapid identification of bacterial genes induced upon association with host cells. This 
assay uses green fluorescent protein (GFP) (Cormack et al., 1996), as a selectable 
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marker, in conjunction with fluorescence-activated cell sorting (F ACS). DFI was 
originally developed to identify S. typhimurium genes that are induced in vitro by 
phagocytic cells, but was also found to be capable of identifying genes induced within 
murine cells in vivo (Valdivia and Falkow, 1997). Following infection, host cells 
infected with a bacterium bearing a transcriptionally active gfp gene fusion, were 
separated by F ACS and lysed. The recovered bacteria were then grown under ex vivo 
conditions, and bacteria, demonstrating low, or no fluorescence in the absence of host 
cells, were isolated by F ACS (Valdivia and Falkow, 1997). 
This methodology led to the identification of 14 S. typhimurium ivi genes. Of these 
eight had bacterial homologues of known function, some of which had previously been 
shown to have a role in virulence. For example, ssaH, a gene encoding part of the type 
III secretion system, located within the Salmonella pathogenicity island 2 (SPI-2) which 
has been shown to be necessary for S. typhimurium survival in mice (Shea et al., 1996). 
Five of the novel ivi genes were disrupted in order to establish their role in virulence. 
Results showed that two of the novel loci demonstrated decreased spleen colonization 
in a murine competition assay (Valdivia and Falkow, 1997). The advantage of this 
system over others is that it allows real-time measurement of gene activity in vivo and 
should be widely applicable to the identification of genes from pathogenic organisms 
that are induced upon association with host cells or tissues. 
The collective success of these IVET approaches is demonstrated by the identification 
of more than 100 S. typhimurium genes that are induced during infection (Mahan et al., 
1993; Mahan et al., 1995). More recently the discovery by Heithoff and colleagues 
(1999), that a S. typhimurium strain deficient in DNA adenine methylase (Dam) was 
totally avirulent, along with the discovery that this locus represses the expression of 
more than 20 in vivo induced genes, further highlighted the importance of IVET and its 
continued use in the future. 
1.11.2.2 Signature-tagged mutagenesis (STM) 
The second technique enabling the study of bacterial pathogenesis in vivo is signature-
tagged mutagenesis (STM) (Hensel et al., 1995). This approach uniquely circumvents 
the previous problems associated with exploiting transposon mutagenesis, due not only 
to the inability to identify mutants with attenuated virulence within pools of mutants, 
but also to the impracticalities of separately assessing the virulence of individual 
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mutants. STM is a comparative hybridization technique that uses a collection of 
uniquely tagged transposons, each one modified by the incorporation of a different 
DNA sequence (tag) (Hensel et ai., 1995). This system allowed the identification of 
bacteria recovered from hosts infected with a mixed population of mutants, in addition 
to the selection of mutants with attenuated virulence. Furthermore, because STM is a 
random process, a large enough study would represent a whole genome scan for ivi 
genes. 
The tags used to label transposons are DNA segments that contain a 40 bp variable 
central region, flanked by 20 bp invariant 'arms' that facilitate the co-amplification and 
labeling of the central portion by PCR (Hensel e/ al., 1995). When tagged transposons 
are used to mutagenize a bacterium, each individual mutant can in theory be 
distinguished from all the other mutants based on the different tag carried by its 
integrated transposon. Tagged mutants are assembled separately in microtitre dishes, 
and combined prior to infection to form the inoculum pool. Pools of up to 96 differently 
tagged mutants (pool complexity is discussed by Chiang et al. (1999» are subjected to a 
selective process, such as infection of an animal. Following a set period of infection, 
bacteria are recovered, and DNA extracted from the infection pools. The tags present in 
these DNA samples are amplified and labeled by PCR. Colony blots are then probed 
and compared with the hybridization patterns obtained with the use of tags amplified 
from the inoculum pool as a probe (Hensel e/ al., 1995). The technique of STM relies 
on the ability of the pathogen in question to replicate in vivo as part of a mixed 
population, and thus it can only be expected to identify virulence genes whose mutant 
phenotype cannot be complemented by other clones present in the same inoculum 
(Chiang et al., 1999). 
The original application of STM was for the identification of ivi in S. typhimurium 
(Hensel et al., 1995), and resulted in the identification of 28 mutants with attenuated 
virulence by the identification of tags that were present in the inoculum pool, but not in 
the pool recovered from the infected mice. Significantly this study resulted in the 
identification of the second pathogenicity island, SPI2 of S. typhimurium. This was later 
determined to encode the type III secretion system (Shea et al., 1996) that is essential 
for infection in two animal models (Hensel et al., 1997). 
The virulence of S. aureus has been assayed on two separate occasions using STM. In 
the first study (Mei e/ al., 1997), pools ofTn917 mutants were tested in a murine model 
of bacteraemia. This screen resulted in the identification of 50 mutants demonstrating 
attenuated virulence (Mei et al., 1997). DNA sequence analysis of regions flanking the 
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transposon insertions revealed, approximately half of these genes have no known 
function. The majority of the remaining loci identified could be categorized into three 
broad groups according to their predicted identity from sequence analysis. These groups 
are those involved in: cell surface metabolism (for example, peptidoglycan cross-
linking and transport functions); nutrient biosynthesis; and cellular repair processes. 
The second S. aureus STM assay (Coulter et al., 1998) was a more complex study 
involving the analysis of pools of S. aureus Tn917 mutants in three murine infection 
models: abscess; bacteraemia; and wound infection, for growth attenuation. This 
enabled the identification of various genes affecting growth and virulence in specific 
disease states. In total 237 mutants were isolated from all three in vivo screens. 
Interestingly a subset of 23 mutants showed significant and reproducible attenuation in 
all three in vivo environments. Notably, 18 of the genes identified in this latter assay 
(Coulter et al., 1998), were also isolated by Mei et al. (1997). 
1.11.2.3 Advantages and disadvantages of the IVET and STM systems 
Chapter 1.11.2.1 described how IVET has been used for the identification of both novel 
and known ivi virulence genes. A significant advantage of this technique over others 
(including STM) is that with the exception of recombinant IVET (Chapter 1.11.2.1.3), 
this methodology employs a positive selection approach for the identification of ivi. 
However not surprisingly only a proportion of the genes identified as specifically 
expressed in vivo, were found to have a significant role in virulence, as determined by 
pathogenicity assays. These non-essential ivi genes however could be responsible for 
damage to the host, which is not assessed in most pathogenicity studies. Furthermore it 
may be that many ivi loci make small individual contributions to virulence, and thus 
their effects may be additive or synergistic (Chiang et al., 1999). 
Ideally, IVET should be capable of studying both increases and decreases in promoter 
activity. However to date, there has been no report of an IVET strategy designed to 
identify genes whose expression must be down regulated during infection. Additionally 
it would also be desirable to be able to analyse changes in expression level 
quantitatively. This type of analysis is potentially possible with the antibiotic-based 
IVET system, which theoretically permits the identification of ivi promoters with 
different levels of activity through variation of antibiotic levels (Chiang et al., 1999). 
However no such studies have been carried out and thus the logistics of such an 
approach are not fully understood. 
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However, the most significant disadvantage of IVET is that in most of its present 
guises, it selects against genes that are expressed in vitro. This is however in spite of the 
fact that there is no evidence suggesting that in vitro-expressed genes are not important 
for either survival in vivo or in the causation of host damage. 
Results from STM experiments differ from those of IVET, as by definition all genes 
identified via STM are attenuated in virulence, regardless of the expression pattern of 
the mutated gene in that strain. Therefore STM is a more direct method for isolating 
genes necessary for in vivo survival, as all genes identified by IVET, must subsequently 
be mutated to enable their role in virulence to be determined. Unfortunately however, 
STM is a technique, based on negative selection whereby mutants bearing the desired 
phenotype (attenuated virulence) are selected against by the host (Hensel et al., 1995). 
These mutants of interest must then be identified following infection by hybridization 
screening. Therefore STM is not as simple a selection process as IVET, although the 
vast majority of mutant strains identified, in S. typhimurium, S. aureus and V. cholerae 
by STM have subsequently been shown by LDso tests or competition analysis to be 
important for growth in vivo (reviewed by Chiang et al., 1999). 
A further problem with STM is that this technique may not be able to identify 
mutations in genes leading to weakly or even moderately attenuated virulence, 
depending on the sensitivity of the strategy used for detecting such changes in tagged 
populations. This is particularly important as this subset includes mutations in genes 
that are essential for the causation of disease, but do not affect the survival of the 
bacterium in the host. Cholera toxin is an example of such a gene, as while its action is 
primarily responsible for the lethality of cholera, its inactivation does not affect the 
bacterium's ability to colonize the host (Taylor et al., 1987). 
It is potentially of interest, that while many of the genes identified by IVET and STM in 
S. typhimurium fall within the definition of a classical virulence factor, the majority of 
S. aureus genes identified by these techniques appear to have more fundamental roles in 
bacterial metabolism (Mahan et al., 1993; Mahan et al., 1995; Hensel et al., 1995; 
Chiang et al., 1999; Lowe et al., 1998; Mei et al., 1997; Coulter et al., 1998). Several 
plausible explanations exist to explain this phenomenon. Firstly it may be due to the 
fact that classical virulence factors are expressed at too high a level in vitro to qualify as 
in vivo-induced. This theory is supported by work carried out by Chan and Foster 
(1998b), who showed that the toxins; a-haemolysin and toxic shock syndrome toxin-l 
along with the global regulator Sar are expressed to a significant level (as determined 
by ~-galactosidase production), in laboratory medium. Secondly a transposon insertion 
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within a gene encoding a toxin may result in a phenotype that can be complemented by 
other mutant strains within the infection pool. Finally, no STM strategy of S. aureus to 
date, has examined more than approximately 1,500 mutants, thus potentially these 
studies have not been of sufficient size to allow saturation of the S. aureus 
chromosome. 
In conclusion these two systems appear to be widely applicable with both IVET and 
STM having been used for the identification of ivi genes in a range of bacterial 
pathogens including; S. typhimurium, S. aureus, and V. cholerae. Of significant 
importance is the fact IVET and STM appear to be complementary approaches in 
respect to the genes which they identify. Therefore these techniques can be used in 
combination, enabling a comprehensive search for ivi genes. Of great concern however, 
is the fact that neither IVET nor STM can be expected to identify genes that are 
essential for bacterial growth. This has major implications, as essential genes provide 
prime targets for antimicrobial programs. 
1.11.2.4 Identifications of essential genes using GAMBIT 
Essential genes are by definition vital for growth and proliferation in vitro. As a result it 
is predicted that these genes would be expressed under all conditions, and thus unless 
expressed only at extremely low levels in vitro, they would not be identified by IVET. 
Additionally mutations within genes essential for pathogenesis would invariably be 
lethal, thus STM would equally be unable to assess this class of genes. For these 
reasons a systematic and effective method for studying essential genes was developed. 
A technique termed GAMBIT for 'genomic analysis and mapping by in vitro 
transposition' allows the identification of essential genes through the application of 
extended-length PCR, in vitro transposon mutagenesis, transformation, and genetic 
footprinting (Akerley et at., 1998). This methodology like STM constitutes a negative 
selection, in which certain mutants are eliminated by the selection conditions. These 
mutants are recognized by the loss of PCR products, corresponding to insertions in the 
essential genes. A particular advantage of GAMBIT is its ability to target specific genes 
or regions of the chromosome for example pathogenicity islands (Akerley et at., 1998). 
However, its application to an entire genome would entail a substantial amount of work 
(Chiang et at., 1999). 
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The technique of GAMBIT has already been applied to both Haemophilus inJluenzae 
and Streptococcus pneumoniae (Akerley et al., 1998). This study detected known 
essential genes and assigned essentiallity to several genes of unknown function from 
both organisms, thus confirming its potential for the analysis of pathogenesis (Akerley 
et al., 1998). The GAMBIT approach is predicted to prove equally useful for the 
identification of genes essential for pathogenic organisms to grow and survive in vivo. 
Unfortunately this methodology is severely limited as it is only available for naturally 
transformable organisms whose genomes have been sequenced. However, the 
completion of genome sequencing projects and the development of efficient linear 
DNA transformation techniques, should allow the use of GAMBIT in a range of 
bacterial pathogens (Akerley et al., 1998; Chiang et al., 1999). 
1.11.3 Summary of strategies for the in vitro and in vivo analysis of 
bacterial virulence 
As described in Chapter 1.11.1 and 1.11.2, many different techniques exist for the 
analysis of bacterial virulence under both in vitro and in vivo conditions. Studies of this 
nature have been greatly advanced by the recent sequencing of bacterial genomes. 
Furthermore with the adoption of techniques such as IVET, STM it is now possible to 
study genes expressed or preferentially induced in vivo, a proportion of which will be 
critical in bacteria-host interactions. Importantly with the introduction of DFI, gene 
expression can now be studied in situ, in real time. Finally, with the development of 
GAMBIT, there now exists a method for the identification of genes with an essential 
role. 
With the introduction of this multitude of in vivo assays there has been a dramatic shift 
away from the use of classical in vitro assays for the analysis of bacterial components. 
However one problem arising from these new technologies is the fact that they rely on 
animal models, with the limitations that such models may impose, along with the 
financial and ethical implications. Therefore there is still a place for the development of 
new in vitro models for the analysis of bacterial virulence. 
This thesis aims to describe the development of such an in vitro model and describes its 
use for the identification and subsequent analysis of genes potentially involved in 
virulence. 
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1.12 Rationale and objectives for this project 
Over many years bacteria have evolved highly sophisticated regulatory mechanisms to 
modulate their gene expression in response to disparate environments. Our 
understanding of such processes during infection is limited by our ability to recreate 
host conditions in an experimental setting. It has been shown that different approaches 
have been undertaken in an attempt to gain a better understanding of the mechanisms by 
which S. aureus causes disease, the majority of these are both time consuming and 
technically demanding. Therefore the main objective of this project was to design a 
simple in vitro assay system, whose conditions mimic those in vivo. This model would 
then be used initially for the analysis and characterisation of the role of known 
virulence determinants in an attempt to gain further information into their 
role/expression in vivo. Secondly the model system will be used for the identification 
and analysis of novel components potentially involved in vivo. 
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CHAPTER 2 
MATERIALS AND METHODS 
2.1 Media and antibiotics 
2.1.1 Media 
Unless otherwise stated all media was prepared using distilled water (dH20) and was 
sterilised by autoclaving for 20 min at 121°C (15 pounds per square inch). 
2.1.1.1 B2 
Casein acid hydrolysate 
Difco Bacto yeast extract 
K2HP04 
NaCI 
10 g 1'\ 
25 g 1'\ 
1 g 1'\ 
25 g 1'1 
The pH was adjusted to 7.5. Once autoclaved and cooled, sterile glucose was added 
to 1 mM (final concentration). 
2.1.1.2 Brain heart infusion (BHI) (Oxoid) 
Brain heart infusion (BHI) 37 g 1'\ 
Oxoid Agar No.1 (1 % (w/v» was used for BHI agar 
Details of the composition of BHI are shown in Table A.I.I. 
2.1.1.3 Chemically defined medium (Hussain et al., 1991) 
A chemically defined medium (COM) as devised by Hussain et al. (1991), is 
composed of 5 solutions (1-5) which were mixed in a ratio of 7 (solution 1) : 
(solution 2) : 0.5 (solution 3) : 0.1 (solution 4) : 1 (solution 5). 
42 
Details of the composition of solutions 1-5 are given in Table A.l.2. 
Solutions 1, 3 and 4 were mixed and autoclaved together, whereas solution 2 was 
filter sterilised (0.2 ~m pore size) and added after cooling to 50 DC. Solution 5 was 
autoclaved separately and added after cooling. Oifco Bacto agar (1.5 % (w/v)) was 
used for CDM agar. 
2.1.1.3.1 Aspartate amino acid varying CDM 
CDM 1-16 was identical to that described in Chapter 2.1.1.3, except for the presence 
or absence of the aspartate amino acids (AAA): lysine; threonine; methionine; and 
isoleucine. In CDM 1-16 these four amino acids were either included in the same 
amounts as shown in Table A.I.2, or they were totally absent. Details of the aspartate 
amino acid composition ofCDM 1-16 are shown in Table 5.2. All COM (1-16) were 
made up lacking all four AAA (COM 15). The AAA were then added from stock 
solutions (Chapter 2.2.2), as required. 
2.1.1.4 Luria-Bertani (LB) (Miller, 1972) 
Difco Bacto tryptone 
Difco Bacto yeast extract 
NaCl 
10 g 1-1 
5 g 1-1 
5 g 1-1 
The pH was adjusted to 7.2 using NaOH. Oxoid Agar No. 1 (1.0 % (w/v)) was added 
for L agar (LA). 
2.1.1.5 LK 
Difco Bacto tryptone 
Difco Bacto yeast extract 
KCI 
Sodium Citrate 
10 g 1-1 
5 g 1-1 
7 g 1-1 
0.5 g 1-1 
Oxoid Agar No. 1 (1.0 % (w/v») was added for LK bottom agar. 
Oxoid Agar No. 1 (0.7 % (w/v)) was added for LK top agar. 
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2.1.1.6 Phage agar 
Casamino acids 
Difco Bacto yeast extract 
NaCl 
3 g 1.1 
3 g 1. 1 
5.9 g 1.1 
Oxoid Agar No.1 (1.0 % (w/v)) was added for phage bottom agar. 
Oxoid Agar No.1 (0.33 % (w/v)) was added for phage top agar. 
2.1.1.7 Sera (Sigma) 
Sera were purchased from Sigma as frozen liquid. This serum had been pooled from 
normal animalslhumans and had been filter sterilised (0.1 ~m pore size) and 
aseptically filled. All sera were collected from clotted whole blood to preclude 
additives. Unless otherwise stated pig serum was used in all serum experiments. 
Pig serum 
Human serum 
(Sigma, S7398) 
(Sigma, S7023) 
Details of the composition of serum are shown in Table A.1.5-A.1.7. 
Liquid - undiluted serum (100 % (v/v)). 
Plates - 1 volume of serum pre-warmed to 50°C, was added to 1 volume of 50 °C 
agar (Difco Bacto agar (2.0 % (w/v)) giving a final concentration of agar (1.0 % 
(w/v)). Agar plates contained 50 % serum (v/v). 
2.1.1.7.1 Serum plus iron 
A 50 mM stock solution of iron sulphate (FeS04·7H20) dissolved in distilled H20 
was filter sterilised (0.2 ~m pore size). This stock solution was added to serum to 
give a range of final concentrations of iron: 0 ~M; 2 ~M; 20 ~M; 200 f.lM; 500 ~M; 
and 2000 f.lM. 
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2.1.1.7.2 Serum plus catalase 
A 10 mg ml- I stock solution of catalase (Sigma) dissolved in 10 mM Tris pH 7.5, was 
filter sterilised (0.45 J.1m pore size) and stored at -20 DC. This stock solution was 
added to serum to give a range of concentrations of catalase: 0 J.1g ml- I ; 10 ~g ml- I ; 
100 J.1g ml- I ; 500 J.1g ml- I ; I 000 ~g ml- I . 
2.1.1.8 Sheep blood agar 
Blood base agar (Difco) 
Agar was allowed to cool to 50DC, and 5 % (v/v) sterile sheep blood was added (TCS 
Microbiology)_ 
2.1.1.9 SOB (Sambrook et al., 1989) 
Difco Bacto tryptone 
Difco Bacto yeast extract 
NaCI 
KCI 
2 % (w/v) 
0.5 % (w/v) 
10mM 
2.5mM 
Once autoclaved and cooled, sterile supplements of MgCl2 and MgS04 were added, 
each to 10 mM (final concentration). 
2.1.1.10 SOC (Sambrook et al., 1989) 
This was prepared by the addition of sterile glucose (to 20 mM) to SOB. 
2.1.1.11 
NaCI 
KCI 
CaCl2 
MgCl2 
Synthetic cerebrospinal fluid I (van Dijk et al., 1994) 
127.64 mM 
2.55 mM 
1.26mM 
0.93 mM 
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2.1.1.12 Synthetic cerebrospinal fluid II (Smith and Johanson, 1983) 
NaCI 
NaHC03 
KH2P04 
CaS04 
MgS04 
Urea 
Glucose 
2.1.1.13 Tryptic Soy Broth (TSB) (Difco) 
Tryptic soy broth 
130mM 
18mM 
3.0mM 
l.4mM 
0.8mM 
2.0mM 
12.1 mM 
Oxoid Agar No.1 (1.0 % (w/v» was used for TSB agar. 
2.1.2 Antibiotics 
All antibiotics used in this study are listed in Table 2.1. The stock solutions were filter 
sterilised (0.2 J.1m pore size) and stored at -20°C. Once the media had cooled to below 
55°C the antibiotic stock solutions were added to the media as appropriate. 
Concentrations of antibiotics used for selection were as in Table 2.1, unless otherwise 
stated in the text. 
2.2 Buffers and stock solutions 
All buffers were prepared in dH20 and stored at room temperature. Solutions for use 
in microbiological work and in vitro DNA manipulations were sterilised by 
autoclaving. All of the methods in this chapter are as in Sambrook et al. (1989), 
unless otherwise stated. Solutions for RNA work were treated with 0.1 % (v/v) DEPC 
overnight at room temperature to remove RNases, before sterilisation by autoclaving. 
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Antibiotic • Stock Working Inducing 
concentration concentration (~g concentration 
(mg ml"!) ml"!) (~g ml"!) 
Erythromycin (Ery) S3 S O.1S 
Tetracycline (Tet) S3 S -
Lincomycin (Lin) 2Sb 2S -
Kanamycin (Kan) SOb SO 
-
Ampicillin (Amp) SOb SO 
-
Chloramphenicol (Cm) 30e S -
Table 2.1 
Concentrations of antibiotics used during this study 
• The antibiotics were dissolved in: SO % (v/v) ethanol3 , water\ ethanolc, filter 
sterilised (0.2 ~m pore size) and stored at -20°C. 
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2.2.1 
NaCI 
K 2HP04 
K.H2P04 
Triton(!\) X-IOO 
ABT buffer 
100mM 
60mM 
40mM 
0.1 % (v/v) 
2.2.2 Aspartate amino acid stock solutions 
Stock solutions of the aspartate amino acids (lysine, threonine, methionine and 
isoleucine) were made up (lOOx working concentration (Table A. 1.2)) and sterilised. 
Lysine 14.29 g I-I 
Threonine 21.43 g I-I 
Methionine 14.29 g I-I 
Isoleucine 2l.43 g 1-\ 
These amino acids were added to the CDM lacking all four AAA (CDM 15), as 
required (Chapter 2.1.1.3.1). 
2.2.3 DNA loading buffer (6x) 
Bromophenol blue 
Xylene cyanol FF 
Ficoll (MW 400,000) 
dH20 
2.2.4 Frozen storage butTer (FBS) 
25mg 
25mg 
1.5 g 
to 10 ml 
KCI 7.4 g 
MnCI2-4H20 8.9 g 
CaCI2·2H20 1.5 g 
Co(NH3)6CI3 0.8 g 
Potassium acetate (l MpH 7.5) 
Glycerol 
10ml 
100 g 
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The above were mixed with sterile dH20 to 1 I and the pH adjusted to 6.4 with 0.1 M 
HCl. The solution was divided into aliquots and stored at -20°C. Aliquots were 
defrosted when needed and filter sterilised (0.45 j.lm pore size) prior to use. 
2.2.5 
2.2.5.1 
NaOH 
Methanol 
HPLC buffers 
HPLC buffer A 
40mM 
20 % v/v 
Buffer A was adjusted to pH 4.23 with phosphoric acid, and a small amount of sodium 
azide (145 j.ll from 1 % (w/v) solution) was added to 11 of buffer A to equalise its A202 
with that of buffer B (Chapter 2.2.5.2). 
2.2.5.2 HPLC buffer B 
NaOH 40mM 
Buffer B was adjusted to pH 4.1 with phosphoric acid. 
2.2.6 
MgS04 
CaCI2 
Phage buffer 
Tris-HCl pH 7.8 
NaCI 
Gelatin 
ImM 
4mM 
50mM 
0.59 % (w/v) 
0.1 % (w/v) 
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2.2.7 
NaCI 
N~HP04 
KCI 
KH2P04 
Phosphate buffered saline (PBS) 
The pH was adjusted to 7.4 using NaOH. 
2.2.8 QIAGEN buffers 
2.2.8.1 Buffer PI 
Tris-HCl, pH 8 
EDTA 
RNase A 
2.2.8.2 
NaOH 
SDS 
2.2.8.3 
Buffer P2 
Buffer P3 
Potassium acetate, pH 5.5 
2.2.8.4 Buffer Bl 
8 g 1-1 
1.4 g 1-1 
0.2 g I-I 
0.2 g I-I 
50mM 
10mM 
100 Ilg ml-1 
200mM 
1 % (w/v) 
3.0M 
Tris-Hel, pH 8 50 mM 
EDTA, pH 8 50 mM 
Tween® 20 0.5 % (v/v) 
Triton® X-IOO 0.5 % (v/v) 
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2.2.8.5 BufferB2 
Guanidine HCI 
Tween® 20 
2.2.8.6 
NaCl 
MOPS, pH 7.0 
Ethanol 
Triton® X-IOO 
2.2.8.7 
NaCl 
MOPS,pH 7.0 
Ethanol 
2.2.8.8 
NaCl 
MOPS, pH 8.5 
Ethanol 
2.2.8.9 
BufferQBT 
BufferQC 
Buffer QF 
BufferQG 
Supplied in the QIAquick kit, details not provided. 
2.2.8.10 Buffer PB 
Supplied in the QIAquick kit, details not provided. 
3.0M 
20 % (v/v) 
750mM 
50mM 
15 % (v/v) 
0.15 % (v/v) 
1.0M 
50mM 
15 % (v/v) 
1.25 M 
50mM 
15 % (v/v) 
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2.2.8.11 BufferPE 
Supplied in the QIAquick kit, details not provided. 
2.2.8.12 BufferEB 
Tris-HCI, pH 8.5 lOmM 
2.2.9 RNA extraction buffers and solutions (BIOI01) 
2.2.9.1 CRSR-BLUE 
Chaotrophic RNA stabilising reagent 
Supplied in the FastRNATM Kit, BLUE, details not provided. 
2.2.9.2 PAR 
Phenol acid reagent 
Supplied in the FastRNATM Kit, BLUE, details not provided. 
2.2.9.3 CIA 
Chloroform isoamyl alcohol (24:1), supplied in the FastRNATM Kit, BLUE. 
2.2.9.4 DIPS 
DEPC-treatediisopropanol precipitation solution 
Supplied in the FastRNA ™ Kit, BLUE, details not provided. 
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2.2.9.5 SEWS 
Salt/ethanol wash solution, RNase-free 
Supplied in the FastRNATM Kit, BLUE, details not provided. 
2.2.9.6 SAFE 
DEPC-treated water for elution, supplied in the FastRNATM Kit, BLUE. 
2.2.10 Southern blot buffers and solutions 
2.2.10.1 
HCI 
2.2.10.2 
NaOH 
NaCI 
2.2.10.3 
Southern depurination solution 
Southern denaturing buffer 
Southern neutralising buffer 
Tris-HCl (PH 7.5) 
NaCI 
2.2.10.4 sse (20x) 
NaCI 
Tri-sodium citrate·2H20 
The pH was adjusted 7.0 with 1 M NaOH. 
250mM 
0.5M 
1.5 M 
O.5M 
3M 
3M 
300mM 
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2.2.10.5 Pre-hybridisation solution 
SSC 
Blocking reagent (Roche) 
N-Iauroylsarcosine, Na salt, 
SDS 
2.2.10.6 Hybridisation solution 
5x 
1 % (w/v) 
0.1 % (w/v) 
0.02 % (w/v) 
The probe was diluted in prehybridisation buffer to 5-25 ng mr l 
2.2.10.7 2x wash solution 
SSC 2x 
SDS 0.1 % (w/v) 
2.2.10.8 0.5x wash solution 
SSC 0.5x 
SDS 0.1 % (w/v) 
2.2.10.9 Maleic acid buffer 
Maleic acid 0.1 M 
NaCI 0.15 M 
The pH was adjusted to 7.5 with solid NaOH. 
2.2.10.10 Washing butTer 
Maleic acid 0.1 M 
Tween® 20 3 % (v/v) 
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2.2.10.11 Blocking solution 
Maleic acid buffer containing 1 % (w/v) blocking reagent (Roche) 
Blocking reagent was dissolved in a microwave and store at -20°C. 
2.2.10.12 Antibody solution 
Blocking solution, containing 75 Urn ml- I Anti-DIG-AP conjugate (Roche) 
2.2.10.13 Detection buffer 
Tris-HCI (PH 9.5) 
NaCI 
MgCl2·6H20 
The pH was adjusted to 7.5 
2.2.10.14 Colour-substrate solution 
100mM 
100mM 
50mM 
Detection buffer containing 2 % (v/v) NBTIBCIP (Roche). 
2.2.11 T AE (SOx) 
Trisma base 
Glacial acetic acid 
N~EDT A (0.5 MpH 8.0) 
dH20 
242g 
57.1 ml 
100mi 
to 1 I 
Before use the buffer was diluted 1 :50 to produce T AE. 
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2.2.12 TE (lOx) 
Trisma base 100 mM 
N~EDTA 10mM 
The pH was adjusted to 7.5 using I M HCl. This solution was diluted I: I 0 with 
sterile dH20 before use, to give TE. 
2.3 Enzymes and chemicals 
All chemicals and enzymes were of analytical grade and purchased from Sigma, 
Fisons or Merck (BDH), unless otherwise stated. All restriction enzymes, RNase AIH, 
DNase, reverse transcriptase, T4 ligase, polymerases, TaqMan components, and 
buffers, for the modification of DNA, were purchased from, ABI Perkin-Elmer, Life 
Technologies (formally Gibco BRL), Northumbria Biologicals Limited (NBL), 
Promega, or Roche (formally Boehringer Mannheim). 
a-Amylase (Sigma) was dissolved in dH20 to 25 mg ml-t and stored at -20°C. Cellosyl 
(gift from R. Marquardt, Hoechst AG, Frankfurt, Germany) was dissolved in 25 mM 
sodium phosphate buffer (PH 5.6), to 2 mg ml-t, and stored at -20°C. Lysostaphin 
(Sigma) was dissolved in 20 mM sodium acetate to 5 mg ml-t and stored at -20°C. 
MUG (4-methylumbelliferyl-~-D-galactopyranoside) (Sigma) was dissolved in DMSO 
to 4 mg ml-t and stored at -20°C. 4-MU (4-methylumbelliferone) (Sigma) was 
dissolved in DMSO to 1 mM and stored at -20 DC. Pronase E (Sigma) was dissolved in 
TES to 10 mg ml't, pre-digested for 30 min at 37°C, and stored at -20°C. RNase A 
(DNase-free) (Sigma), dissolved in dH20 to 10 mg ml-t, and stored at -20 DC. X-Gal 
(5-bromo-4-chloro-3-indolyl-~-D-galactopyranoside) (Sigma) was dissolved in DMF 
to 20 mg ml,t and stored at -20°C. Phenol was purchased pre-equilibrated from NBL. 
TRISOLTM LS (ready to use monophasic solution of phenol and guanidine 
isothiocyanale) was purchased from Life Technologies. 
2.4 Bacterial strains, plasmids and phages 
2.4.1 Bacterial maintenance, culture and storage conditions 
Bacterial strains used in this study are listed in Table 2.2-2.3. 
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2.4.1.1 Staphylococcus aureus strains 
S. aureus NCTC 8325, the propagating strain for typing phage 47, has been the 
organism of choice for studies of the S. aureus genome. This strain is known to carry 
the prophages ~11, ~12 and ~13; an ultraviolet (u.v.) cured/prophage-minus derivative, 
8325-4, has been used for most genetic studies in S. aureus. 8325-4 was the 
background of choice for all work described in this thesis unless otherwise stated. 
Staphylococcus aureus strains (Table 2.2) were grown on BHI, serum, and CDM 
plates, containing antibiotics where appropriate to maintain selection of resistance 
markers. Strains were grown at 37°C under aerobic, microaerobic or anaerobic 
conditions (Chapter 2.9). Plate cultures were stored for up to one month at 4°C, before 
re-streaking onto fresh agar plates. For long-term storage, strains were grown 
overnight in BHI medium. The cells were harvested by centrifugation (5,000 rpm 
(Centaur 2), for 10 min) and then resuspended in sterile BHI containing 20 % (w/v) 
glycerol and stored at -20°C and -70 °C. Liquid cultures were normally prepared by 
inoculation of culture medium with a single isolated colony. These cultures were 
grown overnight in sterile plastic universals containing 1:6 their volume of medium, 
and were aerated on a rotary shaker at 250 rpm. These cultures were then used to 
inoculate conical flasks containing one-fourth their volume (for example 25 ml; 100 
ml flask) of medium, and were aerated on a rotary shaker at 250 rpm. All liquid 
cultures were grown at 37°C and under aerobic conditions unless specified. These 
conditions are referred to as standard conditions. 
2.4.1.2 Escherichia coli strains 
Escherichia coli strains were cultured using LB or LA medium (Chapter 2.1.1.4), 
containing antibiotics where necessary to ensure the selection of plasmid-bearing 
strains. Plate cultures were stored at 4 °C for up to one month before re-streaking onto 
fresh agar plates. Liquid cultures were prepared as for S. aureus (Chapter 2.4.1.1) 
strains except strains were grown using LB or LA medium. All E. coli cultures were 
incubated at 37°C. For long-term storage, E. coli strains and their plasmid-bearing 
derivatives were treated as for S. aureus strains (Chapter 2.4.1.1) except LB media was 
used rather than BHI, and stored at -20°C and/or -70 °C. E. coli strains used in this 
study are shown in Table 2.3. 
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Strain Relevant genotype/markers Source/reference 
8325-4 8325 cured of prophages Novick, 1963 
cp 11, cp 12 and cp 13 
WCUH29 SmithKline Beecham 
RN4220 Restriction minus, Kreiswirth et al., 1983 
modification plus 
PC6911 agr::tetM (Tet) Chan and Foster, 1998 
PC1839 sarA::km (Kan') Chan and Foster, 1998 
PC18391 sarA::km agr::tetM (Kanr, Chan and Foster, 1998 
Tet) 
PC400 sigB::tetM (Tet,) Chan et al., 1998a 
STI katA::Tn917 Horsburgh, unpublished 
SPWI sodA::Tn917 Watson et al., 1998b 
SPW2 lysA::Tn917 Watson et al., 1998b 
SPW3 ctaA::Tn917 Watson et al., 1998b 
SHt09 agr+, hld+ hld::lacZ Eryr Fairhead, 1998 
PC161 sarA+ sarA::lacZEryr Chan and Foster, 1998 
MCtOO sigB+ sigB: :/acZ Eryr Chan et al., 1998a 
MJHOO5 fur + fur: :/acZ Eryr Horsburgh, unpublished 
PC203 spa+ spa::lacZ Eryr Chan and Foster, 1998 
PC322 hla+ hla::/acZ Eryr Chan and Foster, 1998 
MJHOO6 katA+ katA::lacZ Eryr Horsburgh, unpublished 
MDW1941 8325-4/pLTVl This study 
Tetr, Cm" Ery" pLTVl 
segl segl::Tn917 Eryr This study 
seg3 seg3::Tn917 Eryr This study 
seg4 seg4::Tn917 Err' This study 
seg5 seg5::Tn917 Eryr This study 
seg7 seg7::Tn917 Eryr This study 
seg8 seg8::Tn917 Eryr This study 
segl0 segl0::Tn917 Err' This study 
seg13 seg13::Tn917 Eryr This study 
seg14 seg 14: :Tn917 Eryr This study 
seg21 seg21 ::Tn917 Eryr This study 
seg22 seg22::Tn917 Eryr This study 
seg24 seg24::Tn917 Eryr This study 
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Strain Relevant genotype/markers Source/reference 
Cont. 
seg25 seg25: :Tn917 Ery' This study 
seg26 seg26::Tn917 Ery' This study 
seg29 seg29::Tn917 Ery' This study 
seg30 seg30: :Tn917 Ery' This study 
seg33 seg33::Tn917 Ery' This study 
seg35 seg35::Tn917 Ery' This study 
seg37 seg37::Tn917 Ery' This study 
seg39 seg39::Tn917 Ery' This study 
seg40 seg40::Tn917 Ery' This study 
seg43 seg43::Tn917 Ery' This study 
seg45 seg45::Tn917 Ery' This study 
seg48 seg48::Tn917 Ery' This study 
seg50 seg50: :Tn917 Ery' This study 
MDW41 lysC+ lysC: :lacZ Ery' This study 
MDW42 asd+ asd: :/acZ Ery' This study 
MDW43 dapA+ dapA::ZacZEry' This study 
SWCl WCUH29 segl::Tn917 This study 
SWC24 WCUH29 seg24::Tn917 This study 
SWClO WCUH29 seglO::Tn917 This study 
Table 2.2 
List of S. aureus strains used during this study 
Tet', tetracycline resistance; Kan', kanamycin resistance; Ery' erythromycin resistance; 
Cm', Chloramphenicol resistance; 
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Strain of E. coli Relevant genotype/markers Source/reference 
DH5a supE44t11acU169 (F80 lacZ Hanahan, 1983 
~MI5) hsdR17 recAI endAI 
gyrA96 thi-l relAI 
TOPIO F- mcrA ~(mrr-hsdRMS- Invitrogen 
mcrBC) F80 lacZ ~M15 
MacX74 recAI deoR araD139 
~(ara-leu)7697 galK rpsL (Stt) 
endAI nupG 
Table 2.3 
List of E. coli strains used during this study 
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2.4.2 Plasmids 
Plasmid DNA was purified using Q1AGEN plasmid kits in accordance with the 
manufacturer's instructions (Chapter 2.17.1.2-2.17.1.3). Purified plasmid DNA was 
stored in TE buffer at 4°C (short-term storage), or -20°C (long-term storage). 
2.4.3 Phages 
Bacteriophage ~11 (Table 2.4) was used in this study for phage transduction (Chapter 
2.14). This phage is a S. aureus specific, temperate transducing phage of serological 
group B, requiring Ca2+ ions for maintenance. ~11 has an approximate genome size of 
4S kb (Novick, 1991). 
2.5 Centrifugation 
A number of different centrifuges were used for the pelleting of cells and precipitated 
material. These were: i) Eppendorf microfuge S41Sc; maximum volume - 2 ml, 
maximum speed 14,000 rpm (11,000 g); ii) Centaur 2 centrifuge (Sanyo); maximum 
volume - 50 ml, maximum speed 5,000 rpm; iii) AvantjTM 12S1 (Beckman), maximum 
volumes and speeds dependent on the rotor used: JA-20; maximum volume - 50 ml, 
maximum speed 20,000 rpm (48,384 g); JA-I4; maximum volume - 2S0 ml, 
maximum speed 14,000 rpm (30,074 g); JA-lO.S; maximum volume - SOO ml, 
maximum speed 10,000 rpm (18,480 g). 
All centrifugations were carried out at room temperature unless stated otherwise. 
2.6 Starvation-survival 
2.6.1 Starvation-survival assays (Watson, 1998b) 
A 50 m1 culture of CDM was inoculated with S. aureus from an overnight plate and 
incubated with shaking (2S0 rpm) for 18 hours at 37°C. At this stage the approximate 
cell density was I-S xI08 cfu ml-t • Starvation in synthetic cerebrospinal fluids (sCSF) 
(Chapters 2.1.1.11-2.1.1.12) or PBS (Chapter 2.2.7) was examined by harvesting 
the CDM cultures by centrifugation (4000 rpm; 10 min), and twice washing with 
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Plasmid/Phage Relevant genotype/markers Source or reference 
S. aureus plasmids 
pLTVI Tet', Cm', Eri Camilli et al., 1990 
pMDW41 Eri This study 
pMDW42 Eri This study 
pMDW43 Eri This study 
S. aureus phages 
~ 11 Mani et al., 1993 
E. coli plasmids 
pSEGl Amp' This study 
pSEG3 Amp' This study 
pSEG4 Amp' This study 
pSEG5 Amp' This study 
pSEG7 Amp' This study 
pSEG8 Amp' This study 
pSEGIO Amp' This study 
pSEG13 Amp' This study 
pSEG14 Amp' This study 
pSEG21 Amp' This study 
pSEG22 Amp' This study 
pSEG24 Amp' This study 
pSEG25 Amp' This study 
pSEG26 Amp' This study 
pSEG29 Amp' This study 
pSEG30 Amp' This study 
pSEG33 Amp' This study 
pSEG35 Amp' This study 
pSEG37 Amp' This study 
pSEG39 Amp' This study 
pSEG40 Amp' This study 
pSEG43 Amp' This study 
pSEG45 Amp' This study 
pSEG48 Amp' This study 
pSEG50 Amp' This study 
pAZI06 Amp' Kemp et al., 1991 
pMDW41 Amp' This study 
pMDW42 Amp' This study 
pMDW43 Amp' This study 
pCR®2.1-TOPO Amp" Kan' Invitrogen 
pMTOP09 Amp', Kan' This study 
Table 2.4 
List of plasmids and phages used in this project 
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sCSF I, II or PBS by centrifugation and resuspension. Cells were subsequently 
resuspended in 50 ml sCSF I, II or PBS and the cell suspensions were incubated with 
or without shaking at 37°C. For starvation-survival in amino acid limiting CDM 
(16), cells were grown as described above and incubated without shaking at 37°C. 
2.6.2 Determination of S. aureus viability 
Viability (starvation-survival) was determined by serial dilution of samples in PBS 
and dotting 10 III of each dilution onto a COM agar plate. After overnight incubation 
at 37°C the number of colony forming units (cfu) was determined. 
2.7 Determination of bacterial cell density 
2.7.1 Spectrophotometrically (A600) 
To quantify the bacterial yield in a culture, spectrophotometric measurements at 600 
nm (A6oo), were carried out. These measurements were taken using a Jenway 6100 
spectrophotometer. 
2.7.2 Direct cell counts (cfu) 
An alternative method for the quantification of cell numbers is the method of direct 
cell counts. The number of cells was determined by serial dilution of samples in PBS 
and spreading 100 fll of each dilution onto a BHI agar plate. After overnight 
incubation at 37°C the number of colony forming units (cfu) was determined. 
2.8 Serum model 
S. aureus strains to be grown in the serum model were grown overnight on BHI plates 
containing the relevant antibiotics where necessary, at 37°C. For analysis on solid 
serum media a single colony was inoculated onto serum agar (Chapter 2.1.1.7) and 
grown for two days at 37 DC under aerobic, microaerobic or anaerobic conditions 
(Chapter 2.9). Growth was determined after this period by colony diameter 
measurements. Values were taken as an average of at least 3 colonies. For analysis in 
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liquid serum, a single colony was resuspended in 5 ml serum in plastic universals. 
These cultures were also grown overnight at 37°C under aerobic, microaerobic or 
anaerobic conditions. Growth was determined after this period by A600 (Chapter 2.7.1) 
and the appropriate dilution made to allow a starting A600 of 0.2 in 25 ml of pre-
warmed serum in 100 ml flasks. These cultures were grown at 37°C for 24 h under 
aerobic, microaerobic or anaerobic conditions (Chapter 2.9). Growth was monitored 
through out this period by either ~oo or direct counts (Chapter 2.7.2). Alternatively for 
analysis in 5 ml cultures, the overnight culture was used to inoculate 5 ml of fresh 
serum, with a starting ~oo of 0.2. These cultures were grown for 15 h. 
2.9 Gaseous composition of environmental conditions used for growth 
S. aureus cultures and plates were grown under aerobic, microaerobic or anaerobic 
conditions: 
Aerobic: O2 - 20.95 % 
CO2 - 0.03 % 
N2 -78.08 % 
159.2 mmHg 
0.228mmHg 
593.4 mmHg 
Unless other wise stated all cultures were incubated under aerobic conditions. 
Microaerobic: O2 - 10 % 
CO2 - 5 % 
N2 - 85 % 
76mmHg 
38 mmHg 
646mmHg 
A Don Whitley Scientific Limited Variable Atmosphere incubator was used for the 
maintenance of microaerobic conditions as described. 
Anaerobic: O2 -0% 
CO2 - 10 % 
H2 -5 % 
N2 - 85 % 
OmmHg 
76mmHg 
38 mmHg 
646mmHg 
A Don Whitley Scientific Limited MK3 Anaerobic Work Station was used for the 
maintenance of anaerobic conditions as described. 
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2.10 Culture aeration 
Culture aeration was varied, by adjusting the volume of media in the flask: 
Standard 
High aeration 
Low aeration 
25 ml 
20ml 
100ml 
100 ml flask 
250 ml flask 
250 ml flask 
Unless other wise stated all cultures were grown using standard aeration conditions. 
2.11 p-galactosidase assays 
2.11.1 Using X-Gal as a substrate 
p-galactosidase activity was detected directly on solid media using the substrate X-
Gal. X-Gal is hydrolysed by p-galactosidase resulting in p-D-galactopyranoside and 5-
bromo-4-chloro-3-indolyl. 5-bromo-4-chloro-3-indolyl has a blue colouration and is 
thus a visible indicator (blue) of p-galactosidase activity. 80 J..LI X-Gal solution 
(Chapter 2.3) was added to 5 ml of BHI; CDM; or serum agar cooled to 50°C. This 
molten overlay was mixed briefly by inverting and poured on to warmed (- 60°C) 
agar plates (BHI; CDM; or serum respectively). These plates were stored at - 4 °C for 
up to a week. 
2.11.2 Using MUG as a substrate 
100 J..LI samples of cell culture were removed, pelleted (11,000 g; 3 min) and snap 
frozen (-195.8 °C). Samples were stored at -20°C for later analysis. The frozen cells 
were thawed and resuspended in an equal volume of ABT (Chapter 2.2.1). 50 J..LI of 
cells were then diluted (appropriate dilutions generally 1: 10-1: 10000) with ABT in 
microtitre plates giving a total volume of 45 J..L1. These plates were warmed to 25°C 
for approximately 5 min, prior to the addition of 5 J.lI MUG (4 mg ml- I (Chapter 2.3». 
These reactions were mixed gently with a pipette and incubated at 25°C for exactly 
60 min. MUG is hydrolysed to p-D-galactopyranoside and 4-methylumbelliferyl 
(4MU) by the action of p-galactosidase. 4MU is a fluorescent compound and so is a 
quantifiable indicator of p-galactosidase activity. The reaction between p-
galactosidase and MUG was stopped with the addition of 0.2 M Na2C03 (200 J..Ll). A 
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fluorimeter (Victor 1M, Wallac) was used to measure the fluorescence of each sample 
(355/460nm, 0.1 sec). The concentration of 4MU and thus promoter activity was 
calculated from a calibration curve (Chapter 2.11.3; Figure 2.1). For each sample the 
concentration of 4MU was related to l3-galactosidase activity and expressed in MUG 
units of l3-galactosidase activity. Importantly the background level of l3-galactosidase 
activity measured from the 8325-4 samples (control samples) was deducted from the 
lacZ fusion strains l3-galactosidase activity. 
~-galactosidase activity = U / (D x t x A600) 
(MUG units) 
Where: U = pM of MU produced; A600 = A600 at a given time point; t = time of 
incubation at 25°C (min); and D = dilution factor. 
Thus, 1 MUG unit of ~-galactosidase activity is defined as the activity that hydrolyses: 
1 pM of MUG min-I ml- I A600-1 
2.11.3 l3-galactosidase assay calibration curve 
A calibration curve was prepared each time ~-galactosidase assays were performed. 
These were created with the fluorescent product (4-methyl umbelliferone) with final 
concentrations of: 1250; 625; 312.5, 156.25; 78.13; 39.06; 19.531; 9.77 pM. An 
example of such a calibration curve is shown in Figure 2.1. 
2.12 Transposon mutagenesis 
2.12.1 Transposon mutagenesis using Tn917-pLTVl 
A single colony of S. aureus strain MDW1941, from a overnight BHI plate (Tet and 
Ery 5 /-lg ml- I ) was inoculated into 10 ml BHI broth (Tet and Ery 5 /-lg ml- I ). This 
culture was grown overnight, at 37°C with shaking (250 rpm). The A600 was 
determined the following morning and the appropriate dilution was made to allow a 
starting A600 of 0.02 in 50 ml pre-warmed BHI (Tet and Ery 5 J.!g ml- I ). This culture was 
grown aerobically at 37°C with shaking (250 rpm) until an A600 of - 1.0 had been 
reached. A 3 ml sample was removed after this period, and pelleted (11,000g, 2 min). 
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Figure 2.1 
Calibration curve of concentration of 4MU against units of fluorescence 
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The pellet was subsequently resuspended in 100 ml BHI (Ery 5 ~g ml"!) pre-warmed 
to 41-41.8 °C, and grown at this temperature with shaking (250 rpm). Once the A600 
had reached 0.3-0.4, 3 ml of culture was transferred to a further 100 ml BHI (Ery 5 Ilg 
mI'!), again pre-warmed to 41-41.8 0c. This culture was once more grown at the 
increased temperature with shaking (250 rpm) and was allowed to grow to stationary 
phase (18 h). After this time, cells were pelleted (10,000 g; 10 min; 4°C) and 
resuspended in 4 ml BHI containing 10 % (v/v) glycerol, giving approximately 5x109 
cfu mI'!. Cells were then snap frozen (-195.8 °C) and stored at -20°C. 
2.12.2 Tn917 transposon library evaluation and enumeration 
The efficiency of transposon insertion was determined by serial dilutions of cells in 
PBS (Chapter 2.2.7) and plating a range of cell dilutions (104_108) onto BHI agar 
plates containing Ery, or Ery and Tet (5 ~g mI'!). The transposon insertion frequency 
was calculated by comparing the number of colonies that grow on plates containing 
Ery (bacteria containing the transposon (Tn917) inserted into the chromosome along 
with bacteria containing the intact plasmid (Tn917-LTVl)) against the number of 
colonies that grow on plates containing Ery and Tet (bacteria containing the intact 
plasmid (Tn917-LTVl)). 
2.13 
2.13.1 
Screening for genes important for growth in sera 
Isolation of putative sera essential mutants of S. aureus from a 
Tn917 library 
An aliquot of a Tn917 library was suitably diluted in PBS (Chapter 2.2.7) to allow 
-100 colonies per BHI plate (Ery 5 Ilg mI'!) and the plates incubated overnight at 
37°C. The following day the colonies were replica plated onto BHI (control plate) and 
pig sera agar plates (Chapter 2.1.1.7) using sterile velvets. BHI plates were incubated 
aerobically while sera plates were incubated microaerobically, both at 37°C for 24 h. 
Putative sera-essential mutants were isolated by comparing the serum plate with the 
control plate for absent colonies. These colonies were selected from the control plate 
and re-tested under the above conditions. Strains absent on serum were selected from 
the control plate and glycerol stocks made (Chapter 2.4.1.1). 
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2.13.2 Identification of putative sera expressed genes of S. aureus from a 
Tn917 library 
An aliquot of a Tn917 library was suitably diluted in PBS (Chapter 2.2.7), to allow 
-100 colonies per BHI plate (Ery 5 J.lg ml- I ) and the plates incubated overnight at 
37 DC. The following day the colonies were replica plated onto BHI (control plate) 
and pig sera agar plates, containing X-Gal, (Chapter 2.3) using sterile velvets and were 
grown for 24 h at 37 DC. BHI plates were incubated aerobically while sera plates were 
incubated microaerobically. Putative sera expressed mutants were isolated by 
comparing the serum plate with the control plate for colonies that were blue on serum 
but white on BHI. These colonies were selected from the control plate and re-screened 
under the same conditions. Colonies blue on serum and white on BHI were selected 
and glycerol stocks made (Chapter 2.4.1.1). 
2.14 Phage techniques 
2.14.1 Preparation of phage lysates 
S. aureus strains were inoculated into BHI containing the relevant antibiotic, and 
grown at 37°C with shaking (250 rpm) until in log phase (~oo - 0.5). 2-5 ml of cells 
were pelleted (11,000 g; 3 min) and resuspended in 5 ml BHI in a plastic universal. 
5 ml phage buffer (Chapter 2.2.6) and 100 J.lI stock lysate (~Il propagated on 8325-4 
cell : phage ratio of approx. 20: 1) were added to the cells and the mixture was allowed 
to incubate for 10 min at room temperature. The tube was then placed at 30°C shaking 
slowly (50 rpm) for 2-4 hours, until clear. If cells failed to lyse in this time, they were 
left overnight (static) at 25 °C. Lysates were filter sterilised (0.2 J.lm pore size) and 
stored at 4°C. The resulting lysates were between 109 and 1010 pfu ml- I • 
2.14.2 Determination of phage titres 
S. aureus 8325-4 was inoculated into BHI and incubated overnight at 37°C with 
shaking (250 rpm). This was used to inoculate (Awo 0.05) 25 ml of fresh BHI and 
grown until log phase (- 0.5) at 37°C with shaking (250 rpm). Phage lysates were 
diluted in phage buffer (Chapter 2.2.6) to 10-7• 100 J.lI of diluted phage was mixed with 
50 J.lI of 1M CaCI2, and 400 J.lI of 8325-4 culture, and incubated for 10 min at room 
temperature. 5 ml of phage top agar (Chapter 2.1.1.6) cooled to 50°C, was added to 
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the phage mixture and used to overlay a pre-warmed (~ 60°C) phage bottom agar 
plate (Chapter 2.1.1.6). After setting (30 min), plates were incubated overnight at 37 
°C, after which time the number ofpfu ml- t was determined. 
2.14.3 Phage transduction 
S. aureus 8325-4 was inoculated into LK broth (Chapter 2.1.1.5) and incubated 
overnight at 37°C with shaking (250 rpm). This was used to inoculate (A600 0.05) 25 
ml of fresh LK, which was grown until log phase (~oo ~ 0.5) at 37°C with shaking 
(250 rpm). 500 III of cell culture was transferred to a plastic universal containing 500 
III of phage lysate and 1 ml LK broth. After gentle mixing the lysate/cell mixture was 
incubated at 37°C without shaking, for 25 min, followed by 15 min with shaking (250 
rpm). 1 ml ice-cold 0.02 M sodium citrate was added at this time and cells were 
pelleted (5000 rpm (Centaur 2); 10 min) and resuspended in 1 ml 0.02 M sodium 
citrate and left on ice for 2 h. The lysate/cell mixture was spread on LK bottom agar 
plates (Chapter 2.1.1.5) containing 0.05 % (v/v) sodium citrate and inducing levels of 
Ery, O.l51lg ml- t• These plates were incubated at 37°C for 90 min, after which time 
they were overlaid with 5 ml LK top agar (Chapter 2.1.1.5) containing 25 mg ml-t Ery. 
After setting (30 min), plates were incubated for 18-72 h at 37°C. Any resulting 
colonies were putative phage transductants. 
2.15 p-Haemolysin activity 
Blood agar plates were prepared as described in Chapter 2.1.1.8, containing 5 % (v/v) 
sheep blood. S. aureus strains were inoculated by picking colonies onto the test plate. 
After overnight incubation at 37°C p-haemolysin activity was visualised by a zone of 
clearing (lysis) around the bacterial colony. 
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2.16 Transformation techniques 
2.16.1 Transformation of E. coli 
2.16.1.1 Preparation of E. coli competent cells (Hanahan, 1983) 
A generous scoop of E. coli DH5a cells from an overnight plate was inoculated into 1 
ml of SOB (Chapter 2.1.1.9) and the cells dispersed by vortexing. This was inoculated 
into all flask containing 100 ml of pre-warmed SOB and incubated at 37°C, with 
shaking (250 rpm), until A600 0.5-0.6. The culture was transferred to 50 ml centrifuge 
tubes and chilled on ice for 15 min. The cells were then pelleted by centrifugation 
(11,000 g; 15 min; 4°C) and the pellet drained and resuspended in 33 ml of frozen 
storage buffer (FSB) (Chapter 2.2.4). The cells were incubated on ice for 15 min and 
then pelleted and drained as before. This pellet was resuspended in 8 ml FSB. 280 III 
of dimethyl sulphoxide (DMSO) was added, mixed by swirling and the tube incubated 
on ice for 5 min. An equal volume of DMSO was added as before and the tube 
incubated on ice for a further 15 min. Aliquots of 250 III were pipetted into microfuge 
tubes, used immediately or snapped frozen at -195.8 °C and stored at -70°C. 
2.16.1.2 Transformation 
To transform cells of E. coli DH5a, 200 III of a competent cell suspension was 
transferred into a pre-chilled microfuge tube, mixed with the required DNA (- 50 ng) 
in a 10-20 III volume and incubated on ice for 40 min. The tube was then transferred to 
42°C for 90 sec and immediately returned to the ice for a further 2 min. 800 III SOC 
(Chapter 2.1.1.10) was added to the cells, which were then incubated for 45 min at 
37°C to allow the expression of plasmid encoded antibiotic resistance markers. The 
transformed cells were plated onto LB agar containing the appropriate antibiotics and 
then incubated overnight at 37°C or until colonies were visible. 
2.16.2 Transformation of S. aureus 
2.16.2.1 Preparation of S. aureus electrocompetent cells 
S. aureus RN4220 were inoculated into B2 media (Chapter 2.1.1.1) and incubated 
overnight at 37°C with shaking (250 rpm). This was used to inoculate (A600 0.02) 
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500 ml of fresh B2 and grown until late log phase (~oo 0.5-1.0). Cells were pelleted 
(5000 rpm; 10 min; 4°C) and washed 3x with 150 ml sterile water at 4 °C. Cells were 
then concentrated in a series of pelleting (5000 rpm (Centaur 2); 10 min; 4 °C), and 
resuspension steps: i) 1/10 volume of 10 % (v/v) ice-cold glycerol (50 ml); ii) 1120 
volume of 10 % (v/v) ice-cold glycerol (25 ml); and iii) 1140 volume of 10 % (v/v) 
ice-cold glycerol (12.5 ml). All the supernatant was removed after each spin. The 
pellet was finally resuspended in 625 III 10 % (v/v) ice-cold glycerol. Cells were snap 
frozen (-195.8 °C) and stored at -70 °C. The cfu ml-1 of the competent cells was 
determined prior to use. 
2.16.2.2 Transformation of S. aureus (Electroporation) 
5-20 Ilg of plasmid DNA was precipitated by isopropanol precipitation (Chapter 
2.17.1.7), and washed twice with 70 % (v/v) ice-cold (-20 °C) ethanol, ensuring the 
complete removal of salt. The DNA was then resuspended in 100 III of sterile dH20 
and transferred to a 0.1 cm gap cuvette. 2 x 101°_2 X 1011 competent cells, which had 
been allowed to defrost for 5 min at room temperature, were then added to the cuvette. 
The plasmid/cell mix was electroporated at room temperature at 100 ohms, 25 /-IF and 
1.25 kV using a BioRad Gene Pulser. Cells were recovered by adding 1 ml of pre-
warmed B2 containing an inducing concentration of Ery (0.15 J.lg ml- I ) to the cuvette. 
Cells were then transferred to sterile 2 ml microfuge tubes and incubated at 37 °c with 
shaking (250 rpm) for 2 h. Recovered cells were plated directly onto BHI ErylLin 
plates (5 Ilg ml-1/25 Ilg ml-I) and incubated at 37 °c for 24-36 h. 
2.17 Nucleic acid purification techniques 
2.17.1 DNA purification techniques 
2.17.1.1 Chromosomal DNA preparation 
Chromosomal DNA was isolated and purified using a QIAGEN 100/G kit according to 
the manufacturer's instructions, as follows. A single colony of the strain of interest 
was used to inoculate 5 ml of BHI and grown overnight at 37°C. The cells were 
pelleted (5,000 g; 10 min) and resuspended in 5 ml of Buffer Bl containing 50 j.l.g ml- I 
RNase A (Chapter 2.3). After rigorous vortexing, 25 III lysostaphin (5 mg ml- I ) 
(Chapter 2.3), and 200 III Pronase (20 mg ml- I ) (Chapter 2.3) were added and 
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incubated for at least 30 min at 37°C. 1.2 ml of Buffer B2 was added and vortexed 
briefly. The tube was then incubated at 50 °C for at least 30 min. 
The clear lysate was applied to a QIAOEN 10010 tip, which had been equilibrated 
with 5 ml of Buffer QBT. Once the lysate had passed through, the tip was washed 2x 
with 10 ml of Buffer QC. The genomic DNA was then eluted into a sterile 50 ml tube 
by the addition of 5 ml buffer QF. 
Genomic DNA was precipitated by adding 3.5 ml of isopropanol and inverting the 
tube 10-20 times. The genomic DNA was centrifuged (5000 rpm (Centaur 2); 15 min) 
to pellet the DNA. The pellet was washed with 2 ml cold (-20 °C) 70 % (v/v) ethanol 
and air dried for 10 min. The DNA was dissolved in 1 ml TE overnight at 4°C, and 
stored at this temperature. 
All QIAGEN solution details are given in Chapter 2.2.8. 
2.17.1.2 Small scale plasmid preparation from E. coli 
Plasmid DNA was isolated and purified using a QIAprep Spin Miniprep kit DNA 
purification system (QIAOEN) according to the manufacturer's instructions, as 
follows. 1-5 ml LB containing appropriate antibiotic was inoculated with a single 
colony of plasmid-bearing cells of E. coli DH5a and incubated overnight at 37°C. The 
cells were pelleted (10,000 g; 5 min), resuspended in 250 III of Buffer PI and 
transferred to a microfuge tube. 250 III of Buffer P2 was added and mixed by inverting 
the tube 4-6 times. 350 III of Buffer P3 was then added and again mixed by inversion. 
The lysate was centrifuged (11,000 g; 10 min) and the supernatant was applied to a 
QIAprep column (QIAGEN). The plasmid DNA was bound to the column by 
centrifuging for 1 min (11,000 g) and the flow-through discarded. The column was 
then washed, by the addition of 750 J.11 of Buffer PE and centrifuging (11,000 g; 1 
min) and the flow-through was once more discarded before centrifuging for an 
additional 1 min (11,000 g). The plasmid DNA was then eluted into a clean microfuge 
tube with 50 J.11 of Buffer EB after standing for 1 min by centrifugation (11,000 g; 1 
min). Plasmid DNA was stored at -20°C. 
All QIAOEN solution details are given in Chapter 2.2.8. 
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2.17.1.3 Large scale plasmid preparation from E. coli 
Plasmid-containing cells of E. coli DH5a. from 500 ml overnight (37°C) LB cultures 
(containing appropriate antibiotics) were harvested by centrifugation (15,000 g; 3 min; 
4°C). The plasmid was then purified from these cells using a Plasmid Maxi kit DNA 
purification system (QIAGEN), according to the manufacturer's guidelines, as 
follows. The pellet was resuspended completely in 10 ml Buffer PI. 10 ml of Buffer 
P2 was then added and the sample, mixed gently by inversion (4-6 times) before 
incubating at room temperature for 5 min. 10 ml of chilled Buffer P3 was then added 
and the sample was immediately mixed (gently) and incubated on ice for 20 min. The 
resulting white precipitate was then pelleted by centrifugation (20,000 g; 30 min; 
4°C) and the supernatant was promptly removed to a clean tube and filtered using 4 
layers of cheesecloth. The supernatant was then applied to a QIAGEN tip 500 
(equilibrated with 10 ml Buffer QBT) and allowed to enter the resin by gravity flow. 
The tip was then washed with 2x 30 ml Buffer QC and the DNA eluted with 15 ml 
Buffer QF. Plasmid DNA was precipitated with 10.5 ml isopropanol and pelleted by 
centrifugation (27,000 g; 30 min; 4°C). The DNA pellet was washed with 5 ml 70 % 
(v/v) ethanol, re-centrifuged (27,000 g; 20 min; 4°C) and air dried for 10 min. 
Purified plasmid DNA was then resuspended in an appropriate volume of TE and 
stored at -20°C. 
All QIAGEN solution details are given in Chapter 2.2.8. 
2.17.1.4 Phenol/chloroform purification of DNA 
To DNA in a volume of 200 ~l TE, 100 ~l phenol and 100~1 chloroform/isoamyl 
alcohol (24: 1) was added. After mixing, the resultant emulsion was centrifuged 
(11,000 g; 10 min). The mixture separates into an upper layer of aqueous DNA, and a 
lower layer of phenol/chloroform. The upper layer was removed and transferred to a 
fresh microfuge tube containing 200 ~l chloroform/isoamyl alcohol (24: 1) and mixed 
gently. After centrifugation (11,000 g; 2 min), the top layer was again removed to a 
fresh microfuge tube. The DNA was recovered by ethanol precipitation (Chapter 
2.17.1.5). 
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2.17.1.5 Ethanol precipitation of DNA 
DNA was precipitated by the addition of 0.1 volume of 3 M sodium acetate (adjusted 
to pH 5.2 with acetic acid) and 2.5 volumes of 100 % (v/v) ethanol followed by 
incubation at -20°C for 10 min. The precipitated DNA was pelleted by centrifugation 
(11,000 g; 10 min) and the pellet washed with 70 % (v/v) ethanol. The pellet was air 
dried and dissolved in an appropriate volume of TE. DNA was stored at 4 °C (short-
term) and -20°C (long-term). 
2.17.1. 7 Ethanol/sodium acetate precipitation of DNA for sequencing 
2 ,.11 3 M sodium acetate (adjusted to pH 5.2 with acetic acid) and 50 JlI of 95 % (v/v) 
ethanol were added to each completed PCR sequencing reaction (Chapter 2.21.3.1). 
The tubes were vortexed and then placed on ice for 10 min. The DNA was pelleted by 
centrifugation (11,000 g; 30 min). The pellet was rinsed in 250 JlI of 70 % (v/v) 
ethanol and then centrifuged for a further 10 min. The DNA pellet was air dried for 
10 min. DNA was then sequenced (Chapter 2.21.3.1). 
2.17.1.7 Isopropanol precipitation of DNA 
DNA was precipitated by the addition of 0.1 volume of 3 M sodium acetate (adjusted 
to pH 5.2 with acetic acid) and an equal volume of isopropanol, followed by thorough 
mixing and incubation at room temperature for 2 min. The precipitated DNA was 
pelleted by centrifugation (11,000 g; 10 min) and the pellet washed with cold (-20°C) 
70 % (v/v) ethanol. The precipitated DNA was pelleted by centrifugation (11,000 g; 
5 min). The 70 % (v/v) ethanol wash step was then repeated before the pellet was air 
dried and dissolved in an appropriate volume of TE. DNA was stored at 4 °C 
(short-term) and -20°C (long-term). 
2.17.1.8 Gel extraction purification of DNA 
Double stranded DNA fragments were purified from agarose gels (Chapter 2.19.1.3) 
with the QIAquick gel extraction kit (QIAGEN) according to the manufacturer's 
instructions, as follows. Agarose blocks containing the DNA fragment were dissolved 
in 3 volumes of Buffer QG at 50°C for 10 min. One volume of isopropanol was added 
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to the mix, which was then applied to a QIAquick spin column (QIAGEN). The DNA 
was bound to the column by centrifuging the sample for 1 min (11,000 g) and the flow 
through was discarded. The column was then washed with 750 ~l Buffer PE, left to 
stand for 2-5 min and once more centrifuged for 1 min (11,000 g). The flow through 
was discarded and the column centrifuged again for 1 min (11,000 g). The DNA was 
then eluted into a clean microfuge tube with 50 ~l of Buffer EB by centrifugation 
(11,000 g; 1 min). Purified DNA was stored at 4 °C (short-term) and -20°C 
(long-term). 
All QIAGEN solution details are given in Chapter 2.2.8. 
2.17.2 RNA purification techniques 
2.17.2.1 RNA extraction 
S. aureus WCUH29 was inoculated into either, in vitro media (BHI or TSB) or into a 
murine pyelonephritis model (in vivo). The in vitro cultures were grown under 
standard conditions (Chapter 2.4.1.1) and allowed to reach mid exponential phase 
(A6oo 0.5-1.0), before 10 ml of cells were harvested by centrifugation (11,000 g; 3 min; 
4°C) and resuspended in 1 00 ~l sterile dH20. The infected kidneys were removed 
after 7 days and contained - 107_108 cfu ml-I• Total RNA was isolated from these 
S. aureus cells using the FastRNATM kit BLUE (BIOI01) according to the 
manufacturer's instructions, as follows. On ice 500 J-li CRSR-BLUE, 500 ~l PAR and 
100 ~l CIA were added to a FastRNATM BLUE tube (BIOI01) along with the in vitro 
and in vivo grown cells (10 ml cells concentratedll infected kidney). The tube was 
then placed in the FastPrepTM instrument (BIOI01) and processed for 2x 45 sec at 
speed rating 6, with 1 min cooling on ice between each processing. The tube was then 
removed from the machine and cooled on ice for 5 min before centrifuging (11,000 g; 
15 min; 4°C). The top phase was removed to a clean microfuge tube without 
disturbing the interphase. 500 J-li of CIA was then added and the sample was vortexed 
for 10 sec and the layers separated by centrifugation (11,000 g; 2 min). The top layer 
was once more removed to a fresh tube, to which 500 J-li of DIPS was added. The 
sample was mixed and incubated at room temperature for 10 min to precipitate RNA. 
The RNA was then pelleted by centrifugation (11,000 g; 5 min) and washed with 
500 ~l SEWS, without resuspension. The fluid was removed with a small-bore pipette 
tip and the pellet air dried for 10 min. The pellet was then dissolved in 50 J-li SAFE, at 
55°C for 10 min and then stored at -70°C. The yield and integrity of the RNA was 
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then assessed both spectrophotometric ally (Chapter 2.18.2) and through a 1.2 % (w/v) 
agarose gel (Chapter 2.19.1.3). 
All BI0101 solution details are given in Chapter 2.2.9. 
2.18 Quantification of nucleic acids (Sam brook et a/., 1989) 
2.18.1 Quantification of DNA 
To quantify the DNA concentration in a solution, spectrophotometric measurements at 
260 nm were carried out. An absorbance of 1 corresponds to approximately 50 Ilg ml-
' 
for double stranded DNA, and approximately 20 Ilg ml- ' for single stranded 
oligonucleotides. These measurements were taken using a Jenway 6105 
spectrophotometer. The concentration of DNA could also be estimated independently 
by agarose gel electrophoresis (Chapter 2.19.1.3), comparing the intensity of the 
ethidium bromide stained bands, to bands containing known amounts of DNA 
(Table 2.5). 
2.18.2 Quantification of RNA 
To quantify the RNA concentration in a solution, spectrophotometric measurements at 
260 nm were carried out. An absorbance of 1 corresponds to approximately 40 Ilg ml-
' 
RNA. These measurements were taken using a Jenway 6105 spectrophotometer. 
2.19 In vitro nucleic acid manipulation techniques 
2.19.1 In vitro DNA manipulation techniques 
2.19.1.1 DNA restriction 
Restriction digests were performed with up to 17.5 III of DNA (genomic, plasmid or 
PCR product). This solution was combined with 2 III of appropriate lOx restriction 
enzyme buffer and 0.5 III of the appropriate restriction enzyme. The volume was made 
up to 20 I,d with dH20 and incubated at 37°C for up to 15 h. Before the DNA was 
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manipulated it was cleaned up using the QIAquick PCR purification kit (QIAGEN) 
(Chapter 2.21.5) according to the manufacturer's instructions. 
2.19.1.2 DNA ligation 
2.19.1.2.1 Standard 
The following were added on ice: 
DNA in TE buffer 
lOx ligase buffer 
dH20 
T4 DNA ligase 
15 Ill· 
2 III 
2 III 
I III (3 Weiss units) 
The mixture was incubated overnight at 15°C or two days at 4°C. This ligation 
mixture could be used directly in the transformation of E. coli. 
• 15 III of digested DNA (vector to insert ratio 1 :3, 0.2-1 Ilg of vector DNA) 
2.19.1.2.2 Rescue of transposon insertions 
The following were added on ice: 
DNA in TE buffer 
lOx ligase buffer 
dH20 
T4 DNA ligase 
250 III 
30 III 
19 III 
1 III (3 Weiss units) 
Ligations were performed in a total of 300 III to minimise the possibility of multimers. 
A vector to insert ratio 1 :3, 0.2-1 Ilg of vector DNA in TE buffer was used. The 
mixture was incubated overnight at 15°C or for two days at 4°C. Following ethanol 
precipitation (Chapter 2.17.1.5) and resuspension in 20 III IE, this ligation mixture 
could be used directly in the transformation of E. coli. 
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2.19.1.3 Agarose gel electrophoresis 
DNA fragments were separated by horizontal gel electrophoresis using varIOus 
horizontal electrophoresis tanks (Life Technologies). Appropriate volumes of agarose 
gel (0.8-1.5 % (w/v) dissolved in TAE (Chapter 2.2.11) were submerged in suitable 
volumes of TAE electrophoresis buffer. The gel contained 0.2 J.lg m}"1 ethidium 
bromide. DNA samples were mixed with a fifth their volume of 6x DNA loading 
buffer (Chapter 2.2.3) and loaded into slots in the gel. The gel was run at 80-100 V for, 
1-2 h and visualised by means of a u.v. transilluminator at 260 nm. DNA fragment 
sizes were estimated using 1 J.lg of f.... DNA digested with HindIII or double digested 
with HindIIIIEcoRI, I J.lg of a 100 bp ladder (Life Technologies) as size standards 
(Table 2.5). 
2.19.1.3.1 Gel photography 
A permanent record of agarose gels was obtained by photographing the ethidium 
bromide-stained gels illuminated with U.v. light at 260 nm. A Kodak 203 red-orange 
filter, and Polaroid 667 (ASA 3000) film were used. 
2.19.2 In vitro manipulation of RNA 
2.19.2.1 DNase treatment of RNA 
The following were added on ice: 
RNA 
DNase 
RNase inhibitor 
lOx buffer 
dH20 
50 J.lg 
1 J.lI 
2 J.lI 
6 J.lI 
up to 60 J.lI 
These reactions were then incubated at 37°C for 30 min. 
RNA samples were then mixed with 500 J.lI TRIZOLTM LS (Chapter 2.3) and 
incubated at room temperature for 5 min. 100 J.lI of chloroform was then added and the 
tubes were shaken for 20 sec, before incubating at room temperature for 5 min. The 
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DNA size markers 
HindIII (A) HindIIIIEcoRI (A) 100 bp ladder 
23.15 21.23 2072 
9.24 5.15 1500 
6.56 4.97 1400 
4.38 4.27 1300 
2.32 3.53 1200 
2.02 2.02 1100 
0.56 1.90 1000 
0.13 1.58 900 
1.38 800 
0.95 700 
0.83 +600 
0.56 500 
0.13 400 
300 
200 
100 
Table 2.5 
The size of fragments used as size markers for agarose gel electrophoresis 
+600 bp fragment is 2-3 x brighter than the other bands for easy reference. 
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layers were then separated by centrifugation (11,000 g; 15 min; 4°C), after which the 
aqueous layer was removed to a clean tube. The RNA was then precipitated overnight 
at -20°C with an equal volume of isopropanol, before pelleting the RNA by 
centrifugation (11,000 g; 10 min; 4°C). The pellet was finally washed with DEPC 
treated (Chapter 2.2) 75 % (v/v) ethanol before air-drying the pellet for 10 min. The 
pellet was then dissolved in 50 III DEPC treated dH20 at 55°C for 10 min. RNA 
samples were stored at -70°C. The purity of the RNA prep was tested at this point 
using a pair of DNA designed PCR primers (sequence not supplied by SmithKline 
Beecham), in a PCR reaction as described in Chapter 2.21.2.1, except that RNA was 
used as the template rather than DNA, and the number of cycles was increased from 35 
to 40. A DNA free RNA prep was shown by the absence of bands, for the RNA 
samples. 
2.19.2.2 Production of eDNA from RNA 
The following were added on ice: 
RNA 
Random hexamers 
DEPC treated dH20 
6 Ilg 
6 III (300 ng) 
up to 24 JlI 
These reactions were incubated at 70°C for 10 min and then cooled to 4 °C in a 
Perkin-Elmer GeneAmp PCR System 9600. The reaction mix was then split into two: 
A) + reverse transcriptase; B) - reverse transcriptase. 
The following were added at room temperature: 
A B 
RNA mix from the above step 12 JlI 12 III 
lOx buffer 2 III 2 JlI 
MgCl2 2 III 2 III 
dNTPs 1 III 1 III 
DTT 2 JlI 2 JlI 
RNase inhibitor I JlI I III 
These reactions were then incubated at room temperature for 5 min, after which the 
following were added to each reaction. 
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Reverse transcriptase 
DEPC treated dH20 
Incubations of these reactions were carried out using a Perkin-Elmer GeneAmp PCR 
System 9600. 
Room temperature 
42°C 
70°C 
10 min 
50 min 
15 min 
Once complete samples were cooled to 4°C, before the addition of 1 III RNase H to all 
samples. Tubes were then incubated at 37°C for 20 min. cDNA samples were stored 
at-70°C. 
2.20 DNA Hybridisation techniques 
2.20.1 Labelling of DNA probes with Digoxigenin 
DNA fragments were labelled by a random priming method using a commercially 
available digoxigenin (DIG) DNA labelling and detection kit (Roche). The DNA 
template (approximately 3 Ilg in 5 Ill) was heat denatured in a boiling water bath for 
10 min and chilled on ice for another 10 min. To the denatured DNA, 2 III of each of 
lOx hexanucleotide mixture and lOx dNTP labelling mixture were added. The volume 
of the reaction was made up to 20 III with dH20 and 1 III of Klenow enzyme. The 
reaction was incubated overnight at 37°C, and was terminated by the addition of 2 III 
of 200 mM EDTA pH 8.0. The labelled DNA was precipitated by the addition of 0.1 
volume of 4 M LiCI, and 2.5 volumes of 100 % (v/v) ice-cold ethanol. After thorough 
mixing the tube was incubated at -70°C for 30 min, and the DNA pelleted by 
centrifugation (11,000 g; 15 min; 4°C). The ethanol was decanted and the pellet 
washed in 70 % (v/v) ethanol. The pellet was air dried for 10 min, and resuspended in 
50 III of TE buffer. The labelled DNA probe was either used immediately, or stored at 
-20°C. The amount of labelled DNA present was quantified by comparison to 
labelled control DNA of known concentration as follows. The control labelled DNA 
and the probe were diluted and 1 III of various dilutions from I :20 to 1 :2,000,000 were 
spotted onto Hybond-N+ Extra nylon membrane. The DNA was fixed to the 
membrane by u.v. fixation (Chapter 2.20.3), and the DIG labelled DNA was then 
detected immunologically, using alkaline phosphatase linked anti-digoxigenin 
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antibody (Chapter 2.2.10.12). The spot intensities of the control and probe dilutions 
were compared to estimate the concentration of the probe. 
Prior to use, the probe was denatured by placing the tube in a boiling water bath for 
10 min followed by immediate chilling on ice for 10 min. 
2.20.2 Southern blotting 
Agarose gel electrophoresis was performed and photographed as described in Chapters 
2.19.1.3 and 2.19.1.3.1. The gel was soaked in Southern depurination solution 
(Chapter 2.2.10.1) for 10 min to depurinate the DNA. This acts to nick large DNA 
molecules aiding their transfer onto the membrane during the blotting procedure. The 
gel was washed in dH20 and soaked in Southern denaturing buffer (Chapter 2.2.10.2) 
for 45 min. The gel was neutralised by soaking in several volumes of Southern 
neutralisation buffer (Chapter 2.2.10.3) for 45 min. The DNA was then transferred 
overnight from the gel to an Hybond-N+ extra membrane, by capillary transfer 
overnight using lOx SSC as the transfer buffer (Figure 2.2). 
2.20.3 Fixing the DNA to the membrane 
For all hybridisation experiments Amersham Life Sciences Hybond-N+ Extra 
(positively charged nylon membrane) was used. DNA was fixed to the membrane with 
the use of a u.v. crosslinker (Amersham Life Sciences RPN 2500), 70 mJ / cm2; 15 
sec. 
2.20.4 Prehybridisation and hybridisation 
Membranes to be probed with the DIG-labelled DNA were prehybridised for 1 h at 
68°C in pre-hybridisation solution (20 ml per 100 cm2 of membrane) (Chapter 
2.2.1 0.5). The membrane was then hybridised with the labelled probe (Chapter 2.11.1) 
overnight at 68°C (Chapter 2.2.10.6). The concentration of probe used was 5-25 ng 
mI') diluted in pre-hybridisation solution. Unbound probe was removed by washing the 
membrane twice in 2x wash (Chapter 2.2.10.7) for 5 min at room temperature. The 
membrane was then washed twice in 0.5x wash (Chapter 2.2.1 0.8) for 15 min at 68°C. 
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2.20.5 Detection of DIG-labelled DNA 
The hybridised and washed membranes were equilibrated with washing buffer 
(Chapter 2.2.10.10) for 1 min and then blocked for 30 min with gentle rocking in 
blocking solution (Chapter 2.2.10.11). The membrane was then transferred to antibody 
solution (Chapter 2.2.1 0.12) containing a 1 :5000 dilution of the stock solution of anti-
DIG-alkaline phosphatase antibody (Roche). After 30 min incubation with gentle 
rocking, the membrane was rinsed and then washed twice (15 min) with washing 
buffer with gentle rocking. The membrane was then equilibrated for 2 min with 
detection buffer (Chapter 2.2.10.13) and transferred to 10 ml colour substrate solution 
which contains: 66 ~l nitro-blue tetrazolium (NBT); (50 mg mlol in 70 % (v/v) DMF); 
and 33 ~l BCIP (50 mg mlOI) (Chapter 2.2.10.14). This was then incubated in the dark 
to develop the membrane. After the colour development the membrane was washed in 
1 x TE to stop the reaction and stored dry in the dark. 
2.21 Polymerase chain reaction 
2.21.1 Primer design 
The primers used for PCR amplification were short synthetic oligonucleotides (19-28 
bp) that were based on DNA sequences obtained from the S. aureus databases and 
sequences produced as part of this study. Suitable restriction sites were introduced 
where necessary at the 5' ends to enable subsequent cloning. Note this is unnecessary 
for cloning into pCRiI\)2.1-TOPO (Chapter 2.22.2). 
2.21.2 peR procedure 
2.21.2.1 DNA amplification 
2.21.2.1.1 Taq polymerase 
Standard PCR amplification reactions were performed using Taq polymerase. 
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Figure 2.2 
Capillary transfer of nucleic acids from gels 
Buffer is drawn from a reservoir and passes through the gel into a stack of paper 
towels. The nucleic acids (DNA/RNA) is eluted from the gel by the moving stream of 
buffer and is deposited on the nylon membrane. A weight is applied to the top of the 
paper towel stack to ensure a tight connection between the layers of material used in 
the transfer system. 
Reproduced from Sambrook et al. (1989) 
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The following were added on ice: 
Template DNA 
Forward primer 
Reverse primer 
lOx Mg -free buffer 
MgCl2 
dNTPs 
Taq DNA polymerase 
dH20 
100-500 ng 
100 pM 
100pM 
10 III 
1.5-4.5 mM (final concentration) 
0.1 mM (final concentration) 
1 III (2.5 Units) 
to 100 III 
PCR amplification was carried out using an Eppendorf 5330 Mastercycler. The heated 
lid was heated to 106°C and the block was pre-heated to 96°C. Once the tubes were 
added a thermal cycling programme of 35 cycles was initiated: 
Denature 
Anneal 
Extension 
96 °C; 1 min 
50-55°C; 30 sec 
72°C; t min (t=1 min kb'! + 10 %) 
Once the 35 cycles were complete a final step of 72°C for 10 min was added to allow 
complete extension of the primers. The PCR products were stored at 4°C. 
2.21.2.1.2 Pwo polymerase 
DNA amplifications of < 3 kb that required 3' -5' proof-reading activity were 
performed with Pwo polymerase (Roche). 
The following were added on ice: 
Master mix 1: 
Template DNA 
dNTPs 
Forward primer 
Reverse primer 
dH20 
0.1-0.75 Ilg 
0.2 mM (final concentration) 
300 nM (final concentration) 
300 nM (final concentration) 
to 50 III 
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Master mix 2: 
lOx PCR buffer (20 mM MgS04) 
Pwo polymerase 
dH20 
10 III 
0.5 III (2.5 Units) 
to 50 III 
Master mix 1 and 2 were combined on ice in a PCR tube and cycling immediately 
commenced. 
PCR amplification was carried out using an Eppendorf 5330 Mastercycler. The heated 
lid was heated to 106°C and the block was pre-heated to 94°C. Once the tubes were 
added a thermal cycling programme of 10 cycles (A), followed by a second one of 20 
cycles (B) was initiated: 
Cycle A-I 0 cycles 
Denature 
Anneal 
Extension 
Cycle B - 20 cycles 
Denature 
Anneal 
Extension 
94°C; 15 sec 
50-55°C; 30 sec 
72°C; t min (t= -1 min 1.5 kb-J) 
94°C; 15 sec 
50-55°C; 30 sec 
72°C; t min (t= -1 min 1.5 kb- J) 
+ 20 sec for each cycle 
Once the all cycles were complete a final step of 72°C for 7 min was added to allow 
complete extension of the primers. The PCR products were stored at 4°C. 
2.21.2.1.3 Expand™ polymerase 
DNA amplifications of >3 kb that required 3'-5' proof-reading activity were 
performed with the Expand™ Long Template peR system (Roche). This system is 
composed of a unique enzyme mix containing the thermostable Taq and PWD 
polymerases, and is optimised for amplifying fragments of >3-27 kb in length. 
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The following were added on ice: 
Master mix 1: 
Template DNA 
dNTPs 
Forward primer 
Reverse primer 
dH20 
Master mix 2: 
lOx PCR buffer (1.75 mM MgCI2) 
Expand™ polymerase 
dH20 
0.1-0.5 ~g 
0.35 mM (final concentration) 
300 nM (final concentration) 
300 nM (final concentration) 
to 50 ~l 
10 III 
0.75 ~l (2.6 Units) 
to 50 ~l 
Master mix 1 and 2 were combined on ice in a PCR tube and cycling immediately 
commenced. 
PCR amplification was carried out using an Eppendorf 5330 Mastercycler. The heated 
lid was heated to 106 DC and the block was pre-heated to 94 DC. Once the tubes were 
added a thermal cycling programme of 10 cycles (A), followed by a second one of 20 
cycles (B) was initiated: 
Cycle A-I 0 cycles 
Denature 
Anneal 
Extension 
Cycle B - 20 cycles 
Denature 
Anneal 
Extension 
2 
3 
4 8 
6 10 
94°C; 10 sec 
50-55°C; 30 sec 
68°C' t min· ,
94°C; 10 sec 
50-55°C; 30 sec 
68°C; t min· 
+ 20 sec for each cycle 
15 20 
20 30 
30 
40 
Once all cycles were complete a final step of 68°C for 7 min was added to allow 
complete extension of the primers. The PCR products were stored at 4 DC. 
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2.21.2.2 RT-PCR 
The following were added on ice: 
PCR master mix (Life Technologies) 
DNA template· 
Forward primer 
Reverse primer 
43 J.tl 
5 J.tl (700 ng) 
1 J.tl (25 pM) 
1 J.tl (25 pM) 
• cDNA +/- RT, prepared from in vitro (BHIITSB), and in vivo (kidney) grown S. 
aureus; genomic DNA control. 
Note: Primers were designed to a central portion of each gene by SmithKline 
Beecham, sequences not supplied. 
PCR amplification was carried out using a Perkin-Elmer GeneAmp PCR System 9600. 
The heated lid was heated to 106°C and the block was pre-heated to 94°C. Once the 
tubes were added a thermal cycling programme of 40 cycles was initiated: 
Denature 
Anneal 
Extension 
94 °C; 30 sec 
50°C; 30 sec 
72 °C; 30 sec 
Once the 40 cycles were complete a final step of 72°C for 7 min was added to allow 
complete extension of the primers. The PCR products were visualised by agarose gel 
electrophoresis (Chapter 2.19.1.3) and stored at 4 °e. 
2.21.2.3 TaqManPCR 
The following were added to 96 well microtitre plates: 
DNA template· 4 J.tl (- 500 ng) 
lOx buffer 5 III 
MgCl2 11 J.tl (2.75 mM) 
dNTP 4 III 
UNG 0.5 III 
Probe 0.1 J.tl 
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Forward primer 
Reverse primer 
TaqGOLD 
dH20 
1.8 III (45 pM) 
1.8 III (45 pM) 
0.5 III 
to 50 /-L1 
... cDNA +/- RT, prepared from in vitro (BHIITSB), and in vivo (kidney) grown S. 
aureus; dilutions of S. aureus chromosomal DNA (calibration curve); and a no 
template control (dH20). 
S. aureus chromosomal DNA dilutions (ng): 100, 25, 6.25, 1.5625, 0.3906, 0.0977, 
0.0244, 0.0061. 
Note: Primers and probes were designed to a central portion of each gene by 
SmithKline Beecham, sequences not supplied. 
Reactions were carried out with enzymes and reagents from ABI Perkin-Elmer. All 
reactions were performed in at least duplicate in adjacent wells on the microtitre plate. 
PCR amplification was carried out using an ABI PRISM 7700 Sequence Detection 
System (Perkin-Elmer Corporation). The microtitre plate was added to the machine 
and was heated to 50°C for 2 min and then 95 °C for 10 min. A thermal cycling 
programme of 40 cycles was then initiated: 
Denature 
Anneal! extension 
95°C; 15 sec 
60 DC; 1 min 
Once the 40 cycles were complete the reaction was over and results were analysed 
using the TaqMan computer software (Perkin-Elmer) 
2.21.3 Automated DNA sequencing 
2.21.3.1 Short single read sequencing reactions 
Short (300-700 bp) single read sequencing reactions were carried out on the rescued 
DNA flanking the transposon insertion (Chapter 4.2.6.3), and to confirm correct 
construct construction (Chapter 2.21.3.1) using the following protocol. 
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The following were added on ice: 
Terminator ready reaction mix 
Template DNA 
Primer 
dH20 
8 J.11 
0.2-0.5 J.1g 
3.2 pM 
to 20 J.11 
PCR amplification was carried out using an Eppendorf 5330 Mastercycler. The heated 
lid was heated to 106°C and the block was pre-heated to 96 0c. Once the tubes were 
added a thermal cycling programme of 25 cycles was initiated: 
96°C for 30 sec 
50 °c for 15 sec 
60°C for 4 min 
The PCR products were cleaned by ethanol/sodium acetate precipitation (Chapter 
2.17.1.6). The sequencing reactions were carried out on an ABI PRISM dye terminator 
cycler (Perkin-Elmer) according to the manufacturer's instructions. 
2.21.3.1 Single read sequencing reactions for both strands 
PCR products requiring accurate sequencing, for example those necessary for the 
design of TaqMan primers and probes (Chapter 5.2.5.1.4), were sequenced by MWG-
BIOTECH. For these reactions, both strands of the PCR product were sequenced, with 
an accuracy of >99 %. This sequencing was carried out using the LI-COR 4200 
system. 
2.21.3.3 DNA sequencing of the dap operon 
2.21.3.3.1 Publication quality sequencing 
The plasmid pSEG 10 containing the 5' end of the dap operon, rescued from seg 10 
(Chapter 5.2.2.1), required sequencing to confirm the structure of the dap operon. A 
large prep of this plasmid was prepared from E. coli (Chapter 2.17.1.3) and the 
relevant portion of the plasmid was sequenced by MWG-BIOTECH. For this reaction, 
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both strands of the plasmid were completely sequenced, with an accuracy of 
>99.95 %. This sequencing was carried out using the LI-COR 4200 system. 
2.21.3.3.2 Primer walking quality sequencing 
The plasmid pMTOP09 containing the 3' end of the dap operon (Chapter 5.2.2.2.1), 
constructed as described in Chapter 2.22.2, required sequencing to confirm the 
structure of the 3' portion of the dap operon. A large prep of this plasmid was 
produced from E. coli (Chapter 2.17.1.3) and the plasmid insert was sequenced by 
MWG-BIOTECH. For this sequencing reaction only one strand of the insert was 
sequenced in a plasmid vector (pCRi8l2.1-TOPO (Invitrogen)). This sequencing was 
carried out using the LI-COR 4200 system. 
2.21.4 peR screening 
2.21.4.1 E. coli cells 
Colonies from E. coli transformation plates were patched using sterile toothpicks onto 
LB agar plates containing the appropriate antibiotic and grown overnight at 37°C. A 
small amount of the patched positive clone was transferred to a PCR tube containing 
the correct PCR mix (as in Chapter 2.21.2.1.1 minus the DNA) and the primers 
appropriate for the fragment to be screened. The PCR programme followed for 
screening was as in Chapter 2.21.2.1.1 with the tubes heated to 95 DC initially for 
5 min to ensure lysis of the cells and release of DNA. Transformants containing the 
plasmid and correct insertion, were isolated by subjecting the PCR products to gel 
electrophoresis (Chapter 2.19.1.3) and then identifying the associated colonies from 
the LB agar plate. 
2.21.4.2 S. aureus cells 
A small amount of patched clone was resuspended in 30 J..lI PBS (Chapter 2.2.7). 
These cells were then lysed with 3 J..lI of 5 mg ml·1 lysostaphin (Chapter 2.3) at 37°C 
for 10 min. 5 J..lI of the lysed cells were then used in a PCR reaction to determine if 
pAZ 1 06 had integrated into the gene of interest. PCR was conducted as described in 
Chapter 2.21.2.1.2, using primers OLP3 and OL 2-4 (Table A.l.2.1). 
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2.21.5 Purification of peR fragments 
Following PCR, the DNA fragments were cleaned usmg the QIAquick PCR 
purification kit (QIAGEN) according to the manufacturer's instructions, as follows. 5 
volumes of Buffer PB were added to the PCR reaction mix. The DNA was bound to 
the column by centrifuging the sample for 1 min (11,000 g) and the flow through 
discarded. The column was then washed with 750 ~l Buffer PE, and once more 
centrifuged for 1 min (11,000 g). The flow through was discarded and the column was 
again centrifuged for 1 min (11,000 g). The DNA was then eluted into a clean 
microfuge tube with 50 ~l of Buffer EB after standing for 1 min by centrifugation 
(11,000 g; 1 min). DNA was stored at 4°C (short-term) and -20°C (long-term). 
All QIAGEN solution details are given in Chapter 2.2.8. 
2.22 DNA cloning 
2.21.1 Cloning of Tn917 insertion sites 
2.22.1.1 Rescue of chromosomal DNA flanking Tn917 insertion sites 
Chromosomal DNA was prepared for each seg mutant (Chapter 2.17.1.1). 1 0 ~g of 
chromosomal DNA from each seg strain was digested overnight at 37°C (Chapter 
2.19.1.1) with EcoRI or Xbal. Digests were cleaned by phenol/chloroform extraction 
(Chapter 2.17.1.4), and a fraction of the DNA was analysed by agarose gel 
electrophoresis (Chapter 2.19.1.3). 0.2 ~g of the clean digested DNA was then ligated 
(Chapter 2.19.1.2.2) and transformed in to E. coli DH5a (Chapter 2.16.1). E. coli 
containing a plasmid comprising part of the transposon (the colEl replicon and the 
ampicillin resistance gene (bla» plus flanking chromosomal DNA out to the nearest 
relevant restriction site in the chromosomal DNA were recovered followed selection on 
ampicillin (50 Jlg mIOI ). 
2.22.1.2 Recovery of DNA flanking Tn917 insertion sites 
Plasmid DNA was recovered from two independent transformants for each seg mutant 
by a small scale plasmid preparation (Chapter 2.17.1.2). This plasmid DNA was 
analysed by digesting with EcoRI, and EcoRI + san (or XbaI, and XbaI + San) to 
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confirm the presence of a plasmid derived from Tn9 J 7 (pSEGX). Confirmed plasmid 
preparations were stored at -20°C. 
2.22.1.3 Determination of the Tn917 insertion sites 
The transposon insertion site, was identified by sequencing (Chapter 2.21.3.1) 
plasmids recovered in Chapter 2.22.1.2. These plasmids were sequenced using primer 
TnS 1 (Table A.l.2.1), which is complementary to a region at the san end of the 
transposon. 
2.22.2 Cloning the 3' end of the dap operon 
To allow the complete sequencing of the dap operon in 8325-4, the 3' end of the 
operon (3' end of dapA - 3' of /ysA) was cloned into a suitable vector (pCR®2.l-TOPO 
(Invitrogen» using the TOPOTM TA Cloning® kit (Invitrogen). PCR primers (MW41 
and MW44 (Table A.1.2.1» were designed from sequence in the dap database. These 
primers were used to PCR amplify a 5.7 kb fragment using Expand™ DNA 
polymerase mix (Chapter 2.21.2.1.3). The PCR product was gel purified (Chapter 
2.17.1.8) and then cloned into pCR®2.l-TOPO according to the manufacturer's 
guidelines as follows. 
The following were added at room temperature: 
PCRproduct 
pCR®2.1-TOPO 
Sterile water 
5-20 ng 
1 III 
to 5 III 
The reaction was mixed gently and incubated at room temperature for 5 min. The mix 
was then briefly centrifuged (15 sec; 11.000 g) and place on ice. 2 III of 0.5 M 
p-mercaptoethanol was added to each vial of TOPt 0 One Shot™ cells (Invitrogen), 
followed by 2 III of the TOPO cloning reaction. This reaction was gently mixed and 
incubated on ice for 30 min, after which time the cells were heat shocked at 42°C for 
30 sec, before returning back to ice for a further 2 min. 250 III of room temperature 
SOC medium (Chapter 2.1.1.10) was then added to the reaction and the tube was 
shaken horizontally at 37°C for 30 min and then placed on ice. 10-50 III of the 
transformation mix was then plated onto pre-warmed (37°C) LB agar plates 
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(Chapter 2.1.1.4), containing 50 J,tg ml- I Amp, spread with 80 J,tl 20 mg ml- I X-Gal. 
The plates were then incubated overnight at 37°C. 10 white or light blue colonies 
were selected for analysis. These clones were cultured overnight in LB medium 
containing 50 J,tg ml- I Amp and the plasm ids isolated using a small scale E. coli 
plasmid preparation (Chapter 2.l7.1.2). Positive clones were identified by restriction 
analysis using EcoRV, Hindi II, Nsil or Sad (Chapter 2.19.1.1). Confirmation of a 
positive result was achieved by automated sequence analysis (Chapter 2.21.3.l) using 
M13 forward and reverse primers. A positive clone pMTOP09 was then sequenced 
(Chapter 2.21.3.3.2). 
2.22.3 lacZ reporter gene construction 
lacZ reporter gene fusions were created without gene inactivation using pAZ 106. PCR 
primers (OL 1-4) (Table A1.2.l) were designed with unique restriction sites (EcoRI 
and BamHI) to allow cloning into pAZ106. The PCR primers were designed (Chapter 
2.21.1) as shown in Figure 5.18. PCR amplification was performed using Pwo 
polymerase (Chapter 2.21.2.1.2) and the resulting PCR products were gel purified 
(Chapter 2.17.1.8). Both the vector (pAZ 1 06) and the PCR fragments were digested 
with EcoRI and BamHI (Chapter 2.19.1.1) and then cleaned up using the QIAquick 
PCR purification kit (QIAGEN) (Chapter 2.21.5). The PCR fragments and the cut 
vector were then ligated (Chapter 2.19.1.2.1) and transformed into E. coli (Chapter 
2.16.1.2). Transformants were selected on LB containing 50 J,tg ml·1 Amp. 5 
transformants for each construct were picked and analysed. These transformants were 
cultured overnight in LB medium containing 50 J,tg ml·1 Amp. The plasmids were then 
isolated using a small scale E. coli plasmid prep (Chapter 2.17.1.2). Positive 
transductants were identified by restriction analysis using EcoRI and BamHI (Chapter 
2.19.1.1). Following confirmation of positive clones, a large scale E. coli plasmid prep 
(Chapter 2.17.1.3) was performed for each construct. The purified plasmids were then 
electroporated into S. aureus RN4220 and transformants selected on BHI ErylLin 
plates (5 J,tg ml'l/25 J,tg ml·l) (Chapter 2.16.2). Positive transformants were patched 
onto BHI and sera plates with an X-Gal overlay (Chapter 2.11.1) and grown overnight 
at 37°C under aerobic and microaerobic conditions respectively (Chapter 2.9). Clones 
found to be blue on serum but white on BHI were presumed to contain the correct lacZ 
construct. Confirmation of correct lacZ construction was afforded by PCR screening 
(Chapter 2.21.4.1) using primers OLP3 and OL 2-4 (Table A.1.2.1). Correct lacZ 
fusions were determined by PCR products 95 bp larger than the original cloned 
products. Positive constructs were then transduced into 8325-4 by phage transduction 
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(Chapter 2.14). Colonies were once again screened using blue white selection and 
PCR screening as described above. Final confirmation for the construction of lacZ 
transcriptional fusion strains was gained by Southern blot analysis using a DIG 
labelled probe representing the cloned region (Chapter 2.20). 
2.23 Sequence and database analysis 
2.23.1 DNA and amino acid sequence analysis 
Automated sequence data from the ABI PRISM dye terminator cycler was edited and 
analysed using the Applied Biosystems 373A DNA sequencer data analysis program. 
For all mutants putative open reading frames (ORFs) were identified using the Gene 
Jockey II program (BIOSOFT). This package includes tools for determining potential 
ORFs, translations of nucleic acid sequence to protein sequence, and restriction 
enzyme analysis. The amino acid sequence of these putative ORFs were analysed for 
homology with proteins from S. aureus and other bacteria using the BLASTP 
programme via the BLAST 2.0.4 database on the Internet (http://www. 
ncib.nlm.nih.gov/cgi-binlBLASTI). DNA sequence was also analysed using the 
BLASTX programme via the BLAST 2.0.4 database. This same technique was used 
for the analysis of DNA sequence produced by MWG BIOTECH (Chapters 2.21.3.3.1-
2.21.3.3.1). DNA sequences were also analysed using the Staden based NIP program 
(Staden, 1990). This program was also used for determining potential ORFs and 
translations of nucleic acid sequence to protein sequence, but also additionally for the 
analysis of stem-loop structures. 
2.23.2 Database searching 
Genome databases of B. subtilis (SubtiList; http://www.pasteur.fr/Bio/SubtiList.html) 
and E. coli (Colibri; http://www.pasteur.frlBio/Colibri.html) were searched on the 
Internet using: gene; key word; and BLAST search functions, within the databases. 
These searches allow the identification of: genes and their enzymes; potential 
isozymes; homologues; genetic locations; the identity of surrounding genes (and their 
function); and both the DNA and protein sequences of specified genes. The incomplete 
publicly available (Internet) S. aureus databases (TIGR, strain Col; http://www. 
TIGR.org/cgi-binIBlastSearchlblast.cgi? and NCTC 8325; http://www.genome.ou.edu 
/staph.html) were searched using BLAST analysis. Contigs of interest were then 
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extracted and analysed in Gene Jockey II for the presence of ORFs. Putative ORFs 
were then screened for similarity to protein sequences in the NCBI protein sequence 
database library using the BLAST programs (Chapter 2.23.1). The SmithKline 
Beecham, S. aureus databases (strains: WCUH29; and Buttle) were searched in an 
identical manner to that described above for the publicly available S. aureus databases 
(TIGR and NCTC 8325). However extracted contigs were analysed using in-house 
programs and databases (details not supplied). Finally sequences of known proteins 
that could not be obtained from another source were gained from the SWISS-PROT 
and TrEMBL, protein databases via ExPASy (http://www.expasy.ch/) using SRS 
(Sequence Retrieval System). These databases and programs were all accessed through 
the Internet. These sequences were then used to search for homologues in other 
databases. 
2.23.3 Database construction 
Sequence data, both sequenced during this project, and retrieved from the S. aureus 
databases (TIGR and NCTC 8325), were assembled into a database using the Staden 
SAP program (Staden, 1990). The database was then analysed using both Gene Jockey 
II and the Staden NIP package (Staden, 1990). 
2.24 Auxotrophy experiments 
2.24.1 Solid media auxotrophy experiments 
16 different types of chemically defined media were prepared (Chapter 2.1.1.3.1). 
S. aureus strains were inoculated in triplicate onto the different types of CDM agar 
from fresh standard CDM (16) agar plates. These plates were then incubated aerobically 
at 37°C for 48 hours. After this time plates were scored for growth (+1-). 
2.24.2 Liquid media auxotrophy experiments 
5 ml CDM (16) cultures were grown overnight aerobically at 37°C. Cells were 
pelleted by centrifugation (11,000 g; 3 min) and washed twice with 5 ml CDM 15 (-
all 4 AAA). The pellet was then resuspended in 5 ml CDM 15 and used as an 
inoculum. 25 ml CDM cultures (CDM 1-4 and 11-16 (Table 5.2)) were inoculated to 
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~oo 0.07, a value previously determined to be a suitable inoculum for CDM +/- the 
aspartate family of amino acids. Strains were grown aerobically at 37°C with shaking 
(250 rpm) for up to 48 h. Growth was monitored throughout this time by A600 
(Chapter 2.7.l). 
2.25 Murine pathogenicity models 
2.25.1 Murine subcutaneous lesion model (Chan et al., 1998) 
S. aureus strains were grown to stationary phase (t = 15 h) in BHI containing no 
antibiotics as described in Chapter 2.4.1.1. The bacteria were harvested by 
centrifugation (4,000 rpm (Centaur 2); 5 min) and resuspended in phosphate-buffered 
saline (PBS) (Chapter 2.2.7) and adjusted to 5 x 108 cfu mrl. Male and female bald 
mice were inoculated subcutaneously (n = 7 (segl (lysC), seg24 (asd» and n = 8 (seglO 
(dapA») with 0.2 ml of bacterial suspension (- 1 x 108 cfu mrl). After 7 days the mice 
were sacrificed and skin lesions were aseptically removed and stored at -70°C. The 
lesions were weighed and homogenised in 5 ml PBS at 4 °C for approximately 60 min. 
The total number of bacteria recovered from the lesions (cfu lesion-I) was determined 
by direct cell counts (Chapter 2.7.2) on BHI agar. Statistical evaluation of the data was 
determined by the Mann-Whitney U test. 
2.25.2 Murine pyelonephritis model (Nicholas et al., 1999) 
Mice were inoculated (n = 5 (WCUH29, SWC24 (asd» n = 4 SWCl (lysC), and n = 3 
(SWClO (dapA») with - 2 x 107 cfu ml-l WCUH29 cells. After 7 days the mice were 
sacrificed and their kidneys were aseptically removed and stored at -70°C. The kidneys 
were homogenised at 4 °C to extract bacteria. The total number of bacteria recovered 
from the kidney (cfu kidney-I) was determined by direct cell counts (Chapter 2.7.2) on 
TSB agar. Statistical evaluation of the data was determined by the Mann-Whitney U 
test. 
2.25.3 Murine wound infection model (Nicholas et al., 1999) 
Mice were inoculated (n = 5) with 7 x106-2 x 10' cfu ml-I WCUH29 cells. After 7 days 
the mice were sacrificed and wounds were aseptically removed and stored at -70°C. 
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The wounds were homogenised at 4 °C to extract bacteria. The total number of bacteria 
recovered from the wound (cfu wound-I) was determined by direct cell counts (Chapter 
2.7.2) on TSB agar. Statistical evaluation of the data was determined by the Mann-
Whitney U test. 
2.26 Light microscopy 
S. aureus strains were grown under standard conditions (Chapter 2.4.1.1) in both BHI 
and serum. Samples were taken throughout growth and into stationary phase, and were 
viewed under a light microscope using oil immersion at 1000x magnification. 
2.27 HPLC analysis 
2.27.1 HPLC peptidoglycan analysis 
2.27.1.1 Preparation of cell wall peptidoglycan (Atrih et al., 1996) 
S. aureus strains were grown overnight as described in Chapter 2.4.1.1 and used to 
inoculate (A600 0.05) 100 ml of fresh media (BHIIserum). These cultures were grown 
using standard conditions (Chapter 2.4.1.1) until the end of exponential phase (~oo 
dependent on media used). These cells were then pelleted by centrifugation (10,000 g; 
10 min; 4°C), resuspended in 25 ml of hot (80°C) 5 % (v/v) SDS and boiled for 30 
min. Insoluble material was recovered by centrifugation (10,000 g; 10 min) and the 
pellet resuspended in 25 ml warm (50°C) 4 % (v/v) SDS and boiled for 15 min. The 
samples were then centrifuged (l0,000 g; 10 min) and the pellet washed with warm 
(50°C) dH20 4-6 times to remove all trace of SDS. These samples were then 
centrifuged (11,000 g; 5 min) and resuspended in 50 mM Tris-HCI pH 7.5 and treated 
with amylase (200 Jlg ml"1 final concentration) (Chapter 2.3) for 2 hat 37°C. After this 
treatment the samples were treated with pronase (1 mg ml-I final concentration) for 2 h 
at 60°C. The walls were then recovered by centrifugation (11,000 g; 5 min) washed 
with dH20 and pelleted again (11,000 g; 5 min). The pellet was then resuspended in 
hydrofluoric acid (300 Jll of 48 % v/v solution) and incubated on ice for 36 h. The 
sample was then pelleted (11,000 g; 5 min) once more, and washed repeatedly with 
100 mM Tris-HCl pH 7.5 until the pH was neutral. Peptidoglycan was stored at -20°C. 
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2.27.1.2 Enzymatic hydrolysis of peptidoglycan and RP-HPLC separation of 
soluble muropeptides (Atrih et al., 1996) 
Peptidoglycan samples (Chapter 2.27.1.1) were digested overnight at 37°C with 250 I-lg 
ml-t of Cellosyl (Chapter 2.3). The reaction was stopped by boiling the reaction for 
3 min. Insoluble material was removed by centrifugation (14,000 g; 8 min), and the 
resulting peptidoglycan hydrolysate stored at -20°C. Muropeptide-containing samples 
were reduced at room temperature using sodium borohydride at a final concentration of 
8 mg m.-t. The reaction was stopped after 13 min by lowering the pH to 4 with 
phosphoric acid. The reduced muropeptides were then separated by reverse-phase 
HPLC (RP-HPLC). A Hypersil octadecylsilane column purchased from Sigma (4.6 by 
250 mm; particle size 5 J.lm) was used without a guard column. All samples were 
filtered (0.45 J.lm pore size) prior to analysis, to remove insoluble material. The column 
was equilibrated at 52°C with buffer A (Chapter 2.2.5.1) at a flow rate of 0.5 ml minot 
for 17 min at 40°C with a Waters 600E delivery system and column heater. Soluble-
reduced muropeptides (60 J.lI), were then loaded by injection (Waters 717 plus 
autosampler). A linear gradient of 0-100 % buffer B (Chapter 2.2.5.2) over a period of 
270 min was started 5 min after sample injection. The flow rate was constant at 0.5 ml 
minot over the course of the gradient and the eluted compounds were detected by 
monitoring A202 (Waters 486 absorbance detector). 
2.27.2 Amino acid analysis of sera by HPLC (Atrih et al., 1996) 
The pico-Tag amino acid analysis system (Waters) was used for the analysis of both 
pig and human sera. Prior to amino acid analysis, desalted, HPLC-purified 
muropeptides were hydrolysed with 6 M HCI for 14 h at 100°C. The hydrolysates 
were dried and derivatised with phenylisothiocynate as recommended by the 
manufacturer. The phenylthiocarbamyl amino acid derivatives were separated on an 
HPLC Pico-Tag column (Waters; 3.9 by 150 mm) maintained at 38°C. Peaks were 
detected at 254 nm and integrated by use of a Waters 746 data module integrator. The 
results of this analysis are shown in Table A.I.7. 
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CHAPTER 3 
DEVELOPMENT OF IN VITRO MODELS MIMICKING INFECTION 
3.1 Introduction 
3.1.1 Background to the in vitro models mimicking infection 
Two different in vitro models mimicking infection were selected for this study. A brief 
introduction to each model along with the reasoning behind its selection follows. 
3.1.1.1 Synthetic cerebrospinal fluid model 
Cerebrospinal fluid (CSF), is the fluid filling the cavity in the brain and the spinal 
chord, and is the fluid in which they are suspended. CSF is secreted primarily by the 
choroid plexus epithelium in the lateral 3rd and 4th ventricles of the brain, from where it 
circulates to the entire surface of the brain. The fluid has a vital role, supporting and 
cushioning the brain within the skull. The CSF filled subarachnoid space lies protected 
behind the blood brain barrier, which severely limits the passage of even small 
molecules from the blood, into the brain or CSF (Tuomanen, 1996). Thus the 
composition of the CSF is not determined directly by the composition of the plasma, 
but is a specially controlled privileged environment. The ionic composition of CSF 
however is broadly similar to that of plasma, mainly sodium with chloride and 
bicarbonate. Further details of the composition of CSF are given in Tables, A.l.3. 
Importantly, several types of pathogenic bacteria including S. aureus are capable of 
entering the central nervous system (CNS), causing infections. 
S. aureus along with other staphylococci have been shown to be important causative 
agents of a wide range of infections of the CNS. Examples include CSF shunt 
infections, acute purulent meningitis, brain abscess, and epidural abscess. The 
importance of the staphylococci in these infections is highlighted by the fact that 
staphylococci are the etiologic organisms in 79 % of CSF shunt infections, with S. 
aureus causing approximately 20 % of all infections (reviewed by Roos and Scheid, 
1997). These serious infections have varying prognoses for infected individuals, 
ranging from high rates of mortality to pennanent neurologic sequelae and 
postoperative epilepsy. It was because of the important role of S. aureus in infections of 
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the CNS, that synthetic cerebrospinal fluid (sCSF) was chosen as the first of the models 
mimicking infection. 
3.1.1.2 Serum model 
Blood consists of a cellular portion (formed elements), which are suspended and carried 
in the plasma. These formed elements and their major functions include: erythrocytes 
(02 transport); leukocytes (immune defence); and platelets (blood clotting). Plasma is a 
straw coloured liquid consisting of water and dissolved solutes. The major solute of the 
plasma in terms of its concentration is Na+. In addition to Na+, plasma contains many 
other ions, as well as organic molecules such as metabolites, hormones, and enzymes. 
Plasma proteins constitute 7-9 % of the plasma (Scully, et al., 1986). The three types of 
proteins are albumins, globulins and fibrinogen. These are involved in: maintenance of 
blood volume, and pressure; transport of lipids, and fat soluble vitamins; as well as 
functioning as antibodies, and clotting factors. The blood plasma normally has a pH of 
between 7.35 and 7.45, with an average value of 7.40. The pH is maintained at this 
constant value through the function of the lungs and kidneys. The lungs regulate the 
CO2 concentration of the blood, and the kidneys regulate the bicarbonate concentration. 
Further details of the composition of blood are given in Tables A.I.4-A.I.7. 
During the process of clot formation, fibrinogen is converted into insoluble threads of 
fibrin. The fluid from clotted blood, which is called serum, thus does not contain 
fibrinogen but is otherwise identical to plasma. Pathogenic bacteria, including S. aureus 
are capable of growth in blood causing both septicaemia and bacteraemia. 
The incidence of both community and hospital acquired staphylococcal bacteraemia has 
risen substantially over the past two decades, resulting in its recognition as a primary 
nosocomial infection. This increase is related mainly to the increasing use of indwelling 
vascular devices (Ing et al., 1997). Of particular relevance is the fact that by the early 
nineties approximately one fifth of all cases of bacteraemia were caused by S. aureus 
(Ing et al., 1997). Overall mortality from S. aureus bacteraemia remains high, ranging 
from 16 to 48 %, and is greatly dependent on the presence or absence of, a removable 
primary focus, underlying respiratory or cardiac disease, associated infective 
endocarditis or septic shock. Interestingly however, although methicillin-resistant S. 
aureus (MRS A) has emerged as a more prevalent problem in S. aureus bacteraemia 
during the past 10-15 years, this has apparently not affected mortality rates (reviewed 
by Ing et al., 1997). 
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Thus S. aureus bacteraemia is an extremely important infection that is definitely on the 
increase, and with the further increased use of catheters and other indwelling vascular 
devices in combination with the increased prevalence of antibiotic resistant strains, 
much work needs to be done to investigate the role of virulence factors in the induction 
and propagation of S. aureus in bacteraemia. It was for these reasons along with the 
ease and availability of serum that serum was chosen as the second of the models 
mimicking infection. 
3.1.2 Reporter gene fusions for the analysis of gene expression 
Reporter gene fusions are important tools for the analysis of gene expression and have 
been constructed in numerous bacterial species including S. aureus. These function by 
inserting promoterless genes, encoding a measurable gene product, downstream of a 
promoter of interest. Therefore, when the promoter is transcriptionally active, the 
reporter gene is transcribed and the resulting gene product can be assayed to 
quantitatively determine activity of the promoter of interest (Camilli et al., 1990). There 
are several different types of reporter gene systems in use in bacteria, including the 
bioluminescence (lux), and ~-lactamase (lac) systems. For the purpose of this study, 
gene fusions using the lacZ gene, encoding ~-galactosidase were employed. The lac 
system is a commonly used assay system and the genetic and biochemical aspects of the 
system are well understood (Silhavy and Beckwith, 1985). An advantage of this system 
over others is that several substrates are available for this system including: X-Gal, and 
MUG. Fusions used in this assay were constructed in such a way that they were 
transcriptionally fused to the gene of interest. This therefore provides a method for 
distinguishing between transcriptional and post-transcriptional control. 
3.2 Results 
3.2.1 Development of in vitro models mimicking infection 
3.2.1.1 Synthetic cerebrospinal fluid 
Two synthetic cerebrospinal fluids (sCSF) were selected for this study. The first 
synthetic cerebrospinal fluid (sCSF I) is a very simple medium developed by van Dijk 
et al. (1994). sCSF I is comprised of only a few chlorides and completely lacks a 
carbon source (Chapter 2.1.1.11). The second synthetic cerebrospinal fluid (sCSF II) 
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was developed by Smith and Johanson (1985), and is once more a simple medium. 
Notably however, sCSF II contains both a source of phosphorus and carbon (glucose) 
(Chapter 2.1.1.12). These two types of sCSF form the first of the in vitro models 
mimicking infection. Details of the composition of CSF are given in Table A.I.3. 
Results revealed that the S. aureus wild type strain (8325-4) would not grow in either 
sCSF I, or sCSF II. Therefore, further studies involved the use of sCSF as a starvation-
survival medium. 
3.2.1.1.1 Kinetics of starvation-survival in sCSF I and II 
Nutrient limitation of S. aureus induces a starvation-survival state, which enables 
cells to survive for long periods of time until sufficient nutrients become available to 
support growth. Starvation results in decreased cell size (Watson et al., 1998a) and a 
reduced metabolic state (Clements and Foster, 1998). Survival was measured as the 
ability to form a colony on nutrient media (Chapter 2.6.2). This is an accurate 
measure of viability in S. aureus as previous studies have shown there to be no 
apparent 'viable but nonculturable state' in this organism (Watson et al., 1998a). 
The kinetics of the starvation-survival response of S. aureus were examined in both 
sCSF I, and II. Cultures were grown in amino acid limiting CDM until approximately 
6 h post-exponential. Cells were subsequently washed and resuspended in sCSF I, or 
II at the same cell density as the original culture (- 5 x108 - I X 109 cfu ml"l) (Chapter 
2.6.1). Cultures were incubated at 37°C without shaking and viability was 
determined over 35 days (Chapter 2.6.2). Results showed that cells starved in sCSF I 
retained a higher degree of viability than those starved in sCSF II (Figure 3.1). After 
35 days a drop in viability of 103 was observed in sCSF I, and a 104 decrease in 
viability in sCSF II. Comparable survival kinetics, were observed if cultures were 
shaken (250 rpm) during starvation (results not shown). 
3.2.1.2 Serum model 
Two types of sera were selected for this study, pig serum and human serum (Chapter 
2.1.1. 7). Serum is a medium of complex composition (Tables A. I. 5-A. I. 7) and 
although different batches of serum were used during the study, this did not affect 
reproducibility. The majority of experimentation was carried out using pig serum due to 
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Starvation-survival kinetics of S. aureus 8325-4 in sCSF I and II at 37°C 
Approximately 6h post-exponential phase cultures of S. aureus 8325-4, grown in 
amino acid limiting CDM, were washed and resuspended in sCSF I, or Il and 
incubated at 37°C without shaking. Viability (cfu ml>') was determined by serial 
dilution on CDM agar plates. 100 % viability is - I xI09 for both sCSF I, and II. The 
results are representative of two separate experiments. 
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cost constraints, although human serum was used in certain situations to confirm results 
obtained using pig serum. However, unless otherwise stated pig serum was used. 
3.2.1.2.1 Development of the serum model 
The kinetics of the growth of S. aureus in serum, were examined on agar plates and in 
liquid culture, under different conditions. 
3.2.1.2.2 Solid media 
To establish how well S. aureus grows on serum agar plates and to determine the best 
concentration of serum to use in serum agar plates, 8325-4 and WCUH29 (clinical 
isolate), were inoculated from an overnight BRI plate, onto BRI (rich medium), CDM 
(minimal medium) and three concentrations of serum agar plates (80, 50 and 25 % 
(v/v» (Chapter 2.1.1. 7). These plates were all incubated aerobically at 37°C for 48 h. 
The results showed that growth on serum is very poor, especially if compared to that 
achieved with BHI (Table 3.1). The results also showed that while 25 % (v/v) serum 
agar plates gives a further reduced growth yield both 50 and 80 % (v/v) serum agar 
plates gave almost identical growth yields. Thus all serum agar plates used were 50 % 
(v/v) serum. This was the case for both pig and human sera (Chapter 2.1.1.7). Finally 
results showed that both 8325-4 and WCUH29 grew comparably (Table 3.1). 
To investigate the role of environmental oxygen and carbon dioxide concentration on 
the growth of S. aureus on serum, serum agar plates were inoculated from an overnight 
BRI agar plate and grown at 37°C, under both aerobic and microaerobic conditions 
(Chapter 2.9). 8325-4 was shown to grow under both of these conditions, although the 
growth yield was greatly increased by incubating plates microaerobically (Table 3.2). 
3.2.1.2.3 Liquid culture 
Serum cultures (25 ml in 100 ml flasks) were grown at 37°C with shaking (250 rpm) 
under both aerobic and microaerobic conditions (Chapter 2.9). Cultures were grown for 
24 h, and growth was monitored by A600 or by direct counts on BHI agar plates (Chapter 
2.7). Results revealed 8325-4 and WCUH29 reached a final A600 of 4.0-6.0 in pig 
serum (Figure 3.2). 8325-4 was shown to grow to a higher A600 under microaerobic than 
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Average colony diameter (mm) 
Media 8325-4 WCUH29 
BHI 3.8 3.6 
CDM 1.3 1.3 
Sera 80 % (v/v) < 0.1 < 0.1 
Sera 50 % (v/v) < 0.1 < 0.1 
Sera 25 % (v/v) «0.1 « 0.1 
Table 3.1 
The growth of S. aureus 8325-4 and WCUH29 on different solid media 
BHI, CDM and three concentrations of pig serwn agar plates (80, 50 and 25 % (v/v» 
were inoculated with a single colony of either 8325-4 or WCUH29. Plates were 
incubated aerobically at 37°C for 48 h. Growth was measured according to colony size 
(diameter). Average diameters were calculated after measuring at least three colonies 
from two separate experiments. 
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Average colony diameter (rrun) 
Condition 24h 48 h 
Aerobic «0.1 < 0.1 
Microaerobic 0.15 1.25 
Table 3.2 
The effect of environmental oxygen and carbon dioxide on the growth of 8325-4 on 
serum agar plates 
S. aureus 8325-4 was grown on pig serum agar plates, under aerobic and microaerobic 
conditions at 37°C. Growth yield was scored according to colony size (diameter) after 
both 24 h and 48 h incubation. Average diameters were calculated after measuring at 
least three colonies from two separate experiments. 
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Figure 3.2 
[; 8325-4 -I 
_WCUH2~ 
The growth of S. aureus 8325-4 and WCUH29 in pig serum 
S. aureus 8325-4 and WCUH29 were grown at 37°C in pig serum under aerobic 
conditions with shaking (250 rpm). Growth was measured as A 600 for 24 h. The results 
are representative of at least two separate experiments. 
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Figure 3.3 
The growth of S. aureus 8325-4 III pig serum under aerobic and microaerobic 
conditions 
S. aureus 8325-4 was grown at 37°C in pig serum under both aerobic and microaerobic 
conditions with shaking (250 rpm). Growth was measured as A600 for 24 h. The results 
are representative of at least two separate experiments. 
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The growth of S. aureus 8325-4 in human serum under aerobic and microaerobic 
conditions 
S. aureus 8325-4 was grown at 37°C in human serum under both aerobic and 
micro aerobic conditions with shaking (250 rpm). Growth was measured as A600 for 24 h. 
The results are representative of at least two separate experiments. 
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aerobic conditions (A600 of 4.8 Vs 6.0) (Figure 3.3). The same trend is true for growth 
in human serum, with 8325-4 growing to a higher A600 under microaerobic than aerobic 
conditions (Figure 3.4). However, the difference in human serum (A600 of 0.5-5.4) is 
much greater compared with that seen in pig serum. 
3.2.2 Comparison of the growth of S. aureus 8325-4 in different media 
The growth of S. aureus 8325-4 was compared in BHI, CDM and serum. When 
measured by A600 or direct counts (cfu), BHI showed a greater growth rate and yield, 
than the other two media (Figures 3.5-3.6). Growth in CDM and serum was found to be 
comparable. 
3.2.3 Analysis of potential growth limiting factors in the serum model 
The growth of S. aureus in serum is reduced compared to rich media (BHI). The reason 
for this phenomenon is unknown but may be due to relative nutrient deprivation. 
Furthermore, S. aureus grows to a higher yield under microaerobic conditions 
specifically in serum. This may be due to oxidative stress occurring when grown 
aerobically. These potential growth limiting factors of the serum model were 
investigated. 
3.2.3.1 The effect of the addition of iron on the growth of 8325-4 in serum 
Iron is an important element for the growth of almost all living cells (Neilands, 1972) 
and iron availability is of major importance in bacterial pathogenesis (Courcol et al., 
1997). In vivo, intracellular iron is plentiful however the great majority of extracellular 
iron is bound to specific binding proteins such as transferrin and lactoferrin. Therefore, 
for pathogenic bacteria such as S. aureus to cause disease in host tissues, they must 
possess at least one mechanism for scavenging iron, for example by the production of 
siderophores (Neil ands , 1981). Importantly, S. aureus has been shown to have a 
decreased growth rate and yield under iron restricted conditions (Trivier et al., 1995). In 
serum it is predicted that a large percentage of the iron will be bound to proteins such as 
transferrin and haemoglobin. In order to establish whether iron is limiting in serum, iron 
in the form of iron sulphate (Chapter 2.3), was added to serum at a range of 
concentrations (0-2000 J,lM). Experiments were carried out using both solid and liquid 
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The growth of S. aureus 8325-4 in BHI, CDM and serum measured by A600 
S. aureus 8325-4 was grown at 37°C in BHI, CDM and serum under aerobic conditions 
with shaking (250 rpm). Growth was monitored for 24 h by A600 • The results are 
representative of at least two separate experiments. 
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Figure 3.6 
The growth of S. aureus 8325-4 in BHI, CDM and serum measured by direct counts 
S. aureus 8325-4 was grown at 37°C in BHI, CDM and serum, under aerobic 
conditions with shaking (250 rpm). Growth was measured by dilution and plate counts 
on BHI agar plates for 24 h. The results are representative of at least two separate 
experiments. 
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media, and growth was determined by colony diameter (solid media) and A600 (liquid 
cultures). 
3.2.3.1.1 Solid media 
Serum agar plates were prepared containing appropriate concentrations of iron sulphate 
(0-2000 f.lM) (Chapter 2.1.1.7.1). These plates were then inoculated with 8325-4 and 
incubated both aerobically and microaerobically at 37°C for 48 h. Results revealed that 
the addition of iron (200 f.lM) increased the colony diameter under both aerobic and 
microaerobic conditions (Table 3.3). Under microaerobic conditions, increasing iron 
concentrations up to 200 f.lM resulted in greater colony diameter. Whereas 
concentrations of 500 f.lM and above were no longer beneficial and reduced growth 
below that obtained with 200 JlM iron. Finally as expected, under aerobic conditions 
the average colony diameter was much smaller than that for microaerobically incubated 
cells, however the same iron concentration dependent trend was visible as seen for 
microaerobic growth (Table 3.3). 
3.2.3.1.2 Liquid media 
Sera, containing sterile additions of iron sulphate (Chapter 2.1.1.7.1) at a range of 
concentrations (0-200 JlM), were inoculated with cells from an overnight serum culture 
containing no iron supplement. These cultures were grown aerobically at 37°C with 
shaking (250 rpm) for 24 h. Results revealed 8325-4 showed no significant increased 
growth yield, as determined by ~oo, when iron was added to serum (Figure 3.7). 
3.2.3.2 Examination of the role of oxygen and carbon dioxide levels on the 
growth of 8325-4 in serum 
Early observations revealed that S. aureus grew to a higher growth yield in serum under 
microaerobic than aerobic conditions (Table 3.2). This could be due to a reduced O2 
(10 %), or an increased CO2 (5 %) tension aiding growth, or a combination both. 
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Average Colony Diameter (mm) 
Concentration Aerobic Aerobic Microaerobic Microaerobic 
of iron (FeS04) 24 h 48 h 24h 48 h 
OJ-lM «0.1 < 0.1 0.15 1.25 
2J-lM «0.1 < 0.1 0.5 1.65 
20 J-lM «0.1 < 0.1 1.0 2.0 
200 J-lM 0.25 0.5 1.2 2.45 
500 J-lM 0.2 0.25 0.9 1.8 
2000 J-lM 0.2 OJ 0.8 1.5 
Table 3.3 
The effect of iron on the growth of 8325-4 on serum agar 
S. aureus 8325-4 was inoculated onto serum agar plates containing a range of 
concentrations of iron sulphate (0-2000 J-lM). Plates were incubated aerobically and 
microaerobically at 37°C. Growth yield was scored according to colony size 
(diameter), after both 24 h and 48 h incubation. Average colony diameters were 
calculated after measuring at least three colonies from two separate experiments. 
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Figure 3.7 
The effect of iron on the growth of 8325-4 in liquid serum cultures 
S. aureus 8325-4 was grown at 37°C in serum containing a range of concentrations of 
iron sulphate (0-200 ~M). Cultures were incubated aerobically with shaking (250 rpm) 
and growth was measured as A600 for 24 h. The results are representative of at least two 
separate experiments. 
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3.2.3.2.1 The effect of oxygen availability on the growth of 8325-4 in serum 
The simplest way to look at oxygen sensitivity of S. aureus grown in serum was to 
grow plate cultures under different environmental oxygen concentration conditions. As 
S. aureus is a facultative aerobe it can be grown both aerobically and anaerobically. To 
investigate oxygen sensitivity in serum, serum agar plates inoculated with 8325-4, were 
incubated aerobically, microaerobically and anaerobically (Chapter 2.9) at 37°C, and 
growth yields were compared (Table 3.4). This showed that the growth yield (colony 
diameter) was greatest microaerobically, then anaerobically and poorest aerobically. 
This suggests that in serum, S. aureus is susceptible to high levels of environmental 
oxygen. 
3.2.3.2.2 The effect of culture aeration on the growth of 8325-4 in serum 
Culture aeration has been previously shown to affect both growth yield and virulence 
determinant production in S. aureus (Lindsay and Foster, 1999). Aeration, was varied 
by using different culture volumes in identical flasks (Chapter 2.10). These cultures 
were all grown aerobically with shaking (250 rpm) at 37°C (Figure 3.8). Results 
showed no difference in growth rates or yields for cultures with 20 ml or 100 ml in 
250 ml flasks. This indicates that culture aeration is not crucial for the growth of 8325-4 
in serum. 
3.2.3.3 The effect of the addition of catalase on the growth of 8325-4 in 
serum 
Certain supplements added to liquid or solid media have been reported to increase the 
aerotolerance of bacteria (reviewed by Krieg and Hoffman, 1986). The only common 
link among these diverse agents is their ability to quench toxic forms of oxygen. These 
include catalase, which destroys hydrogen peroxide (H20 2). Sterile additions of catalase 
(Chapter 2.3) were added to serum at a range of concentrations (0-1000 Ilg ml- I ). 
Experiments were carried out using both solid and liquid media and growth yield was 
determined by colony diameter (solid media) and ~oo (liquid cultures). 
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Condition Average colony diameter (mm) 
Aerobic (21 % 02) <0.1 
Microaerobic (10 % 02) 1.25 
Anaerobic (0 % 02) 0.75 
Table 3.4 
The effect oxygen availability on the growth of 8325-4 on serum 
S. aureus 8325-4 was grown on serum agar plates under aerobic, microaerobic and 
anaerobic conditions at 37°C. Growth yield was scored according to colony size 
(diameter) after 48 h. Average diameters were calculated after measuring at least three 
colonies from two separate experiments. 
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The effect of culture aeration on the growth of 8325-4 in serum 
S. aureus 8325-4 was grown at 37°C in serum in 20, or 100 ml cultures in 250 ml 
flasks. Growth was measured as A 600 for 24 h. The results are representative of at least 
two separate experiments. 
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3.2.3.3.1 Solid media 
Serum plates containing the appropriate concentration of catalase (0-1 000 ~g ml-') 
(Chapter 2.1.1.7.2), were inoculated with 8325-4 and incubated both aerobically and 
microaerobically at 37°C for 48 h. Results revealed that the addition of catalase (500 
and 1 000 ~g ml-') increased the growth yield of 8325-4 under aerobic conditions 
(Table 3.5). Under microaerobic conditions there appeared to be no increase in growth 
yield with any concentration of catalase (up to 1 000 ~g ml-') (Table 3.5). 
3.2.3.3.2 Liquid media 
Serum cultures with sterile additions of catalase (Chapter 2.3) at a range of 
concentrations (0-1000 ~g ml-') were grown for 24 h, at 37°C with shaking (250 rpm), 
under aerobic conditions. Results revealed that 8325-4 showed no increased growth 
yield when catalase was added to serum (10-100 ~g ml-'), reaching an almost identical 
final A600 to that obtain without the addition of catalase (Figure 3 _ 9)_ Interestingly, when 
1000 ~g ml- I catalase was added both the growth rate and the final A600 were reduced. 
Thus a high concentration of catalase may be toxic to cells. 
3.2.3.4 The combined effect of the addition of iron and catalase on the 
growth of 8325-4 in serum 
The addition of both iron and catalase to serum plates improved the growth of 
S. aureus, but not beyond the level achieved by the addition of iron alone (results not 
shown). 
3.2.4 Analysis of the role and expression of known components in the 
serum model 
Within our laboratory there exists a large number of insertionally inactivated and 
transcriptional fusion strains in the 8325-4 background. These are within genes with 
known function, and are all putative virulence factors, or regulators of putative 
virulence factors. These strains were grown in the serum model (and in BHI as a 
control), to ascertain their importance, if any (mutant strains), and any difference in 
transcriptional regulation (fusion strains). 
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Average colony diameter (mm) 
Concentration Aerobic Aerobic Microaerobic Microaerobic 
of catalase 24 h 48 h 24 h 48 h 
o J.1g mI'! «0.1 < 0.1 0.15 1.25 
10 J.1g mI'! «0.1 < 0.1 0.15 1.1 
100 J.1g mI'! «0.1 < 0.1 0.15 1.2 
500 J.1g mI'! < 0.1 0.1 0.15 1.25 
1000 J.1g ml"! 0.1 0.2 0.25 1.15 
Table 3.5 
The effect of catalase on the growth of S. aureus 8325-4 on serum agar plates 
S. aureus 8325-4 was grown at 37°C, on serum agar plates containing a range of 
concentrations of catalase (0-1000 J.1g mI'!). Plates were incubated under aerobic or 
microaerobic conditions. Growth yield was scored according to colony diameter after 
both 24 h and 48 h incubation. Average colony diameters were calculated after 
measuring at least three colonies from two separate experiments. 
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3.2.4.1 The role of the major global regulators agr and sarA in the serum 
model 
The accessory gene regulator (agr), and the staphylococcal accessory regulator (sarA), 
are important regulators of virulence factor production in S. aureus (Chapter 1.7.1-
1.7.2). Previous studies revealed these regulators to be important for infection in vivo 
(Abdelnour et al., 1993; Booth et al., 1995), and thus it was postulated that these 
regulators might be important for growth in the serum model. Insertionally inactivated 
mutants, of both agr, sarA and a double agr, sarA mutant constructed in the isogenic 
parental background 8325-4 (Chan and Foster, 1998a), were grown in the serum model. 
Growth experiments revealed that in both BHI and serum under all conditions, PC6911 
(agr) and PCl8391 (agr sarA) strains consistently reach a slightly higher A600 than the 
parental strain (8325-4). PC1839 (sarA) however grew at approximately the same rate 
and gave the same yield as 8325-4 (results not shown). Thus agr and sarA do not play 
an important role during growth in the serum model. 
3.2.4.2 The role of sigma factor o-B in the serum model 
Under deleterious conditions, such as a lack of nutrients or other environmental 
stresses, S. aureus induce sophisticated response mechanisms, in order to protect 
against environmental stress and thus allow continued growth. The alternative sigma 
factor o-B (sigB) has been shown to control the environmental stress response, in S. 
aureus. Therefore it is possible that sigma factor 0'8, may be important for growth in the 
serum model. 
To test this theory, a sigB insertionally inactivated mutant (PC400) (Chan el al., 1998b) 
was grown in serum to determine whether the loss of this stress sigma factor was 
deleterious to growth. Cultures of 8325-4, along with PC400 (sigB) were grown in BHI 
and serum at 37 DC with shaking (250 rpm), under both aerobic and microaerobic 
conditions. Cultures were grown for 24 h and growth was monitored by A600• Results 
revealed that the growth rate and final growth yield of PC400 (sigB) and 8325-4 were 
identical to each other under all four conditions (results not shown). Thus ~ has no role 
in the ability of S. aureus to grow in the serum model. 
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Figure 3.9 
The effect of catalase on the growth of 8325-4 in liquid serum cultures 
S. aureus 8325-4 was grown at 37°C in serum containing a range of concentrations of 
catalase (0-1000 flg ml- I). Cultures were incubated aerobically with shaking (250 rpm) 
and growth was measured as A600 for 24 h. The results are representative of at least two 
separate experiments. 
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3.2.4.3 The role of enzymes protecting against toxic forms of oxygen in the 
serum model 
Resistance against oxidative stress is important for the growth and survival of S. aureus 
in all conditions were oxygen is present. Reactive oxygen species cause severe damage 
to macromolecular cellular components, including membranes, proteins, RNA and most 
importantly DNA (Fridovich, 1995). The cell has several mechanisms of defence 
against oxidative stress. One line of defence is the synthesis of enzymes, including 
catalase and superoxide dismutase (SOD), which directly destroy reactive oxygen 
species and thus prevent oxidative damage occurring. 
As already discussed (Chapter 3.2.3.2), oxygen stress/toxicity is believed to play an 
important role in the growth of S. aureus in serum. To investigate this further, strains 
defective in catalase (STI (katA)), and SOD (SPWI (sodA)), were grown along with 
8325-4 under all four experimental conditions. Growth rates and yields were then 
compared to determine if the lack of these protective enzymes was deleterious to the 
organism. 
3.2.4.3.1 The role of the KatA in the serum model 
Catalase is an enzyme that functions to protect cells from hydrogen peroxide (H20 2), 
which is a reactive oxygen species and can cause cell damage and death. Therefore the 
loss of this enzyme will potentially reduce the cells aerotolerance. The major catalase 
(KatA) of S. aureus has recently been identified as a starvation-survival mutant and 
furthermore has been shown to be important in a mouse abscess model of pathogenicity 
(Horsburgh and Foster, unpublished data). To investigate the role ofKatA in the ability 
of S. aureus to grow in serum, the growth kinetics of STI (kalA) were compared to the 
parent 8325-4. Strains were grown in BHI or serum at 37°C with shaking (250 rpm), 
under both aerobic and microaerobic conditions. 
The growth rate and final yield of STI (katA) and 8325-4 were identical to each other in 
BHI under all conditions (Figure 3.10). In contrast, the results in serum showed that 
while the growth yield is not significantly altered, there is a clear defect in the growth 
kinetics of STI (kalA) compared to 8325-4 (Figure 3.lla and 3.11b). This is true for 
both aerobic (Figure 3.lla), and microaerobic conditions (Figure 3.l1b). The growth 
defect is greater under aerobic than microaerobic conditions. This result is therefore in 
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Figure 3.10 
The role of the KatA in the growth of S. aureus in BRI 
S. aureus 8325-4 and STI (katA) were grown at 37°C in BHI under aerobic and 
microaerobic conditions with shaking (250 rpm). Growth was measured as A600 for 24 
h. The results are representative of at least two separate experiments. 
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The role of the KatA in the growth of S. aureus in serum under aerobic conditions 
S. aureus 8325-4 and SIl (katA) were grown at 37°C in serum under aerobic 
conditions with shaking (250 rpm). Growth was measured as A600 for 24 h. The results 
are representative of at least two separate experiments. 
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Figure 3.11b 
The role of the KatA in the growth of S. aureus in serum under microaerobic conditions 
S. aureus 8325-4 and STI (katA) were grown at 37°C in serum under microaerobic 
conditions with shaking (250 rpm). Growth was measured as A 600 for 24 h. The results 
are representative of at least two separate experiments. 
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agreement with the postulation that oxidative stress is lower under reduced O2 levels 
(microaerobic conditions). 
3.2.4.3.2 The role of SodA in the serum model 
SODs are a class of enzyme that function to protect cells from superoxide radicals (02"). 
Thus loss of these enzymes will potentially reduce the aerotolerance of bacterial cells. 
Three types of SOD have been identified in eubacteria: Mn-SOD (Touati, 1988), Fe-
SOD (Yost and Fridovich, 1973) and Cu-Zn-SOD (Imlay and Imlay, 1996), two of 
which have to date, been identified in S. aureus (Mn-SOD and Fe-SOD) (Clements et 
ai., 1999b). 
A sodA (Mn-SOD) mutant was recently identified in S. aureus as a starvation-survival 
mutant following Tn917 mutagenesis (Watson et al., 1998b). This strain was used to 
investigate the potential role of oxidative stress on S. aureus when grown in serum. If 
oxidative stress is important for the growth of S. aureus then the sodA mutant (which 
has lowered SOD activity (Clements et al., 1999b» may well be impaired in growth, 
either demonstrating, a reduced growth rate, and/or a reduced yield. SPWI (sodA) along 
with 8325-4 were grown in BHI and serum under both aerobic and microaerobic 
conditions, at 37°C with shaking (250 rpm). The growth rate and final yield of SPWI 
(sodA) and 8325-4 were identical to each other, under all four experimental conditions 
(Figures 3.12-3.13). Therefore the loss of the Mn-SOD (SodA) is not detrimental to 
growth in serum. 
3.2.4.4 The role of CtaA in the serum model 
A Tn917 insertion mutant with a defect in starvation-survival and recovery was recently 
identified (Watson et al., 1998b). Sequencing and analysis of chromosomal DNA 
flanking the Tn917 insert revealed that the transposon had inserted in a gene with 39.7 
% identity to ctaA of B. subtilis (Clements et al., 1999a). ctaA encodes a haem 0 
monoxygenase which converts haem 0 to haem A (Svensson et al., 1993). SPW3 
(ctaA) had a major defect in its ability to recover following starvation. However, this 
defect was partially alleviated, by the addition of catalase to the recovery medium, 
indicating a probable involvement of oxidative stress (Clements et al., 1999a). To 
investigate the role of CtaA in the ability of S. aureus to grow in serum, the growth 
kinetics of SPW3 (ctaA) were compared to the parental strain 8325-4. Strains were 
129 
100 
10 ----
_ 8325-4 Aerobic 
-.-SPWI Aerobic 
<:> 
<:> 
"" -e-8325-4 
-< 
Microaerobic 
-e- SPW1 
Microaerobic 
0.1 
0.01 
o 5 10 15 20 25 
Time (h) 
Figure 3.12 
The role of SodA in the growth of S. aureus in BHI 
S. aureus 8325-4 and SPWI (sodA) were grown at 37°C in BHI under aerobic and 
microaerobic conditions with shaking (250 rpm). Growth was measured as A 600 for 
24 h. The results are representative of at least two separate experiments. 
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The role of SodA in the growth of S. aureus in serum 
S. aureus 8325-4 and SPWI (sodA) were grown at 37 °C in serum under aerobic and 
microaerobic conditions with shaking (250 rpm). Growth was measured as A600 for 
24 h. The results are representative of at least two separate experiments. 
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grown in BHI and serum under both aerobic and microaerobic conditions, at 37°C with 
shaking (250 rpm). The growth rate and final yield of SPW3 (ctaA) and 8325-4 were 
identical to each other under all four experimental conditions (results not shown). 
Therefore the loss of haem A synthase is not detrimental to growth in serum. However, 
when SPW3 (ctaA) is plated onto serum agar plates, small colony variants are observed, 
as previously reported for other types of solid media (Clements et al., 1999a). 
3.2.5 Expression of known components in the serum model 
The serum model was used to analyze the expression of known components, many of 
which are known to be involved in pathogenesis. These components are: the major 
global regulators agr, and sarA; sigma factor as (sigB), a stress response sigma factor; 
fur, ferric uptake regulator; surface protein A (spa), negatively regulated by agr; 
a-haemolysin (hla), positively regulated by agr; catalase (katA); SOD (sodA); and 
haem 0 monoxygenase (ctaA). The expression of these nine genes was investigated 
using chromosomal transcriptional-reporter gene fusions in 8325-4. 
Seven of the nine lacZ strains (SH109 (hZd::lacZ), PC161 (sarA::lacZ), MClOO 
(sigB::ZacZ), MJH005 (fur::ZacZ)), PC203 (spa::ZacZ), PC322 (hla::lacZ) and MJH006 
(katA::lacZ) had previously been constructed (Fairhead, 1998; Chan and Foster, 1998a; 
Chan et al., 1998; Horsburgh and Foster, unpublished data) using a suicide vector 
(PAZ 1 06) resulting in a single-crossover integrational event. The fusions contain an 
intact copy of the gene plus a truncated copy fused to ZacZ stably inserted into the 
chromosome of 8325-4. However, SPWI (sodA::lacZ) and SPW3 (ctaA::ZacZ) were 
created by Tn917 insertion (Watson et at., 1998b), and thus do not contain intact copies 
of the fused genes. The expression of these nine known components was investigated in 
BHI and serum, under both aerobic and microaerobic conditions. BHI is a nutrient-rich 
growth medium and thus differences in expression pattern between BHI and serum, 
represent differential regulation. 
3.2.5.1 Expression of lacZ transcriptional fusions on solid media 
Initially all lacZ fusion strains along with 8325-4 were grown on BHI and serum agar 
plates containing X-Gal (Chapter 2.11.1). X-Gal is hydrolysed by ~-galactosidase, 
resulting in ~-D-galactopyranoside and 5-bromo-4-chloro-3-indolyl. 5-bromo-4-chloro-
3-indolyl has a blue colouration and is thus a visible indicator of ~-galactosidase. 
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LacZ BHI BHI Sera Sera BHI BHI Sera Sera 
Fusion Strain Aero Aero Aero Aero Micro Micro Micro Micro 
24h 48h 24h 48h 24h 48h 24h 48h 
SH109 
hld::lacZ ++++ ++++ ++ +++ ++++ ++++ +++ +++ 
PC161 
sarA::lacZ +++ +++ ++ +++ +++ +++ +++ +++ 
MCIOO 
sigB::lacZ +++ +++ ++ +++ +++ +++ ++ +++ 
MJHOO5 
Jur::lacZ +++ +++ ++ +++ +++ +++ +++ +++ 
PC203 
spa::lacZ 
- - - - - - - -
PC322 
hla::lacZ ++++ ++++ ++ +++ ++++ ++++ +++ +++ 
MJHOO6 
katA::lacZ +++ +++ ++ +++ +++ +++ ++ +++ 
SPWI 
sod.A::lacZ - - - - - - - -
SPW3 
ctaA::lacZ +++ +++ + ++ +++ +++ + ++ 
8325-4 - - - -
- - - -
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Table 3.6 
Expression of lacZ transcriptional fusions of known components on solid media (BHI 
and serum agar plates) under aerobic and micro aerobic conditions 
lacZ strains were grown on BHI and serum agar plates containing X-Gal, (a visible 
indicator of p-galactosidase activity) under both aerobic and microaerobic conditions. 
Plates were scored for blue colouration after 24 and 48 h. A scale to score colouration 
was designed: dark blue ++++; blue +++; light blue ++; very light blue +; white -. The 
results are representative of at least two separate experiments. 
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Strains were incubated at 37 °C under both aerobic and microaerobic conditions. Plates 
were scored for blue colouration after 24 and 48 h, and the results obtained are 
summarised in Table 3.6. All lacZ fusion strains except spa and sodA had a blue 
colouration on both BHI and serum agar, under both aerobic and microaerobic 
conditions after 48 h. As neither spa nor sodA produced blue colonies under any 
conditions, X-Gal is not sufficiently sensitive to study expression of these genes. Strain 
8325-4, which was used as a control, was not blue on X-Gal under any conditions. The 
results (Table 3.6) indicate that there is little difference in transcriptional control 
between growth aerobically or microaerobically, or on BHIIserum. However, from this 
work there are two apparent differences in the expression of the known components 
under the different conditions. The first is that both agr and hla have a greater blue 
coloration (greater expression) on BHI than serum. The second is that agr, sarA, fur and 
hla appear to be expressed to a greater level on serum microaerobically after 24 h 
compared with the level of expression aerobically. 
3.2.5.2 Expression of lacZ transcriptional fusions in liquid media 
The plate assay is very insensitive and does not allow temporal expression to be 
measured. The use of liquid cultures with the fluorogenic substrate MUG (Chapter 
2.11.2) is sensitive, quantitative and allows temporal expression to be measured. The 
expression of each fusion strain was measured during growth in BHI and serum, under 
both aerobic and microaerobic conditions. Previous studies (Chan and Foster, 1998b; 
Lindsay and Foster, 1999) have shown that slight alterations in growth conditions have 
a significant effect on the expression of virulence determinants. Hence, specific growth 
conditions defined in Chapter 2.4.1.1 were strictly adhered to. All fusion strains showed 
identical growth kinetics to each other and to the parental strain, 8325-4 (results not 
shown). Strain 8325-4 was used as a control in all the following experiments. The 
background level measured from 8325-4 samples (control samples), were deducted 
from the ~-galactosidase activity values from the lacZ fusion strains. 
3.2.5.2.1 SH109 (hld::lacZ) 
The SH109 (hld::lacZ) fusion strain had been previously constructed (Fairhead, 1998). 
Production of ~-galactosidase in this strain, allowed the convenient assay of hid and 
hence RNAIII expression, and therefore allows the expression of agr to be monitored 
during growth in BHI and serum under both aerobic and microaerobic conditions. 
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Expression of hld::lacZ during growth in BHI (a) and serum (b) under aerobic and 
microaerobic conditions 
S. aureus SHI09 (hld::lacZ) was grown at 37°C in both BHI and serum under aerobic 
and microaerobic conditions with shaking (250 rpm). Specific p-galactosidase activity 
was determined and expressed in MUG units. The results are representative of at least 
two separate experiments. 
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Expression in BHI was shown to increase dramatically as cells entered post-exponential 
phase (- 52,000 MUG units; t = 5 h) achieving a maximum in stationary phase (t = 24 
h) (Figure 3.14a). Expression of agr in serum however was considerably lower (>15-
fold) than that achieved in BHI, (Figure 3.14b) although the expression kinetics, were 
very similar. In serum under both aerobic and microaerobic conditions the expression of 
agr, increased as cells entered post-exponential phase (t = 5 h), where it remained high 
throughout stationary phase (Figure 3.14b). Expression of agr in both media was not 
significantly altered by growth under the different conditions (Table 3.7). 
3.2.5.2.2 PC161 (sar::lacZ) 
The sarA::lacZ fusion (PCI61), measures transcription initiated from all three sar 
promoters (Chan and Foster, 1998a). The pattern of sarA expression was determined to 
be similar in BHI under both environmental conditions (Figure 3.l5a). sarA expression 
was found to increase during exponential phase, level off during early stationary phase 
(expression decreases slightly under microaerobic conditions) and finally increase 
during late stationary phase. The maximum MUG unit expression values however were 
altered for the different aeration conditions with expression being - 2-fold greater under 
aerobic (5,800 MUG units; t = 24 h) than microaerobic (3,000 MUG units; t = 4 h) 
conditions. Expression of sarA in serum was also similar under aerobic and 
microaerobic conditions (Figure 3 .15b). The general trend was constitutive expression 
during exponential phases followed by an increase in relative levels in stationary phase. 
As for BHI, the maximum MUG unit expression values in serum were altered for the 
different conditions with maxima of - 2,300 (t = 12.5 h) and 1,700 (t = 12.5 h) MUG 
units for aerobic and microaerobic conditions, respectively. Interestingly, for both 
media the expression of sarA was higher under aerobic than microaerobic conditions 
(Table 3.7). 
3.2.5.2.3 MC100 (sigB::lacZ) 
Growth of S. aureus MClOO allows the expression of sigB to be determined (Chan et 
al., 1998). The expression of sigB when grown in BHI was found to be very similar 
under both aerobic and microaerobic conditions, exhibiting comparable patterns of 
expression and similar levels of gene expression (p-galactosidase production) (Figure 
3.l6a). Under both aerobic and microaerobic conditions, sigB showed a peak of 
expression as cells entered the post-exponential phase, following this, there was a 
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Expression of sarA: :lacZ during growth in BHI (a) and serum (b) under aerobic and 
microaerobic conditions 
S. aureus PC161 (sar::lacZ) was grown at 37°C in both BHI and serum under aerobic 
and microaerobic conditions with shaking (250 rpm). Specific p-galactosidase activity 
was determined and expressed in MUG units. The results are representative of at least 
two separate experiments. 
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Figure 3.16 
Expression of sigB::lacZ during growth in BHI (a) and serum (b) under aerobic and 
microaerobic conditions 
S. aureus MClOO (sigB::lacZ) was grown at 37 DC in both BHI and serum under 
aerobic and microaerobic conditions with shaking (250 rpm). Specific p-galactosidase 
activity was determined and expressed in MUG units. The results are representative of 
at least two separate experiments, 
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reduction before a further increase in expression during stationary phase (- t = 15 h). 
The kinetics of expression of sigB when grown in serum under the different conditions 
were found to be similar to each other. Under both aerobic and microaerobic conditions 
there was an increase in sigB transcription during exponential phase reaching a 
maximum of 140 MUG units (t = 6 h aerobic, t = 5 h microaerobic), (Figure 3.16b). 
However, after this point, expression decreased without the characteristic stationary 
phase increase observed in BHI. Once more the level of expression in the two media 
was slightly different with sigB being expressed 2- 3-fold higher in BHI (Table 3.7). 
3.2.5.2.4 MJH005 (fur: :lacZ) 
The expression of fur was studied using the lacZ fusion strain MJH005 (Horsburgh and 
Foster, unpublished data) and was shown to be regulated in a comparable growth phase 
dependent manner, under all four experimental conditions. fur expression was shown to 
increase during exponential phase, before reaching a maximal MUG unit count during 
post-exponential phase (t = 4-5 h) (1,700 and 900 MUG units BHI, aerobic and 
microaerobic conditions respectively; and 365 and 270 MUG units serum, aerobic and 
microaerobic conditions respectively). Following this period of maximum transcription, 
expression rapidly declined to a basal level (- 400 and 100 MUG units, BHI and serum 
respectively) where it remained throughout stationary phase (Figure 3.17). 
Transcription of fur was seen to be greater in both growth media under aerobic 
conditions and expression was - 4-fold greater in BHI than in serum (Table 3.7). 
3.2.5.2.5 PC203 (spa::lacZ) 
Surface protein A expression was monitored throughout growth using the spa: :lacZ 
strain PC203 (Chan and Foster, 1998b). In both BHI and serum under aerobic 
conditions, levels increased during exponential phase, achieving maximal expression of 
75 and 210 MUG units for BHI and serum respectively, during late exponential phase 
(t = 4 h). Following this period of maximal expression, the expression decreased 
dramatically as cells entered stationary phase, « 5 and < 20 MUG units for BHI and 
serum respectively) (Figure 3.18). spa expression in serum followed exactly the same 
trend microaerobicallyas it did aerobically, with maximal expression occurring in late 
exponential phase (t = 4 h) followed by a decline on entry to stationary phase 
(Figure 3.18b). Maximum expression was however only - 15 % (30 MUG units) of that 
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Figure 3.17 
Expression of Jur::lacZ during growth in BHI (a) and serum (b) under aerobic and 
microaerobic conditions 
S. aureus MJH005 ifur::lacZ) was grown at 37°C in both BHI and serum under aerobic 
and microaerobic conditions with shaking (250 rpm). Specific p-galactosidase activity 
was determined and expressed in MUG units. The results are representative of at least 
two separate experiments. 
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Expression of spa::lacZ during growth in BHI (a) and serum (b) under aerobic and 
microaerobic conditions 
S. aureus PC203 (spa::lacZ) was grown at 37°C in both BHI and serum under aerobic 
and microaerobic conditions with shaking (250 rpm). Specific p-galactosidase activity 
was determined and expressed in MUG units. The results are representative of at least 
two separate experiments. 
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obtained under aerobic conditions. The same reduction in expression was witnessed in 
BHI under microaerobic conditions as in serum. However, under these conditions the 
characteristic increase in expression during exponential phase was not observed 
(Figure 3.18a) (Table 3.7). 
3.2.5.2.6 PC322 (hla: :lacZ) 
The PC322 (hla::lacZ) fusion strain has been previously constructed allowing the 
expression of the toxin a-haemolysin to be monitored (Chan and Foster, 1998b). 
During growth in BHI, transcription of hla was found to increase dramatically during 
the transition between exponential and post-exponential phases (Figure 3.19a). The 
expression of hla in BHI is almost identical under both aerobic and microaerobic 
conditions, with very similar patterns of expression and almost identical maximum 
levels of gene expression (B-galactosidase activity) of - 42,000 MUG units (t = 24 h 
aerobic, t = 5 h microaerobic). Expression of a-haemolysin in serum aerobically, 
followed a similar trend to that observed in BHI with a rapid increase in hla 
transcription occurring during the post-exponential phase, maximum of - 9,000 MUG 
units t = 15 h (Figure 3 .19b) (Table 3.7). A similar increase in expression was observed 
in serum under microaerobic conditions, however maximum expression occurs earlier 
in the growth phase (post-exponential phase t = 5 h) and at a significantly lower level 
(- 2,500 MUG units). Following this maximal expression, as for all other conditions, 
the expression remained relatively high throughout stationary phase (Figure 3 .19b). 
3.2.5.2.7 MJH006 (katA::lacZ) 
Production of KatA was investigated throughout growth using MJH006 (kalA: :/acZ 
(Horsburgh and Foster, unpublished data)). Under all four experimental conditions 
studies revealed that maximal expression occurred during stationary phase. Expression 
of katA is significantly higher in both growth media under aerobic than microaerobic 
conditions (> 4-fold, BHI and> 2.5-fold, serum) and higher in BHI than serum (Figure 
3.20; Table 3.7). Furthermore, the kinetics of expression of kalA, were almost identical 
within the same media. Expression in BHI showed an increase as cells entered post-
exponential phase and then a second increase (a large increase aerobically) in stationary 
phase, reaching maximal MUG unit values of 1,800 and 475 when grown aerobically 
and microaerobically respectively (Figure 3.20a). In serum the first increase in 
expression seen in BHI, as cells entered post-exponential phase was not apparent but 
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Figure 3.19 
Expression of hla::lacZ during growth in BHI (a) and serum (b) under aerobic and 
microaerobic conditions 
S. aureus PC322 (hla::lacZ) was grown at 37°C in both BHI and serum under aerobic 
and microaerobic conditions with shaking (250 rpm). Specific p-galactosidase activity 
was determined and expressed in MUG units. The results are representative of at least 
two separate experiments. 
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Figure 3.20 
Expression of katA::lacZ during growth in BHI (a) and serum (b) under aerobic and 
microaerobic conditions 
S. aureus MJH006 (katA::lacZ) was grown at 37°C in both BHI and serum under 
aerobic and microaerobic conditions with shaking (250 rpm). Specific p-galactosidase 
activity was determined and expressed in MUG units. The results are representative of 
at least two separate experiments. 
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the large increase during stationary phase to a maximal expression value was observed, 
(460 and 170 MUG units aerobic and microaerobic conditions respectively) 
(Figure 3 .20b). 
3.2.5.2.8 SPWI (sodA::lacZ) 
The sodA::lacZ fusion strain (SPW1) was constructed as a result of the insertion of the 
transposon Tn917 into the sodA gene (Watson et al., 1998b). sodA had the lowest 
transcriptional levels of all the fusion strains studied, with expression at the very limits 
of MUG detection. Expression of sodA was detectable in BHI, (~ 6-10 MUG units 
during post-exponential phase), with some increase in expression of sodA in BHI as 
cells entered post-exponential and stationary phase (Figure 3.21a). Transcription of 
sodA in serum however was either 'switched off or was below the level of detection 
(Figure 3 .21 b). The effect of incubation under either aerobic or microaerobic conditions 
was negligible on the expression of sodA, in both BHI and serum (Table 3.7). 
3.2.5.2.9 SPW3 (ctaA::lacZ) 
The ctaA::lacZ fusion strain (SPW3) was also created by Tn917 transposon 
mutagenesis (Watson et al., 1998b). The kinetics of ctaA expression, were found under 
all conditions, to increase sharply during exponential growth and to be maximally 
expressed at the end of this growth period. Following entry into stationary phase the 
expression of ctaA declined. Throughout growth transcription is low under all 
conditions but is > lO-fold higher in BHI than it is in serum (Figure 3.22). Transcription 
of ctaA in BHI was reduced microaerobically (t = 5; l30 Vs 94 MUG units), however 
the reverse is true in serum (t = 4; 6 Vs 10 MUG units), although the expression levels 
in serum are approaching the limits of detection (Table 3.7). 
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Figure 3.21 
Expression of sodA::lacZ during growth in BHI (a) and serum (b) under aerobic and 
microaerobic conditions 
S. aureus SPWI (sodA::lacZ) was grown at 37°C in both BHI and serum under aerobic 
and microaerobic conditions with shaking (250 rpm). Specific ~-galactosidase activity 
was determined and expressed in MUG units. The results are representative of at least 
two separate experiments. 
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Figure 3.22 
Expression of ctaA::lacZ during growth in BHI (a) and serum (b) under aerobic and 
microaerobic conditions 
S. aureus SPW3 (ctaA::lacZ) was grown at 37 °C in both BHI and serum under aerobic 
and microaerobic conditions with shaking (250 rpm). Specific p-galactosidase activity 
was determined and expressed in MUG units. The results are representative of at least 
two separate experiments. 
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lacZ 
fusion BHI BHI Sera Sera 
strain Aerobic Microaerobic Aerobic Microaerobic 
SH109 Large increase in Almost identical Expression reduced Expression reduced 
hid expression during expression kinetics > 20-fold > 20-fold 
late exponentiaV to aerobic throughout post- throughout post-
early post- conditions. exponential and exponential and 
exponential phase. Maximum - 53,000 stationary phases. stationary phases. 
Maximum - 53,000 MU, t=24 h. Maximum - 2,250 Maximum - 2,700 
MU,t=24h. MU, t = 14 h. MU, t= 5 h. 
PC161 Expressed Expression reduced Expression reduced Expression reduced 
sarA constitutively 1.5- 2.5-fold during 1.5- 2.5-fold during 2- 5-fold during 
throughout growth. stationary phase. stationary phase. stationary phase. 
Large increase in Maximum - 3,200 Maximum - 2,300 Maximum - 1,700 
expression during MU, t=4 h. MU, t= 13 h. MU, t=4 h. 
stationary phase 
Maximum - 5,700 
MU, t=24 h. 
MC100 Increases in Increased Reduced expression Reduced expression 
sigB expression occur expression (1.5- 2- during exponential during exponential 
during both fold) during phase (- 2-fold) and phase (- 2-fold) and 
exponential and late exponential and stationary phase stationary phase 
stationary phase. post-exponential (- 9-fold). (- 9-fold). 
Maximum - 360 phases. Maximum Maximum - 140 Maximum - 140 
MU, t= 24h. -450 MU, t= 5 h. MU, t=6 h. MU, t= 5 h. 
MJH005 Expression increased Expression reduced Expression reduced Expression reduced 
fur during exponential - 2-fold during - 4-fold during 
- 5-fold during 
phase (to - 1,700 post-exponential post-exponential post-exponential 
units), followed by a phase. Maximum phase. Maximum phase. Maximum 
rapid decrease to a -900 MU, t= 5 h. 
- 470 MU, t = 6 h. 
- 280 MU, t = 4 h. 
basal level on entry 
to post-exponential 
phase. Maximum 
- 1,650 MU, t = 5 h. 
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lacZ 
fusion BHI BHI Sera Sera 
strain Aerobic Microaerobic Aerobic Microaerobic 
(cont.) 
PC203 Expression increased Reduced Increased Reduced expression 
spa during exponential expression. No expression during during exponential 
growth (maximum characteristic peak exponential phase phase (> 2-fold). 
-70 MU, t = 4). of expression during (3-fold). Maximum Maximum -25 
Expression decreased exponential phase. -210MU,t=4h. MU, t=4 h. 
as cells entered post- Maximum 
exponential phase. - 10 MU, t = 7 h. 
PC322 Expression increases Expression reduced Expression reduced Expression reduced 
hla rapidly during post- slightly during late - S-fold throughout - I5-fold 
exponential phase, statuary phase. post-exponential throughout post-
levels remained high Maximum and stationary exponential and 
during stationary -41,000 MU, phases. Maximum stationary phases. 
phase. Maximum t = 5 h. -9,000 MU, Maximum - 2,500 
-42,500 MU, t = 14 h. MU, t= 5 h. 
t = 24 h. 
MJH006 Large increase in Reduced expression Reduced expression Reduced expression 
kalA expression during throughout growth. throughout growth. throughout growth. 
stationary phase, Maximum - 470 Maximum - 460 Maximum - 170 
Maximum - 1,780 MU, t=24 h. MU, t= 14h. MU, t= 24 h. 
MU, t=24h. 
SPWI Very low but Very similar No detectable level No detectable level 
sodA constitutive expression kinetics. of expression. of expression. 
expression. Maximum - 5 MU, 
Maximum - 10 MU, t = 8 h. 
on entry to stationary 
phase (t = 7 h). 
SPW3 Expression increased Slight reduction in Reduced expression Reduced expression 
claA throughout expression > lO-fold > lO-fold 
exponential phase throughout growth. throughout growth. throughout growth. 
(maximum - 130 Maximum-95 Maximum - 7 MU, Maximum -10 
MU, t = 5 h), MU, t=5 h. t = 5 h. MU, t=4h. 
followed by a sharp 
decrease to a basal 
level. 
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Table 3.7 
Comparison of lacZ fusion expression data grown under different conditions, to 
expression in BHI under aerobic conditions 
Summary of the major difference between the expression ofSHl09 (hld::lacZ), PC16l 
(sarA::lacZ), MCIOO (sigB::lacZ), MJH005 (jur::lacZ), PC203 (spa::lacZ), PC322 
(hla::lacZ), MJH006 (katA::lacZ) SPWI (sodA::lacZ) and SPW3 (ctaA::lacZ) strains, 
when grown in BHI under microaerobic conditions and in serum under both aerobic and 
microaerobic conditions, compared to that when the same fusion strain is grown in BHI 
under aerobic conditions, (standard laboratory conditions). All fusion strains were 
grown in 25 ml cultures, in 100 ml flasks for 24 h at 37°C with shaking (250 rpm). 
Expression of lacZ fusion strains was followed throughout growth by measuring the 
amount of ~-galactosidase produced (encoded by lacZ) using the fluorescent substrate 
MUG. 
MU - ~-galactosidase activity (MUG units). 
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3.3 Discussion 
Two in vitro models mimicking infection have been developed. The first, synthetic 
cerebrospinal fluid (sCSF) proved to be a starvation-survival medium and so was of no 
use for the growth and culturing of bacteria. For this reason, it was deemed not to be a 
suitable model mimicking infection. 
S. aureus is capable of surviving for a long period of time (> 35 days) in both sCSF I 
and II. Starvation-survival kinetics similar to those previously seen in S. aureus 
(Watson et al., 1998a/b), were seen in sCSF. Results showed that survival was greater 
in the simpler of the two sCSF's (sCSF I). This can be explained as when S. aureus is 
nutrient limited, particularly for carbon source, it enters a dormant type state and so 
cells are capable of long-term survival. sCSF II however contains glucose and studies 
have shown that under starvation conditions, when excess glucose is present, the 
glucose is fermented bringing about a decrease in pH. This reduction in pH has been 
shown to increase the rate at which S. aureus dies (Watson et ai., 1998a). 
The second model mimicking infection is the serum model. S. aureus was shown to 
grow in both solid and liquid sera (pig and human), under both aerobic and 
microaerobic conditions. Microaerobic conditions were discovered to have a large 
beneficial effect on the growth of S. aureus on solid serum medium, with a much 
smaller but still noticeable effect in liquid medium. The possible reasons for this 
increased growth yield on serum microaerobically are discussed later. Why the increase 
is so much more dramatic on solid media than liquid however was not elucidated, but is 
potentially linked to the fact that growth on solid serum media is very poor and so any 
increase in growth rate or yield is likely to be much more noticeable. However, 
microaerobic conditions not only improve growth rates and yields in serum, but are also 
postulated to make the model more akin to conditions found in vivo (reduced O2 and 
increased CO2 tension). Thus in general micro aerobic conditions were used for the 
growth of S. aureus unless the effect of environmental conditions needed to be 
investigated. 
Examination of the growth of S. aureus on different media revealed that the growth 
yield in serum is significantly lower than that found on BHI. However, growth is 
comparable to that found in a chemically defined medium (CDM), as determined by 
both ~ and cfu. Thus despite serum being a complex medium containing many 
different components (Tables A.1.5-A.1.7) it does not support such profuse growth as 
BHI. The serum model therefore proved to be a suitable model for the potential 
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identification of components important to the growth of S. aureus under conditions 
mimicking infection. However, as the growth yield was low, especially on solid media, 
there is some factor, or factors which are limiting. 
The effect of environmental oxygen and carbon dioxide concentrations was investigated 
following the discovery that microaerobic conditions (reduced oxygen and increased 
carbon dioxide concentration) increased the growth yield in serum. S. aureus grew to a 
increased growth yield anaerobically than aerobically, detennined by colony size, 
although the growth in serum was found to be greatest under microaerobic conditions. 
This indicated that the presence of oxygen is potentially both harmful and beneficial to 
the growth of S. aureus in serum, as optimal growth is achieved in a microaerobic 
environment. This therefore hints towards a threshold level above which oxygen 
becomes toxic and below which impairs growth. Following the discovery that oxygen 
levels were important in detennining the growth yield of S. aureus in serum, the effect 
of increasing culture aeration was investigated. This revealed that increasing the 
aeration of serum cultures (by decreasing the culture volume) had little or no effect on 
either the growth rate or final growth yield. This was not expected, as it was presumed 
that increasing culture aeration would increase the oxygen concentration in serum, and 
thus decrease the growth yield, as seen for aerobic Vs microaerobic growth. This result 
is also in contrast to those for S. aureus 8325-4 grown in BHI, where it has been shown 
that increasing culture aeration (by decreasing the culture volume) increases the growth 
yield (Lindsay and Foster, 1999). Therefore the role of oxygen concentration (and 
probably carbon dioxide) in the growth of S. aureus is not simple and further studies are 
required. 
To further study oxidative stress in serum, catalase was added. Interestingly, this 
produced different results for solid and liquid media, with an advantageous effect only 
being witnessed on solid media. The results of the addition of catalase to solid serum 
showed that while catalase promotes growth aerobically it has no significant effect 
microaerobically. In liquid serum an improved growth yield was not even observed 
aerobically, and in fact high concentrations of catalase (1000 JlM) proved toxic. 
However, from the results obtained from growth on solid media aerobically in the 
presence of catalase, it can be concluded that oxidative stress is a factor limiting growth 
on serum. More accurately S. aureus appears to be sensitive to H20 2 toxicity, as this 
reactive oxygen species is destroyed by catalase. However, because the growth yield is 
not improved to the level that was obtained microaerobically it can be hypothosized that 
other toxic fonns of oxygen (for example O2' or 'OH) may also be problematic and/or 
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the higher levels of carbon dioxide are also important for the improved growth of S. 
aureus under microaerobic conditions. 
Iron was added to serum in an attempt to determine whether iron concentration was a 
factor limiting growth in serum, as it had been seen that the growth yield of S. aureus 
was low, especially on solid media. The addition of iron to serum however, once more 
revealed differences between the growth of S. aureus on solid and liquid media, with an 
advantageous effect only witnessed on solid media. The addition of iron (up to 500 11M) 
to solid media was shown to improve the growth of S. aureus under both aerobic and 
microaerobic conditions although the increase was much more dramatic under aerobic 
conditions. In liquid cultures however the addition of iron had no obvious beneficial 
effect on growth. The reason for this increase in growth yield on solid media could 
simply be due to the concentration of freely available iron being low in serum. Trivier 
et ai., (1995) showed that S. aureus strains had a decreased growth rate and yield under 
iron restricted conditions. Alternatively the addition of iron may mean that S. aureus no 
longer has to produce large quantities of siderophores (iron scavenging proteins) 
(Courcol et at., 1997), thus conserving energy for growth. The addition of iron to serum 
however did not improve the growth to that achieved with BHI. Therefore it can be 
concluded that while the concentration of iron in serum appears to be a limiting factor, 
it is by no means the only one and so the iron concentration in serum is not the vital 
nutrient limiting growth. Why the benefit of iron addition is only seen on solid media is 
unclear, although it could be linked to the use of 50 % (v/v) serum in serum agar plates 
and 100 % (v/v) serum in serum cultures. Thus there is twice the amount of iron ml·t in 
liquid than solid media. However, more work is needed to further prove this hypothesis. 
Investigations into the role of the major global regulators agr and sar showed that these 
loci are not essential for growth in the serum model, as strains containing mutations in 
these genes were not attenuated in growth in the serum model. These results were 
comparable to published data for agr and sarA mutants in vitro (Lindsay and Foster, 
1999; Chan and Foster, 1998a). The increased growth yield seen for both agr and agr 
sarA mutants may be due to energy constraints being lifted, as the cell is no longer 
capable of producing large quantities of many of the extracellular protein that are 
normally produced at the end of exponential phase, in an agr dependent manner. Thus a 
greater amount of energy is available for growth, increasing the culture yield. The fact 
that both agr and sarA mutants have been shown to have reduced virulence in some 
animal models (Abdelnour et at., 1993; Booth et at., 1995) indicates that pathogenicity 
is multifactorial, and no in vitro model can emulate its complexity. 
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Like the global regulators agr and sar, the alternative sigma factor a B does not appear to 
play an important role in the serum model. This conclusion can be drawn, as there was 
no growth attenuation of the strain defective at the sigB locus (PC400), compared to the 
parental strain 8325-4. Therefore, although it is postulated in this study that serum is a 
stressful environment, particularly under aerobic conditions, the alternative sigma factor 
~, which has been shown to control the environmental stress response in S. aureus 
(Chan et al., 1998), does not play an important role in the serum model. 
To continue with the analysis of the role of oxidative stress, S. aureus strains containing 
chromosomal mutations in loci known to be important in oxidative stress were analysed 
in the serum model. These were STI (katA (catalase», SPWI (sodA (SOD» and SPW3 
(ctaA (haem 0 monoxygenase». 
KatA has previously been shown not only to be important in the ability of S. aureus to 
successfully withstand long-term starvation, but also in its capability to form lesions in 
a subcutaneous mouse infection model (Horsburgh and Foster, unpublished data). This 
study showed STI (katA) to have a reduced growth rate when grown in serum. 
Interestingly, this growth defect was found to be partially alleviated by incubation 
under microaerobic conditions. Finally as STI (katA) showed no such grow defect in 
BHI, this study provided direct evidence for the increased sensitivity of S. aureus to 
toxic forms of oxygen (oxidative stress) when grown in serum. The absence of the 
major catalase (KatA), due to insertional inactivation may also have an effect on the 
production of other virulence factors as the failure to produce one substance may affect 
cellular regulatory circuitry. 
Analysis of SPWI (sodA) showed that SOD did not have an important role in the serum 
model, as this strain showed no growth defect when compared to the isogenic parent 
8325-4. SPWI (sodA), like STI (kalA) was postulated to be important in the serum 
model, as superoxide dismutase is the key enzyme in the protection against O2', a toxic 
form of oxygen. SPWI (sodA) has been shown to have a reduced SOD activity 
(Clements et ai., I999b), however there is at least one further SOD enzyme in S. aureus 
(Fe-SOD) whose activity must be sufficient to accommodate the postulated additional 
oxygen toxicity of growth on serum. 
CtaA has previously been shown to be important in oxidative stress, following the 
discovery that the addition of catalase to media aided the recovery of starved cells 
deficient at the ctaA locus (Clements et al., 1999a). Furthermore, SPW3 (ctaA) has been 
shown to have, reduced amounts of all exoproteins in the culture supernatant, including 
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toxins such as a-haemolysin and toxic shock syndrome toxin-I. This decrease in 
exoprotein production is because exoproteins are preferentially expressed in post-
exponential phase when growth appears to be conditional on haem A dependent 
cytochromes (Clements et al., I 999a). SPW3 (ctaA) however was not defective in 
growth when compared to the parental strain 8325-4 under any condition examined. 
Expression analysis, using the lacZ transcriptional fusions to the known components 
using X-Gal (solid media), showed this assay to be insufficiently sensitive to detect 
transcription from both spa and sodA. Furthermore, as this technique does not allow the 
temporal expression of genes to be measured, only a few conclusions can be drawn 
from this work. The most obvious conclusions are that agr (hid) and hla are expressed 
to a higher level on BHI than serum. The most probable explanation for this result is the 
fact that growth on BHI is significantly greater than that achieved on serum. As a result 
the concentration of AlP (Chapter 1.7.1.3), is increased and thus gene expression (agr 
and hla) is greater. This results in greater production of ~-galactosidase and thus a 
greater amount of the blue end product. It can also be seen that sarA, fur and hla are 
expressed to a higher level on serum under microaerobic than aerobic conditions, 
particularly after 24 h. Rather than this being due to an up regulation of transcription 
under microaerobic conditions, an increased growth rate and thus a greater number of 
cells producing ~-galactosidase, could be the explanation for this disparity in 
expression under aerobic and microaerobic conditions. Therefore, the expression of all 
nine genes appears to be identical on BHIIserum under aerobic and microaerobic 
conditions. These results would appear to be preliminary data indicating that these nine 
genes are not differentially regulated under aerobic and microaerobic conditions. 
Expression analysis of the lacZ transcriptional fusions of known components in liquid 
cultures using the fluorogenic substrate MUG is a much more sensitive and accurate 
method for measuring gene expression than the X-Gal assay. This technique showed 
that all nine lacZ strains (hid (agr), sarA, sigE, fur, spa, hla, katA, sodA, and ctaA) 
when grown in BHI, under both aerobic and micro aerobic conditions had detectable 
levels of ~-galactosidase activity. The same is essentially true for the growth of the lacZ 
strains in serum with (hid (agr), sarA, sigE, fur, spa, hla, katA, and ctaA all producing 
detectable levels of ~-galactosidase activity. However, under both aerobic and 
microaerobic conditions sodA::/acZ activity in serum was below the level of 
detection for the assay. Interestingly, in general the pattern of expression of lacZ fusion 
strains is similar under all four experimental conditions. However, there were some 
important regulatory differences, which are summarised in Table 3.7 and will be 
discussed further here. 
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The kinetics of agr (hid) expression showed the expected growth phase dependent 
pattern expected from previous studies (Fairhead, 1999). Expression in BHI rapidly 
increased as cells entered post-exponential phase, correlating with an increase in cell 
density, or more accurately octapeptide (AlP) density, reaching the threshold level 
necessary to switch on agr expression. In serum the final growth yield is significantly 
reduced compared to that in BHI, thus possibly explaining the decreased levels of agr 
(hid) expression. 
sarA expression was shown to be expressed constitutively under all four conditions in 
agreement with previous work by Chan and Foster, (1998a). Expression of sarA was 
shown to increase during the exponential growth phase, which is consistent with RNA 
analysis (Bayer et al., 1996). 
The kinetics of sigB expression in S. aureus have previously been reported (Chan et al., 
1998), and were shown to rise steadily throughout the growth period, with the highest 
levels attained during late stationary phase. Expression kinetics in this study however, 
are different to those described above. In this study, under all four conditions there was 
a peak of activity as cells entered post-exponential phase, followed by decreased 
expression during stationary phase. S. aureus o'P has been shown to playa role in stress 
resistance (Chan et al., 1998) and proteins including alkaline shock protein 23 and a 
thermonuclease have been shown to be regulated in a o'P dependent manner (Kullik et 
al., 1998a). Therefore the kinetics of o'P expression, are consistent with o'P expression 
being necessary to regulate stress response proteins, to prevent damage to cellular 
components as the cells entered stationary phase. 
The expression of the iron uptake regulator fur, which has been shown to repress 
siderophore biosynthesis and other iron uptake mechanisms in many Gram-negative 
bacteria, as well as in both B. subtilis and S. aureus (Bsat et al., 1998; Xiong et al., 
2000), was seen to be regulated in a growth phase dependent manner. The regulation 
was very similar under all four experimental conditions with maximum expression 
occurring as cells entered post-exponential phase. This peak of maximal expression just 
before cells entered post-exponential phase may be explained by the fact that during 
this transitional period, proteins involved in oxidative stress are known to be produced 
in large amounts while the cell is still relatively metabolically active, to combat the 
increased oxidative stress that occurs during stationary phase. This is important as iron 
in the cell can lead to oxidative stress by the Fenton reaction, thus stopping the uptake 
of iron into the cell, will reduce oxidative stress in the cell (Keyer and Imlay, 1996). 
The expression pattern of fur in serum was similar to that seen in BHI, however the 
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overall levels of expression were reduced. An explanation for this reduced level of 
transcription in serum compared with BHI could be that available iron levels are lower 
in serum and therefore there is a need for higher siderophore production. 
Surface protein A has been reported to be optimally expressed in late log phase and 
decreased during stationary phase (Vandenesch et al., 1991; Chan and Foster, 1998b), 
in unison with the expected expression kinetics for a gene repressed by agr 
(Chapter 1.7.1). Results for spa::lacZ (PCI61) expression in BHI under aerobic 
conditions and for serum under both aerobic and microaerobic conditions, were in 
agreement with this published work. Expression in BHI under microaerobic conditions 
however showed no transcription during late log phase. As spa is repressed by agr, it 
would be expected that in BHI under microaerobic conditions, when the cell density is 
reduced, spa expression would be greater as agr expression is reduced. This however is 
not the case, as it has been shown that sarA is a specific regulator of spa under 
microaerobic conditions (Chan and Foster, 1998a). spa expression was greater in serum 
than in BHI (under both conditions) as expected of a gene repressed by agr, as the final 
cell yield is lower in serum and as discussed above agr expression is significantly lower 
in serum. Furthermore, surface protein A is well known for its ability to bind 
immunoglobulins, which is important for the induction and propagation of any 
infection, including bacteraemia and therefore it would be expected that spa would be 
expressed preferentially in vivo. This result is therefore in agreement with the prediction 
of greater spa expression in the model mimicking infection (serum), than in BHI. 
Interestingly, expression is lower in serum under microaerobic conditions, showing a 
90 % reduction in expression compared to that found under aerobic conditions and is 
thus in agreement with both increased agr expression and microaerobic repression by 
sarA (Chan and Foster, 1998a). 
Expression of hla occurs preferentially in the transition between post-exponential and 
stationary phases of growth (Janzon et al., 1989; Vandenesch et a1., 1991; Chan and 
Foster, 1998b). Results here are in agreement with this pattern of growth phase 
dependent expression. Furthermore, levels of expression were seen to be linked to 
culture growth yield. In other words expression of hla is greatest when Aooo values are 
highest (BHI aerobic; highest growth yield, highest hla expression value). This is 
expected for a gene under regulatory control (positive) of agr, due to the density 
dependent signalling function (AlP) employed by agr, which up regulates hla 
expression. Microaerobically in BHI, levels of Hla and hla expression, have been 
shown to be diminished (Chan and Foster, 1998b). This may be due to a decrease in 
growth yield, and thus reduced quorum-sensing potential (Chapter 1.6.2) compared to 
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aerobic growth, although a specific regulatory mechanism may also account for this 
reduction. However, in this study only a small decrease in hla expression is seen as 
opposed to the large decrease seen by Chan and Foster (I 998b ). This disparity may be 
explained by the employment of different growth conditions which results in a greater 
growth yield microaerobically in this study (A600 - 8; t = 10 h) than that obtained by 
Chan and Foster (l998b) (~ - 4, t = 10 h). This indicates that a fall in quorum-
sensing potential may be at the heart of the difference in a-haemolysin expression 
levels. Interestingly, it has been reported that an increased level of CO2 (10 %) has a 
stimulatory effect on the production of a-haemolysin. The reasons for this increase are 
not clear, but it is thought to be due to a combination of factors including CO2 buffering 
capability and the role of CO2 fixation in the formation of key amino acids essential for 
a-haemolysin production (reviewed by Wiseman, 1975). However, data from this 
study, in particular the low level of expression detected in serum under microaerobic 
conditions, and that by Chan and Foster (I 998b) did not find this enhancement by CO2, 
These inconsistencies are almost certainly due to the employment of different growth 
conditions. The large difference seen in hla expression levels in BHI and serum may 
however not just be due to a reduced quorum-sensing potential as there are several 
reports where nutritional factors influence production of a-haemolysin. For example, a-
haemolysin has been found to be produced at different levels in different in vitro media, 
with an emphasis placed on the concentration of a few key amino acids (including 
arginine and valine) and glucose (Wiseman, 1975). Chan and Foster (l998b) also 
showed that salt and sucrose concentration were important as the additions of these to 
BHI (I M NaCI and 20 mM sucrose), lead to a dramatic decrease in hla expression. 
Therefore, the large discrepancy in hla expression in BHI and serum may be, at least in 
part due to the difference in nutritional status of the two media (Tables A.I.l and 
A.1.5-A.1.7). 
kalA was preferentially expressed during stationary phase and the level of expression in 
both media was greater under aerobic conditions. This is in accordance with the 
prediction that oxidative stress would be greater under aerobic conditions, and thus a 
gene involved in combatting oxidative stress (H20 2 toxicity), would be expressed to a 
greater level under aerobic (21 % 02) than microaerobic (10 % 02) conditions. 
The expression of sodA in BHI was low during exponential phase growth (t = 3h; 2 
MUG units) but increased by - 5-fold aerobically (t = 9h; 11 MUG units) and 3-fold 
microaerobically (t = 9h 6 MUG units) during stationary phase. This trend in SOD 
expression has previously been witnessed in S. aureus (Clements et al., 1999b). The 
fact that expression was increased aerobically compared to microaerobically, was most 
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probably a result of increased internal superoxide levels, leading to greater oxidative 
stress within the cell. Increased levels of SOD during stationary phase growth have also 
been observed in other bacteria including E. coli (Benov and Fridovich, 1995) and B. 
subtilis (Inaoka et al., 1998). The increase in SOD in cells during stationary phase 
growth may be a mechanism to prevent the accumulation of O2- damage to proteins, as 
damaged proteins will accumulate due to the low rate of protein synthesis (Nystrom and 
Gustavsson, 1998), and hence increased protein turnover as opposed to an increase in 
O2- generation is responsible for the increased SOD expression during this period. 
The expression of ctaA::lacZ was low under all conditions throughout growth. 
However, like SPWI (sodA::lacZ), SPW3 is a mutant strain (ctaA), with the lacZ fusion 
created by Tn917 insertional mutagensis, and importantly this deficiency may affect the 
absolute level of expression. Maximal levels of ctaA expression occur during the 
transition from exponential to stationary phases of growth. This increase in expression 
at the onset of stationary phase has previously been documented in B. subtilis (Vander 
Oost et al., 1991) and S. aureus (Clements et al., 1999a). This pattern of expression 
links in well with the theory that in post-exponential phase, growth appears to be 
dependent on haem A dependent cytochromes (Clements et al., 1999a). Therefore etaA 
is maximally expressed when CtaA is required to enable energy production for cellular 
maintenance. 
In this chapter it has been shown that while S. aureus shows classical starvation-
survival kinetics in sCSF, it is capable of growth in serum. The level of oxygen and/or 
carbon dioxide is important for the growth of S. aureus in serum as an increased growth 
yield is observed microaerobically. The addition of both iron and catalase to solid 
serum media demonstrated an increase in growth, particularly under aerobic conditions, 
although additions of these had no apparent beneficial effect in liquid culture. None of 
the major global regulators of stress resistance or virulence determinant production had 
an important role in growth in serum. Finally the transcriptional pattern of several 
proven and potential virulence determinants were not altered dramatically in serum V s 
BHI. The following chapters seek to determine components, which are important in the 
serum model. 
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4.1 
CHAPTER 4 
THE IDENTIFICATION OF S. A UREUS GENES SPECIFICALLY 
EXPRESSED IN THE SERUM MODEL 
Introduction 
The isolation and characterisation of mutants attenuated in pathogenicity or with altered 
virulence determinant production has proved an invaluable tool for dissecting and 
understanding the mechanisms of disease. Transposon mutagenesis has been used 
extensively in the study of pathogenesis and other functions in many organisms. For 
example, the three major (known) global regulators of S. aureus virulence factor 
production, agr, sar and sae were all isolated following transposon mutagenesis (Recsei 
et al., 1986; Cheung et al., 1992; Giraudo et al., 1994). agr was identified as a 
transposon mutant displaying a pleiotropic exoprotein deficient phenotype (Recsei et 
al., 1986) (Chapter 1.7.1). A screen for fibrinogen-binding-negative mutants, led to the 
identification of sar (Cheung et al., 1992) (Chapter 1.7.2). Finally a transposon screen 
for mutants with decreased ~-haemolysin production led to the identification of sae 
(Giraudo et al., 1994)(Chapter 1.7.3). 
Reporter gene fusions have also given important insights into the processes controlling 
gene expression. A combination of random transposon mutagenesis linked with reporter 
gene analysis, provides a powerful tool for the identification of genes important in 
and/or expressed in a given process (Camilli et al., 1990). An example of a commonly 
used transposon with fusion generating capability is Tn917 -lac. This transposon has 
been shown to be capable of generating fusions that connect the transcripts of 
chromosomal genes to the coding sequence of the lacZ gene of E. coli (Perkins and 
Youngman, 1986). Furthermore, Tn917-lac-mediated transcriptional fusions have been 
demonstrated to produce levels of ~-galactosidase that reflects accurately the regulated 
expression of interrupted genes (Perkins and Youngman, 1986). 
This transposon has been modified (Camilli et al., 1990) to allow the direct cloning of 
DNA flanking the transposon insertions thus facilitating the identification of the 
insertionally inactivated gene. A novel derivative of Tn917 (Tn917-LTVI) (Figure 4.1) 
was first used in L. monocytogenes (Camilli et al., 1990). This transposon was again 
used in L. monocytogenes, in a screen for genes preferentially expressed in mammalian 
cells, compared to a rich broth (Klarsfeld et al., 1994). This study led to the 
161 
identification of five pic (Qreferentially intra~ellular expression) genes, with up to 100-
fold induction inside macrophage like cells (Chapter 1.11.1.2.1). 
Although Tn9]7-LTVI was originally constructed for the genetic analysis of 
L. monocytogenes (Camilli et al., 1990), owing to its enhanced transposition frequency 
and the convenience for cloning DNA adjacent to sites of insertion, has meant that this 
system has been widely used for the insertional mutagenesis of Gram-positive bacteria. 
For example Tn9]7 has been used in both B. subtilis and B. cereus, for the 
identification of germination deficient mutants and the subsequent identification of 
these inactivated genes (Clements and Moir, 1998, Behravan et al., 2000). 
Importantly, this Tn9] 7 system has also been used in S. aureus. Examples of this work 
include the isolation of: the staphylococcal accessory regulator (sar); two autolysin-
defective mutants; and a whole host of starvation survival mutants (Cheung et al., 1992; 
Mani et al., 1993; Watson et al., 1998b). Additionally Tn9] 7 has been used for the 
identification of genes specifically expressed upon interaction with human endothelial 
cells and with human serum (Vriesema, 2000). The transposon Tn9] 7 has been shown 
to randomly insert into the S. aureus chromosome (Youngman, 1987). This makes it 
ideal for generating mutant libraries in S. aureus. Furthermore, Tn917-LTVI has been 
developed with a number of features making it particularly useful as a genetic tool. At 
one end of the transposon is a promoterless lacZ gene with a B. subtilis ribosome 
binding site. Thus Tn9]7 generates transcriptional fusions between the promoterless 
lacZ and chromosomal genes when the transposon inserts into the chromosome in the 
appropriate orientation (Figure 4.2). There is an erythromycin resistance gene within 
the transposon region of pLTLI for selection in S. aureus. Finally Tn917-LTVI 
contains an ampicillin resistance gene for selection in E. coli and an E. coli replicon 
(colEl) along with a large number of restriction sites. These components allow the 
'straightforward' rescue of chromosomal DNA flanking the Tn917 insertion as a 
plasmid in E. coli. 
This chapter describes the use ofTn917-LTVl in the search for genes that are important 
and/or expressed in the serum model. 
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4.2 Results 
4.2.1 Tn917 mutagenesis of S. aureus 8325-4 
The plasmid pL TV 1 (Figure 4.1) is a 20.6 kb plasmid, comprising the transposon 
Tn917-1ac, and additional flanking sequences. The flanking sequences contain a 
tetracycline resistance gene, and a Gram-positive temperature sensitive origin of 
replication. The copy number of the plasmid decreases rapidly at high temperatures 
with replication inhibited totally above 37°C (Villafane et ai., 1987). This 
thermoinstability enables the selection of Tn917 insertion mutants by growth at 
elevated temperatures in the presence of erythromycin. Elevated temperature treatment 
(> 37°C) cures the bacteria of pL TV 1, and thus selects for cells containing a 
chromosomal transposon insertion (Figure 4.2). Transposon mutagenesis of S. aureus 
8325-4 was performed as described in Chapter 2.12.1. 
4.2.1.1 Evaluation and enumeration of Tn917 transposon libraries 
Eight Tn917 libraries were created (Table 4.1). These contained - 3 xl08 - 5 x109 cfu 
ml- I . The libraries were created using different plasmid curing temperatures with 
varying success. The first two libraries (1 a and 1 b) were cured of the plasmid at 41°C, 
the third and fourth (2a and 2b) at 41.5 °C and the final four (I, II, X and Z) at 
approximately 41.8 °C. Temperatures of greater than 41.8 °C were not used in this 
study as previous work had shown that higher temperatures reduced the final growth 
yield dramatically (Foster, unpublished work). From Table 4.1 it can clearly be seen 
that raising the plasmid curing temperature increases the frequency of transposon 
insertion (Chapter 2.12.2). Of the eight libraries created only those with > 90 % 
transposon insertion frequency were deemed useful for screening, the others would 
have too high a proportion of colonies still containing the plasmid (pL TV 1). Therefore 
only four (I, II, X and Z) of the eight libraries generated were used in this study. 
4.2.2 Screening for genes involved in the growth of S. aureus in the serum 
model 
Two screens were carried out using four transposon libraries for genes involved in the 
growth of S. aureus in serum. The first, was for genes that are essential for the growth 
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Figure 4.1 
Physical map of pL TV 1 
pLTV1 
20.6kb 
Sp 
P 
S 
X 
B 
Sm 
K 
Ss 
E 
Vector harbouring a transposon-proficient derivative of Tn9 J 7. Thicker lines represent 
the ends of the transposon. Features of this map: bla; pBR322 ~-lactamase gene; ColEl 
origin of replication; M13 ori, origin of replication for single stranded DNA synthesis; 
erm, erythromycin resistance gene; cat, a chloramphenicol acetyl transferase gene 
derived from pCl94; laeZ, promotorless laeZ gene from E.coli, with translation 
initiation signals derived from B. subtilis; tet, tetracycline resistance gene from 
pAM a 1 d 1; Ts rep, pE 194ts temperature sensitive replicon. Restriction sites: B BamHI; 
Bg, Bg/II; E, EeoR!; H, HindIII; Hp, HpaI; K, KpnI; P, PstI;S, san; Sm, SmaI; Sp, SphI; 
Ss, SstI; X, XbaI; Xh, XhoI. 
Reproduced from Youngman (1990). 
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Figure 4.2 
Map of Tn917-1ac from pLTVl inserted into the chromosome 
Features shown: lacZ, promoterless lacZ gene from E.coli, with translation initiation 
signals derived from B. subtilis; bla; pBR322 ~-lactamase gene; ColEl origin of 
replication; cat, a chloramphenicol acetyl transferase gene derived from pC194; erm, a 
ribosomal RNA methyltransferase gene. Restriction sites: B BamHI; E, EcoRl; 
K, KpnI; P, PstI; S, san; Sm, SmaI; Sp, SphI; X,Xbal. 
Reproduced from Clements (1996). 
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Library Plasmid curing Mean cfu ml"1 Mean cfu ml- I % Transposon 
temperature Ery Resistant Ery, tet Resistant insertion 
1 a 41°C 3.28 x 108 1.55 X 108 52.7 
1 b 41°C 3.48 x 108 1.70 X 108 51.1 
2a 41.5°C 4.5 x 109 5.80 X 108 87.1 
2b 41.5°C 1.2 x 109 3.60 X 108 70.0 
I 41.8°C 5.38 x 109 2.44 x 108 95.5 
II 41.8°C 4.27 x 109 1.68 X 108 96.1 
X 41.8°C 3.65 x 109 2.35 X 108 93.6 
Z 41.8°C 4.12 x 108 1.76 X 107 95.7 
Table 4.1 
Evaluation and enumeration ofTn917 transposon libraries of S. aureus 
Table demonstrating how plasmid curing temperature affects Tn917 transposon 
insertion efficiency in S. aureus. The mean cfu ml- I values were calculated from the 
results of at least 2 separate experiments where colonies were plated onto BHI agar 
plates containing erythromycin (Ery), or erythromycin and tetracycline (Ery, tet). 
Libraries (and their % transposon insertion) used for screening are shown in bold. 
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of S. aureus in serum, and the second for genes that are specifically, or preferentially, 
expressed in serum. 
4.2.2.1 Selection of genes essential for the growth of S. aureus in the serum 
model 
This first screen aimed to identify mutants based on their inability to grow on serum 
under micro aerobic conditions (Chapter 2.13.1; Figure 4.3). 
The transposon library stocks were diluted and plated onto BHI agar plates, resulting in 
- 100 colonies per plate. Colonies were then replica plated onto a BHI agar plate and a 
serum agar plate (Chapter 2.1.1.2 and 2.1.1.7). The BHI plate was placed under aerobic 
conditions, and the serum plate under microaerobic conditions. After 24 h incubation at 
37°C the serum plate was then compared to the BHI plate. Any colonies absent from 
the serum plate, as compared to the BHI plate were putative serum specific mutants. 
Putative serum specific mutants were then picked from the BHI plate and re-tested for 
their inability to grow on serum (Chapter 2.13.1; Figure 4.3). 
Multiple screens were carried out using the above selection process, resulting in the 
screening of - 7,000 colonies from four independent Tn917 transposon libraries. 
Although 39 putative serum growth defective mutants were initially identified, after re-
testing, all were shown to grow on serum and thus were false positives (results not 
shown). 
4.2.2.2 Selection of genes preferentially expressed in the serum model 
The second screen was developed to identify S. aureus genes preferentially expressed 
during growth in serum V s BHI. The screen utilises the promoterless lacZ reporter gene 
carried by Tn917-1ac (Chapter 4.1) that on insertion into the chromosome may form a 
transcriptional fusion with the interrupted gene. A plate test was developed using X-Gal 
as the lacZ (l3-galactosidase) substrate (Chapter 2.11.1). Colonies were examined for 
enhanced expression of the fused promoter (via l3-galactosidase activity) on serum 
(Chapter 2.13.2; Figure 4.4). 
The transposon library stocks were diluted and plated onto BHI agar plates resulting 
in - 100 colonies per plate. Colonies, were then replica plated onto a BHI agar plate and 
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4 Tn917 transposon libraries 
Clones plated onto BHI agar 
(100-125 colones per plate 
Plates incubated overnight at 37°C 
Clones replica plated 
BHI Aerobic Plates incubated 
for 24 h at 37°C 
Sera Microaerobic 
Figure 4.3 
Putative sera growth 
defective clone 
Colonies, which grew on BHI (aerobic) 
but not sera (microaerobic) were selected 
Putative clones retested 
Confirmed clones 
Diagrammatic representation of the screen developed for the identification of genes 
essential for the growth of S. aureus in the serum model 
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a serum agar plate both overlaid with X-Gal (Chapter 2.11.1). The BHI plate was 
incubated aerobically while the serum plate was incubated microaerobically. X-Gal is 
hydrolysed by j3-galactosidase producing a blue coloured compound (S-bromo-4-
chloro-3-indolyl), which is a visual indicator of j3-galactosidase activity. After 24 h 
incubation at 37°C the serum plate was compared to the BHI plate. Any colonies which 
appeared blue on the serum plate and white on the BHI agar plate were re-tested using 
the same X-Gal based screening process (Chapter 2.13.2; Figure 4.4). 
In total, - 7,000 clones from four independent Tn917 transposon libraries were 
screened. This led to the isolation of 77 clones with transposon insertions in loci that 
exhibited expression (increased expression) when grown on serum compared to BHI. 
The inactivated genes were called seg (Sera Expressed Gene) (Table 4.2). All four 
independent libraries generated clones, which should prevent the isolation of a high 
proportion of siblings. Importantly, none of the seg clones were Tet resistant, and thus 
do not contain an intact copy of the plasmid (PL TV 1). 
4.2.3 Characterisation and analysis of seg mutants 
4.2.3.1 Expression analysis of Tn9171acZ transcriptional fusions 
The transposon Tn917, contains a promoterless lacZ gene, which in all seg mutants is 
inserted in the correct orientation downstream of the mutated gene's promoter, creating 
a transcriptional lacZ fusion. Thus the expression of the seg can be analysed by 
measuring p-galactosidase activity (Chapter 2.11). 
All 77 seg mutants were grown on two BHI and serum agar plates overlaid with X-Gal 
(Chapter 2.3), which were incubated under aerobic or microaerobic conditions. Plates 
were scored for blue colouration after 24 and 48 h incubation (Table 4.3). The scoring 
of blue colouration on serum was difficult due to low level expression coupled with 
poor growth, particularly under aerobic conditions (Chapter 3.2.1.2.2). Therefore no 
attempt was made to distinguish between light and dark blue, instead colonies were 
simply scored as blue (B) or white (W). 
The results show that four mutants (segI8, 19,73 and 74), that were isolated following 
the observation that they were blue on serum but not on BHI, proved on further 
investigation to be white on serum, and thus were discarded (Table 4.3). Interestingly, 
after prolonged incubation (48 h), 16 seg strains that were white on BHI after 24 h had 
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BHI Aerobic 
(X-gal overlay) 
4 Tn917 transposon libraries 
Clones plated onto BHI agar 
(100-125 colones per plate 
Plates incubated overnight at 37°C 
Clones replica plated 
Plates incubated 
for 24 h at 37°C 
Sera Microaerobic 
(X-gal overlay) 
Colonies, which were blue on sera (microaerobic) 
but not on BHI (aerobic) were selected 
Putative clones retested 
Confirmed clones 
Figure 4.4 
Putative sera 
expressed 
gene 
Diagrammatic representation of the screen developed for the identification of genes 
preferentially expressed during the growth of S. aureus in the serum model 
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Library Number of colonies Number of seg isolated 
screened 
I - 1,500 11 
II - 2,550 37 
X - 1,800 16 
Z - 1,150 13 
4 different libraries - 7,000 Colonies 77 seg mutants 
Table 4.2 
Summary of screening Tn917 transposon libraries for sera expressed genes (seg) 
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become faintly blue under both aerobic and microaerobic conditions. These mutants are 
still classed as seg strains as they are preferentially expressed (PE) on serum. 
Additionally, six clones were found to be blue, only on serum when grown 
microaerobically. Finally, all other clones were white on BHI, and blue on serum 
(Table 4.3). 
4.2.4 Selection of seg mutants for further analysis 
Of the 73 confirmed seg mutants, 25 were selected for further analysis. The selected 
mutants were representational of all libraries and expression classes (Table 4.3). 
Interestingly, the colour of the selected colonies on serum plates containing X-Gal 
varied from pale blue to dark blue indicating that the different mutants had various 
levels of p-galactosidase activity. 
4.2.5 Analysis of selected seg mutants 
A number of different techniques were used to study the 25 selected seg mutants at the 
physiological and molecular level, in order to determine the number and nature of the 
seg loci. 
4.2.5.1 Phage transduction analysis 
It was important to confirm that the seg: :/acZ fusion created by the transposon 
insertion, was measuring expression of the sera expressed genes in an otherwise 
isogenic background to the parent (8325-4). Phage transduction was used to cross the 
transposon markers into the parental S. aureus strain 8325-4 (Chapter 2.14). 100 % 
cotransduction of the seg phenotype with the transposon indicates no other erroneous 
mutations. 
All of the Ery lLin resistant transductants isolated (> 1 0 of each) from the transduction of 
8325-4 with phage ~ 11 propagated on each of the original seg mutants had 
identical phenotypes (IacZ expression) to the corresponding donor strain. This strongly 
indicates that the seg are induced by environmental conditions and are not the result of 
secondary mutations, confirming linkage of the transposon antibiotic resistance to the 
seg mutation. 
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Class of seg seg clone Total 
(Mutant Number) number 
1,6,8,9,10,11,12,13,14, 
Sera specific 21,22,23,24,25,26,27,29, 
30,31,33,37,39,40,43,44, 
45,46,47,48,49,50,52,53, 
54,55,56,57,58,60,61,62, 
63,64,65,66,67,68,69,72, 
76,77. 
51 
Sera-microaerobic specific 35,51,59,70,71,75. 
6 
Preferentially expressed on sera (PE) 2,3,4, S, 7,15, 16, 17,20,28, 
32,34,36,38,41,42. 
16 
Not expressed on sera (W) 18,19, 73, 74. 
4 
Total = 73 seg mutants 
Table 4.3 
Summary of the classification of seg mutants 
Those clones analysed further are shown in bold. 
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4.2.5.2 Growth of seg mutants 
All the seg mutants grow on both BHI and serum agar plates under both aerobic and 
microaerobic conditions. This technique however does not detect reduced growth rates 
or yields. To investigate whether the transposon insertions resulted in growth defects, 
all seg clones along with the wild type strain (8325-4) were grown in BHI and serum 
under both aerobic and microaerobic conditions. All seg mutants showed 
indistinguishable growth rates and yields, to 8325-4 under all conditions tested (results 
not shown), and were comparable to previous results for the growth of S. aureus strains 
under these conditions (Chapter 3.2.5.2). 
4.2.5.3 p-Haemolysin activity of seg mutants 
The production of p-haemolysin was examined by patching strains onto blood test agar 
plates (Chapter 2.15). The wildtype strain (8325-4) produced zones of clearing with an 
average diameter of 18 mm on p-haemolysin test agar plates. All mutant strains were 
found to be hemolytic, producing zones of clearing of a similar size (results not shown). 
4.2.5.4 Expression ofTn917 lacZ transcriptional fusions in liquid media 
The plate method (Chapter 4.2.3.1), although very useful for studying the expression of 
large numbers of strains, is relatively insensitive and non-quantitative. Therefore 
following this analysis it was not known whether seg are completely switched off in 
BHI, or just down regulated in BHIIup regulated in serum. Furthermore, the magnitude 
of this difference in seg regulation is not known. This problem was addressed with the 
use of liquid cultures and the fluorogenic substrate MUG (Chapter 2.11.2). However, 
unlike in Chapter 3.2.5.2 where the expression of each strain was measured throughout 
growth, in this assay, gene expression was only measured once (during stationary 
phase). Cultures (5 ml) were incubated under both aerobic and microaerobic conditions 
for 15 hours (Chapter 2.4.1.1). p-galactosidase activity of each culture was then 
determined using the MUG assay (Chapter 2.11.2). This analysis showed that the 
difference in p-galactosidase expression observed on plates was also detected in liquid 
media. The results showed that all selected seg loci were expressed 2.5-260x higher in 
serum than BHI (Figure 4.5). The consequence of incubating cultures microaerobically 
had little or no effect on seg expression, and again much greater expression was 
afforded in serum than BHI (results not shown). 
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Figure 4.5 
Expression of seg::lacZ transcriptional fusions in liquid media 
• BHI 
o Sera 
The 25 selected seg strains along with S. aureus 8325-4 (W) were grown with shaking 
(250 rpm), at 37°C, under aerobic conditions, in both BHI and serum. Specific 
~-galactosidase activity was determined after 15 h, and expressed in MUG units. The 
results are representative of two separate experiments. 
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There was however one exception, seg35 which was classified on solid media as sera-
microaerobic specific (Table 4.3). This strain was also found to be induced -5-fold on 
serum under microaerobic compared to aerobic conditions (results not shown). 
4.2.6 Identification of sera expressed genes 
4.2.6.1 Rescue of chromosomal DNA flanking Tn917 insertion sites 
In order to identify the seg loci, the transposon insertions were rescued along with 
flanking chromosomal DNA (Chapter 2.22.1.1). Chromosomal DNA from the seg 
mutants was digested with EcoRI or Xbal. This generated a fragment comprising part of 
the transposon (the colEl replicon and the ampicillin (Amp) resistance gene (b/a)) plus 
flanking chromosomal DNA out to the nearest relevant restriction site in the 
chromosomal DNA (Figures 4.1-4.2). By self-ligation, at a low concentration (Chapter 
2.19.1.2.2), a plasmid was generated which was recovered by transformation into E. 
coli followed by selection for Amp resistant transformants (Chapter 2.16.1). 
4.2.6.2 Recovery of DNA flanking Tn917 insertions 
Plasmid DNA was recovered from 2 independent transformants from each of the seg 
mutants (Chapter 2.16.1.2). Transformants were obtained from all seg mutants using 
either EcoRI or Xbal, except for seg3 and seg4, for which no transformants were 
obtained (Table 4.4). 
The sizes of the recovered flanking chromosomal DNA fragments are shown in Table 
4.4. For EcoRI transformants the size was determined by restriction with EcoRI and 
San. The sizes of XbaI transformants were determined by restriction with XbaI and 
San. A -8 kb fragment was present in every plasmid digest, corresponding to the 
plasmid backbone. The chromosomal DNA fragment excised from the plasmids by 
double digestion includes, 276 bp of the transposon, due to the position of the San 
restriction site, which is set back from the end of the transposon (Figure 4.2). 
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seg Plasmid Restriction Insert fragment size Insert fragment size 
number number enzyme used for (Digestion with (Digestion with XbaI 
rescue EcoRi and san (bp)) and san (bp)) 
1 pSEGl EcoRi 2700 ND 
3 pSEG3 EcoRi or XbaI No transformants No transformants 
4 pSEG4 EcoRI or XbaI No transformants No transformants 
5 pSEG5 EcoRI 4300 ND 
7 pSEG7 EcoRi or XbaI 2600 1800 
8 pSEG8 EcoRI or XbaI 4300 1700 
10 pSEGIO EcoRi or XbaI 4000 No transformants 
13 pSEG13 EcoRI or XbaI 2600 5250 
14 pSEG14 EcoRI or XbaI 1250 5000 
21 pSEG21 EcoRI 2750 ND 
22 pSEG22 EcoRI 1500 ND 
24 pSEG24 EcoRi or XbaI 3000 No transformants 
25 pSEG25 EcoRI or XbaI 2150 5500 
26 pSEG26 EcoRI or XbaI 3250 No transformants 
29 pSEG29 EcoRi 5000 ND 
30 pSEG30 EcoRI or XbaI 1500 4600 
33 pSEG33 EcoRI or XbaI 1500 4700 
35 pSEG35 EcoRI 1250 ND 
37 pSEG37 EcoRI 2200 ND 
39 pSEG39 EcoRI or XbaI 2200 3000 
40 pSEG40 EcoRI or XbaI 2200 3000 
43 pSEG43 EcoRI 3000 ND 
45 pSEG45 EcoRI or XbaI 2150 5750 
48 pSEG48 EcoRI 2100 ND 
50 pSEG50 EcoRI 2100 ND 
Table 4.4 
Fragment sizes of recovered DNA flanking Tn917 insertions 
Plasmids recovered from seg transformants were digested with EcoRI and san or XbaI 
and san, for transformants created with EcoRI and XbaI respectively. This produces 
two fragments, one is a fragment of - 8 kb (the plasmid backbone) and the other is the 
size of the cloned insert plus 276 bp (transposon). 
ND - Not done. 
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4.2.6.3 Sequencing and analysis of the rescued S. aureus chromosomal DNA 
flanking Tn917 insertion sites 
Rescued chromosomal DNA flanking the transposon insertion sites, was sequenced 
from the EcoRI recovered plasmids, using a 25 bp oligonucleotide as a primer (TnSI) 
(Table A.I.2), designed corresponding to the lacZ-proximal end of the transposon. The 
primer hybridises 181 bp upstream from the lacZ end of the transposon and the 
sequencing reaction proceeds through this end into the flanking chromosomal DNA 
(Watson, 1997). 
Chromosomal DNA flanking Tn917 insertion sites was sequenced (Chapter 2.21.3.1) 
from 23 seg mutants (2 seg strains failed to produce transformants). These sequencing 
reactions, in all cases produced 200-370 bp of useful chromosomal DNA sequence. 
This sequence was analysed to identify the Tn917 insertion site and hence the 
insertionally inactivated gene (Chapter 2.23.1). As all the Tn917 insertions are in the 
correct orientation to give a lacZ transcriptional reporter gene fusion, all the ORFs 
identified adjacent to the transposon in the rescued DNA are in the reverse orientation 
from the derived sequence. Database analysis (NCBI BLAST) was used to determine if 
any of the possible ORFs had homologues (Chapter 2.23.2). The results of these 
sequencing reactions along with their analysis are shown in Appendix A.2.1. In these 
figures the sequence is displayed so that the longest ORF is shown and the position of 
the Tn9} 7 insertion indicated. Where homologues were found, the percentage identity 
and extent of homology are shown along with the appropriate amino acid alignments 
between ORFs and database homologues (Figure A.2.la-w). 
Results of this analysis revealed 15 of the 23 sequenced mutants had transposons within 
ORFs. Upon database (NCBI) analysis, homologues were found to all except one of 
these ORFs (ORF5/seg5). The results of this analysis are shown in Table 4.5. This 
table shows the proposed identity of the insertionally inactivated gene, along with the 
% identity between possible ORFs and database homologues. 
The sequence of pSEGI revealed upon analysis to have a partial ORF (ORFl) of 76 
amino acids in the same orientation as the lacZ (Figure A.2.la). ORFI is truncated by 
the Tn917 insertion, and by the end of the sequenced DNA. ORFI has a similarity to 
aspartokinase II (lysC) of Helicobacter pylori (41 % identity over 75 amino acids). 
Interestingly, chromosomal DNA sequenced and analysed from pSEG21 showed the 
transposon in this mutant to be inserted at exactly the same site as in segl (Figure 
A.2.1h). Furthermore, the sequence obtained from the rescue of DNA flanking the 
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seg Likely identity of the Identities Organism segwith 
No. insertionally inactivated identical Tn 
gene insertion site 
1 Aspartokinase II 31/75 Helicobacter seg21 
(41 %) pylori 
3 Not cloned/rescued - - -
4 Not cloned/rescued - - -
5 No significant homology - - None 
7 Hypothetical protein 18/66 Staphylococcus None 
(surface protein) (27 %) aureus 
8 No significant homology - - None 
10 Dihydrodipicolinate 38/73 Bacillus None 
synthase (52 %) subtilis 
13 Aspartokinase II 29/75 Helicobacter None 
(38 %) pylori 
14 Aspartokinase II 13/24 Mycobacterium None 
(54 %) smegmatis 
21 Aspartokinase II 28/82 Bacillus segl 
(34 %) subtilis 
22 No significant homology - - seg30 and 
seg33 
24 Aspartate semi aldehyde 26/56 Campylobacter None 
dehydrogenase (46 %) jejuni 
25 Aspartokinase II 48/96 Thermotoga seg50 
(50 %) maritima 
26 Aspartate semi aldehyde 58/100 Aquifex None 
dehydrogenase (58 %) aeolicus 
29 Glutamate synthase 98/116 Bacillus None 
large subunit (84 %) subtilis 
30 No significant homology - - seg22 and 
seg33 
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seg Likely identity of the Identities Organism seg with identical 
No. insertionally inactivated Tn insertion sites 
cont. gene 
33 No significant homology - - seg22 and seg30 
35 No significant homology - - None 
37 No significant homology - - seg39 and seg40 
39 No significant homology - - seg37 and seg40 
40 No significant homology - - seg37 and seg39 
43 Glutamate synthase 53/105 Bacillus None 
large subunit (50%) subtilis 
45 Aspartokinase II 38/76 Thermotoga seg48 
(50 %) maritima 
48 Aspartokinase II 53/107 Thermotoga seg45 
(49%) maritima 
50 Aspartokinase II 45/92 Thermotoga seg25 
(48 %) maritima 
Table 4.5 
Summary of sequence analysis of the selected seg mutants 
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transposon in seg14 overlaps this sequence. However, the transposon insertion in seg14 
is 62 bp upstream of the Tn917 insertion in seg 1 (Figure A.2.1 a). 
Chromosomal DNA sequenced and analysed from pSEG5 indicated a partial ORF 
(ORF 5) of 74 amino acids in the same orientation as the lacZ (Figure A.2.1b). The 
ORF is truncated by the Tn917 insertion, as well as by the end of the sequenced DNA. 
ORF5 showed no similarity to any sequence in the NCB! database (BLAST search). 
DNA sequence derived from pSEG7 on analysis revealed a partial ORF (ORF7) of 69 
amino acids in the same orientation as the lacZ (Figure A.2.lc). The ORF is truncated 
by the Tn917 insertion, as well as by the end of the sequenced DNA. ORF7 has 27 % 
identity over 66 amino acids to a hypothetical protein from S. aureus. Owing to the 
similarity of this hypothetical protein to sequences of surface proteins, ORF7 is thought 
to encode a surface protein. 
Analysed DNA sequences derived from pSEG8 revealed no ORFs in the same 
orientation as the lacZ gene (Figure A.2.1 d). Furthermore, the DNA sequence showed 
no striking similarity to any sequence in the NCB! database (BLAST search). 
pSEGlO DNA sequence contained a partial ORF (ORFIO) of 87 amino acids in the 
same orientation as the lacZ (Figure A.2.l e). ORF 10 is truncated by the Tn917 
insertion and by the end of the sequenced DNA. Comparison of translated sequence 
with the NCB! database shows that the ORFIO partial polypeptide, has a strong 
similarity to dihydrodipicolinate synthase (DapA) of B. subtilis. ORFIO has 52 % 
identity over 73 amino acids to this DapA polypeptide. 
Analysis of DNA derived from pSEG 13 indicated a single partial ORF (ORF13) of 97 
amino acids in the same orientation as the lacZ (Figure A.2.1f). ORF13 is truncated by 
the Tn917 insertion, as well as by the end of the sequenced DNA. The ORF13 partial 
polypeptide is similar to aspartokinase II of H. pylori of (38 % identity over 75 amino 
acids). 
The chromosomal DNA sequenced and analysed from pSEG14 showed a partial ORF 
(ORF14) of 34 amino acids in the same orientation as the lacZ gene that is truncated by 
the Tn917 insertion (Figure A.2.lg). ORF14 has a similarity to the 5' end of the 
aspartokinase gene (lysC) of Mycobacterium smegmatis (54 % identity over 24 amino 
acids). The Tn917 insertion of seg 14 is 62 bp upstream of the transposon insertion site 
in segl (Figure A.2.la). 
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For DNA sequences derived from pSEG22, analysis revealed no significant ORFs in 
the same direction as the lacZ gene (Figure A.2.l i). Furthermore, the DNA sequence 
showed no striking similarity to any sequence in the NCBI database (BLAST search). 
Chromosomal DNA sequenced and analysed from pSEG30 and pSEG33 showed that 
the transposon in these mutants is inserted at exactly the same site as for seg22 (Figures 
A.2.li and A.2.ln-A.2.lo). These three mutants (seg22, seg30 and seg33) were isolated 
from the same library and thus are likely to be siblings. 
Analysed sequences derived from pSEG24 indicated a partial ORF (ORF24) of 62 
amino acids in the same orientation as the lacZ (Figure A.2.Ij). The ORF is truncated 
by the Tn917 insertion. Comparison with the NCB I database shows that ORF24 has 
homology to asd, which encodes aspartate semialdehyde dehydrogenase. ORF24 has 
46 % identity over 56 amino acids to the N-terminal end of Asd from Campylobacter 
jejuni. 
Chromosomal DNA derived from pSEG25 showed upon analysis to have a partial ORF 
(ORF25) of 100 amino acids in the same orientation as the lacZ (Figure A.2.l k). 
ORF25 is truncated by both the Tn917 insertion, and the end of the sequenced DNA. 
ORF25 is strongly similar to aspartokinase II (lysC) from Thermotoga maritima. 
ORF25 has 50 % identity over 96 amino acids to the LysC derived from T. maritima. 
DNA sequence derived from pSEG50 showed that the transposon in this strain has 
inserted into an identical site in both seg2S and seg50 (Figures A.2.1 k and A.2.l w). As 
these two mutants (seg25 and seg50) were isolated from the same library they are most 
likely to be siblings. 
pSEG26 DNA sequence indicates the presence of a partial ORF (ORF26) of 100 amino 
acids in the same orientation as the lacZ gene (Figure A.2.ll). The ORF is truncated by 
the Tn917 insertion, and by the end of the sequenced DNA. The sequence of ORF26 
has strong similarity to aspartate semialdehyde dehydrogenase (Asd) of Aquifex 
aeolicus showing 58 % identity over 100 amino acids. 
Analysis of DNA derived from pSEG29 indicated a partial ORF (ORF29) of 119 amino 
acids in the same orientation as the lacZ (Figure A.2.1m). ORF29 is truncated by both 
the Tn917 insertion, and the end of the sequenced DNA. The ORF29 partial 
polypeptide shows very strong similarity to GltB of B. subtilis with 84 % identity over 
116 amino acids. gltB encodes glutamate synthase (large subunit). 
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Analysed DNA sequence derived from pSEG35 revealed no significant ORFs (Figure 
A.2.1 p). Furthermore, the DNA sequence showed no striking similarity to any sequence 
in the NCBI database (BLAST search). 
Analysis of DNA sequence derived from pSEG37 failed to reveal any ORFs, in any 
reading frame or direction (Figure A.2.1q). Furthermore, the region of DNA sequenced 
showed no significant similarity to any sequences in the NCBI database (BLAST 
search). Interestingly, chromosomal DNA sequenced and analysed from both pSEG39 
and pSEG40 showed that the transposon in these mutants was inserted at exactly the 
same site as in seg37 (Figure A.2.1q - A.ls). These three mutants (seg37, seg39 and 
seg40) were isolated from the same library, and are thus likely to be siblings. 
For DNA sequence derived from pSEG43, analysis revealed a partial ORF (ORF43) of 
109 amino acids in the same orientation as the lacZ (Figure A.2.1 t). The ORF is 
truncated by the Tn917 insertion, and by the end of the sequenced DNA. ORF43 has 
strong similarity (50 % identity over lOS amino acids) to glutamate synthase (gltB) 
large subunit of B. subtilis. 
The chromosomal DNA sequenced and analysed from pSEG48 showed a single partial 
ORF (ORF45) of 86 amino acids in the same orientation as the lacZ. The ORF is 
truncated by both the Tn917 insertion, and the end of the sequenced DNA (Figure 
A.2.1 u). ORF45 has similarity to aspartokinase II (lysC) of T maritima (50 % identity 
over 76 amino acids). Analysis of DNA sequences from pSEG48 revealed that the 
transposon insertion site is identical in seg48 and seg45 (Figures A.2.1u and A.2.1v). 
As these two mutants (seg45 and seg48) were isolated from the same library they are 
most likely to be siblings. 
Following the analysis of the sequence recovered flanking the Tn917 insertions, it can 
be seen that seven of the mutants (seg21 , seg30, seg33, seg39, seg40, seg48 and seg50) 
have insertion sites identical to other mutants (Figure A.2.la-w; Tables 4.5). For this 
reason no further analysis or investigation was carried out on these strains. 
4.2.6.4 Further sequence analysis of seg mutants 
Sequence analysis failed to identify homologues in the NCBI database to the region of 
DNA adjacent to the transposon insert for 5 of the sequenced seg strains, not including 
those with identical Tn917 insertion sites to other strains. Thus the identity of the 
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promoter driving transcription of the reporter gene in these strains was unknown. 
Therefore to identify the region where the transposon has inserted, and to attempt to 
identify the sera expressed gene, further database analysis was carried out on 5 mutants: 
seg5, seg8, seg22 (seg30 and seg33), seg35 and seg37 (seg39 and seg40)). Two 
databases were searched, these were; the incomplete TIGR, and NCTC 8325 databases 
(Chapter 2.23.2). The results of this analysis are represented diagrammatically In 
Appendix A.2.2, and a summary of these results is shown in Table 4.6. 
S. aureus database searching with the sequence produced from pSEG5 identified a 
contig from the TIGR database (97 % over 343 bp). Analysis of this contig confirmed 
the prediction that the transposon insertion of seg5 has inserted within an ORF (ORF5). 
ORF5 was found to be 363 amino acids long (Figure A.2.2a), however its amino acid 
sequence showed no significant homology to any know sequence in the NCBI database. 
Therefore the identity of ORF5 and hence of the sera expressed gene, remains 
unknown. 
Initial analysis of sequence from pSEG8 failed to identify an ORF into which the 
transposon of seg8 had inserted. Searching the S. aureus databases with this sequence 
identified a contig with 100 % identity (over 250 bp) to the region sequenced from 
pSEG8. Analysis of this contig revealed that the transposon appears to have inserted 
13 bp upstream of the translational start site of a gene with strong homology (49 % 
identity over 324 amino acids) to cystathionine y-synthase of B. subtilis (Figure 
A.2.2b). Thus the transposon may have inserted within the control region of 
cystathionine y-synthase, downstream of its promoter, from which expression of the 
promoterless lacZ must be driven. 
Analysis of pSEG22 sequence with sequences in the S. aureus databases, revealed the 
transposon insertion site to be over 800 bp from a convergent ABC transporter (ykpA). 
More interestingly however was the discovery that the insertion in seg22 was 31 bp 
upstream of the translational start codon (ATG) of an aspartokinase II gene (40 % 
identity over 396 amino acids to lyse of T. maritima). (Figure A.2.2c). Thus it was 
postulated that the transposon insertion site was downstream of the aspartokinase II 
promoter region. Therefore in seg22, it is the aspartokinase II promoter that is driving 
production of p-galactosidase. As both seg30 and seg33 have identical insertion sites to 
seg22 the same is true of these strains. 
Searching the S. aureus NCTC 8325 database with the sequence flanking the Tn917 
insertion in seg35 identified a contig with 99 % identity (over 298 bp) to this sequence. 
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This contig was analysed for putative ORFs, and revealed that the transposon within 
seg35 had inserted into a small putative ORF (ORF35) of 51 amino acids. ORF35 has 
an alternative initiation codon (TTG), which would produce a polypeptide of 47 amino 
acids (Figure A.2.2d). This polypeptide shows 51 % identity (over 45 amino acids) to 
lantibiotic gallidermin precursor (gdmA) from Staphylococcus gallinarum. Therefore it 
appears that the transposon insertion of seg35 has inserted within a lantibiotic of S. 
aureus, named auridermin owing to its significant sequence homology with both 
gallidermin (8. gallinarum), and epidermin (8. epidermidis). Thus it is postulated that 
transcription of the promoterless lacZ gene of seg35, is initiated by the promoter of the 
antimicrobial peptide, auridermin. 
Sequence from pSEG37 showed no striking similarity to any proteins in the NCBI 
database. However, the transposon must have inserted downstream of an active 
promoter. As there are no obvious ORFs in the 250 bases sequenced from pSEG37, 
either the insert is just upstream of a seg translational start site, or transcription of the 
lacZ is being driven by read through from an ORF greater than 250 bp away. Database 
searching identified a contig from the TIGR database (98 % identity over 277 bp), 
however no ORF could be located immediately downstream of the transposon insertion 
site (within 250 bp). Owing to the absence of an adjacent downstream ORF, an 800 bp 
region upstream of this insertion site was analysed for ORFs. Although several putative 
ORFs were identified none of these were of any significant size (:$;; 38 amino acids). 
Furthermore, this region has no significant homology to any sequence in the NCBI 
database (Figure A.2.2e). However, analysis of this contig did reveal there to be a gene 
in the correct orientation (convergent) to lacZ, with its stop codon approximately 
845 bp upstream of the transposon insertion site. This gene has strong homology (76 % 
over 143 amino acids) to a lipoprotein (adhesin) from Staphylococcus epidermidis 
(SWISS-PROT accession number AA67571). Therefore it is possible that lacZ 
expression in seg37, is being driven by the promoter of the upstream adhesin gene 
(Figure A.2.2e). However, owing to the large distance between the surface protein 
(adhesin) stop codon and the transposon insertion site, the classification of the adhesin 
as a sera expressed gene is far from certain. Finally, as both seg39 and seg40 have 
identical insertion sites to seg37 the same is true of these strains, as for seg37. 
4.3 Discussion 
The screen for genes essential for the growth of S. aureus in the serum model was 
unsuccessful despite the screening of approximately 7,000 clones, from four different 
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seg Chromosomal promoter Sequence Organism seg with identical 
No. driving lacZ expression identity Tn insertion sites 
5 Unknown - - None 
8 Cystathionine y-synthase 159/324 Bacillus None 
(49 %) subtilis 
22 Aspartokinase II 160/396 Thermotoga seg30 and seg33 
(40 %) maritima 
35 Lantibiotic gallidermin 23/45 Staphylococcus None 
(51 %) gallinarum 
37 Lipoprotein 109/143 Staphylococcus seg39 and seg40 
(adhesin) (76 %) epidermidis 
Table 4.6 
Summary of sequence analysis of the selected seg mutants following further analysis 
186 
libraries. The reason for this, is unlikely to be due to not enough clones being screened, 
as given the estimated 2.8 Mb genome size of S. aureus, an assumption of a 1 kb 
average gene size, suggests that complete coverage by transposon mutagenesis would 
require the screening of approximately 3,000 clones (Coulter et al., 1998). This is 
particularly true for the transposon Tn917, which inserts randomly into the S. aureus 
chromosome (Youngman, 1987). Therefore in theory 7,000 transposons should have 
inserted into 'every's. aureus gene at least once. Thus the most likely explanation for 
the failure to isolate clones essential for growth in the serum model, is that any defects 
in components leading to attenuated growth on serum, are so detrimental to the cell that 
they were also unable to grow on BHI. Therefore further work of this nature would 
most probably be futile. 
The screen for genes preferentially expressed in the serum model was more successful, 
resulting in the isolation of 73 mutants that showed increased gene expression on serum 
compared to BHI, as determined by lacZ (~-galactosidase) activity. Transposon 
insertions in these strains are in loci that are preferentially expressed in sera, and have 
been termed sera expressed genes (seg). These 73 mutants were isolated from four 
different libraries with - 1 % of all colonies screened, being classed as seg strains. The 
73 isolated seg strains were grouped according to their expression on different media 
(BHIIserum), under different conditions (aerobic/microaerobic), following 48 h growth, 
compared to 24 hours in the original screen. The discovery that sixteen seg strains 
produced colonies that were faintly blue on BHI after 48 h demonstrates that these 
genes are expressed at low levels on BHI, but at much enhanced levels on serum. This 
analysis also showed differences in the gene expression of seg strains, between aerobic 
and microaerobic conditions on solid media. This was interesting since the expression 
of the known components were not affected by this variable (Chapter 3.2.5). 
Twenty five of the 73 seg mutants, were selected for further analysis, from all four 
transposon libraries, and representing all lacZ expression pattern classes. All the 
selected seg mutants showed identical growth kinetics and yields to the parental strain 
in liquid culture under all conditions. Thus even though the seg are expressed in serum 
they are not absolutely required for growth in that medium. 
Importantly, the results of the reporter gene fusion assays in liquid culture, agreed with 
those for solid media. Notably, they showed a wide variety of promoter activity during 
stationary phase, but in all cases expression was found to be 2.5- 260-fold greater in 
serum than in BHI. This difference in activity during stationary phase, may be due to 
some seg promoters being more active than others, but might also infer differential 
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expression of these sera expressed genes. For example, a subset of these seg may be 
regulated in an agr dependent manner (Chapter 1.7.1) i.e. some may be expressed 
during exponential phase and repressed during stationary phase (thus display low 
activity levels during stationary phase), while others may be up regulated during post-
exponential phase (therefore have significantly higher levels during stationary phase). 
Finally the classification of seg35 as a gene specifically expressed on serum under 
microaerobic conditions was confirmed using liquid cultures. 
Recovery of flanking DNA and its subsequent sequencing, coupled with database 
searching, revealed that all clones (16 in total following the removal of siblings) have 
transposon insertions within regions homologous to others in the databases. In total, 9 
putative sera expressed genes were identified. Of these, four were found to be involved 
in the biosynthesis of the aspartate family of amino acids (lysine, threonine, isoleucine 
and methionine) (Figure 5.1). These were: aspartokinase II (lysC) - seg1 (seg21), seg13, 
seg14, seg22 (seg30 and seg33), seg2S (seg SO), and seg45 (seg48); aspartate 
semi aldehyde dehydrogenase (asd) - seg24 and seg26; dihydrodipicolinate synthase 
(dapA) - seglO; and cystathionine y-synthase (yjcl) - seg8. The remaining insertions 
were within, or putatively linked to: glutamate synthase (gltB) - seg29 and seg43; 
auridermin (lantibiotc) - seg3S; an ORF with homology to a hypothetical protein 
(surface protein) - seg7; a large ORF (ORFS) with no significant homology to any 
known sequence - seg5; and a lipoprotein (adhesin) - seg37 (seg39 and seg40). 
Owing to the identification of four genes involved in the biosynthesis of the aspartate 
family of amino acids, mutations in each of these four genes (lyse (seg 1), yjcI (seg8), 
dapA (segIO), and asd (seg24» were selected for further analysis and will be discussed 
in more detail in Chapter 5. The 5 remaining putative seg identified in the serum screen, 
were not studied further, and thus will be discussed here. 
Two seg strains, (seg29 and seg43) contained transposon insertions within genes 
showing significant homology to glutamate synthase (large subunit), of B. subtilis. 
Glutamate synthase is an enzyme that enables bacteria to incorporate ammonium ions 
into organic compounds. Only a few amino acids can be directly aminated (introduction 
of the amino group) by free ammonium ions. These are alanine, glutamine and 
glutamate catalysed by the enzymes, alanine dehydrogenase, glutamine synthetase and 
glutamate dehydrogenase respectively (Schlegel, 1993). As well as this the amide group 
of glutamine can be transferred to 2-oxogluturate by glutamate synthase. This system 
for the assimilation of ammonia nitrogen into organic compounds is apparently always 
formed and utilised by bacteria when the concentration of available ammonium ions is 
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low « 1 mM) (Schlegel, 1993). The majority of the other amino acids obtain their 
amino groups by transamination with a primary amino acid. Therefore the incorporation 
of ammonium ions in which glutamate synthase plays a critical role is an important step 
in the production of amino acids. Due to the role of glutamate synthase in the 
biosynthesis of amino acids, not only directly in the production of glutamate, but also in 
the transamination of other amino acids, its identification as a gene specifically induced 
on serum is perhaps not that surprising, as amino acids may be limiting in serum 
(Tables A.l.6-A.l.7). This theory is further supported in light of the discovery of other 
seg, as being involved in the biosynthesis of amino acids (Chapter 5). 
seg5 was identified as containing a transposon within an ORF (ORF5), of 363 amino 
acid, but which has no homology to any known protein. Therefore the serum screen has 
identified a novel gene, with a potentially important role in the growth of S. aureus in 
vivo. The identification of a gene with unknown function is not surprising owing to the 
fact that only a fraction of all bacterial genes have been studied. More importantly 
however, up to half the genes identified by both IVET and STM techniques of S. aureus 
have been reported to be of unknown function (Lowe et al., 1998; Mei et al., 1998). 
Further analysis of ORF5 may lead to the identification of a protein with an important 
role in vivo/pathogenicity. 
The transposons of strains seg37, seg39 and seg40, were all found to have inserted into 
the same site and are believed to be siblings. Interestingly, the transposon in these 
strains has neither inserted within an ORF, nor inside the controlling region of a gene. 
Instead the insertion site is over 800 bp downstream of the translational stop codon of a 
gene showing significant homology to an iron-regulated lipoprotein (adhesin) of S. 
epidermidis (Personal communication, Dr M. Burnham, SmithKline Beecham). 
Therefore it is just possible that it is the adhesin promoter that is driving expression of 
the lacZ reporter gene, and thus the adhesin is the sera expressed gene. Interestingly, the 
expression kinetics of seg37 (seg39 and seg40) were studied, and demonstrated that in 
serum lacZ expression appeared to be switched on during exponential phase but fell 
rapidly during stationary phase (results not shown). Therefore these fusion strains 
showed classic surface protein expression kinetics (Chapter 1.6.3; Chapter 3.2.5.2.5), 
and thus these results provide evidence for the correct identification of the adhesin as 
the sera expressed gene. 
The identification of a surface protein (adhesin) as a gene specifically induced upon 
interaction with serum is not surprising since adhesins have been shown to have an 
important role in infection. For example, the adhesion of S. aureus to human 
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endothelial cells has been implicated in the pathogenesis of invasive staphylococcal 
disease (Peacock et al., 1999). This is true for all bacterial pathogens, but especially so 
of bacteria such as S. aureus which are primarily extracellular. These adhesins enable 
the attachment of the bacteria to components of the extracellular matrix of the host 
(Foster and Hook, 1998). This attachment initiates colonization, which is a vital step in 
the early stages of infection (Projan and Novick, 1997). Most relevant for the 
identification of an adhesin as being specifically induced in serum is the frequency with 
which S. aureus sepsis, seeds from the blood stream to other body sites (reviewed by 
Ing et al. 1997). This is postulated to involve interactions between circulating bacterial 
cells and vascular endothelial cells (Peacock et ai., 1999). However, although S. aureus 
has been shown to adhere to human endothelial cells in vitro (Ogawa et ai., 1985), the 
bacterial cell wall adhesin(s) responsible remain undefined (Peacock et ai., 1999). 
Therefore it is possible that the serum screen may have identified one of the adhesins 
involved in this adherence process. 
seg7 was identified as containing a transposon within an ORF (ORF7), with homology 
to sequences in the databases. This clone has sequence homology to a hypothetical 
protein from S. aureus. However, these two sequences are not identical indicating that 
the transposon in seg7 has not inserted into that particular gene. Interestingly however, 
some of the other 'hits', although relatively low, are to surface proteins of S. aureus, for 
example 22 % homology over 63 amino acids to sdrE, part of a family of surface 
proteins (Foster and Hook, 1998). Therefore it is postulated that the transposon of seg7 
has inserted within a gene encoding a novel surface protein, which may have an 
important role in attachment and in the establishment of infection in vivo. It is therefore 
possible that two of the sera expressed genes are involved in bacterial adherence to host 
tissues, indicating that the serum screen may be a valid screen for the identification of 
novel cell surface proteins that potentially play an important role in virulence. 
The last of the genes identified by the serum screen, was insertionally inactivated in 
seg35. This clone was determined to have its transposon inserted within a gene showing 
strong homology to a lantibiotic precusor (gdmA) from S. gallinarum. Lantibiotics are a 
group of unique antibiotic peptides, which are produced by and primarily act on Gram-
positive bacteria. The term lantibiotics was introduced as an abbreviation for 
lanthionine-containing antibiotic peptides (Schnell et ai., 1988). This term refers to the 
most prominent features of this group, which are the strong antibacterial activity and 
the intra-molecular rings formed by the thioether amino acids lanthionine and 
3-methyllanthionine. In addition to lanthionine, other modified amino acids are present, 
which are synthesized by post-translational side-chain modifications of the ribosomally 
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produced precursor peptides (Sahl et al., 1995). Lantibiotics are broadly divided into 
two groups on the basis of their structure and resulting function: type-A lantibiotics are 
elongated, amphiphilic peptides, which kill bacterial cells by forming pores in the 
targets cytoplasmic membrane; while type-B lantibiotics are compact globular proteins 
whose action appears to be directed at the inhibition of enzyme functions (Sahl et al., 
1995). Interestingly, although lantibiotics have unique structure they are functionally 
similar to other antimicrobial peptides and can be regarded as a structurally based 
subgroup of the bacteriocins (Klaenhammer, 1993). Staphylococcal lantibiotics 
including epidermin and gallidermin produced by S. epidermidis and S. gallinarum 
respectively, fall into the first group of lantibiotics (type-A) and thus form pores in the 
cytoplasmic membrane of susceptible cells. 
Potentially the most interesting fact about the discovery of a lantibiotic of S. aureus 
(auridermin), as a gene preferentially expressed in sera, was that a lantibiotic was 
identified during signature tagged mutagenesis (STM) of S. aureus. Coulter et al. 
(1998) described the identification of a transposon insertion in a gene possessing 
sequence homology to the S. epidermidis lantibiotic gene encoding epidermin. Due to 
the nature of STM, genes identified by this method are attenuated for growth in vivo, 
and a mutation within the lantibiotic led to significant growth attenuation in the mouse 
abscess model and in an LDso assay. Importantly, the lantibiotic identified in this study 
was also homologous to epidermin (59 % identity over 22 amino acids) and thus it is 
postulated that, Tn917 has disrupted the same gene in both this study, and the STM 
strategy described by Coulter et al. (1998). If this is the case, then the serum screen has 
identified a gene as being preferentially expressed in serum, compared with a nutrient-
rich medium that has been shown to have an important role in vivo. Finally it must be 
remembered that seg35 was classified as a serum-micro aerobic specific strain, i.e. 
transcription of the gene insertionally inactivated in seg35 was only induced on serum 
under microaerobic conditions. Importantly however, this gene was not induced on 
nutrient-rich media under microaerobic conditions. This result therefore provides proof 
for the initial hypothesis, that the use of microaerobic conditions would make the model 
more a kin to those found in vivo. Finally the identification of a gene (auridermin) with 
an attenuated phenotype in vivo lends credibility to the serum screen, as a method for 
the identification of genes important for the growth of S. aureus in vivo. 
The serum screen has therefore putatively identified: two surface proteins, an 
antimicrobial peptide (auridermin), a novel gene with unknown function, and 
five biosynthetic genes. The discovery that the 12 out of 16 of the seg mutants 
sequenced (not including siblings), had insertions in loci with likely biosynthetic 
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function was not totally unexpected as serum, is likely to be limiting for certain 
nutrients. Importantly, screens for genes whose products are expressed, or are important 
in vivo have also identified numerous biosynthetic loci. 
IVET of Salmonella typhimurium led to the identification of the carAB operon, whose 
genes encode two subunits of carbamoyl-phosphate synthetase, which is involved in 
arginine and pyrimidine biosynthesis (Mahan et al., 1993). Furthermore, in all studies 
for in vivo induced genes (Chapter 1.11.2) a large proportion of genes identified are 
involved in nutrient biosynthesis, in particular in the biosynthesis of amino acids. 
Additionally it has been reported that following STM of S. aureus, a significant 
proportion of mutants identified as being attenuated in vivo had transposon insertions 
within genes encoding enzymes involved in cellular biosynthesis pathways (Mei et al. 
1997; Coulter et at., 1998). Interestingly, the study by Mei et al. (1997) identified two 
genes involved in lysine biosynthesis, whereas the study by Coulter and colleagues 
(1998) identified three lysine biosynthetic genes. Importantly, both of these STM 
approaches isolated aspartate semialdehyde dehydrogenase (asd) as a mutant attenuated 
in vivo. Additionally a recent publication studying altered S. aureus gene expression 
(increased expression) upon interaction with both endothelial cells and human serum, 
identified four lysine biosynthetic genes including aspartokinase II and aspartate 
semi aldehyde dehydrogenase (Vriesema et ai., 2000). These studies further highlight 
the potential importance of biosynthetic genes, especially those required for lysine 
synthesis, during infection. Finally these results provide solid evidence for the 
authenticity of the serum screen as an in vitro model mimicking infection. 
In depth analysis of the four aspartate family ammo acid biosynthetic genes; 
aspartokinase II (seg 1), aspartate semialdehyde dehydrogenase (seg24), 
dihydrodipicolinate synthase (segIO), and cystathionine y-synthase (seg8), will ensue in 
the following chapter. 
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CHAPTERS 
ANALYSIS OF THE ROLE OF THE ASPARTATE FAMILY OF AMINO ACID 
BIOSYNTHETIC LOCI 
5.1 Introduction 
5.1.1 Biosynthesis of the aspartate family amino acids 
Many microorganisms are able to synthesize all 20 amino acids, which are required for 
protein synthesis. The amino acids lysine, threonine, methionine, and isoleucine derive 
the majority of their carbon atoms from L-aspartate, hence these amino acids are 
sometimes referred to as the aspartate family of amino acids. The biosynthesis of these 
amino acids, is accomplished by a complex pathway involving common intermediates 
from which multiple branches lead to the end products (Figure 5.1). 
5.1.2 Functions of the aspartate pathway 
The major function of the aspartate pathway in growing bacteria is the provision of 
amino acids for protein synthesis. However, the pathway also provides 
meso-diaminopimelate (DAP) and lysine, which are constituents of the cell 
wall peptidoglycan. B. subtilis utilises DAP within its cell wall, whereas the 
peptidoglycan of S. aureus contains lysine (Schleiffer and Kandler, 1972; Tipper and 
Strominger, 1968). 
5.1.3 The common pathway 
The first two catalytic steps are common to the biosynthesis of all end products of the 
aspartate biosynthetic pathway. These culminate in the production of aspartate 
semialdehyde, via aspartyl phosphate and are catalysed by the enzymes, aspartokinase 
(AK) and aspartate semialdehyde dehydrogenase (ASADH) (Figure 5.1). 
However, differences in the regulation of the pathway give rise to multiple forms of 
some enzymes, and enzyme multiplicity can vary with the organism. Multiple isozymes 
of aspartokinase (AK), have been identified in several bacteria including: B. subtilis, 
E. coli and Streptococcus bovis (Zhang et al., 1990; Theze et al., 1974; Kalcheva et al., 
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Overview of the pathway for the biosynthesis of the aspartate family of amino acids 
The biosynthesis of isoleucine from threonine indicated by dotted arrows is a multi-step 
process. Adapted from Paulus (1993). 
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1993). In comparison only one AK has been discovered in pseudomonads, brevibacteria 
and corynebacteria (Shiio and Miyajima, 1969; Cohen et al., 1969; Cremer et al., 
1988). B. subtilis, like E. coli has three distinct isozymes of aspartokinase (Zhang et al., 
1990; Theze et al., 1974), and these differ in their regulation of synthesis and activity. 
5.1.3.1 Aspartokinase isozymes of B. subtilis 
The properties of the AK isozymes of B. subtilis (I, II, III) are summarised in Table 5.1. 
The putative AK identified in the present study (Chapter 4.2.2.2) showed greatest 
homology to AK II of B. subtilis. 
5.1.3.1.1 Aspartokinase II (Lysine-sensitive aspartokinase) 
AK II of B. subtilis is encoded by (lysC) and is regulated at both the activity and 
trancriptional level by lysine. Its activity has been shown to decline rapidly during 
glucose starvation or at the onset of stationary phase (Graves and Switzer, 1990), 
suggesting its primary function is the provision of precursors for the biosynthesis of 
lysine as a building block for proteins. AK II is a tetramer composed of two dissimilar 
subunits, (a2~2) (Moir and Paulus, 1977). Interestingly, the ~ subunit corresponds to the 
carboxyl-terminal portion of the larger a subunit, thus the lysC subunits, a and ~ share 
a coding region. In fact the subunits are encoded by in-phase overlapping genes, which 
are independently translated (Bondaryk and Paulus, 1985). Problematically the function 
of the ~ subunit is unknown, for example purified ~ subunits yield no aspartokinase 
activity, whereas the a subunit alone possess activity that is virtually indistinguishable 
from the holo enzyme (Paulus, 1993). 
5.1.3.1.2 Regulation of lyse in B. subtilis 
The two in-phase overlapping coding regions are the only structural genes encoded by 
the lysC operon, being immediately followed by a putative rho-independent 
transcriptional terminator (Chen and Paulus, 1988). Preceding lysC is an unusually 
extensive control region. Transcript mapping (Chen et al., 1987) and site-directed 
mutagenesis (Lu et al., 1991), have shown that the expression of AK II involves a 
single transcriptional initiation site, about 330 bp upstream of the AK gene. 
Interestingly, the lysC leader region plays an important role in the regulation of AK II 
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synthesis by lysine. This leader region contains a number of potential control sites: i) an 
ORF encoding a potential 24 amino acid peptide (lyse leader peptide), with tandem 
lysine codons near the N-terminus, which is postulated to function as an attenuator; ii) 
an inverted repeat required for lysine repression; and iii) a series of four inverted 
repeats, the last of which resembles a rho-independent terminator, while the other three 
can assume alternate hairpin loops reminiscent of terminator and antiterminator 
structures (Chen et al., 1987). The putative 24 amino acid leader peptide contains four 
lysine residues, and is located in the region that overlaps the protector loop, so that 
lysine deficiency would cause the stalling of the ribosomes in this region, thereby 
destabilising the protector structure and favouring the alternate base pairing pattern 
involving two pre-emptor loops without a functional transcriptional terminator. 
According to this model, lysine limitation would allow transcription to proceed beyond 
the attenuator site, into the structural gene for AK, thus enabling synthesis of the lysine 
biosynthetic enzyme (Chen et al., 1987). The action of this model is supported by the 
finding that lysine regulates the expression of the lyse operon by effecting the 
premature termination of transcription at the rho-independent terminator site in the lyse 
leader region (Kochhar and Paulus, 1996). However, there are several problems with 
this model, including the fact that there is no evidence from translational fusion studies 
to the putative leader peptide, for translation of this ORF (Kochhar and Paulus, 1996). 
Additionally, the lysine induced truncation of mRNA transcripts is completely 
suppressed by an aecA mutation which is a single G-to-A substitution in the leader 
transcript (Lu et al., 1991). However, this mutation is positioned remote from both the 
putative leader peptide and the terminator stem-loop structures. Therefore the 
mechanism of transcriptional attenuation of the lyse operon is unclear but seems to 
involve the lysine-dependent interaction between the site of the aecA mutation, and a 
remote transcription terminator element by a mechanism yet to be defined (Kochhar and 
Paulus, 1996). 
5.1.3.2 Aspartate semialdebyde debydrogenase 
Aspartate semialdehyde dehydrogenase (ASADH), catalyses the second step in the 
common pathway and the S. aureus homologue was identified during the present study 
(Chapter 4.2.2.2). This enzyme catalyses the reversible substrate-dependent conversion 
of aspartyl phosphate, to aspartate semialdehyde. All microorganisms examined to date, 
have only a single ASADH encoded by asd. 
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Property Aspartokinase I Aspartokinase II Aspartokinase III 
Structural gene dapG lyse ? 
Mol. wt ~50 000 122900 ~120 000 
Subunit mol. wt 42900 43 700 (a) ? 
17 700 (~) 
Feedback meso- L-Lysine L-Lysine and 
inhibitor(s) diaminopimelate L-Threonine 
Inhibition kinetics Noncompetitive Noncompetitive Competitive 
Corepressor of None known L-Lysine L-Threonine 
enzyme synthesis 
Relative enzyme Rich ~ minimal Rich« minimal Rich« minimal 
level in rich and 
minimal media 
Change in enzyme None Decreases Decreases 
level in stationary 
phase 
Table 5.1 
Aspartokinase isozymes of B. subtilis 
Reproduced from Paulus (1993). 
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The regulation of ASADH by amino acids appears to vary widely in different bacteria. 
ASADH activity in E. coli is not inhibited by lysine, although the synthesis of the 
enzyme is subject to repression by lysine. Additionally threonine and methionine may 
also participate with lysine in a multivalent repression of ASADH (Boy and Patte, 
1972). However, in B. sphaericus (Bartlett and white, 1996), Streptomyces 
akiyoshiensis (Le et al., 1996) and C. glutamicum (Cremer et al., 1988), ASADH is not 
influenced in its specific activity or in its synthesis by any of the aspartate amino acids 
(AAA). 
5.1.4 The biosynthetic branch leading to lysine 
The aspartate pathway splits after the synthesis of aspartate semi aldehyde (Figure 5.1), 
with one branch leading to the biosynthesis of DAP and lysine, and the other leading to 
the biosynthesis of threonine (and isoleucine), and methionine (Chapter 5.1.5). The 
production of lysine from aspartate semialdehyde is a multi-step process for which three 
different pathways are known in prokaryotes (Schrumpf et ai., 1991). These are: 
i) The acetylase variant, involving acetylated intermediates, and is the pathway found in 
B. subtilis, and the majority of other Bacillus species (Paulus, 1993). 
ii) The succinylase variant, in which succinyl residues are used instead of acetyl, as the 
blocking group and is the route found in E. coli (Weinberger and Gilvarg, 1970). 
Together the acetylase and the succinylase variants are known as the epimerase 
pathway, and involve seven enzymatic steps. 
iii) The dehydrogenase variant is present In corynebacterium, for example 
Corynebacterium glutamicum (Schrumpf et al., 1991), and a few Bacillus species 
including B. sphaericus and B. pasteurii (Paulus, 1993). This pathway is a four step 
process, in which four of the reactions of the seven-step epimerase pathway are 
replaced by a single reaction catalysed by diaminopimelate dehydrogenase (Figure 5.2). 
5.1.4.1 Dihydrodipicolinate synthase 
The first step in DAP and lysine biosynthesis in all bacteria (independent of the 
pathway variant used (Chapter 5.1.4», is catalysed by dihydrodipicolinate synthase 
(DHPS) (Figure 5.2). A putative DHPS was identified as part of the present study 
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(Chapter 4.2.2.2). DHPS is coded for by dapA in both E. coli and B. subtilis, and their 
polypeptides show a high degree of sequence similarity. This enzyme as with many of 
the lysine biosynthetic enzymes, is differently regulated in different bacteria. In B. 
subtilis and C. glutamicum DHPS is not subject to feedback inhibit by the end products 
lysine or DAP (Yamakura et aI., 1974; Cremer et al., 1988), whereas the corresponding 
enzyme in E. coli, is inhibited by lysine (Yugari and Gilvarg, 1965). This difference in 
the regulation of DHPS in E. coli and B. subtilis is important and allows DHPS of B. 
subtilis to function in the biosynthesis of DAP and dipicolinate during sporulation even 
at high intracellular concentrations of lysine (Paulus, 1993). 
5.1.5 The biosynthetic branch leading to threonine and methionine 
The first step in the committed biosynthesis of threonine and methionine is the 
production of L-homoserine, which is catalysed by homo serine dehydrogenase 
(Figure 5.1). From this point the pathway once more splits, with one route resulting in 
the biosynthesis of threonine (and isoleucine), and the other methionine (Figure 5.3). 
The mechanism of threonine biosynthesis will not be discussed further in this report. 
5.1.5.1 Methionine biosynthesis and cystathionine y-synthase 
There are two known mechanisms for methionine biosynthesis in bacteria. The route 
leading to the biosynthesis of methionine in both B. subtilis and E. coli requires four 
enzymes for the conversion of L-homoserine to L-methionine, and proceeds via 
cystathionine (Figure 5.3). In these species the formation of cystathionine is catalysed 
by cystathionine y-synthase (CTGS) and a putative CTGS was identified during the 
present study (Chapter 4.2.2.2). In coryneform bacteria, such as Brevibacterium flavum, 
there is an alternative route for methionine biosynthesis, in addition to the pathway with 
cystathionine as an intermediate (Figure 5.3). This mechanism utilises the enzyme 
O-acetylhomoserine sulphydrylase, to catalyse the direct conversion of 0-
acetylhomoserine to homocysteine (Ozaki and Shiio, 1982). Interestingly, in spite of the 
presence of CTGS and cystathionine p-lyase (CTBL) (Figure 5.3) in coryneform 
bacteria these enzymes do not playa critical role in methionine biosynthesis (Ozaki and 
Shiio, 1982). 
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5.1.6 The genetic organisation of the four aspartate amino acid 
biosynthetic seg in non-staphylococcal bacteria 
The four aspartate amino acid biosynthetic (AAAB) genes (lyse. asd, dapA and yjcf), 
identified in the serum screen (Chapter 4.2.2.2), have been studied in many bacterial 
species. This work has revealed among other things the genetic organisation of these 
genes. The organisation of genes encoding; AK (II), ASADH, DHPS and CTOS in non-
staphylococcal bacteria will be reviewed briefly in the following sections. 
5.1.6.1 Organisation of AK II, ASADH, and DHPS in non-staphylococcal 
bacteria 
The lysine sensitive AK of both E. coli (lysC) and B. subtilis (lysC) are found at loci 
distinct from all other AAAB genes (Theze et ai, 1974; Paulus, 1993; SubtiList 
(Chapter 2.23.2». Although in B. subtilis, lyse is downstream, but the other side of a 
rho-independent transcriptional terminator, of a short ORF (24 amino acids), which is 
proposed to be the AK II attenuator, also known as the lyse leader peptide (Figure 5.4). 
In E. coli, ASADH (asd) and DHPS (dapA) are found at different chromosomal loci. 
asd like lyse is located away from all other AAAB genes, although dapA is found 
clustered with one other lysine biosynthetic gene, dapE encoding DAP desuccinylase 
(Theze et ai, 1974). 
In B. subtilis asd and dapA are clustered within an operon (dap operon) along with the 
structural gene for the DAP sensitive aspartokinase (AK I), encoded by dapG (Chen 
et al., 1993). The dap operon (Figure 5.5) contains 6 genes; spoVFA, spoVFB, dapG 
and ymfA, in addition to asd and dapA (SubtilList). This potential operon has two 
promoters, one is located upstream of spo VF A and the other upstream of asd (Figure 
5.5). spoVFA and spoVFB are the two structural genes for dipicolinate synthase 
subunits A and B (SubtilList), and therefore the polypeptide products of these genes are 
also involved in the aspartate pathway (Figure 5.1). Interestingly, there is no terminator 
located between the spoVFB and asd (Chen et al., 1993), and it is believed that these six 
genes are transcribed as a single unit. The final gene of the operon is ymfA, the 
polypeptide product of this gene has unknown function. 
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lyse 
Aspartokinase II 
250 bp 
Figure 5.4 
The location of the lysine sensitive AK (AK II) of B. subtilis 
Reproduced from SubtiList. 
spa VFA spa VFB asd dapG dapA 
1000 bp 
Figure 5.5 
ask 
lyse leader 
peptide 
ymfA 
The dap operon of B. subtilis, showing the organisation of AK I (dapG), ASADH (asd) 
and DHPS (dapA) 
Reproduced from SubtiList. 
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5.1.6.2 Organisation of cystathionine y-synthase in non-staphylococcal 
bacteria 
There is also great variation in the organisation of genes involved in methionine 
biosynthesis, for example between E. coli and B. subtilis. Cystathionine y-synthase 
(CTGS), which in E. coli is encoded by metB, is located within an operon with metL, 
which in turn is part of the metJBLF cluster (Theze et al., 1974). All three of these 
genes are involved in methionine biosynthesis and are regulated at the gene level (along 
with all met genes), by metJ (Rowbury and Woods, 1966). The gene encoding CTas 
(yjcf) has not been extensively studied in B. subtilis, although the SubtiList database 
shows that yjcI is in a bi-cistronic operon with yjcJ (yjcI-yjcJ). Interestingly, yjcJ 
encodes the enzyme cystathionine p-Iyase (CTBL) which catalyses the next step in 
methionine synthesis, following the CTaS catalysed conversion of succinyl homo serine 
to cystathionine (Figure 5.3). 
5.2 Results 
As part of the screening process for sera expressed genes, four putative aspartate amino 
acid biosynthetic (AAAB) genes were identified (Chapter 4.2.2.2 and 4.2.6). These 
were segl (lysC), seg24 (asd), segl0 (dapA) and seg8 (yjcf). Comprehensive analysis of 
these four genes is described in this chapter. 
5.2.1 Molecular analysis of the putative aspartate family of amino acid 
biosynthesis mutants 
5.2.1.1 Chromosomal mapping of Tn917 insertions 
The four aspartate amino acid biosynthetic (AAAB) mutants, were examined by 
Southern blot analysis in order to map the site of the transposon insertion. 
Chromosomal DNA purified from each strain (Chapter 2.17.1.1) was digested with 
EcoRI or XbaI, and then analysed by Southern blot analysis as described in Chapter 
2.20. The blot was probed with a DIG labeled 8kb San I EcoRI fragment from seglO 
(PMDWIO). The probe covers the region of the Tn917 including the lacZreporter gene. 
The probe is expected to hybridise with homologous DNA fragments in the 
chromosome of the mutants containing the transposon. For each of the four mutants a 
single fragment hybridised, indicating a single transposon insertion (results not shown). 
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5.2.1.2 Auxotrophy experiments 
Auxotrophy experiments were carried out using chemically defined media (COM), 
designed for the analysis of strains potentially auxotrophic for the aspartate family of 
amino acids (Chapter 2.1.1.3.1). In total 16 different CDMs were prepared, although 
only 10 different CDMs were used in the liquid assays (Table 5.2). 
5.2.1.2.1 Solid media auxotrophy experiments 
Initially auxotrophy experiments were carried out on CDM agar (Table 5.2). Results 
showed that segl (lysC) and seglO (dapA) required lysine along with one other amino 
acid (threonine, methionine or isoleucine) for growth (Table 5.3). seg24 (asd) was 
auxotrophic for lysine, threonine and methionine for growth, while seg8 (yjcI) had a 
need for only methionine (Table 5.3). The auxotrophy experiments on solid media 
however, proved difficult to score as the fewer aspartate amino acids (AAA) present the 
slower the growth rate, and the lower the overall growth yield. 
5.2.1.2.2 Liquid media auxotrophy experiments 
Liquid CDM assays were used in an attempt to determine the exact auxotrophic 
requirements of the seg strains. This was achieved by following the growth kinetics of 
the AAAB strains (Figure 5.6-5.10), in selected CDM media (Table 5.2). The inclusion 
of isoleucine into the growth medium was found to make no difference to the growth 
kinetics of any of the mutant strains or of the wild type strain (results not shown), and 
thus was not included in any of the CDM. Furthermore, the addition of threonine alone 
to CDM (CDM 2) did not restore growth to any of the AAAB mutant strains (Figures 
5.7-5.10). However, its addition did increase both the growth rate and yield of 8325-4, 
compared to CDM lacking all 4 AAA (result not shown). 
The wildtype strain 8325-4 grew in the absence of lysine, threonine and methionine, 
and as for the AAAB mutant strains, the less amino acids included in the media, the 
slower the growth rate (Figure 5.6). segl (lysC) only grew in COM containing lysine. 
When lysine alone was included in the growth media (CDM 1), growth to the same 
final A600 as in the presence of lysine, threonine and methionine (CDM 11) was 
observed. However, an increased lag period was witnessed in CDM 1, compared with 
media containing lysine, threonine and methionine (CDM 11) (Figure 5.7). seg24 (asd) 
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CDMNo. Amino acids 
1* + lysine 
2* + threonine 
3* + methionine 
4* + isoleucine 
5 + lysine + threonine 
6 + lysine + methionine 
7 + lysine + isoleucine 
8 + threonine + methionine 
9 + threonine + isoleucine 
10 + methionine + isoleucine 
11* + lysine + threonine + methionine 
12* + lysine + threonine + isoleucine 
13* + lysine + methionine + isoleucine 
14* + threonine + methionine + isoleucine 
15* - all four aspartate amino acids 
16* + lysine + threonine + methionine + isoleucine 
Table 5.2 
Aspartate amino acid composition of CDM 1-16 
For basic CDM composition see Table A. 1. 1.2. Note CDM 16 is identical to CDM 
described in Chapter 2.1.1.3. 
* Denotes CDM used for both solid and liquid culture experiments. Other CDM, were 
only used for solid media studies. 
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Strain 
CDM 8325-4 segl (lysC) se,g24 (asd) sef!lO(davi) sef!8(v;d) 
1. 
(+ K) + - - - -
2. 
(+T) + - - - -
3. 
(+M) + - - - + 
4. 
(+ I) + - - - -
5. 
(+ K, T) + + - + -
6. 
(+K, M) + + - + + 
7. 
(+ K, I) + + - + -
8. 
(+T, M) + - - - + 
9. 
(+ T, I) + - - - -
10. 
(+ M, I) + - - - + 
11. 
(+K, T, M) + + + + + 
12. 
(+ K, T, I) + + - + -
13. 
(+ K, M, I) + + - + + 
14. 
(+ T, M, I) + - - - + 
15. 
(- A1l4AA) + - - - -
16. 
(+ A1l4AA) + + + + + 
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Table 5.3 
Growth of seg mutants on CDM agar 
Strains were inoculated onto the 16 types of CDM in triplicate, and incubated 
aerobically at 37°C for 48 hours. Plates were then scored for growth: +, growth; -, no 
growth. The results are representative of at least two separate experiments. 
K-lysine, T - threonine, M- methionine, I - isoleucine. 
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required lysine, threonine and methionine for growth (Figure 5.8). Interestingly 
however, seg24 (asd) does not appear to be auxotrophic for isoleucine, which must 
therefore be synthesised from threonine. segl0 (dapA) required lysine for growth, 
however there was an extended lag in the absence of methionine and threonine (Figure 
5.9). Finally seg8 (yjcl) was unable to grow without methionine. An extended lag was 
seen without the inclusion of lysine or threonine, although a similar growth yield is 
reached (Figure 5.10). 
5.2.1.3 Confirmation of the lyse mutant phenotype 
The observation that seg 1 (lysC) was auxotrophic for only lysine, and not lysine, 
threonine and methionine, implied the presence of at least one other functional 
aspartokinase (AK). More than one AK however, does not explain lysine auxotrophy 
especially as in B. subtilis a strain deficient at the lyse locus has a wild type phenotype 
(Zhang et al., 1990; Chan and Paulus, 1998). Initial database searching revealed that the 
position of the Tn917 insertion in seg 1 was such that it is plausible for a near complete 
enzyme to be translated as the transposon has inserted at amino acid 386 leaving the 
mutant enzyme only 22 amino acids short of the holo enzyme (Figure A.2.1 a). It was 
therefore necessary to confirm the phenotype of the lyse mutant (segl). This was done 
using seg25 (lysC). seg25 (lysC) has an insertion which would result in at best a 
truncated protein of 168 amino acids (out of 408) (Figure A.2.lk). seg25 (lysC) 
demonstrated identical auxotrophy and growth kinetics to seg1 (lysC) in all CDM 
media (results not shown). Therefore the discovery that an S. aureus strain deficient at 
the lyse locus was a lysine auxotroph was upheld. 
5.2.2 DNA sequence analysis of the lysine biosynthetic seg loci 
The aspartate amino acid biosynthetic enzymes encoded by lyse, asd and dapA, were 
analysed in their role in the context of lysine biosynthesis. Importantly however, it 
should be noted that AK II (lysC) and ASADH (asd) are enzymes of the common 
pathway, and thus are involved in the biosynthesis of methionine, threonine and 
isoleucine, in addition to that of lysine. 
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Figure 5.6 
The growth of S. aureus 8325-4 in different CDM 
S. aureus 8325-4 was grown at 37°C in CDM 1 (+ K), CDM 2 (+ T), CDM 3 (+ M), 
and CDM 11 (+ K, T, M), under aerobic conditions with shaking (250 rpm). Growth 
was measured as A 600 for 45 h. The results are representative of two separate 
experiments. 
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The growth of seg 1 (lysC) in different CDM 
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The growth of seg24 (asd) in different CDM 
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segl and seg24, were grown at 37°C in CDM 1 (+ K), CDM 2 (+ T), CDM 3 (+ M), 
and CDM 11 (+ K, T, M), under aerobic conditions with shaking (250 rpm). Growth 
was measured as A 600 for 45 h. The results are representative of two separate 
experiments. 
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The growth of seg10 (dapA) in different CDM 
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The growth of seg8 (yjcI) in different COM 
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segl0 and seg8, were grown at 37°C in CDM 1 (+ K), CDM 2 (+ T), CDM 3 (+ M), 
and CDM 11 (+ K, T, M), under aerobic conditions with shaking (250 rpm). Growth 
was measured as A 600 for 45 h. The results are representative of two separate 
experiments. 
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5.2.2.1 Determination of the chromosomal location and organisation of 
lyse, asd and dapA genes in S. aureus 
A combination of peR and database searching approaches revealed the genetic 
organisation of lysC, asd and dapA. DNA sequencing was then used to confirm these 
results. 
5.2.2.1.1 peR approach 
Based on the gene organisation in other organisms (Chapter 5.1. 6.1), PCR was used to 
determine if a conserved arrangement is present in S. aureus (Chapter 2.21.2.1.1). PCR 
was carried out using both genomic and pSEO 10 DNA (Chapter 4.2.4.2.2), as a 
template. All primer sequences are shown in Table A.I.2.I. 
Reactions were designed to determine whether: i) lysC and asd are clustered; ii) asd and 
dapA are clustered; and iii) lysC, asd and dapA are clustered. Each reaction gave a 
product of predicted size, and revealed the likelihood of no dapG homologue in the 
lysC-dapA region (results not shown). Results from PCR on pSEO 1 0 demonstrated that 
this plasmid contains a truncated dapA gene, along with an intact copy of both asd and 
lysC upstream. These initial results were soon superseded by DNA sequence analysis. 
5.2.2.1.2 Sequencing approach 
In order to confirm the PCR results the chromosomal insert in pSEG 10 (4.1 kb) was 
sequenced (Chapter 2.21.3.3.1). The results of this sequencing reaction are shown 
diagramatically in Figure 5.11, and demonstrate that the first three enzymes in lysine 
biosynthesis (lysC, asd and dapA) are present in a putative operon. The putative operon, 
which may encode other downstream genes was named the dap operon (Figure 5.11). 
5.2.2.1.3 Database construction and analysis to further study the dap operon 
ofS. aureus 
During the course of the project, the publicly available S. aureus genome databases 
(TIOR and NCTC 8325) were being released. Repeated searching over the duration of 
the study allowed the entire dap operon to be compiled (Chapter 2.23.3). 
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5.2.2.2 The dap operon of S. aureus 
The consensus sequence of the 13 kb 'dap' database (Figure 5.11) was analysed to 
identify potential open reading frames (ORFs). Using the computer program Gene 
Jockey II (Chapter 2.23.l), a putative 8 gene operon (dap) was identified. In addition to 
this a single ORF was discovered 3' of the dap operon and a further three upstream 
ORFs were detected. The sequences of these 12 ORFs were analysed (BLAST) to 
determine their relationship to sequences in the NCBI database (Chapter 2.23.2). The 
results of this analysis are shown in Figure 5.11 and Table 5.4. The 3' ORF shows 
homology to cspC (cold shock protein C), while the upstream ORFs show homology to 
ykpA (unknown, similar to ABC transporter), yilL (unknown) and sphX (SPHX protein 
precusor) (Figure 5.11; Table 5.4). Since these genes are only located close to the dap 
operon and are not apparently involved in lysine biosynthesis, no further attention will 
be paid to these genes. 
The first three genes of the 8 gene dap operon as predicted (Chapter 5 .2.2.l) are lysC, 
asd and dapA. Interestingly, the 41\ 5th and 81h genes also show homology to genes 
encoding lysine biosynthetic enzymes (LBE). These are dapB (dihydrodipicolinate 
reductase), ykuQ (tetrahydrodipicolinate acetyltransferase) and lysA (DAP 
decarboxylase). The final two genes of the dap operon (genes 6 and 7) show homology 
to hipO (hippurate hydrolase), and dal (alanine racemase), which do not have an 
apparent role in lysine biosynthesis (Figure 5.l1; Table 5.4). In between lysA and cspC, 
is an intergenic region of approximately 650 bp (Figure 5.l1). This region was found to 
contain several stem loop structures, one or more of which may function as rho-
independent terminators (Chapter 2.23.1). However, further analysis is required to 
confirm function to these putative rho-independent terminator structures. 
5.2.2.2.1 Sequencing of the entire dap operon of S. aureus 
The dap database sequence has been compiled from four different strains of S. aureus 
(Figure 5.11). The organisation of the dap operon was confirmed in S. aureus strain 
8325-4, by sequencing the entire dap locus from this strain. A PCR product was 
generated from genomic DNA of 5.7 kb, spanning from the 3' end of dapA through to 
lysA and a short region beyond this final gene (Figure 5.11), using primers MDW41 and 
MDW44 (Table A.1.2.1). The amplified fragment was then cloned into pCRGD2.1-TOPO 
to produce pMTOP09 (Chapter 2.22.2). The DNA insert was then sequenced (Chapter 
2.21.3.3.2). The entire dap region's sequence, from 8325-4 is shown in Figure 5.12. 
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Figure 5.11 
Diagrammatic representation of the dap operon and surrounding regions 
* Sequenced as part of this project. 
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Gene Enzyme % Identity Organism 
AA/AA 
lyse Aspartokinase II 40% Thermotoga 
160 1396 maritima 
asd Aspartate semi aldehyde 50% Aquifex aeolicus 
dehydrogenase 164 I 322 
dapA Dihydrodipicolinate synthase 41 % Methanococcus 
119 I 279 jannaschii 
dapB Dihydrodipicolinate reductase 43% Aquifex aeolicus 
73/166 
ykuQ Unknown, similar to 60% B. subtilis 
tetrahydrodipicolinate succinylase 142/233 
hipO Hippurate hydrolase 36% B. subtilis 
123 1333 
air Alanine racemase 50% S. aureus 
91 /308 
lysA Diaminopimelate decarboxylase 50% B. subtilis 
210 / 415 
cspC Cold shock protein C 80% S. aureus 
53/60 
ykpA Unknown, similar to ABC 73 % B. subtilis 
transporter 394 I 533 
yitL Unknown 37% B. subtilis 
99 I 262 
sphX SPHX protein precusor 36% Synechococcussp. 
62 I 171 (Strain PCC 7942) 
Table 5.4 
Identification of genes from the dap database 
% Identity - The number of identical amino acids, from those within the homologous 
region. 
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P F R L Q E F F E G V N M N L V D W L R 
CCCTTTCGTCTTCAAGAATTCTTTGAGGGCGTTAATATGAACCTTGTAGATTGGTTAAGA 
Q YAP E D E Q T E T F L R G F L G R M 
CAATACGCACCAGAAGATGAGCAAACTGAAACATTTTTACGCGGCTTCTTAGGCCGTATG 
L F S GEE V KKK A S V L S G G E K V 
CTATTTAGTGGAGAAGAAGTTAAGAAAAAAGCTAGTGTACTTTCAGGTGGAGAAAAAGTA 
R C M L S K M M L S SAN V L L L D E P 
CGTTGTATGCTAAGTAAAATGATGTTATCAAGTGCAAACGTTCTTTTACTTGATGAACCA 
T N H L D L E SIT A V N D G L K S F K 
ACAAACCACTTAGACTTAGAAAGTATTACTGCTGTTAATGATGGACTTAAATCATTCAAA 
G S I 1FT S Y D F E FIN T I A N R V 
GGTTCTATTATCTTTACTTCATATGACTTTGAATTTATCAATACAATCGCAAACCGTGTT 
I D L N K Q G G V S K E I P Y E E Y L Q 
ATCGATTTAAATAAACAAGGTGGCGTTTCAAAAGAAATTCCATATGAAGAATATTTACAA 
E I G V L K * 
GAAATCGGCGTTTTAAAATAAACATAATATGTAGAATTTCTTTTCGAAAATCTCTGTATT 
GAGGCCCGACCAACTTGCACATTATTGTAAGTTGGCTTACTGTCACCTTCTATATTGGGA 
CTTATTCCGCAACTTGTATTGTTTGTAGAAATTAGGAATCCAATTTCTCTATGTGTTGCA 
Putative lyse leader peptide 
M K K A S Y K V I F I Q S T T V N 
CCGACAAGGATTGAAAAAAGCTAGCTACAAAGTCATTTTCATTCAGTCAACTACTGTCAA 
I T L Q G L G H * 
TATAACATTGCAGGGCCTAGGGCATTGATTCATGTCCGAGACTATATTCAATTTAATAGA 
CATTAACTGGGCGTCTCGATGCTAATATTTATAGCATCGAGGTGTCCTTTTTATTTTATT 
TTTTAACACATCAGCATAGTGAACACCCCTTCTCTAAATTACAAATACAGTTATCAACGC 
ATTAAAAGAGTACATTTATTTAATGTGCATATTGATTATGCTATAAGTATTTTGAATTTT 
ATTTTTCAAAAAGTCTCATTATCACCACCTTTTAAAATATAAGCAACGCTATAACTTGAA 
TTTTCAGGTTATTCCAAAAAATCTAAATTATCGGTTTACATTCATATTTGTCATATGTAT 
AATGAACACATACCAATTTAATAATATTTTGATGAGGCGCATCAATCATGAGTAAAGTTT 
AGATTACTGTCTGCTAACAGCTAAATTTGAAAGGGTGCGATGCCGAAGCAATTATAATAG 
CAGTTATAATTTGTTGGACTTTTTGGTTAAGAGCTGAGAGTTTGTCATTATTTAAAAATA 
ATGGAGTGCATCACTTGTATATAGATTAAGAGCAAGTTCGCATTCCGAACTTGTTCTTTT 
60 
120 
180 
240 
300 
360 
420 
480 
540 
600 
660 
720 
780 
840 
900 
960 
1020 
1080 
1140 
1200 
1260 
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seg22 (30,33) 
V 
lyse (a subunit) 
M V T R S V L 
TTTATTATTGTGTGCCCTTCCTAACAATTAGGAGGATTATATGGTAACAAGAAGTGTGTT 1320 
K F G G S S V S D F T K I K R I A E M L 
GAAATTTGGCGGATCATCCGTCAGTGATTTTACAAAAATAAAAAGGATCGCTGAAATGTT 1380 
seg14 
V 
K E R V N Q D E Q L I V V V SAM G N T 
AAAGGAGCGAGTCAATCAAGATGAACAATTAATTGTCGTTGTAAGTGCTATGGGTAACAC 1440 
T D Q L M T N V S T L T K A P K Q Q E L 
AACAGATCAATTAATGACGAATGTATCAACCTTGACTAAAGCACCAAAACAACAAGAACT 1500 
ALL L T T G E Q Q T V S Y L S M V L N 
GGCATTATTATTGACAACCGGAGAGCAACAAACTGTATCTTATTTATCAATGGTATTAAA 1560 
DIG M N A K A M T G Y Q A G I K T I G 
TGATATCGGTATGAATGCCAAAGCAATGACTGGCTATCAAGCGGGTATTAAAACCATTGG 1620 
H H L K SKI A Q I N P Q T F E Q A F Q 
CCATCATTTAAAAAGTAAAATTGCTCAAATTAATCCTCAAACATTTGAACAAGCCTTTCA 1680 
END I L V V A G F Q GIN E H Q E L T 
AGAAAACGATATTTTAGTAGTTGCTGGATTTCAAGGCATCAATGAACATCAGGAATTAAC 1740 
T L G R G G S D T T A V A L A V S N Q I 
AACTTTAGGCAGAGGTGGTTCTGATACGACCGCTGTGGCACTTGCTGTTAGTAATCAAAT 1800 
seg2S{SO)seg4S{48) 
VV 
P C ElY T D V D G V Y A T D P R L L P 
ACCTTGTGAAATTTATACCGACGTTGATGGTGTGTATGCCACTGACCCAAGACTTTTACC 1860 
K A K R L D I V S Y E E M M EMS A L G 
AAAGGCTAAACGACTAGACATCGTCTCATATGAAGAAATGATGGAAATGAGCGCTTTAGG 1920 
A G V LET R S VEL A K N Y NIP L Y 
TGCTGGTGTACTTGAAACAAGAAGTGTTGAATTAGCTAAAAACTATAATATCCCTTTATA 1980 
lyse (P subunit) 
L G K T L S N V K G T W I M S NEE I L 
TTTAGGAAAAACTTTATCGAACGTGAAAGGAACATGGATTATGTCAAATGAAGAAATATT 2040 
E K K A V T G V A L D K H M M H V TIS 
AGAGAAAAAAGCAGTTACTGGTGTGGCTTTGGATAAACATATGATGCATGTAACAATTAG 2100 
Y P L P D N Q L L T Q L F TEL E EGA 
TTATCCCCTACCTGACAATCAGCTACTTACCCAACTATTTACGGAACTTGAAGAAGGTGC 2160 
V N V D MIS Q I V N L D G L Q L S F T 
TGTAAATGTTGATATGATTTCACAAATCGTCAACTTGGATGGGCTACAACTATCCTTCAC 2220 
I K D S D F H Q ISM I LET L K N Q Y 
GATTAAAGATAGTGATTTTCATCAAATTTCTATGATTCTTGAAACATTAAAGAATCAATA 2280 
E A LAY KIN E H Y V K I S L I G S G 
TGAAGCATTAGCTTATAAAATCAATGAGCATTATGTCAAAATTTCATTAATTGGCTCAGG 2340 
Beg13 
V 
M R D M S G V ASK A F L T LIE N N I 
CATGCGTGATATGTCAGGTGTGGCATCAAAAGCATTTTTGACATTAATTGAAAATAATAT 2400 
218 
segl(21) 
V 
P F Y Q T T T S E I SIS Y V I D D F N 
ACCTTTCTACCAAACAACAACATCTGAAATAAGTATTTCATACGTCATTGATGATTTTAA 2460 
G Q Q A V E K L Y D A F N I * 
TGGGCAACAAGCGGTAGAAAAACTATATGACGCATTTAACATTTAATGGTAAAATGATTG 2520 
asd 
M T K L 
TTAAAATATTCTAAAAATTGGAAATTATTATAAAATGGAGTGACAAGTTATGACAAAGTT 2580 
A V V GAT G L V G T K M LET L N R K 
AGCAGTTGTGGGTGCAACAGGATTAGTAGGTACAAAAATGTTGGAGACATTAAATCGTAA 2640 
NIP F DEL V L F S S A R SAG Q E V 
AAATATTCCTTTCGATGAATTAGTATTATTTTCATCAGCACGTTCTGCAGGGCAAGAAGT 2700 
seg24 
V 
E F Q G K T Y T V Q E LTD A R A S E H 
TGAATTTCAAGGAAAAACATATACAGTTCAAGAATTAACTGATGCTCGTGCAAGTGAACA 2760 
F D Y V L M SAG G G T S E H F A P L F 
TTTCGATTATGTATTAATGAGTGCTGGTGGCGGTACAAGCGAACACTTTGCCCCACTTTT 2820 
E K A G A I V I D N S S Q W R MAE D I 
TGAAAAAGCTGGTGCAATCGTTATAGACAATTCAAGTCAATGGCGTATGGCAGAAGATAT 2880 
D L I V P E V N E P T F T R G I I A N P 
TGATTTAATCGTTCCGGAAGTCAATGAACCTACATTTACAAGAGGTATCATTGCCAATCC 2940 
N CST I Q S v v P L K V L Q DAY G L 
AAACTGCTCTACGATTCAATCTGTTGTACCTCTAAAAGTATTGCAAGATGCTTATGGTTT 3000 
K R V A Y TTY Q A V S G S G M K G K K 
AAAACGAGTGGCATATACAACATATCAAGCTGTATCAGGTTCAGGGATGAAAGGTAAGAA 3060 
D L A E G V N G K APE A Y P H PlY N 
AGATTTAGCTGAAGGTGTAAATGGTAAAGCACCAGAAGCATATCCACATCCAATTTATAA 3120 
seg26 
V 
N V L PHI D V F LEN G Y T K E E Q K 
TAATGTGTTACCGCATATTGATGTGTTTTTAGAAAACGGATATACAAAAGAAGAACAAAA 
MID E T R K I L NAP D L K V TAT C 
AATGATTGATGAGACGAGAAAAATTTTAAATGCGCCAGACTTAAAAGTAACAGCAACATG 
A R V P v Q D S H S v E I D v T L D K E 
CGCACGTGTGCCTGTTCAAGATAGTCATAGTGTTGAAATTGATGTAACGCTTGACAAAGA 
T T A E D I K A L F D Q D D R V V L V D 
AACAACAGCAGAAGATATTAAAGCGTTATTTGATCAAGATGACCGCGTTGTTTTAGTAGA 
N PEN N E Y P M A INS T N K D E V F 
CAATCCAGAGAACAATGAATATCCAATGGCAATCAATTCTACTAATAAAGATGAAGTGTT 
v G R I R R DDS LEN T F H v W C T S 
TGTTGGCCGTATACGTAGAGATGATTCATTAGAAAATACTTTCCATGTATGGTGTACATC 
D N L L K G A A L N A V Q v L E Q v M R 
AGACAATTTATTAAAAGGTGCTGCATTAAATGCTGTACAAGTATTGGAACAAGTTATGCG 
L K G A N * 
dapA 
M T H L F E G V G V A L T 
TTTAAAAGGAGCGAATTAAAATGACACATTTATTTGAGGGTGTTGGCGTTGCACTTACAA 
3180 
3240 
3300 
3360 
3420 
3480 
3540 
3600 
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T P F T N N K V N I E A L K T H V NFL 
CCCCTTTTACAAATAACAAAGTTAATATTGAAGCTTTGAAAACACACGTTAATTTTTTAC 3660 
LEN N A Q A I I V N G T T A ESP T L 
TAGAAAATAATGCCCAAGCAATCATCGTTAATGGAACTACTGCTGAGAGCCCTACTTTAA 3720 
T T D EKE R ILK T V I D L V D K R V 
CAACAGATGAAAAAGAACGCATTCTAAAAACAGTTATTGATCTTGTAGATAAACGTGTTC 3780 
P V I A G T G T N D T E K S I Q A S I Q 
CTGTCATAGCAGGAACTGGCACTAATGATACTGAAAAGTCAATCCAAGCTTCAATCCAAG 3840 
A K A L GAD A I M LIT P Y Y N K T N 
CTAAAGCCTTAGGGGCTGATGCAATTATGTTAATTACGCCCTACTACAACAAAACGAACC 3900 
Q R G L V K H F E A I A D A V K L P V V 
AACGTGGTTTAGTCAAACACTTTGAAGCGATTGCAGATGCTGTGAAATTACCAGTCGTGC 3960 
L Y N V P S R T N M TIE PET V ElL 
TGTACAATGTTCCTTCAAGAACGAACATGACAATTGAACCAGAAACTGTAGAAATATTAA 4020 
•• glO 
V 
S Q H P Y I V A L K D A T N D FEY L E 
GTCAACATCCTTATATAGTTGCTTTAAAAGATGCTACGAATGATTTTGAGTATTTAGAAG 
E V K K RID T NSF A L Y S G N D D N 
AAGTGAAAAAGCGCATTGATACAAATTCATTTGCATTATATAGTGGCAATGATGACAACG 
v V E Y Y Q R G G Q G V I S V I A N V I 
TCGTCGAATACTATCAACGTGGCGGTCAAGGGGTTATCTCTGTTATTGCCAATGTCATTC 
P KEF Q A L Y D A Q Q S G L D I Q D Q 
CTAAAGAATTTCAAGCGTTATACGATGCTCAACAAAGTGGATTAGATATTCAAGATCAAT 
F K PIG T L L SAL S V DIN PIP I 
TTAAACCAATCGGCACACTGTTATCAGCTTTATCAGTTGATATTAACCCAATTCCTATTA 
K A L T S Y L G F G N Y E L R L P L V S 
AAGCTCTAACAAGTTATTTAGGATTTGGAAATTATGAATTACGTCTACCATTGGTTAGCC 
LED T D T K V L RET Y D T F K AGE 
TAGAAGATACAGATACTAAAGTGCTTCGTGAAACATATGACACATTTAAAGCGGGTGAAA 
dapB 
N E * M N Q R V A R L A 
ATGAGTGAAAATATTACTAATTGGCTATGGCGCAATGAATCAACGCGTTGCTAGATTAGC 
E E K G H E I V G V lEN T P KAT T P 
AGAAGAAAAAGGACATGAAATCGTTGGGGTCATTGAAAATACACCGAAAGCAACAACGCC 
Y Q Q Y Q H I A D V K GAD V A I D F S 
ATATCAACAATATCAACATATTGCAGATGTTAAAGGTGCCGATGTTGCAATAGATTTTTC 
N P N L L F P L L D E D F HLP L V V A 
AAATCCAAATCTGCTTTTCCCTTTATTAGATGAAGATTTTCATTTGCCATTAGTTGTGGC 
T T G EKE K L L N K L DEL S Q N M P 
AACAACTGGCGAGAAAGAAAAACTACTTAATAAGTTAGATGAATTGAGTCAAAATATGCC 
V F F SAN M S Y G V HAL T K I L A A 
TGTGTTTTTCAGCGCGAACATGAGTTATGGCGTTCATGCATTGACTAAAATTTTAGCAGC 
A V P L L D D F DIE L TEA H H N K K 
TGCTGTTCCCCTACTTGATGATTTCGACATCGAATTGACTGAGGCACATCATAATAAAAA 
4080 
4140 
4200 
4260 
4320 
4380 
4440 
4500 
4560 
4620 
4680 
4740 
4800 
4860 
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V D A PSG T L E K L Y D V I V S L K E 
AGTAGATGCACCAAGTGGTACGTTAGAAAAATTGTATGATGTGATCGTATCTTTGAAAGA 
N V T P V Y D R H E L N E K R Q P Q D I 
AAATGTAACACCTGTGTATGATAGACATGAATTAAATGAAAAACGCCAGCCACAAGATAT 
G I H SIR G G T I V G E H E V L FAG 
TGGTATACATTCTATTCGTGGAGGTACGATTGTCGGTGAACATGAAGTTCTATTTGCTGG 
T D E T I Q I T H R A Q S K D I FAN G 
CACTGATGAAACGATTCAAATCACGCATCGTGCACAATCAAAAGATATTTTTGCGAATGG 
A I Q A A E R L V N G P N G F Y T F D N 
TGCAATACAAGCAGCAGAACGCTTAGTTAATGGGCCAAACGGCTTTTATACGTTTGACAA 
ykuQ 
L * M V Q H L T A E E 
CTTATAAACATATTAAAGGAGATCGATTATTTTATGGTACAACATTTAACAGCTGAAGAA 
I I Q Y I S D A K K S T P I K V Y LNG 
ATTATTCAATATATAAGTGATGCTAAAAAGTCTACACCAATAAAAGTATATTTAAATGGT 
N F E G I T Y PES F K V F G SEQ S K 
AATTTTGAAGGCATCACATATCCAGAAAGTTTTAAAGTATTTGGTTCAGAACAATCTAAA 
V I F C E ADD W K P F YEA Y G S Q F 
GTAATCTTTTGTGAAGCGGATGATTGGAAACCTTTTTACGAAGCATATGGTAGTCAATTC 
E DIE I E M D R R N S A I P L K D L T 
GAAGATATAGAAATTGAAATGGATCGTCGCAATTCTGCTATTCCATTAAAAGACTTAACA 
N T N A R I E P G A FIR E Q A I lED 
AATACGAATGCACGAATTGAACCAGGTGCGTTTATTAGAGAACAAGCCATTATTGAAGAT 
G A V V M M GAT I N I G A V V G E G T 
GGTGCTGTCGTTATGATGGGCGCAACAATTAATATTGGCGCAGTCGTTGGCGAAGGTACA 
MID M NAT L G G RAT T G K N V H V 
ATGATTGATATGAATGCTACTCTCGGTGGTCGTGCTACAACTGGTAAAAATGTACATGTA 
GAG A V LAG V I E P P S ASP V I I 
GGGGCTGGCGCAGTATTAGCAGGTGTGATTGAACCCCCTAGTGCTTCACCGGTTATAATC 
E D D V L I G A N A V I LEG V R V G K 
GAGGATGATGTATTAATCGGTGCAAATGCAGTTATTTTAGAAGGTGTACGTGTTGGTAAA 
G A I V A A G A I V T Q D V P A G A V V 
GGTGCTATTGTTGCAGCTGGCGCGATTGTGACACAAGATGTACCAGCTGGTGCAGTTGTT 
A G T P A K V I K Q A S E V Q D T K K E 
GCTGGTACACCTGCAAAAGTGATTAAGCAAGCTTCTGAAGTACAAGATACTAAAAAAGAG 
I V A A L R K L N D * 
ATTGTAGCAGCATTAAGAAAACTGAATGACTAGTGACGTCAACGTATAATAATTTCAAGG 
TTGAGATACGATTATGTCTCAACCCTATTGTTTAGCATTGAATAAACTTATGATCACAAA 
hipO 
M N 
TTTCGAAATACGTTACACTATTTATATAGTAATTTAACACAAAGGATTGATAATTATGAA 
E L E F V T K H R R H L H Q H PEL S L 
TGAATTAGAATTTGTTACGAAACATCGCCGTCATTTACATCAACATCCTGAATTAAGCTT 
4920 
4980 
5040 
5100 
5160 
5220 
5280 
5340 
5400 
5460 
5520 
5580 
5640 
5700 
5760 
5820 
5880 
5940 
6000 
6060 
6120 
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H E F E T T A Y I K A F L D S L N I K Y 
ACATGAATTTGAAACAACTGCTTATATTAAAGCGTTTTTAGATAGTTTAAATATTAAATA 
D C P LET G V I A Y LEG N G S H T I 
CGATTGCCCATTGGAAACTGGCGTCATTGCATACTTAGAAGGTAATGGCTCACATACGAT 
A Y R A DID ALP I LEE N D V P Y R 
AGCGTATAGAGCTGATATTGATGCGTTACCTATTTTAGAGGAAAATGATGTGCCTTATCG 
S Q S D H V M HAC G H D G H T TAL M 
CAGTCAATCTGATCATGTGATGCATGCTTGTGGACATGATGGTCATACAACTGCATTAAT 
L F V Q R C K D M Q D A G Q L P Q N V V 
GCTTTTTGTACAACGTTGCAAAGACATGCAAGATGCAGGTCAATTACCGCAAAATGTCGT 
F I F Q P A E E T G G G A N R L I K A G 
TTTCATTTTCCAACCTGCAGAAGAAACTGGTGGCGGTGCAAATCGATTAATAAAAGCCGG 
A F D K Y PIE A V F G I H V N P FAD 
TGCCTTTGATAAGTATCCAATTGAAGCGGTATTTGGTATTCATGTTAACCCATTTGCTGA 
E G I A V I R DEE I T A SAT E Y R F 
TGAAGGCATTGCAGTGATAAGAGATGAAGAAATTACGGCCAGCGCAACAGAGTATCGCTT 
F LTG L S S H V A D K E Q G H S C G E 
TTTCTTAACAGGCCTGTCAAGTCATGTTGCTGATAAAGAACAAGGTCATTCTTGTGGTGA 
A L Q H V L T Q I S Q I Q Q F H LNG L 
AGCATTACAACATGTATTAACTCAAATATCACAAATTCAACAATTTCACCTTAACGGTTT 
K R N I V H I G H F K AGE A I N T V P 
GAAACGAAATATTGTTCATATTGGTCATTTTAAAGCTGGTGAAGCGATTAACACTGTACC 
S N G Y LEG T I R T Y DID D L T I V 
AAGTAATGGCTATTTAGAAGGTACTATTCGTACATATGATATTGATGATTTAACAATCGT 
K N Q M H K I A E S V K L L F N V D C E 
TAAAAATCAAATGCACAAGATAGCAGAAAGTGTCAAGCTTCTGTTTAATGTAGATTGTGA 
V K F A E GYP P TIN S P K L R T Q I 
AGTTAAATTTGCAGAAGGTTATCCCCCTACAATCAATAGTCCGAAATTACGTACTCAAAT 
E D A L I K A D L N V Y D K P T P F L F 
AGAGGACGCCTTAATAAAAGCTGATTTAAATGTCTATGACAAACCAACGCCATTCTTATT 
G E D F S F Y G Q Q LAP A Y F V FIG 
TGGGGAAGATTTTAGTTTTTATGGTCAACAACTAGCTCCAGCTTACTTTGTTTTTATAGG 
T R NED K G F V T G L H T S H L N F D 
AACACGAAATGAAGATAAAGGTTTTGTAACTGGTTTGCACACATCACATTTAAATTTTGA 
E K V LIN V I N F YEN L L N N Y K E 
TGAAAAAGTGTTAATAAACGTGATTAATTTTTACGAAAATTTATTAAATAATTACAAAGA 
v * 
GGTGTAATACATTGACAGCAACATGGTCTGTAAATAAGAAAATATTTTTACAAAATGCAA 
dal 
M A V V K N NAY H Y 
TCACAGTCAAAAACAATCAGCCATTAATGGCAGTTGTTAAAAATAATGCATATCACTATG 
D L E F A V T Q F I HAG I D T F S T T 
ACCTAGAATTTGCTGTAACTCAGTTTATCCATGCAGGTATAGATACATTTAGCACAACAT 
6180 
6240 
6300 
6360 
6420 
6480 
6540 
6600 
6660 
6720 
6780 
6840 
6900 
6960 
7020 
7080 
7140 
7200 
7260 
7320 
7380 
222 
S L REA I Q IRQ LAP D A T I F L M 
CACTACGAGAAGCAATTCAAATTAGACAACTTGCTCCAGATGCAACAATCTTTTTAATGA 7440 
N A V Y E F D L V R E H Q I H M T L P S 
ATGCAGTTTACGAGTTTGATTTAGTCCGTGAACATCAAATACACATGACTTTGCCGTCGT 7500 
L T Y Y Y N H K N D LAG I H V H L E F 
TGACATATTACTATAACCATAAAAATGATTTAGCTGGTATTCATGTTCACTTAGAATTTG 7560 
E N L L H R S G F K D L N ElK E v L K 
AAAATTTATTACATCGGTCTGGATTTAAAGATTTAAACGAAATTAAAGAAGTATTGAAAG 7620 
D H H H N Q N A K M I I S G L W T H F G 
ATCACCATCATAATCAAAATGCAAAAATGATTATTAGTGGTTTATGGACCCATTTTGGAT 7680 
Y A D E F D V S D Y N V E R S Q W MEl 
ATGCTGATGAATTCGATGTGTCAGATTATAATGTTGAACGTTCACAATGGATGGAAATTG 7740 
V E ALL S E G Y Q F D L I H A Q N S A 
TTGAAGCACTTTTATCTGAAGGTTATCAGTTCGACCTAATCCATGCTCAAAATAGTGCGA 7800 
S F Y REG Q ILL P H H T H A R V G I 
GTTTTTATCGGGAAGGACAAATATTACTACCCCACCATACACATGCGCGTGTAGGTATTG 7860 
A L Y G S R P Y S S L N Q H D I V Q S L 
CGTTATACGGTTCAAGACCATATAGTTCACTGAATCAACATGATATAGTTCAGTCATTAA 7920 
T L K A H V I Q v REV Q A G D Y C G Y 
CTTTAAAAGCACATGTTATTCAAGTGCGCGAAGTACAAGCTGGTGATTATTGCGGTTATA 7980 
S F A F E V T K N N T K L A V V DIG Y 
GCTTTGCCTTTGAAGTGACTAAAAACAATACAAAATTAGCTGTAGTTGATATCGGTTATG 8040 
G D GIL R T R A K H E A LIN G K R Y 
GCGATGGAATTTTAAGAACTCGTGCTAAACATGAAGCACTTATCAATGGTAAACGCTACC 8100 
P I R A L M M S H M F V E V D G N V H A 
CGATACGTGCATTAATGATGAGCCATATGTTTGTTGAAGTAGATGGCAATGTACATGCAC 8160 
Q D E v I L Y N N D I RID E Y T F K G 
AAGATGAAGTTATTCTTTATAATAATGATATCCGCATCGATGAATATACCTTTAAAGGTG 8220 
V G A N SEQ L SAM N H D S L K KEY 
TTGGTGCAAATTCTGAACAATTAAGTGCTATGAATCATGATTCTTTAAAAAAGGAGTACA 8280 
I S N D C * 
M T v K Y N Q N GEL T M D G I 
lysA 
S L 
TTTCAAATGACTGTTAAATATAATCAAAATGGCGAATTAACAATGGATGGTATTAGTTTA 8340 
K T I A Q S F G T P T I V Y DEL Q I R 
AAAACGATTGCACAAAGCTTTGGTACACCTACCATTGTTTATGATGAACTACAAATTAGA 8400 
E Q M R R Y H R A F K D S G L K Y N I S 
GAACAGATGCGCCGTTACCATCGCGCATTTAAAGATAGTGGATTAAAATACAATATTTCA 8460 
Y ASK AFT C I Q M v K L v A E E D L 
TACGCCTCAAAGGCATTTACTTGCATTCAAATGGTCAAACTTGTAGCTGAGGAAGATTTA 8520 
Q L D V V S E GEL Y TAL E A G F E P 
CAGTTAGATGTTGTTTCTGAAGGTGAATTATATACAGCTTTAGAAGCAGGTTTTGAACCG 8580 
SRI H F H G N N K T K H E I R Y ALE 
AGTCGCATCCATTTCCATGGTAACAATAAAACGAAACATGAAATTAGGTATGCTTTAGAA 8640 
223 
N N I G Y F V IDS LEE I ELI DRY 
AATAATATCGGTTATTTTGTTATAGATTCATTAGAAGAAATTGAATTAATAGACCGCTAT B700 
AND T V Q V V L R V N P G V E A H T H 
GCTAATGATACGGTTCAAGTTGTATTACGAGTTAATCCAGGTGTTGAAGCACATACACAC B760 
E F I Q T G QED S K F G LSI Q Y G L 
GAATTTATTCAAACTGGGCAAGAAGATAGTAAGTTTGGATTATCAATTCAATATGGCTTA BB20 
A K K A I D K V Q Q S K H L K L K G V H 
GCTAAAAAAGCAATTGACAAAGTCCAACAATCTAAACACTTAAAATTAAAAGGTGTACAT BBBO 
CHI G S Q lEG TEA FIE T A K I V 
TGTCATATTGGTTCACAGATTGAAGGTACAGAAGCATTTATTGAAACTGCTAAAATTGTT B940 
L R W L K E Q G I Q VEL L N L G G G F 
TTACGTTGGCTTAAAGAGCAAGGCATTCAAGTTGAATTATTAAACCTTGGTGGTGGCTTT 9000 
G I K Y V E G DES F PIE S G I K D I 
GGTATTAAATATGTTGAAGGTGACGAAAGTTTCCCTATCGAAAGTGGTATTAAAGATATT 9060 
T D A I K S ElK V L G I D APE I G I 
ACAGACGCAATAAAATCCGAAATTAAAGTTCTAGGTATAGATGCACCAGAAATAGGTATT 9120 
E P G R S I V G E A G V T LYE V G T I 
GAACCGGGACGATCAATTGTAGGTGAAGCTGGCGTTACTTTATATGAAGTTGGAACCATT 91BO 
K E I PEl N K Y V SID G G M S D H I 
AAAGAAATTCCAGAGATTAATAAATATGTTTCAATCGATGGCGGTATGAGTGATCATATC 9240 
R TAL Y D A K Y Q ALL V N R NEE A 
AGAACTGCACTTTATGACGCAAAGTATCAAGCATTGCTTGTTAATAGAAATGAAGAAGCA 9300 
DDS V T I A G K L C E S G D I I I K D 
GATGACAGTGTAACTATAGCTGGAAAATTATGTGAGTCTGGTGATATCATTATTAAAGAC 9360 
A K L P S S V K R G D Y L A I L S T G A 
GCTAAATTACCTTCATCAGTCAAACGTGGAGACTATCTTGCTATATTATCAACTGGTGCA 9420 
Y H Y SMA S N Y N Q M Q K P S V F F L 
TATCATTACTCTATGGCATCCAATTACAATCAAATGCAAAAGCCTTCTGTGTTTTTCTTA 9480 
K D G K ARE V I K R Q S L R Q L I I N 
AAAGATGGCAAAGCACGTGAAGTTATAAAGCGACAATCGTTAAGACAACTCATTATTAAT 9540 
D T K * 
GATACAAAATAAAAATAAACAAAGTAATCCCCGAAGCACAGAAAATTATACTGTGACTCG 9600 
GGGAATTTTTATGCATTATAGATGACTGTAGAAAACATGCTTGGACATATACTC 9654 
Figure 5.12 
The nucleotide and deduced amino acid sequence of the dap operon and the 
surrounding regions of S. aureus 
The putative ribosome binding sites are shown in italics, and the stop co dons are shown 
in bold. V represent Tn917 insertion sites of seg genes. Numbers in brackets represent 
seg mutants with identical transposon insertion sites. 
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5.2.2.2.2 Transposon insertions in the dap operon in S. aureus 
The dap operon is clearly a major lysine biosynthetic locus in S. aureus, since it 
encodes six of the nine enzymes required for the synthesis of lysine, not including 
isozymes (Figures 5.1 and 5.2). A total of nine different Tn917 insertion sites in the dap 
operon were identified in the serum screen (Figure 5.13). This demonstrates that the 
dap operon is important in the serum model. Five of these transposons have inserted 
within lyse (AK II), two within asd (ASADH) and one within dapA (DHPS). 
Interestingly, one further transposon was found to have inserted 31 bp upstream of 
codon one (ATG) of lyse (Figure 5.12). This therefore provides evidence for the 
presence of upstream control regions for lyse, in S. aureus that are perhaps similar to 
that found in B. subtilis. 
5.2.2.2.3 Analysis of the untranslated region upstream of lyse in S. aureus 
As described in Chapter 5.1.4.2, preceding lysC in B. subtilis is an unusually extensive 
control region (untranslated leader region) of 330 bp, which is involved in the 
regulation of lysine synthesis. This region, termed the lyse leader region, has been 
analysed (Chen et al., 1987), and shown to contain a number of potential control sites, 
including: a 24 amino acid polypeptide; and terminator, antiterminator structures 
(Chapter 5.1.4.2). The region upstream of lyse in S. aureus (859 bp) was examined for 
the potential presence of similar regulatory elements. 
In B. subtilis a short ORF (72 bp) potentially encoding the lysC leader peptide is present 
upstream of lysC that is believed to be involved in an attenuation mechanism of lyse 
synthesis (Chen et ai., 1987). Analysis of the sequence upstream of lyse in S. aureus 
has revealed the presence of several putative ORFs including, a potential ORF of 75 bp 
(25 amino acids), that shows similarities to the leader peptide of B. subtilis. Firstly both 
putative leader peptides start with an alternative start codon, GTG (B. subtilis) and TTG 
(s. aureus). Secondly and most importantly both putative polypeptides have a dyad of 
lysine codons at positions two and three. In B. subtilis this pair of lysine codons is 
thought to have an important role in lyse regulation by lysine as under conditions of 
lysine deficiency, the ribosomes would be stalled, destabilising the secondary structure 
of the rho-independent terminator, thus allowing synthesis of the LBE enzyme. 
However, a BLAST search within the SubtiList database (Chapter 2.23.1), using the 
amino acid sequence of the proposed lysC leader sequence of S. aureus, failed to show 
any significant homology to that of B. subtilis (results not shown). Furthermore, no 
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putative Shine-Dalgamo sequence, could be identified immediately upstream of the 
putative start codon. This therefore creates doubt over whether this ORF is actually 
translated or not. The putative leader region was also analysed for the presence of stem-
loops and potential rho-independent terminator (Chapter 2.23.1). This revealed an 
number of short repeats, which have the potential to form stem-loops. However, none of 
these structures appear to be strong candidates for terminator anti terminator structures 
(results not shown). 
5.2.2.3 Searching for isozymes of LBE genes in S. aureus and B. subtilis 
It has been proposed that a reason for the failure to identify mutations in the majority of 
LBE genes of B. subtilis is due to the presence of multiple isozymes, of these 
biosynthetic enzymes (Roten et al., 1991). Interestingly, from searching the SubtiList 
database this does not appear to be the case (results not shown). It is known however 
that there are three isozymes of AK in B. subtilis (Chapter 5.1.3). 
5.2.2.3.1 Identification of AK III (yclM) of B. subtilis 
It is known that B. subtilis, has three isozymes of aspartokinase, although the gene 
encoding AK III has not been identified. On searching the B. subtilis database 
(SubtiList) with sequences of known AKs, three genes were identified. These were 
dapG (AK I), lyse (AK II) and yclM. 
Analysis of yclM within SubtiList demonstrated that this gene encodes a protein of 454 
amino acids with similarity to homoserine dehydrogenase (HDH). Two of the AK 
isozymes in E. coli are bifunctional proteins having both AK and HDH activity (AK 1-
HDH I, and AK II-HDH II) (Cohen and Saint-Girons, 1987). However, none of the B. 
subtilis AKs have HDH activity (Parsot and Cohen, 1988). Two pieces of evidence 
confirmed that yclM could not be a bifunctional protein formed by the fusion of genes 
encoding an AK and a HDH. Firstly, AK I-HDH I (thrA) of E. coli is 820 amino acids 
in length, and secondly yclM shows no significant sequence homology to HDH (hom) 
of B. subtilis (results not shown). 
YclM shows greatest homology to AK I-HDH I, of Serratia marcescens (32 % over 
171 amino acids). This is a bifunctional enzyme, but the region of homology withyclM 
only corresponds to the AK domain. Thus yclM is predicted to be AK III of B. subtilis. 
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lyse asd dapA dapB ykuQ hipO dal lysA 
r-I , 
500 bp Transposon insertion sites 
Figure 5.13 
Diagram showing Tn917 insertion sites in the dap operon 
Tn917 insertions from left to right: Aspartokinase II (lysC) control/leader region 
(putative): seg22 (seg30, seg33); Aspartokinase II (lysC): seg14, seg25 (seg50) , seg45 
(seg48), seg13, segl (seg2l); Aspartate semialdehyde dehydrogenase (asd): seg24, 
seg26; Dihydrodipicolinate synthase (dapA): seg 10. 
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5.2.2.3.2 Searching S. aureus databases for isozymes of LBE genes 
During this study, it was discovered that S. aureus encodes two isozymes of DAP 
dehydrogenase. One copy is located within the dap operon (/ysA), while the other 
(named dapH) is found clustered with iucC (aerobactin siderophore biosynthesis 
protein), and ORF256, which shows homology to hypothetical aldolases, in the order 
iucC-ORF256-dapH (results not shown). However, due to the absence of isozymes of 
LBE genes in B. subtilis, a large scale search for LBE isozymes in S. aureus was not 
undertaken. There are however likely to be at least two AK isozymes in S. aureus, as 
lysC mutants (segllseg25) were not auxotrophic for methionine or threonine (Chapter 
5.2.1.2-5.2.1.3). 
5.2.2.3.3 Searching S. aureus databases for aspartokinase isozymes 
To identify the number of AK isozymes in S. aureus both the publicly available (TIOR 
and NCTC 8325) and the SmithKline Beecham databases were searched with the three 
AK sequences from both B. subtilis and E. coli (Chapter 2.23.1). 
These searches showed much greater sequence homology between B. subtilis and S. 
aureus, than E. coli and S. aureus (results not shown). Searching with B. subtilis AK 
sequences identified homologues of lyse (AK II); 40 % over 397 amino acids, and yclM 
(AK III); 44 % over 171 amino acids, in S. aureus. Therefore S. aureus possesses at 
least two isozymes of AK, these being encoded lysC and ask. There is no evidence of a 
homologue of AK I, which in B. subtilis is the DAP sensitive aspartokinase (dapG). 
Searching with E. coli AK sequences also failed to identify a third AK isozyme (results 
not shown). Therefore it is unlikely that AK I exists in S. aureus as the SmithKline 
Beecham private databases are essentially complete. 
5.2.2.3.4 Determination of the mechanism(s) of lysine biosynthesis in 
S. aureus 
Broadly two alternative pathways exist for the biosynthesis of lysine. These are the four 
step epimerase pathway, and the one-step dehydrogenase pathway (Chapter 5.1.4; 
Figure 5.2). Previous to this study the mechanism for the biosynthesis of lysine in S. 
aureus had been poorly studied and thus it was not known which of the pathways (or 
both as in C. glutamicum), is responsible for lysine biosynthesis in S. aureus. The dap 
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operon of S. aureus encodes a protein with significant homology (60 % identity over 
233 amino acids) to tetrahydrodipicolinate acetyltransferase (ykuQ) of B. subtilis, which 
is the first enzyme in the epimerase pathway. On searching S. aureus databases with the 
sequence of DAP dehydrogenase (ddh) from C. glutamicum, no evidence for the 
presence of a homologue of this enzyme was found. Thus it is likely that s. aureus, like 
B. subtilis, only synthesizes lysine via the epimerase pathway, and not by the one step 
dehydrogenase pathway. 
5.2.3 DNA sequence analysis of the cystathionine y-synthase locus 
A putative cystathionine y-synthase (yjcl) (seg8) has been identified during the screen 
for sera expressed genes (Chapter 4.2.2.2). The question as to whether mUltiple 
pathways of methionine biosynthesis exist in S. aureus (Chapter 5.1.5.1), along with the 
genetic organisation of cystathionine y-synthase (CTGS) and the other methionine 
biosynthetic enzymes (MBE) genes are studied here. 
5.2.3.1 Database searching for methionine biosynthetic enzymes of 
S. aureus 
Corynebacteria, for example C. glutamicium and B. flavum, possess the enzymes to 
synthesize methionine via two different pathways: One pathway requires cystathionine 
y-synthase (CTGS) and cystathionine p-Iyase (CTBL) for the conversion of 0-
acetylhomoserine to homocysteine. This pathway proceeds via cystathionine and is the 
pathway used by both B. subtilis and E. coli. The other pathway requires only a single 
enzyme, O-acetylhomoserine sulphydrylase to perform the above enzymatic conversion 
(Chapter 5.1.5.1; Figure 5.3). 
Auxotrophy analysis revealed seg8 (yjcl) to be a methionine auxotroph. This strongly 
suggests that S. aureus only possesses the enzymes (CrGS and CTBL) for the 
biosynthesis of methionine via cystathionine. In an attempt to confirm this, S. aureus 
databases were searched using the DNA sequences of methionine biosynthetic genes 
from both B. subtilis and Thermotoga maritima. 
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5.2.3.2 Determination of the mechanism(s) for the biosynthesis of 
methionine in S. aureus 
S. aureus databases were searched with DNA sequences for CTaS (yjcl) and CTBL 
(yjcJ) from B. subtilis, and O-acetylhomoserine sulphydrylase from T. maritima. This 
analysis confirmed the presence of CTas (yjcl) in S. aureus (49 % identity over 331 
amino acids to yjel of B. subtilis) and revealed the presence a homologue to CTBL 
(yjcJ) (48 % identity over 316 amino acids toyjcJof B. subtilis). However, none of the 
databases searched contained homologs to O-acetylhomoserine sulphydrylase. 
Unfortunately as both the S. aureus databases searched (NCTC 8325 and TlaR) are 
currently incomplete this does not provide conclusive proof for the absence of this 
enzyme. This result however, coupled with the auxotrophic nature of seg8 (yjcl) 
suggests that like both B. subtilis and E. coli, S. aureus only encodes the enzymes for 
the synthesis of methionine via cystathionine, and not by the direct conversion of 
O-acetylhomoserine to homocysteine using O-acetylhomoserine sulphydrylase as in 
C. glutamicium. 
Interestingly, while searching the S. aureus databases for CTas and CTBL, a third 
gene, (named metX), was identified as having significant homology to both CTGS (yjcl) 
(44 % identity over 374 amino acids) and CTBL (yjcJ) (48 % identity over 374 amino 
acids) of B. subtilis. Searching the B. subtilis genome (SubtiList) with the DNA 
sequence of me/X, revealed a third gene, in addition to yjel and yjcJ with significant 
homology to this sequence: yrhB (unknown, similar to CTaS), 58 % identity over 380 
amino acids. Thus B. subtilis encodes a homologue of metx. The fact that both 
S. aureus and B. subtilis potentially possess two isozymes of CTaS was a surprising 
discovery since if S. aureus encode two isozymes of CTaS, then why is seg8 (yjcl) 
a methionine auxotroph? Furthermore, there have been no previous reports of 
any bacterium encoding mUltiple isozymes of methionine biosynthetic enzymes, 
with the exception of AK / AK-HDH (Chapter 5.1.3) and methionine synthase 
(Figures 5.14-5.17). 
Three explanations for seg8 (yjcl) being a methionine auxotroph are outlined here: The 
first is that metX, despite its high similarity to CTas and CTBL (of both S. aureus and 
B. subtilis), could encode an enzymatically inactive protein. The second explanation for 
the methionine auxotrophy of seg8 (yjcl) in the presence of two isozymes of CTas, is 
that yrhB and its S. aureus homologue (metX) do not encode an isozyme of CTaS, 
perhaps instead it encodes an isozyme of CTBL, and thus yrhB has been wrongly 
classified in the B. subtilis database (SubtiList). The final explanation is that the genes 
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encoding MBE are organised in an operon, in such an arrangement that, a mutation in 
yjcI would be polar on one, or more downstream biosynthetic genes. Under this 
arrangement in spite of the presence of a second CTOS isozyme (encoded by metX) at a 
distinct locus, seg8 (yjcl) would still be a auxotrophic for methionine, as the pathway to 
methionine would remain blocked. 
5.2.3.3 Investigation into the identity of metX of S. aureus 
In an attempt to determine the identity of metX and hence its role in methionine 
biosynthesis, the DNA sequence of both yrhB (B. subtilis) and metX (8. aureus) were 
compared against known sequences using NCBI BLAST (Chapter 2.23.1). 
The results obtained searching with yrhB, revealed that this gene has been previously 
been entered in the NCBI database, as cystathionine y-Iyase (CTOL) (100 % identity 
over 379 amino acids). The next closest homologue is CTBL from Lactococcus lactis 
(63 % identity over 374 amino acids), followed by CTOS from Helicobacter pylori (60 
% identity over 379 amino acids). Additionally a BLAST search within SubtiList 
showed that yrhB has slightly greater homology to yjcJ (CTBL) (52 % identity over 376 
amino acids) than yjcI (CTOS) (49 % identity over 373 amino acids). Therefore the 
identity of yrhB is not clear, as it is similar to both CTOS and CTBL, and has been 
entered into the NCBI database as CTOL. Without enzyme assay data it is impossible to 
determine with 100 % certainty that metX or yrhB encode a protein with CTOS or 
CTBL activity. If metX is in fact an isozyme of CTBL, then the methionine auxotrophy 
of seg8 (yjcl) is simply explained due to the lack of CTOS «insertionally inactivated by 
the Tn917 insertion of seg8). Therefore the conversion of O-acetylhomoserine to 
cystathionine is blocked, preventing the biosynthesis of methionine (Figure 5.15). 
Interestingly however, in a NCBI BLAST search, met X showed greatest homology to 
cystathionine y-Iyase (yrhB) from B. subtilis (58% identity over 380 amino acids). 
Therefore since metX shows the greatest homology to yrhB, the two homologues are 
almost certainly isozymes of the same enzyme. 
5.2.3.4 Organisation of methionine biosynthetic genes in B. subtilis 
In B. subtilis CTOS (yjcl) and CTBL (yjcJ) are in a bi-cistronic operon, at a site distant 
from all other methionine biosynthetic enzymes (Chapter 5.1.6.2; Figure 5.14). yrhB 
(CTOL), is part of a five gene operon in which only one other gene (yrhA) has been 
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assigned a function (Figure 5.16). yrhA is the gene immediately upstream ofyrhB and is 
similar to cysteine synthase. Therefore yrhB appears to be located within a locus devoid 
of other methionine biosynthetic enzymes. 
5.2.3.5 Organisation of putative methionine biosynthetic genes in S. aureus 
Determination of the organisation of methionine biosynthetic genes in S. aureus was 
not straightforward, owing not only to the lack of a completed genome, but also to the 
absence of published work on methionine biosynthesis in S. aureus. However, contigs 
from the incomplete NCTC 8325 and TIGR databases identified in Chapter 5.2.3.2, as 
having homology to yjcI and yjcJ of B. subtilis, were examined to determine the 
identity and organisation of genes surrounding those involved in methionine 
biosynthesis. 
The results of this analysis are shown in Figures 5.15 and 5.17 and show the 
identification of a methionine biosynthetic operon (yjc) in S. aureus and the location of 
the putative CTGS isozyme (metX). From this analysis it can be seen that owing to the 
genetic organisation of the yjc operon of S. aureus, a mutation in yjcI (seg8) would be 
polar on yjcJ (CTBL), and thus in spite of a second isozyme of CTGS (metX), seg8 
(yjcl) would still be auxotrophic for methionine. 
5.2.4 Analysis of the expression and regulation of lyse, asd and dapA 
In order to accurately study the regulation of the three LBE seg; lysC, asd and dapA, 
reporter gene fusions were constructed in the wildtype (8325-4) background. This was 
necessary as the original seg strains, although reporter gene fusions, are mutants and 
thus do not grow under certain amino acid limiting conditions (Chapter 5.2.1.2). 
5.2.4.1 The construction of lacZ reporter gene fusions 
Three lacZ reporter gene fusions were constructed, one in each of the three LBE genes 
(lysC, asd and dapA). Suitable DNA fragments (Figure 5.18) were cloned into the 
reporter gene fusion vector pAZ106 (Chapter 2.22.3), using primers, OL 1-4 (Table 
A.1.2.1). The three plasmids generated were transformed into S. aureus RN4220 
(Chapter 2.16.2), and the stable insertions transduced into 8325-4 (Chapter 2.14). to 
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yjcH 
Unknown 
I I 
yjc! 
Cystathionine 
y-synthase* 
yjcJ 
Cystathionine 
p-Iyase* 
yjcK 
Unknown 
500 bp ? Terminator * Unknown but similar to 
Figure 5.14 
Organisation of the yjc locus region of the B. subtilis chromosome 
Reproduced from SubtiList. 
spoOJ yjcl yjcJ metH metE mmgA 
1000 bp 
Figure 5.15 
Organisation of the yjc locus region of the S. aureus chromosome 
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yrhC 
Unknown 
yrhB 
Cystathionine 
y-Iyase 
I I 
500 bp 
Figure 5.16 
yrhA 
Cysteine 
synthase * 
? Terminator 
Organisation of the yrhB locus region of B. subtilis 
Reproduced from SubtiList. 
yrrU 
Purine 
nucleoside 
phosphorylase * 
yrrT yrzA 
Unknown 
* Unknown but similar to 
lytF yusA yusB yusC metX yrhA yocR 
I I 
1000 bp 
Figure 5.17 
Organisation of the metX locus region of S. aureus 
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create strains: MDW41 (lysC::lacZ), MDW42 (asd::lacZ) and MDW43 (dapA::lacZ). 
The construction of these lacZ strains is shown diagramatically in Figure 5.19. In the 
presence of X-Gal, all strains were blue on serum and white on BHI, which confirmed 
the presence of an active lacZ fusion. The correct insertional events were verified by 
Southern blot analysis. 
5.2.4.1.1 Confirmation of LBE::lacZ transcriptional fusion construction by 
Southern blot 
Chromosomal DNA was digested with EcoRI and Xbal (Chapter 2.19.1.1), and 
analysed by Southern blot analysis as described in Chapter 2.20. The blot was probed 
with a labeled 4.1 kb EcoRI fragment from pMDWI0 (Figure 5.11). The probe covers 
the region of lysC, asd and the 5' end of dapA. For all strains, the expected fragment 
sizes were determined, for digestion with EcoRI and Xbal, and are shown in Figures 
5.19a-d. The Southern blots for EcoRI and Xbal are shown in Figure 5.20. These blots 
show that all three lacZ strains gave the predicted patterns for correct reporter gene 
construction. 
5.2.4.2 Growth of lacZ transcriptional fusion strains 
The newly constructed strains MDW41 (lysC::lacZ), MDW42 (asd::lacZ) and MDW43 
(dapA::lacZ), along with the parental strain 8325-4, were grown in BHI, serum and 
CDM (16), under both aerobic and microaerobic conditions. As expected under each 
condition, all strains showed identical growth rates and yields (results not shown). 
5.2.4.3 Expression of lacZ transcriptional fusions in the serum model 
The serum model was used to analyse the expression of the LBE seg, lysC, asd and 
dapA. Expression was examined on both solid and liquid media. MDW41 (lysC::lacZ), 
MDW42 (asd::lacZ) and MDW43 (dapA::lacZ), when grown on agar containing X-Gal, 
produced blue colonies on serum and white colonies on BHI, under both aerobic and 
microaerobic conditions. 
MDW41 (lysC::lacZ), MDW42 (asd::lacZ) and MDW43 (dapA::lacZ) along with 
8325-4, were grown in BHI and serum using standard conditions (Chapter 2.4.1.1), 
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Diagrammatic representation of genomic fragments used for the construction of LBE 
lacZ fusion strains 
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MDW43 - dapA::lacZ, dapA+ 
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Figure 5.19a-d 
lacZ construction and Southern blot fragment size predictions 
pAZ106 plasmid is indicated and the lacZ reporter gene fusion is depicted in bold. 
EcoRI (E) and XbaI (X) restriction sites are shown (not to scale). 
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7.67kb-~ 
3.75 kb ~ 
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Figure 5.20 
12345678 
/28.5 kb 
~ ~24.5kb 
4s:::- 15.75 kb 
"'" 15 kb 14 kb 
Southern blots of chromosomal DNA (EeoRl and Xbal digests) of 8325-4 (WT), 
MDW 41 (lysC::laeZ), MOW 42 (asd::laeZ) and MDW 41 (dapA::laeZ), probed for 
lysC-dapA 
EeoRl digests lanes: 1, 8325-4 (WT); 2, MDW 41 (lysC: :laeZ); 3, MDW 42 
(asd::laeZ); and 4, MDW 41 (dapA::laeZ). 
Xbal digests lanes: 5,8325-4 (WT); 6, MOW 41 (lysC::laeZ); 7, MDW 42 (asd::laeZ); 
and 8, MDW 41 (dapA::laeZ). 
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under both aerobic and microaerobic conditions. Negligible expression was observed in 
BHI under the different conditions (Figure 5.21). In serum all three LBE genes were 
expressed in a growth phase dependent manner, primarily as the cultures entered 
stationary phase (- 40-180 MUG units). asd showed the highest level of expression of 
these fusions under both aerobic and microaerobic conditions (180 and 170 MUG units 
respectively) (Figure 5.22). 
5.2.4.4 Regulation of lysine biosynthetic genes 
MDW41 (/ysC::/acZ), MDW42 (asd::/acZ) and MDW43 (dapA::/acZ) were grown in 
10 different types of CDM (1-4 and 11-16 (Table 5.2), aerobically under standard 
conditions (Chapter 2.4.1.1), and gene expression, via p-galactosidase activity 
was monitored throughout growth. Results of these experiments are shown in Figures 
5.23a - 5.23j, and are summarised in Table 5.5. 
The presence of lysine in the growth medium was found to repress lysC expression. In 
media lacking lysine (CDM 2-4, 14 and 15), the maximum expression was between 650 
and 2500 MUG units. However, in the presence of lysine (CDM 1, 11-13 and 16) 
maximum expression was between 40 and 140 MUG units. Therefore on average 
expression was > lO-fold higher in CDM lacking lysine. Interestingly, maximal 
expression occurred in all cultures as the cells entered post-exponential phase. The 
other AAA also appeared to play a role in the regulation of lysC expression. Results 
show that CDM cultures containing all four AAA (CDM 16), or lacking just isoleucine 
(CDM 11), had the lowest lysC expression as determined by ~-galactosidase activity 
(Figure 5.23; Table 5.5). 
Lysine was also shown to repress asd expression. In media where lysine was absent 
(CDM 2-4, 14 and 15), the maximum expression was between 475 and 2300 MUG 
units. In contrast when MDW42 (asd::/acZ) was grown in media containing lysine 
(CDM 1, 11-13 and 16), the maximum expression was significantly lower being 
between 40 and 150 MUG units. Therefore on average, expression was> 10-fold higher 
in CDM lacking lysine. Expression of asd occurred primarily in the post-exponential 
phase. Finally as seen for lysC, the inclusion of the other AAA in the growth medium, 
further reduced the expression of asd in the presence oflysine (Figure 5.23; Table 5.5). 
dapA expression was also found to be repressed by lysine, however in general the levels 
of expression were lower than those observed for both lysC and asd. In CDM media 
where lysine was absent (CDM 2-4, 14 and 15), the maximum expression observed was 
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Figure 5.21 
Expression ofMDW41 (lysC::laeZ), MDW42 (asd::laeZ) and MDW43 (dapA ::lacZ) in 
BHI under aerobic (a) and microaerobic (b) conditions 
MDW41 (lysC:: laeZ) , MDW42 (asd::laeZ) and MDW43 (dapA::laeZ), along with the 
parental strain 8325-4 were grown at 37°C in BHI under aerobic or microaerobic 
conditions with shaking (250 rpm). Specific p-galactosidase activity was determined 
and expressed in MUG units. The results are representative of two separate 
experiments. 
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Figure 5.22 
Expression ofMDW41 (lysC::lacZ) , MDW42 (asd::lacZ) and MDW43 (dapA::lacZ) in 
serum under aerobic (a) and microaerobic (b) conditions 
MDW41 (lysC::lacZ), MDW42 (asd::lacZ) and MDW43 (dapA::lacZ) , along with the 
parental strain 8325-4 were grown at 37°C in serum under aerobic or microaerobic 
conditions with shaking (250 rpm). Specific p-galactosidase activity was determined 
and expressed in MUG units. The results are representative of two separate 
experiments. 
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between 475 and 1200 MUG units. While in media in which lysine was present (COM 
1, 11-13 and 16), the expression of MDW43 (dapA::lacZ) was between 40 and 125 
MUG units. Therefore the expression of this LBE gene, like lysC and asd is - 10-fold 
higher in CDM, lacking lysine. Once more growth phase dependent expression was 
exhibited for dapA, with maximal expression occurring, as cells enter post-exponential 
phase. Finally as witnessed for the other LBE seg the presence of the other AAA family 
members further repressed dapA synthesis in the presence of lysine (Figure 5.23; 
Table 5.5). 
5.2.5 Role and regulation of LBE seg in pathogenicity and other functions 
5.2.5.1 In vivo and in vitro expression analysis of LBE seg 
In order to verify that the serum model mimics infection, it was important to determine 
whether the sera expressed genes were expressed in vivo. Reverse transcription-PCR 
(RT-PCR), and TaqMan techniques were used to study the expression of lysC, asd, and 
dapA under both in vivo and in vitro conditions. Both these techniques are based on the 
detection of mRNA levels. RT-PCR uses primers in an attempt to amplify specific 
sequences from mRNA via cDNA. Therefore this technique allows the determination as 
to whether a gene was being transcribed or not. TaqMan, is a similar approach, but 
importantly is a quantitative PCR technique. Two in vitro media were used BHI and 
TSB (Chapter 2.1.1.2 and 2.1.1.13), and the results obtained from growth in these 
media were compared to the expression from bacterial cells recovered from the murine 
pyelonephritis (kidney) model in CD-1 mice. The experiments were carried out in 
S. aureus strain WCUH29 (Clinical isolate) rather than 8325-4 (standard laboratory 
strain), as this work was conducted in collaboration with Dr. M. Burnham and 
Dr. L. Palmer (SmithKline Beecham (SB)). 
5.2.5.1.1 Production of cDNA from S. aureus WCUH29 
RNA was extracted from S. aureus WCUH29 cells, grown in both BHI and ISB (in 
vitro) along with cells recovered from infected murine kidneys (in vivo) (Chapter 
2.17.2.1). The integrity and purity of the RNA preps were analysed by peR and were 
shown to be free from DNA (results not shown). The isolated RNA was then converted 
to cDNA by reverse transcription (RT), in a reaction catalysed by the enzyme, reverse 
transcriptase (Chapter 2.19.2.2). The process of cDNA production is diagramatically 
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Figure 5.23a 
Expression of lysC::lacZ, asd::lacZ and dapA::lacZ during growth in CDM 1 
(CDM 1; + lysine) 
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Figure 5.23b 
Expression of lysC::lacZ, asd::lacZ and dapA::lacZ during growth in CDM 2 
(CDM 2; + threonine) 
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Figure 5.23d 
Expression of lysC::lacZ, asd::lacZ and dapA ::lacZ during growth in COM 4 
(CDM 4; + isoleucine) 
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Figure 5.23f 
Expression of lysC::laeZ, asd::lacZ and dapA::laeZ during growth in CDM 12 
(CDM 12; + lysine, threonine and isoleucine) 
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Figure 5.23a-j 
Expression of lyse, asd and dapA in different CDM 
S. aureus MDW41 (lysC::lacZ), MDW42 (asd::lacZ), and MDW43 (dapA::lacZ) along 
with the parental strain 8325-4, were grown at 37°C in CDM 1-4, and CDM 11-16, 
under aerobic conditions, with shaking (250 rpm). Specific p-galactosidase activity was 
determined and expressed in MUG units. The results are representative of at least two 
separate experiments. 
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CDM Maximum expression Gene expression Media 
No. (MUG units) On / Off + / -lysine 
lyse asd dapA 
1 120 80 110 Off + 
2 875 1050 620 On -
3 2200 2300 1200 On -
4 650 475 475 On -
11 55 60 40 Off + 
12 140 150 125 Off + 
13 90 140 60 Off + 
14 2500 1900 950 On -
15 775 1000 500 On -
16 40 40 40 Off + 
Table 5.5 
Summary of the expression of lyse, asd and dapA in different CDM 
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represented in Figure 5.24. The cDNA samples produced were suitable for use in both 
RT-PCR and TaqMan procedures. 
5.2.5.1.2 RT ·peR on lyse, asd and dapA 
Pairs of primers designed to lyse (AK II), asd (ASADH) and dapA (DHPS) (sequences 
not provided by SB) were used to amplify fragments of each gene. PCR amplification 
reactions (Chapter 2.21.2.2), were prepared with one of the following templates: cDNA 
reverse transcribed from S. aureus WCUH29 total RNA (isolated from in vitro or in 
vivo grown cells), or S. aureus genomic DNA (positive control). Additionally during 
the RT step for each RNA sample, control reactions were set up that did not include 
reverse transcriptase (Figure 5.24), these samples were included as a negative control 
(-RT control). 
The results of these RT-PCR reactions showed that lysC, asd and dapA were expressed 
under all three conditions (BHI, TSB and mouse kidney). Results for RT-PCR on the 
mouse kidney, and BHI samples, are shown in Figure 5.25. The results for cells grown 
in TSB were almost identical to those grown in BHI (results not shown). RT-PCR is not 
quantitative thus even low level expression in BHI would count as positive, owing to 
the exponential nature of PCR. 
5.2.5.1.3 RT ·peR on dapB, ykuQ, and lysA, the other LBE genes in the dap 
operon 
The other three LBE genes of the dap operon, dapB (DHPS), ykuQ (THPA), and lysA 
(DAP decarboxylase) were also examined. An identical set of reactions, were carried 
out for these three LBE genes, as for lysC, asd and dapA (Chapter 5.2.5.1.2), using 
pairs of primers designed to each gene (sequences not provided by SB). These RT-PCR 
experiments revealed once more that all genes were transcribed under both in vivo 
(mouse kidney) and in vitro conditions (BHI and TSB). Results for RT-PCR on the 
mouse kidney, and BHI samples, are shown in Figure 5.26. The results for S. aureus 
grown in TSB were almost identical to those grown in BHI (results not shown). 
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lysC osd dopA 
b) 
I M I +RT -RT G I +RT -RT G I +RT -RT G 
lysC asd dapA 
Figure 5.25 
Expression of lysC, asd and dapA under in vitro (a) and in vivo (b) condition as 
determined by RT-PCR 
In vitro, BHI; In vivo, Mouse kidney (pyelonephritis); +RT, + reverse transcriptase; 
-RT, - reverse transcriptase; G, Genomic DNA. 
These results are representative of two separate experiments. 
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a) 
I M I +RT -RT G I +RT -RT G I +RT -RT G 
dapB ykuQ /ysA 
b) 
I M I +RT -RT G I +RT -RT G I +RT -RT G 
dapB ykuQ /ysA 
Figure 5.26 
Expression of dapB, ykuQ and lysA under in vitro (a) and in vivo (b) conditions as 
determined by RT-PCR 
In vitro, BHI; In vivo, Mouse kidney (pyelonephritis); +RT, + reverse transcriptase; 
-RT, - reverse transcriptase; G, Genomic DNA. 
These results are representative of two separate experiments. 
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5.2.5.1.4 TaqMan 
TaqMan is a fluorescence-based 5'-nuclease assay, pioneered by the Perkin-Elmer 
Corporation. In this assay, PCR products are detected directly without removing them 
from their reaction tubes. This is possible by monitoring the increase in fluorescence 
associated with polymerase cleavage of a quenched, dye labeled oligonucleotide DNA 
probe, during PCR (Figure 5.27a-c). This assay therefore provides a simple and reliable 
procedure for determining the presence or absence of a specific sequence (gene 
expression) (Perkin-Elmer, 1999). 
The TaqMan assay exploits the 5' nuclease activity of TaqGold DNA polymerase 
(Chapter 2.21.2.3), to allow direct detection of the PCR product by the release of the 
fluorescent reporter during PCR amplification. The TaqMan fluorogenic 
oligonucleotide probes were constructed with a fluorescent reporter dye covalently 
linked to the 5' terminus. The 3' terminus contains both a blocking group, to prevent 
probe extension and a quencher, which inhibits fluorescence of the reporter group. 
When the probe is intact, the proximity of the reporter dye to the quencher dye results 
in suppression of the reporter fluorescence (Figure 5.27b). Reactions are performed 
with the normal components for PCR, with the addition of the target-specific TaqMan 
probe (Chapter 2.21.2.3). If hybridization occurs, polymerisation of the targeted 
amplicon takes place. During extension of the upstream primer, Taq polymerase 
encounters the annealed probe and begins to displace it. This leads to 'clipping' of the 
probe by the 5' nuclease activity of the polymerase, which continues strand synthesis. 
Clipping the probe separates the reporter and quencher groups (Figure 5.27c), resulting 
in a concomitant rise in reporter-associated fluorescence. Results were obtained, by 
calculating the ratio of reporter-to-quencher fluorescence. and comparing a no-template 
control to an identical reaction containing the sample of interest. The difference 
between the two values represented the relative amount of PCR product formed 
(Perkin-Elmer, 1999). 
TaqMan is ideally suited for gene expression analyses because quantification is based 
on threshold cycle (Ct). a measurement taken during the exponential phase of 
amplification where limiting reagents, and small differences in starting reagent amounts 
have yet to influence PCR efficiency. Using the fluorescent probe in combination with 
the appropriate instrumentation. real-time peR experiments report a fluorescence value 
during every cycle that represents the amount of product amplified to that point. Ct. 
defined as the cycle at which fluorescence is first detectable above background. is 
inversely proportional to the log of the initial copy number (in this case mRNA). Thus, 
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Figure 5.27 
Diagrammatic representation of TaqMan peR 
F - Fluorescent reporter dye Q - Quencher reporter dye 
Reproduced from Perkin-Elmer (1999). 
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the more template present at cycle 0, the fewer the number of cycles taken to reach a 
point where the fluorescent signal is detectable, above background (Ct) (Cayouette et 
al., 1999). 
5.2.5.1.5 TaqMan on lyse, asd and dapA 
Probes and primers for TaqMan were designed for the detection of lyse, asd and dapA 
in cDNA prepared from cells grown both, in vitro (BHI and TSB) and in vivo (Mouse 
kidney). The same cDNA samples were used for TaqMan as for the RT-PCR 
experiments (Chapter 5.2.5.1.2-5.2.1.3). To enable the design of primers and probes for 
TaqMan a region of each gene had to be sequenced in the WCUH29 background (the 
strain used for TaqMan analysis). This was carried out using primers MDW 9 and 10 
(lysC), SKB 3 and 4 (asd) and MW 3 and 4 (dapA) (Table A.1.2.1), to amplify a region 
of - 660-770 bp (Chapter 2.21.2.1.1). This sequence was then used to design both 
TaqMan primers and probes (sequences not provided by SB). In addition to the three 
LBE genes (lyse, asd and dapA), a probe and primers (sequences not provided by SB), 
for the housekeeping gene 16S RNA, were included as a control. 
PCR amplification reactions were prepared with one of the following templates: cDNA 
reverse transcribed from S. aureus WCUH29 total RNA isolated from in vitro grown 
cells (BHI or TSB); cDNA reverse transcribed from S. aureus WCUH29 total RNA 
isolated from in vivo grown cells (murine pyelonephritis 7 day infection); or a no 
template (NTC). A further negative control was also included, containing the sample 
prepared from RNA, which did not receive reverse transcriptase treatment (-RT control) 
(Figure 5.24). TaqMan PCR was carried out using an ABI PRISM 7700 Sequence 
Detection System (Perkin-Elmer Corporation) (Chapter 2.21.2.3). 
The results of the assay using primers and probes specific for the housekeeping gene 
16S RNA, demonstrated that as predicted the gene was expressed under both in vivo 
and in vitro conditions (Figure 5.28a). Interestingly, the expression was significantly 
greater under in vitro than in vivo conditions as shown by the threshold cycle (Ct) 
(mean Ct: 16.5, in vitro; and 22.8, in vivo) (Table 5.6). Results from TSB and BHI were 
found to be very similar (results not shown). 
Results of the TaqMan analysis of the three LBE seg showed the presence of sequences 
corresponding to lyse, asd and dapA in all three cDNA samples (BHI, TSB and mouse 
kidney). The results for the BHI and ISB samples were found to be very similar and so 
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once more only results for BHI in addition to the mouse kidney samples are shown 
(Figures 5.28b-d). Surprisingly, these results showed that the level of LBE transcript 
recovered from in vitro grown cells (BHI) was considerably greater than the level from 
in vivo grown cell (mouse kidney). This was initially determined by the Ct value, where 
fluorescence is first detected (Table 5.6). Furthermore, from the Ct values, it can be 
determined that the level of transcript of each of the LBE genes is very similar to each 
other. This was determined by the fact that the Ct values are very similar, for the in 
vitro samples (25.2 - 27.3) and for the in vivo samples (32.3 - 34.5) (Table 5.6). 
For every TaqMan reaction it is necessary to produce a calibration curve, using the 
same primers and probes, but using S. aureus genomic DNA rather than cDNA 
(Chapter 2.21.2.3), an example of a calibration curve is shown in Figure 5.29. By 
comparison of the samples with the calibration curve, the amount of mRNA of each 
gene is automatically calculated. These values are shown in Table 5.6. This further 
confirmed the very similar levels of all three LBE gene transcripts present, under the 
same condition (in vivo or in vitro). 
5.2.5.2 Role of lyse, asd and dapA in pathogenicity 
Three murine pathogenicity models were employed to study the ability of S. aureus to 
cause infection. The three models used were: subcutaneous lesion; pyelonephritis; and 
wound infection. These models allowed the determination as to whether S. aureus 
strains with defective AK II (IysC), ASADH (asd) or DHPS (dapA), were attenuated in 
growth/survival in vivo, compared to the parental wildtype strain. For the subcutaneous 
lesion model lyse (segl), asd (seg24) and dapA (seglO), mutants were present in the 
8325-4 background and results were compared to wildtype 8325-4. However, for both 
the pyelonephritis and the wound infection models, the mutations were transferred by 
phage transduction (Chapter 2.14) to the clinical strain WCUH29. This produced 
SWCl (lysC), SWC24 (asd) and SWClO (dapA), and was necessary as this work was 
conducted in collaboration with Dr. M. Burnham (SB). The generation of these strains 
was verified by Southern blot (results not shown). Thus results for these pathogenicity 
assays were compared to wild type WCUH29. 
258 
a) 
4.0 
3.5 
3.0 
2.5 
~ 2.0 
<I 
1.5 
1.0 
0.5 
0.0 
0 5 10 
b) 
4.0 
3.5 
3.0 
2.5 
~ 2.0 
<I 
1.5 
1.0 
0.5 
0.0 
0 5 10 
Figure 5.28 
15 20 25 30 
Cycle 
15 20 25 30 
Cycle 
i 
35 40 
35 40 
___ In vitro +RT 1 
-e- In vitro -RT 
-e-In vivo +RT 
-Er In vivo -RT 
-Ir- NTC 
___ In vitro +RT 
-e-In vitro -RT 
-e-In vivo +RT 
-Er In vivo -RT 
-Ir-NTC 
TaqMan trace detecting the presence of 16S RNA (a) (control), and lyse (b) sequence 
in the population of cDNA prepared from S. aureus grown in vitro (BHI) and in vivo 
(mouse kidney) 
The results are representative of two separate experiments. ~Rn: Fluorescence of the 
reporter divided by the fluorescence of the passive reference dye. 
Controls included: - Reverse transcriptase (-RT); No template control (NTC). 
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TaqMan trace detecting the presence of asd (c), and dapA (d) sequence in the 
population of cDNA prepared from S. aureus grown in vi/ro (BHI) and in vivo (mouse 
kidney) 
The results are representative of two separate experiments. ~Rn : Fluorescence of the 
reporter divided by the fluorescence of the passive reference dye. 
Controls included: - Reverse transcriptase (-RT); No template control (NTC). 
260 
4.0 
3.5 
-+-SAC 100 
3.0 
_SAC25 
2.5 -1il- SAC 6.25 
~ 2.0 ___ SAC 1.5625 
<] 
-+- SAC 0.3906 
1.5 
-a- SAC 0.0977 
1.0 
-b- SAC 0.0244 
0.5 -e--SAC 0.0061 
0.0 i 
0 5 10 15 20 25 30 40 
Cycle 
Figure 5.29 
TaqMan calibration curve using dilutions of S. aureus genomic DNA 
A fresh calibration curve was prepared for each individual assay. The results are 
representative of at least two separate experiments. t1Rn: Fluorescence of the reporter 
divided by the fluorescence of the passive reference dye. SAC - S. aureus chromosomal 
DNA [ng]. 
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Sample Name Average Ct Average quantity 
16S RNA in vitro +RT 16.50 5.03 xlO+ 1 
168 RNA in vitro -RT 32.33 5.5xl0-4 
168 RNA in vivo +RT 22.79 5.0 xlO-1 
16S RNA in vivo -RT 32.83 4 xl0-4 
NTC 33.35 N/A 
lyse in vitro +RT 25.78 2.9 xlO- 1 
lyse in vitro -RT 40 N/A 
lyse in vivo +RT 32.71 4.7 xlO-3 
lyse in vivo -RT 40 N/A 
NTC 40 N/A 
asd in vitro +RT 25.2 5.1 xlO-1 
asd in vitro -RT 40 N/A 
asd in vivo +RT 32.34 8.8 xlO-3 
asd in vivo -RT 40 N/A 
NTC 40 N/A 
dapA in vitro +RT 27.33 2.4 xlO-1 
dapA in vitro -RT 40 N/A 
dapA in vivo +RT 34.47 4.07 xlO-3 
dapA in vivo -RT 40 N/A 
NTC 40 N/A 
Table 5.6 
Summary of TaqMan analysis of 16S RNA, lyse, asd and dapA using cDNA prepared 
from both in vitro (BHI) and in vivo (mouse kidney) grown S. aureus cells 
Average cycle numbers and quantities of transcripts are calculated from three values for 
+RT and two values for -RT and NTC. Results are representative of two separate 
experiments. 
262 
5.2.5.2.1 Role of lyse, asd and dapA in the subcutaneous lesion model 
The ability of S. aureus to cause infection by abscess formation on the skin was 
investigated in collaboration with Dr. E. Ingham (University of Leeds) (Chapter 
2.25.1). Following 7 days of infection 1.3 x 108, 1.0 X 108 and 7.45 x 107 cfu of segl 
(lysC), seg24 (asd) or seglO (dapA) were recovered from the lesion, respectively. These 
values were compared to 2.51 x 108 cfu recovered from the 8325-4 lesion. The values 
for the mutant strains were shown not to be significantly different from the wild type 
strain (results not shown). 
5.2.5.2.2 Role of lyse, asd and dapA in the pyelonephritis model 
The virulence of S. aureus strains SWCl (lysC), SWC24 (asd) and SWClO (dapA) in 
comparison with the parental strain WCUH29 was determined using a murine 
pyelonephritis (kidney) model (Chapter 2.25.2). After 7 days of infection 5.01 x 1O~, 
1.48 X 106 and 4.64 x lOs cfu of SWCl (lysC), SWC24 (asd) or SWCI0 (dapA) were 
recovered from the kidney, respectively. These four values were compared to 6.31 x lOs 
cfu recovered from the wild type (WCUH29) infected kidney. These values were found 
not to differ significantly from one another (results not shown). 
5.2.5.2.3 Role of lyse, asd and dapA in the wound infection model 
The virulence of S. aureus strains SWCl (lysC), SWC24 (asd) and SWClO (dapA) in 
comparison with the parental strain WCUH29 was determined using a murine wound 
infection model (Chapter 2.25.3). Following 7 days infection 5.62 x 106 (SWCl 
(lysC)), 9.55 x 106 (SWC24 (asd») or 1.12 x 107 (SWC10 (dapA)) cfu were recovered 
from the infected wound. These values were compared to 4.22 x 106 cfu recovered from 
the WCUH29 infected wound. Once more the LBE defective strains were not 
significantly attenuated in virulence, compared with the wild type (WCUH29) (results 
not shown). 
5.2.5.3 Starvation-survival assays on LBE seg mutants 
The role of segl (lysC), seg24 (asd), and seglO (dapA), in starvation-survival under 
amino acid limiting conditions was investigated (Chapter 2.6.1). It has previously been 
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found that a S. aureus strain bearing a mutation in lysA (SPW2) has a starvation-
survival defect (Watson et al., 1998b). Results showed that although seg I (lysC) and 
seglO (dapA) do have a significant defect in starvation-survival compared to wild type 
(8325-4) after 15 days, this defect is not as pronounced as that of SPW2 (lysA) 
(Figure 5.30). Finally no starvation-survival defects were noted for any strain when 
incubated in phosphate buffered saline (PBS) (results not shown). 
5.2.5.4 Cell wall morphology study of the three LBE mutant strains 
As lysine is an essential constituent of the stem peptide in peptidoglycan of S. aureus. a 
defect in lysine metabolism may lead to alterations in the cell wall structure. Such 
changes could result in morphological defects to the cell. Two methods were employed 
to study the cell wall morphology. The first was light microscopy, which was used 
simply to visualize the cells in an attempt to detect any obvious morphological changes 
(Chapter 2.26). The second involved studying the cell wall petidoglycan using High-
Perfonnance Liquid Chromatography (HPLC) analysis. 
5.2.5.4.1 Light microscopy experiments 
When compared to 8325-4, none of the LBE seg mutants (segl (lysC), seg24 (asd), or 
seglO (dapA» showed any significant difference when grown in BHI or serum (results 
not shown). 
5.2.5.4.2 Analysis on the cell wall peptidoglycan 
In collaboration with Dr. A. Atrih (University of Sheffield) the peptidoglycan structure 
of the LBE mutants was investigated (Chapter 2.27.1). Reverse phase-HPLC analysis of 
muropeptides allows the detennination of peptidoglycan fine structure (Atrih et al., 
1996). Muropeptide analysis revealed no significant difference between seg I (lysC) and 
8325-4, when grown in serum or BHI, (results not shown). Due to the lysine 
requirements of seg24 (asd) and seglO (dapA), which is also essential for the growth of 
seg I (lysC), muropeptide analysis was not conducted on either of the other two 
LBE seg strains. 
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Starvation-survival ·kinetics of 8325-4, segJ (lysC), seg24 (asci) , seglO (dapA) , and 
SPW2 (lysA) in amino acid limiting CDM (CDM 16) 
S. aureus strains, 8325-4, segl (lysC), seg24 (asci) , segJ 0 (dapA) , and SPW2 (lysA ) 
were grown for 18 h, at 37°C with shaking (250 rpm), in amino acid limiting COM 
(CDM 16). These 6h post-exponential cultures were then incubated at 37°C without 
shaking. 100 % viability corresponds to the number of viable cells counted 18 hours 
after inoculation (6h post-exponential), which is approximately 5 x 108 cfu ml·'. The 
results are representative of two separate experiments. 
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5.3 Discussion 
The auxotrophic nature of the AAAB seg strains was investigated initially on solid 
media, and then in liquid media owing to the difficulties in scoring growth on solid 
media lacking some of the aspartate amino acids (AAA). This series of experiments 
confirmed the predication that segl (lysC), seg24 (asel) , seglO (dapA) and seg8 (yjcf) 
would be auxotrophic for one or more AAA. Interestingly however, whereas seg24 
(asel), segl0 (dapA) and seg8 (yjcl), all had the auxotrophic phenotype, predicted from 
their location in the biosynthetic pathway (lysine, threonine, methionine; lysine; and 
methionine, respectively), the phenotype of segl (lysC) was rather unexpected, with this 
mutant being auxotrophic for lysine. In B. subtilis three isozymes of aspartokinase (AK) 
exist and these have been shown to have a certain degree of functional redundancy 
(reviewed by Paulus 1993). For example the activity of the lysine sensitive AK II of B. 
subtilis (lysC), can be fully compensated for by AK III, and thus a mutation within lysC 
does not create an auxotrophic phenotype (Chen and Paulus, 1988; Zhang et al., 1990). 
Therefore it would be predicted that in the presence of multiple AK isozymes, seg 1 
(lysC) would not be auxotrophic for any amino acid, whereas if S. aureus is like 
corynebacteria and only encodes a single AK, then a mutation within this gene would 
be expected to have an identical phenotype to seg24 (asel), i.e. requiring lysine, 
methionine and threonine, owing to the role of this enzyme in the biosynthesis of all 
AAA. Therefore the result that a lysC deficient strain was auxotrophic for lysine was 
surprising. However, the phenotype of the lysC mutant was confirmed using another 
seg mutant also containing an insertion within lysC (seg25). The auxotrophic nature of 
a lyse mutant can only be explained by the presence of at least one further AK isozyme 
in S. aureus that is able to rescue the methionine and threonine functions of AK II, but 
not that of lysine biosynthesis. 
A further problem with the auxotrophy results, that only became apparent after the 
operonic organisation of the LBE genes was determined, was that a mutation within 
lyse (seg 1, seg25) did not have a polar effect on the downstream genes including asd. 
This was determined as segllseg25 (lysC) are auxotrophic only for lysine and not for 
threonine and methionine. This strongly suggests the presence of a further promoter 
upstream of asd, enabling transcription of the other genes of the dap operon, as without 
this additional promoter then segl/seg25 (lysC) would also have a deficiency for 
ASADH, and thus would be auxotrophic for lysine, threonine and methionine. 
One last observation, made from these auxotrophy studies, was that the growth rate, but 
not the growth yield of the wild type strain 8325-4, as well as that of the mutant strains 
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was dramatically affected by the number of AAA included in the defined media 
(CDM). As a rule the fewer AAA included in the media, the greater the reduction in the 
growth rate. Interestingly however, lysine appears to be the most important of the AAA, 
as the addition of this amino acid alone increases the growth rate significantly more 
than the addition of any of the other AAA individually. This is probably due to the dual 
role of lysine in S. aureus, with it not only required as a building block for proteins, but 
also as component of the cell wall peptidoglycan. 
PCR and DNA sequencing strategies, revealed the putative dap operon of S. aureus to 
contain a total of 8 genes, 6 of which potentially encode enzymes involved in the 
biosynthesis of lysine (Figure 5.11). This operon therefore represents the major locus 
for lysine biosynthesis in S. aureus. The first gene of the dap operon lysC, codes for an 
isozyme of AK, the first enzyme required for the conversion of aspartate to lysine 
(Chapter 5.1.3). Many bacterial AKs including lysC of B. subtilis (Bondaryk and 
Paulus, 1985) have been found to be composed of two dissimilar subunits (a and p) 
(Chapter 5.1.4.1). These AK subunits in the above examples, have been shown to be 
encoded by in-phase overlapping coding regions. Analysis of the sequence of lysC from 
S. aureus revealed that an identical situation may also be present for this AK. This is 
postulated due to the presence of a start codon (ATG) and a putative ribosome binding 
site (Shine-Dalgarno), at approximately the correct position as predicted from the 
structure of lysC from B. subtilis (Chen et al. 1987). This prediction is also supported 
by the strong sequence homology between lyse of S. aureus, and lysC of B. subtilis 
(40 % over 397 amino acids). The second and third genes of the dap operon are asd and 
dapA encoding the second enzyme of the common pathway (ASADH) (Chapter 5.1.3), 
and the first enzyme in the branch specific for lysine biosynthesis (DHPS) (Chapter 
5.1.4.1). As these genes have already been reviewed extensively these genes will not be 
further discussed here. 
The two genes immediately downstream of dapA, are dapB and ykuQ (Figure 5.11), 
which potentially encode the fourth and fifth enzymes respectively for the biosynthesis 
of lysine. These enzymes are, dihydrodipicolinate reductase (dapB) and 
tetrahydrodipicolinate acetyltransferase (ykuQ) , which catalyse the conversion of 
dihydrodipicolinate to tetrahydrodipicolinate, and tetrahydrodipicolinate to acetyl-
amino-ketopimelate (Figure 5.2). 
Dihydrodipicolinate reductase (DHPR) of B. subtilis, encoded by dapB is inhibited in a 
noncompetitive manner by physiological concentrations of dipicolinate. This inhibition 
is thought to function as a regulator in sporulating cells by diverting the common 
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intermediate dihydrodipicolinate from the synthesis of DAP and lysine to produce more 
dipicolinate as this product begins to accumulate in spores (Kimura and Goto 1975). 
Therefore DHPR of S. aureus is thought to have a slightly different role in S. aureus 
with it being a non-sporulating bacterium and thus not synthesizing dipicolinate. As a 
result DHPR of S. aureus is only involved in the biosynthesis of lysine and like the 
DHPR enzymes of E. coli and C. glutamicum, DHPR of S. aureus is predicted to have 
no regulatory function. 
Tetrahydrodipicolinate succinylase (THPS) and tetrahydrodipicolinate acetyltransferase 
(THPA) catalyse the first reactions in the epimerase pathway in E. coli and B. sub/iUs 
respectively. THP A of B. subtilis is thought from this study to be encoded by ykuQ, 
since this gene has been classed as unknown, similar to tetrahydrodipicolinate 
succinylase in SubtiList. However, as B. subtilis uses acetylated, rather than 
succinylated intermediates for lysine biosynthesis (Weinberger and Gilvarg, 1970), it is 
predicted that the polypeptide encoded by ykuQ is in fact THPA. Whether S. aureus 
uses acetylated intermediates, like B. sub/ilis, for the biosynthesis of lysine, rather than 
succinylated intermediates as in E. coli is not known. However, the discovery that the 
sequence of the fifth ORF in the dap operon had greatest homology to ykuQ of B. 
subtilis (60 % over 233 amino acids) suggests that like B. subtilis, S. aureus also uses 
acetylated intermediates. Therefore the gene product of ykuQ, of S. aureus like that of 
B. subtilis is predicted to be THP A. 
The final lysine biosynthetic enzyme encoded by the dap operon (8th ORF) is 
diaminopimelate decarboxylase (DAP decarboxylase). This enzyme is encoded by lysA, 
and catalyses the final step in the biosynthesis of lysine (Figure 5.2). This step is the 
pyridoxal phosphate-dependent decarboxylation of meso-DAP, to lysine. In E. coli, a 
positive regulatory element, lysR, whose product is essential for /ysA expression, is 
transcribed divergently from lysA (Stragier et al., 1983). However, none of the deduced 
products of the ORFs surrounding either lysA of B. subtilis (SubtiList) of S. aureus have 
any similarity to the /ysR product. However, a gene remote from the lysA locus, that 
leads to the loss of DAP decarboxylase activity in B. subtilis may represent an 
analogous control element to lysR in B. subtilis (reviewed by Paulus, 1993). Therefore 
a similar system may be found in S. aureus. This situation however is complicated 
in S. aureus as this study revealed the presence of a DAP decarboxylase isozyme 
(dapH). This was a surprising discovery, as a homology search revealed that neither B. 
subtilis nor E. coli possess multiple isozymes of DAP decarboxylase (results not 
shown). Finally, a homologue of /ysR was not found to be located adjacent to dapH in 
S. aureus. The reason for the presence of multiple isozymes ofDAP decarboxylase in S. 
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aureus, but not in B. subtilis, may be linked to the dual role of this enzymatic step in 
S. aureus. Whereas in B. subtilis DAP decarboxylase is only required for the conversion 
of DAP to lysine, for use in protein biosynthesis (DAP is the cell wall component). In 
S. aureus, in addition to its role in protein synthesis, lysine is also an essential 
component of the cell wall peptidoglycan. 
The remaining two genes of the dap operon are: hipO and dal which encode hippurate 
hydrolase and alanine racemase respectively (Figure 5.11). Hippurate hydrolase is the 
first of the two non-lysine biosynthetic genes encoded by the dap operon. This enzyme 
is an amidohydrolase also known as hippuricase, and acts to cleave benzoglycine 
(hippuric acid) into the constituent products, benzoic acid and glycine (Hani and Chan, 
1995). Hippurate hydrolase has no apparent function in the biosynthesis of lysine and 
thus its presence in the dap operon was initially unexpected. A possible explanation 
behind a gene encoding hippurate hydrolase being present in the dap operon, was 
discovered following the examination of the organisation of the hippurate hydrolase 
genes in B. subtilis. Searching the SubtiList database revealed that there are possibly 
two isozymes of hippurate hydrolase in B. subtilis: hipO (hippurate hydrolase) and ykuR 
(unknown, similar to hippurate hydrolase). Interestingly, the second isozyme of 
hippurate hydrolase encoded by ykuR is in an operon immediately downstream of ykuQ 
(THP A). Thus the organisation of the genes encoding THP A and hippurate hydrolase is 
identical in B. subtilis and S. aureus. Furthermore, analysis of the S. aureus databases 
revealed that like B. subtiUs, S. aureus also encodes at least two putative isozymes of 
hippurate hydrolase. This second isozyme of hippurate hydrolase (named, amhX), 
shows greater homology to hipO of B. subtilis than the isozyme encoded by the dap 
operon (results not shown), indicating that the hippurate hydrolase in the dap operon is 
the homologue of ykuR. 
Alanine racemases are unique prokaryotic enzymes that interconvert L-alanine and 
D-alanine, and are the sole identified biosynthetic pathway of D-alanine for bacterial 
cell wall synthesis (Wasserman et al., 1984). D-Ala is generally present as a dipeptide, 
D-alanyl-D-Ala, in the C-terminal position of UDP-N-acetylmuramyl (MurNAc)-
pentapeptide precusor of the peptidoglycan. The penultimate D-Ala residue of 
this precusor is directly involved in the cross-linking of adjacent peptidoglycan stands 
in cell wall growth. Furthermore, the cell wall of S. aureus and other Gram-positive 
bacteria contains teichoic acids. These teichoic acids contain various substituents , 
such as D-Ala esters and glycosyl residues. Thus in S. aureus, D-Ala is a central 
molecule in the biosynthesis of two cell wall polymers, peptidoglycan and teichoic 
acids (Hols et al. 1997). 
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In E. coli two alanine racemases have been identified. The air encoded alanine 
racemase (biosynthetic racemase), is constitutively expressed whereas the dadX 
encoded enzyme (catabolic racemase), is essential only for L-alanine catabolism (Lilley 
et al., 1993; Wild et al., 1985). The dadX gene product is the major source of alanine 
racemase (85 % of total activity) and is probably a secondary source of D-Ala for cell 
wall biosynthesis (Wasserman et al., 1984). In B. subtilis a single racemase gene (da/) 
has been identified, however a Dal- mutant is not dependent on D-Ala under all 
conditions suggesting that a second alanine racemase is present in B. subtilis (Ferrari et 
al., 1985). The second isozyme of alanine racemase in B. subtilis was identified during 
the course of this study, by searching the SubtiList database; yncD (unknown, similar to 
alanine racemase). Interestingly, both dal andyncD showed significant homology to the 
dap operon encoded alanine racemase (dal) of S. aureus (27% over 331 amino acids 
(dal); and 23% over 371 amino acids (yncD». 
The identification of an alanine racemase in the dap operon confirms the fact that S. 
aureus like E. coli and B. subtiUs encodes two alanine racemases. The first alanine 
racemase of S. aureus (air) was identified 5' to the sigB operon by Kullik and 
colleagues (1998b). Their work suggested that a mutation polar on this gene didn't 
affect the D-Ala substitution of the wall teichoic acid, and thus it was proposed that a 
second alanine racemase is present in S. aureus. Furthermore, identification of the 
second alanine racemase (dal) is in agreement with the non-essential nature of air in 
S. aureus, which has been found to be essential in some bacteria, for example 
Lactobacillus plantarum (Hols et al., 1997). The alanine racemase of the dap operon 
has greater homology to dal of B. subtilis than yncD (homologue of air from E. coli) 
and thus in accordance has been named dal. The reasoning for the inclusion of dal in a 
lysine biosynthetic operon is not exactly clear. However, as described above, alanine 
racemase has an important role in cell wall biosynthesis, which may explain its 
presence in the dap operon, owing to the involvement of lysine in the cell wall 
peptidoglycan. 
This study has identified the gene encoding the third AK isozyme of B. subtilis (yclM). 
Interestingly, a homologue of yclM was found in S. aureus (ask), however 
comprehensive analysis of S. aureus databases revealed there to be no isozyme of dapG 
(AK I) in S. aureus. Therefore from this work it would appear that unlike both 
B. subtilis and E. coli, S. aureus encodes only two AK isozymes. Due to the homology 
of these genes with other AKs in the database, it is predicted that, the dap operon 
encoded AK (lysC) is a lysine regulated AK, while the other (ask), is threonine-plus-
lysine regulated. The presence of at least two AKs isozymes in S. aureus was initially 
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predicted, from the fact that mutants deficient in lyse (seg 1, and seg2S) were 
auxotrophic for only lysine. This theory was further supported by the fact that in 
bacteria with only one AK, for example C. glutamicium and Streptomyces 
akiyoshiensis, this enzyme (encoded by ask) is regulated by threonine-plus-lysine 
(Cremer et al., 1991; Le et al., 1996), whereas the AK identified by the serum screen, 
was predicted to be only sensitive to lysine. This dual amino acid regulation is essential 
for organisms with only one AK as it affords control to both sides of the biosynthetic 
pathway (Paulus, 1993). Therefore the discovery of the second AK of S. aureus was in 
keeping with the above predictions. The fact that S. aureus does not encode a DAP 
sensitive AK, is not that surprising considering that the only role that DAP plays in 
S. aureus is as a precusor for lysine, whereas in B. subtiUs, DAP is an essential 
component of the cell wall peptidoglycan. 
The presence of THP A (ykuQ) in the dap operon, suggests that S. aureus like B. subtiUs 
and E. coli, synthesize lysine via the epimerase pathway. However, conclusive proof 
that S. aureus, unlike C. glutamicum, is unable to also synthesize lysine via the 
dehydrogenase pathway was not ascertained owing to the incomplete nature of the 
publicly available databases (TIGR and NCTC 8325). However, from published data it 
would appear that the presence of both the epimerase and the dehydrogenase pathways 
is limited to certain coryneform bacteria, such as C. glutamicum and Brevibacterium 
lactofermentum (Schrumpf et al., 1991). Although in Bacillus marcerans, DAP 
dehydrogenase has been detected in addition to two of the epimerase variant enzymes 
(Bartlett and White, 1985). Therefore the possibility of two mechanisms of lysine 
biosynthesis existing side by side in S. aureus cannot at this time be ruled out. 
Analysis of the mechanism of methionine biosynthesis in S. aureus, although not totally 
conclusive, very strongly suggests that S. aureus, like B. subtilis is capable of only 
synthesizing methionine via cystathionine (Figure 5.3). This argument is two fold: 
Firstly seg8 (yjc/) is a methionine auxotroph; and secondly, database searches failed to 
identify a homologue of O-acetylhomoserine sulphydrylase. 
The identification of a third gene (metX) with homology to both yjcI (Cystathionine y-
synthase (CTOS)) andyjcJ(cystathionine ~-lyase (CTBL)), of S. aureus and B. subtilis, 
complicate the issue of methionine auxotrophy for seg8 (yjc/) , due to the tentative 
classification of metX as an isozyme of CTOS. This was due to the fact that metX 
showed greatest homology to yrhB of B. subtiUs, which has been classified as unknown, 
similar to CTOS (SubtiList). However, this classification was never completely 
confirmed mainly due to the considerable identity between, yjcl yjcJ and metXlyrhB, 
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pointing to a common ancestor for these proteins. This tentative classification of metX 
as an isozyme of CTGS did however hold throughout the course of the study, owing to 
the arrangement of methionine biosynthetic genes in S. aureus. However, the possibility 
still remains that metX and yrhB both encode enzymatically inactive proteins. 
In S. aureus the organisation of methionine biosynthetic genes is different from that in 
B. subtilis (Figures 5.14-5.17). Analysis of S. aureus databases revealed that in 
S. aureus CTGS (yjcl) and CTBL (yjcJ) are located in an operon (yjc) with two further 
genes involved in methionine biosynthesis. Interestingly, both these genes show 
significant homology to methionine synthase, which is the final enzyme in the 
biosynthesis of methionine (Figure 5.3). Closer inspection revealed that these two genes 
encode different isozymes of methionine synthase. The first methionine synthase 
isozyme, (named metH), shows greatest homology (46 % identity over 597 amino 
acids) to yitJ of B. subtilis. However, yitJ is classified as unknown, similar to unknown 
proteins in the SubtiList database. Importantly, this synthase has strong homology 
(33 % over 281 amino acids) to the vitamin-Bl2 dependent methionine synthase 
isozyme of Mycobacterium tuberculosis (metH). The second methionine synthase 
isozyme, (named metE), shows greatest homology (52 % identity over 697 amino acids) 
to methionine synthase, vitamin-Bl2 independent isozyme of B. subtilis (metC). The 
discovery of two isozymes of methionine synthase in S. aureus was interesting since 
previously E. coli was thought to be an exception, in that it possesses both methylase 
isozymes (metE and metH), (Cohen and Saint-Girons, 1987). However, a BLAST 
search on the B. subtilis chromosome also showed the presence of both isozymes of 
methionine synthase; yitJ (metH homologue), and mete (metE homologue) (results not 
shown). Thus in regards to methionine synthase, E. coli is perhaps not as exceptional as 
once thought. 
Despite the differences in the organisation of the methionine biosynthesis genes of S. 
aureus and B. subtilis, in both organisms, CTGS and CTBL are adjacent, potentially 
within an operon (Figure 5.14-5.15). As CTGS is upstream ofCTBL, a mutation within 
this gene (seg8) will be polar on CTBL. Thus a second functional CTGS (metX) will 
make no difference to the growth of the mutant strain (seg8) , on media lacking 
methionine, since without CTBL the biosynthetic pathway to methionine remains 
blocked. The polar effect is partiCUlarly significant for S. aureus, which has four 
putative genes encoding MBE, encoded by the putative yjc locus (Figure 5.15). The 
organisation of these genes is such that if they represent a single transcriptional unit, 
then a mutation in CTGS (seg8) would be polar on the three downstream MBE genes, 
thus producing a methionine auxotrophic phenotype despite the presence of a second 
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isozyme of CTGS. Therefore the original classification of met X as a second isozyme of 
CTGS was upheld. 
The role of the three LBE sera expressed genes, was analysed in terms of their role in 
the starvation-survival response of S. aureus. Results of this analysis in amino acid 
limiting CDM (16), demonstrated that both lysC and dapA mutants showed a 
starvation-survival defect. This analysis also confirmed the previous observation, that a 
strain with a defective dap operon encoded lysA (SPW2), had a significant starvation-
survival defect (Watson et al., 1998b). The conformation of the starvation-survival 
defective phenotype was surprising in light of the discovery that S. aureus encodes two 
isozymes of DAP decarboxylase (lysA; dapH). Furthermore, as SPW2 (lysA) is not 
auxotrophic for lysine (results not shown), dapH must be active under some conditions. 
The LBE: :lacZ transcriptional fusion strains constructed in the wild type background 
(MDW4l (lysC::lacZ); (MDW42 (asd::lacZ); and (MDW43 (dapA::lacZ»), were used 
initially to study the expression of the three LBE seg in the serum model. These results 
confirmed the preferential expression of lysC, asd and dapA in serum compared to BHI, 
with expression levels between 4- and lO-fold higher in serum. Interestingly, the 
expression patterns were very similar for all three LBE genes, with maximal expression 
occurring during the transition from post-exponential to stationary phase. Interestingly, 
this analysis appeared to reveal that while lysC and asd were expressed at very similar 
levels, dapA was expressed at a slightly reduced level. The reason for this increased 
expression of lyse and asd would be argued to be due to the involvement of these two 
genes in the biosynthesis of all four amino acids, and not just in that of lysine as for 
dapA. However, result from the analysis of transcript levels using TaqMan showed that 
all three genes were expressed to an almost identical level to each other under both in 
vivo and in vitro conditions. As TaqMan is thought to be a more sensitive and reliable 
method for the determination of transcript levels, the apparent decrease level of dapA 
transcription, may be an artifact. 
Using the transcriptional fusions to lysC (MDW41), asd (MDW42), and dapA 
(MDW43), the role of each of the four AAA (lysine, threonine, methionine and 
isoleucine) was investigated. The major findings of this series of experiments were that: 
i) all three LBE seg were regulated (repressed) at the transcriptional level by lysine; and 
ii) the other AAA (threonine, methionine and isoleucine) also appear to have a 
secondary role in the regulation of these LBE genes. 
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The aspartokinase (AK) identified in the serum screen, showed strong homology to the 
lysine sensitive AK of B. subtilis (lysC), (40 % over 397 amino acids). As a result from 
homology analysis alone it was predicted that lyse of S. aureus would also be regulated 
by lysine. This assumption proved correct, and thus this work describes the 
identification of a lysine sensitive (regulated) AK in S. aureus. Importantly however, 
the genetic location of the lysine sensitive AK (lysC), is different in B. subtilis and 
S. aureus. Therefore the important question exists, as to whether these two lysine 
sensitive AK isozymes are regulated by lysine in the same manner? 
The mechanism for lysine regulation of lyse in B. subtilis has been the subject of much 
work, but despite this, the exact details of the regulation are not understood. As 
described in Chapter 5.1.3.1.2, lysC is regulated at the transcriptional level by lysine, 
and when lysine is present the lysC operon is repressed by > 100-fold (Kochhar and 
Paulus, 1996). Work has revealed that lysine has no effect on the molar amounts of total 
lyse RNA synthesized, but rather caused a quantitative shift of full-length 1.6 kb lyse 
mRNA to a truncated 0.27 kb RNA species (Kochhar and Paulus, 1996). In other words 
lysine regulates the expression of the lyse operon by effecting the premature 
termination of transcription, at a rho-independent terminator site within the lyse leader 
region, upstream of the translational start site of lyse. The results of the reporter gene 
fusion assays using MDW41 , revealed a decreased transcription of lyse in the presence 
of lysine. However, owing to the nature of the lysC::lacZ fusion (Chapter 5.2.4.1), 
regulation by premature transcript termination, would also be observed as a reduction in 
~-galactosidase production. Thus these results are in keeping with an identical 
mechanism of lyse regulation by lysine in both B. subtilis and S. aureus. 
Central to the regulation of lyse (premature transcript termination) in B. subtilis is an 
extensive untranslated region upstream of lysC. This region is 330 bp long and contains 
several control features, including terminator, antiterminator structures and a putative 
24 amino acid ORF (the lyse leader peptide). which is thought to playa role in the 
regulation of lyse (Chen et al., 1987). 
S. aureus has the potential for the production of an extensive untranslated leader region, 
as the closest gene to lyse (ykpA) has its stop codon, > 850 bp upstream of the 
translational start of lysC. Unfortunately. the position of the lyse promoter was not 
mapped during this study therefore it is not known whether S. aureus is in fact like 
B. subtilis in possessing an extensive untranslated leader region. However, owing to the 
discovery that a transposon insertion, 31 bp upstream of the start codon of lyse, is 
within a transcribed region (active lacZ gene on serum) indicates a potential role for the 
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upstream region, in the regulation of lyse of S. aureus. The putative lysC leader region 
of S. aureus has the potential for the production of several short polypeptides, owing to 
the presence of multiple ORFs. One such ORF has the potential for the production of a 
25 amino acid peptide, with a dyad of lysine codons in an identical position to the lyse 
leader peptide of B. subtilis (positions 2 and 3). Therefore this putative peptide has 
tentatively been classed as, the lyse leader peptide. However, three factors are against 
this ORF encoding a leader peptide. Firstly, other than the dyad of lysine codons at the 
start of the putative peptide, there is no significant similarity between the two ORFs at 
the amino acid level, indicating that they may not have evolved from the same 
sequence, and thus the ORF may not encode a lyse leader peptide. Secondly, the ORF 
is located approximately 700 bp upstream of the start site (ATG) of the lyse gene. This 
would require the untranslated leader region to be ~ 700 bp long, making it over twice 
the length of the leader regions found in both B. subtilis and E. coli (Chen et al., 1988; 
Cassan et al., 1983). Finally, even if the putative leader peptide ORF, is located 
downstream of the lyse promoter, owing to the absence of an apparent ribosome 
binding site upstream of the putative leader peptide of S. aureus, there is some doubt as 
to whether this peptide is translated or not. Importantly, despite the lack of evidence for 
the translation of the leader peptide of B. subtilis (Kochhar and Paulus, 1996), a 
consensus ribosome binding site can be identified upstream of the leader peptide ORF. 
Further evidence for a different mechanism of regulation of lyse by lysine in S. aureus 
and B. subtilis came from the failure to identify structures potentially resembling 
terminator, antiterminator elements within the putative lysC leader region. However, 
further analysis is required to confirm this postulation. 
Therefore despite lyse of S. aureus being regulated at the transcriptional level by lysine 
and the possible involvement of upstream sequences, owing to the apparent absence 
of sequences resembling those of terminator, antiterminator elements, the regulation of 
lyse is predicted from sequence analysis to be different to that which occurs in 
B. subtilis. It is however of interest that the lysine sensitive AK (lysC) of E. coli also 
has an extensive untranslated leader transcript (308 bp). This region however, differs 
from that of B. subtilis by the absence of elements resembling a transcription attenuator 
(Cassan et al., 1983). Therefore it is possible that lyse of S. aureus is regulated in the 
same manner as found in E. coli, which although is not known, is believed to occur 
at the transcriptional level (Richaud et al., 1980). Alternatively, yet another 
different regulatory mechanism may be employed for the control of lyse transcription 
in S. aureus. 
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The discovery that asd and dapA of S. aureus are regulated by lysine is not unexpected, 
especially in view of their inclusion in the dap operon of S. aureus immediately 
downstream of the lysine regulated lyse. Importantly however, results from auxotrophy 
studies have revealed that asd must have its own promoter, as a mutation in lysC does 
not have a polar effect on asd. 
As mentioned above threonine, methionine and isoleucine also appear to play a 
secondary role in the regulation of lysC, asd and dapA gene expression. For example all 
three LBE seg were repressed by a further 2- 3-fold in the presence of all four AAA, 
compared to the inclusion of lysine alone. Therefore, it appears that the AAA have an 
additive (multivalent) effect on the repression of the LBE seg. This type of cooperative 
regulation of biosynthetic genes is not unusual and is in agreement with the type of 
control witnessed for asd of E. coli (Boy and Patte, 1972). Conversely, there is 
evidence for the fact that methionine, far from repressing transcription of lysC, asd and 
dapA induces the synthesis of all three of these LBE genes by > 2-fold compared to 
media in which methionine is absent. This would appear to be the first observation of 
an induction of AK, ASADH and DHPS by methionine, and is the complete reverse of 
the effect of methionine on asd from B. megaterium (Chatterjee and White, 1982). 
Importantly however, in the presence of both methionine and lysine, these LBE genes 
are still strongly repressed indicating that activation by methionine is a secondary 
regulatory function. 
From analysis of the distances between genes, it could be predicted that the entire 8 
gene dap operon, could be transcribed as a single transcriptional unit despite the 
potential for the presence of multiple promoters. Supporting this postulation is the fact 
that there are apparently no strong candidate rho-independent terminator structures, 
within the dap operon, indicating the potential for the production of a single 8.5 kb 
transcript. However, attempts at Northern blots probing for lysC, asd and dapA 
transcripts were unsuccessful, failing to identify any significant transcript. Thus the size 
and nature of mRNA transcripts from the dap locus remains unknown. 
The importance of the dap operon was originally shown by its identification in the 
serum screen. As the serum screen was designed to mimic in vivo conditions it was 
predicted that the dap operon, or more accurately lyse. asd and dapA may be important 
in vivo. The results of the in vivo expression studies confirmed that serum is a valid 
model for the identification of genes induced in vivo. Using both RT-PCR and TaqMan, 
all three LBE seg were found to be expressed in the mouse kidney (pyelonephritis) 
model. In addition RT-PCR demonstrated that the three other LBE genes (dapB, ykuQ 
276 
and lysA) encoded by the dap operon of S. aureus are also expressed in the mouse 
kidney model. However, significant expression of all 6 of the dap operon encoded LBE 
was also found in BHI. Additionally, TaqMan showed significant expression in vitro as 
compared to the kidney model. Thus it is likely that expression levels in the mouse 
kidney are significantly lower than those in serum. S. aureus is able to grow in a wide 
range of niches and so it may be that in blood, expression of the dap operon would be 
found to be much greater than that witnessed in the mouse kidney. Interestingly, these 
results correspond well with those published recently by Vriesema et ai, (2000). In this 
study at least three S. aureus LBE genes encoded by the dap operon (lyse, asd and 
dapB) were identified as expressed on contact with human endothelial cells. In addition 
a DAP decarboxylase (lysA/dapH) was also identified, although it is not possible from 
the published data to determine which isozyme of DAP decarboxylase was identified. 
Expression of these four LBE genes, was also found to be induced by human serum. 
Thus the results published by Vriesema et ai, (2000) and the results reported in this 
study are in complete agreement, with both studies showing the preferential expression 
of LBE genes in sera. 
The roles of AK II (lysC), ASADH (asd) and DHPS (dapA) in infection were 
investigated with the aid of three murine pathogenicity models. In all 3 models 
(subcutaneous lesion, pyelonephritis and wound infection), there was no significant 
difference in the number of cells recovered from the host for any of the mutant strains 
(segllSWCl (lysC); seg241 SWC24 (asd); or seglO/SWCIO (dapA», compared to the 
number recovered for the wild type strain (832S-4/WCUH29). Thus it can be concluded 
that none of the LBE seg mutant are important for growth or survival under these 
in vivo conditions. However, one fact that should be kept in mind when examining data 
from pathogenicity studies is that the assay for virulence may not be sufficiently 
sensitive or even appropriate for the virulence factor being examined (Projan and 
Novick, 1997). This statement is particularly pertinent in this situation as these results 
appear to contradict previously published work in particular, the work of Mei et al. 
(1997), and Coulter et al. (1998) who carried out signature-tagged mutagenesis (STM) 
on S. aureus. Both of these studies identified asd, which by definition of the technique 
must be attenuated in virulence. The study by Mei et al. (1997) identified asd using a 
model of bacteremia. The bacteremia model would be predicted to be the most likely 
model to identify a virulence defect in a strain deficient in asd, as the serum model 
would presumably, most closely resemble this in vivo situation. The study conducted by 
Coulter et al. (1998) also identified the dap operon encoded ykuQ (THPA), in addition 
to asd. In this study three models were used for the identification of in vivo attenuated 
genes. These were bacteremia, abscess and wound, models of infection. Interestingly, 
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the mutant strain, unable to produce an active THP A polypeptide was found to be 
attenuated in all three models. Unfortunately however, the asd transposon mutant 
isolated in this study was unable to grow to measurable, reproducible levels in vitro 
(AS40< 0.02) and thus could not be related comparatively in vivo. This meant that the 
report did not indicate which, or how many models the asd mutant strain was attenuated 
in, although presumably from comparison with the other work outlined here, the asd 
mutant was only attenuated in the bacteremia model. Interestingly however, no such 
problems were found growing strains with a defective asd in BHI media, with growth 
yields consistently reaching densities of> I 0 (A600)' The reason for this difference in, in 
vitro growth is not known, but it does represent a direct conflict in results between the 
two studies. Finally both STM strategies identified a DAP decarboxylase, as having 
attenuated virulence. However, which isozyme (lysA/daplf) was identified in each study 
is not known. 
The discovery that ASADH, THPA and DAP decarboxylase mutants are attenuated 
in vivo (bacteremia model of infection), further highlights the importance of S. aureus 
LBE genes in pathogenicity. Thus, these published results provide additional weight for 
the validity of the serum model, as a means for the identification of genes important for 
the growth of S. aureus in vivo. 
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CHAPTER 6 
GENERAL DISCUSSION 
6.1 Introduction 
The experiments reported in this thesis have been fully discussed at the end of each 
chapter. It is however now necessary to combine the important points of each 
discussion into a comprehensive picture of the growth and gene expression of S. aureus 
both in serum and in vivo. 
The growth of S. aureus along with gene expression had not previously been 
investigated in serum. The growth of S. aureus in pig and human sera under different 
aeration conditions, the role of regulatory loci, and of oxygen protecting enzymes, in 
addition to the expression of known components, were all examined (Chapter 3). To 
characterise specific components of the response to growth in serum, lacZ reporter gene 
fusions to genes preferentially expressed in serum compared to a nutrient-rich growth 
medium were isolated (Chapter 4). Subsequent characterisation of genes preferentially 
expressed in serum enabled the identification of genes involved in the growth of 
S. aureus in serum and potentially in vivo. A subset of these sera expressed genes (seg) 
identified were involved in the biosynthesis of lysine, threonine, methionine and 
isoleucine (Chapter 4). Genes involved in the biosynthesis of these amino acids were 
comprehensively studied, investigating; the biosynthetic pathways for the production of 
these amino acids, the genetic organisation of these genes and their regulation, along 
with the role of these seg in pathogenicity and other functions (Chapter 5). 
6.2 S. aureus and the serum model 
The environmental concentration of 0/C02 appears to be the most important factor 
affecting both the growth rate and yield of S. aureus in serum. Increased CO2 and/or 
decreased O2 concentrations (microaerobic) had a beneficial effect on the growth of 
S. aureus compared to that for aerobic conditions, in both solid and liquid media. 
The possible role of oxidative stress in serum was analysed by investigating the role of 
genes and their enzymatic gene products, with a role in the protection against toxic 
forms of oxygen. Catalase was found to play an important role in combating this 
oxidative stress as the addition of catalase to solid media enhanced the growth yield. 
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Additionally, the inactivation of the major catalase of S. aureus (KatA) decreased the 
growth yield. The importance of the role of catalase was further highlighted as from 
gene fusion studies, katA was shown to be expressed, to significantly lower levels under 
microaerobic than aerobic conditions. Interestingly, neither the addition of catalase nor 
the presence of a defective KatA (ST!) made a significant difference to the growth of 
S. aureus on BHI, indicating an increased sensitivity to toxic forms of O2 in serum. 
However, despite the apparent importance of O2 toxicity in serum, a further enzyme 
involved in the protection against these stresses, superoxide dismutase does not have an 
important role in the serum model. This was deduced from the fact that a strain (SPWl) 
encoding a defective SOD (sodA) is not attenuated for growth in the serum model, and 
because sodA transcription could not be detected during growth in serum. 
Significantly the major global regulators of accessory factors, agr and sar were not 
essential for the growth of S. aureus in serum. Furthermore the alternative sigma 
factor erD, which has been shown to control the environmental stress response in 
S. aureus (Chan et al., 1998), does not play an important role in the serum model. The 
results of transcriptional fusion analysis is in agreement with the absence of an 
important role for these regulatory loci in the serum model, showing that agr, sarA and 
sigB are all expressed to a relatively low level in serum. 
The screen for genes important for the growth of S. aureus in the serum model 
identified 73 clones that were either specifically or preferentially expressed in serum 
compared to a nutrient-rich growth medium. This increased gene expression is similar 
to that observed for Tn917-1ac mutants of S. aureus in response to both, milk 
containing agar plates (Lammers et al., 2000) and on interaction with human 
endothelial cells in vitro (Vriesema et al., 2000). Interestingly, these 73 strains have 
transcriptional fusions to genes with a range of expression levels on serum, as 
determined by the colour of the colonies on serum agar plates containing X-Gal. 
25 seg were selected at random, for further analysis and characterisation. These mutant 
strains were shown to have a growth rate that was indistinguishable from each other and 
from the wild type, when grown in serum. This demonstrated that although these genes 
were preferentially expressed in serum their disruption did not cause an attenuated 
growth phenotype. Importantly growth in liquid media confirmed the classification of 
reporter gene fusions to serum specific genes. 
Cloning and sequencing of the regions flanking the Tn917 insertion, resulted in the 
identification of a number of transposon disrupted ORFs with similarities to known 
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proteins in the NCBI database. In addition, several mutants were determined to contain 
the transposon within an untranslated region. However, on further analysis these 
regions were found to be 'linked' to genes of known function. These disrupted or linked 
genes are transcribed by promoters with preferential activity on serum, and thus are the 
sera expressed genes. These genes included; putative cell surface proteins, an 
antimicrobial peptide (lantibiotic), and five genes involved in nutrient biosynthesis, 
including four genes encoding aspartate amino acid biosynthetic enzymes. Additionally, 
a further gene was identified as a sera expressed gene, although this seg had no 
significant homology to known sequences. 
The four genes involved in the biosynthesis of the aspartate amino acids (lysine, 
threonine, methionine and isoleucine), were comprehensively analysed, and their role in 
both the serum model and in vivo is discussed in the remainder of this chapter. 
6.3 The aspartate amino acid biosynthetic sera expressed genes 
The screening of S. aureus Tn917 libraries during growth on serum identified four 
aspartate amino acid biosynthetic genes, as being expressed in serum but not in a 
nutrient-rich growth media (BHI). These genes are lyse, encoding an aspartokinase 
isozyme (AK II); asd, encoding aspartate-semialdehyde dehydrogenase; dapA, coding 
for dihydrodipicolinate synthase; and yjcI, encoding cystathionine y-synthase. 
The transposon insertion of seg8 was identified to be 13 bp upstream of the 
translational start site of cystathionine y-synthase (yje]). This enzyme is involved in the 
biosynthesis of methionine, catalysing the conversion of acetyl-homo serine to 
cystathionine. Cystathionine y-synthase and the mechanism of methionine biosynthesis 
had not previously been studied in S. aureus, and thus were studied as part of this study. 
Cystathionine y-synthase was found not only to be preferentially expressed in serum, 
but was found to be regulated in a growth phase dependent manner with maximum 
expression occurring during the transition from exponential to post-exponential phase. 
seg8 was found to have a methionine auxotrophic phenotype, demonstrating that 
cystathionine y-synthase is essential for methionine biosynthesis, thus providing 
evidence for the presence of only a single pathway for the biosynthesis of methionine in 
S. aureus. This proposal was further supported by the failure to identify a homologue of 
acetylhomoserine sulphydrylase, the enzyme of the alternative mechanism for the 
biosynthesis of methionine (Ozaki and Shiio, 1982). However, the discovery of a 
putative isozyme of cystathionine y-synthase (metX) in S. aureus indicated that the true 
281 
key to the auxotrophic nature of a strain with a defective yjcI gene was due to the 
genetic organisation of methionine biosynthetic genes in S. aureus. 
The organisation of methionine biosynthetic genes in S. aureus was found to be 
different to that found in other bacteria. S. aureus possess an operon termed the yjc 
operon which encodes four enzymes, for the biosynthesis of methionine. These genes 
are the yjcI encoded cystathionine y-synthase, cystathionine ~-lyase (yjcJ), methionine 
synthase vitamin-B 12 dependent isozyme (metH), and methionine synthase vitamin-
B12 independent isozyme (metE}. This organisation results in a polar effect of the yjc/ 
mutation on yjcJ and potentially on the methionine synthase genes. Therefore a 
mutation in yjc/ bringing about premature transcriptional termination of the yjc 
transcript creating a methionine auxotrophic phenotype even in the presence of a second 
isozyme of cystathionine y-synthase (metX'). 
The two enzymes of the common pathway for the biosynthesis of the aspartate amino 
acids, aspartokinase (lysC), and aspartate-semi aldehyde dehydrogenase (asd) along with 
the first enzyme specific for the biosynthesis of lysine, dihydrodipicolinate synthase 
(dapA) were all identified in the serum screen. These three genes were shown to be 
clustered in S. aureus within an eight gene operon, along with genes involved in lysine 
biosynthesis and other functions. This organisation of lysine biosynthetic genes was 
found to be different to that found in all other organisms studied. The operon was 
named the dap operon, and represents the major operon in terms of lysine biosynthesis, 
encoding six enzymes involved in the production of lysine. These enzymes are: 
aspartokinase II (lysC) , aspartate semialdehyde dehydrogenase (asd) , 
dihydrodipicolinate synthase (dapA), dihydrodipicolinate reductase (dapB) , 
tetrahydrodipicolinate acetyltransferase (ykuQ) , and diaminopimelate carboxylase 
(lysA). The remaining two genes of the dap operon are hippurate hydrolase (hipO) and 
alanine racemase (dal) and are located in the dap operon between ykuQ and lysA. These 
two genes are not involved in lysine biosynthesis and are discussed fully in Chapter 5. 
The genes of the dap operon were postulated to be transcriptionally linked. This was 
believed to be the case, due to the short intercistronic regions between genes of the dap 
operon and the apparent absence of rho-independent terminator structures within the 
putative operon. Furthermore evidence that the first three genes of the dap operon were 
transcribed as a single unit, was supported by the observation that the growth phase 
dependent expression kinetics of all three lysine biosynthetic seg was very similar to 
each other under a specific condition. Maximal expression of these genes was generally 
witnessed during the transition between exponential and post-exponential phase, 
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although in some chemically defined media this was delayed until cells entered 
stationary phase. Additionally, work with the lacZ reporter gene fusions in the wild type 
background showed all three genes to be regulated in an identical manner. This 
regulation was found to be at the transcriptional level, primarily by lysine, although 
multivalent effects were also observed for threonine, methionine and isoleucine. The 
regulation of lysine biosynthetic genes by lysine has been witnessed in other bacteria 
including B. subtilis (Paulus, 1993) and multivalent regulation has been observed for 
asd of E. coli (Boy and Patte, 1972). Importantly however, in general not all three of 
these lysine biosynthetic enzymes are regulated in anyone organism. A further 
regulatory difference observed with lyse, asd and dapA of S. aureus compared to the 
equivalent genes of other organisms, was the apparent induction of these genes by 
methionine, in the absence of lysine. These similarities in regulation therefore provide 
evidence for the transcription of these genes as a single transcriptional unit. The final 
piece of evidence for the production of a single transcript containing lyse. asd and 
dapA and possibly all eight genes of the dap operon was the very similar levels of 
transcript of each lysine biosynthetic enzyme as determined by TaqMan. 
Importantly however, results of the auxotrophic analysis revealed that transcription of 
the dap operon was driven from at least two promoters, with the second located 
upstream of asd. This was concluded because mutations in lyse were found not to have 
a polar effect on asd. Finally, the regulatory mechanism controlling the synthesis of the 
lysine biosynthetic genes remains unknown, although there is evidence supporting the 
possible role of a putative untranslated leader sequence upstream of lyse. 
Studying the auxotrophic requirements of lyse mutants revealed the existence of a 
further aspartokinase isozyme in S. aureus. This additional isozyme was later confirmed 
by database searching. The isozyme was found to be homologous to threonine-plus-
lysine sensitive aspartokinase of other bacteria, for example B. subtiUs. Notably, from 
the analysis of the essentially complete S. aureus databases, it appears that unlike both 
B. subtiUs and E. coli, S. aureus encodes two rather than three aspartokinase isozymes. 
The importance of the lysine biosynthetic pathway was highlighted by the identification 
of 9 transposon insertions within; lyse (Tn = 6), asd (Tn = 2), and dapA (Tn = 1). This 
poses the interesting question as to why should this particular biosynthetic pathway be 
so important for the growth of S. aureus in serum? One reason for the important nature 
of this pathway is possibly due to the dual role that lysine biosynthesis plays in S. 
aureus, as it not only provides lysine as a building block for protein synthesis, but 
lysine is also an essential component of the cell wall peptidoglycan of S. aureus. This 
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theory was investigated, with the examination of the cell wall peptidoglycan of the lysC 
mutant strain (segl), by HPLC. Interestingly, the cell wall of this lysine auxotrophic 
strain was found to be identical to that of the wild type strain (8325-4) under all 
conditions tested. This demonstrated that in spite of a defective lysine synthetic 
pathway, the mechanism for the incorporation of lysine into the cell wall peptidoglycan 
was unaffected by this mutation. 
An alternative, and obvious explanation, for the identification of lysine and methionine 
biosynthetic genes during the course of this study, was perhaps due to a shortage of free 
lysine and methionine in serum. This theory is borne out by the concentration of free 
lysine and methionine present in human serum (lysine, 196 - 222 J.lM; methionine, 
21 - 26 J.lM) (Table A. 1. 1.6). Interestingly, these values are 6.1x (lysine) and 55x 
(methionine) lower than that present in COM (16). Therefore these values appear to be 
low enough, to allow the expression of genes repressed by lysine or methionine. 
Interestingly, lyse, asd, and dapA in addition to lysA, were all identified in a recent 
screen of S. aureus Tn917 mutants, as being expressed in an in vitro model mimicking 
infection. This study used milk as a model for the selection of genes important in 
bovine mastitis (Lammers et al., 2000) and thus demonstrates the potential importance 
of these lysine biosynthetic enzymes for growth in milk. Additionally, a further report 
recently described the identification of lysC and asd, as well as dapB and lysA 
following Tn917 mutagenesis, and screening for increased gene expression upon 
interaction with human endothelial cells (Vriesema et al., 2000). Of particular 
importance was the observation that the expression of lyse, asd, dapB and /ysA was 
also induced by human serum (Vriesema et al., 2000). These two reports combined 
with the results described in this study indicate an important role for lysine biosynthetic 
genes in three different models mimicking infection. However, an interesting 
observation from these three studies was that an absence of lysine and the other 
aspartate amino acids did not appear to be the key factor in the high expression of these 
genes. This was deduced from several pieces of information. Firstly although the 
concentration of free lysine in serum is relatively low (- 0.21 mM) compared to that 
found in CDM (1.3 mM) (A. 1. 1.6 and A. 1. 1.2), the addition of lysine and the other 
aspartate amino acids to serum agar plates, to a final concentration of 2.75 mM did not 
switch off gene expression (results not shown). Secondly in the work conducted in milk 
by Lammers et al. (2000), to 'prevent' selection of amino acid biosynthetic genes 0.5 % 
(w/v) casein enzymic hydrolysate (casamino acids) was added to the media. However, 
despite this addition, four aspartate pathway enzymes were identified. Finally, the 
identification of four aspartate pathway enzymes upon interaction with human 
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endothelial cells was reported not to be due to a lysine deficiency, as the media used to 
culture cells (M199, Life Technologies) contains sufficient lysine (Vriesema et al., 
2000). These results therefore show that genes of the lysine biosynthetic pathway are 
expressed in a variety of in vitro models, where the trigger for their expression is not 
necessarily lysine limitation. Instead amino acid biosynthetic genes maybe specifically 
induced by a signal, or signals found in the host as well as in these in vitro models. A 
reason for the activation of the lysine biosynthetic pathway in the presence of lysine, is 
to cause alteration in the cell wall, which maybe beneficial or essential for bacterial 
survival in vivo. 
6.4 The role of lysine biosynthetic genes in vivo 
This study, along with the two described above (Lammers et al., 2000; Vriesema et al., 
2000), demonstrated the importance of lysine biosynthetic genes in vitro. As these three 
screens were all designed to mimic in vivo conditions it was postulated that lyse, asd 
and dapA maybe important in vivo. In vivo expression analysis, using both RT-PCR and 
TaqMan showed that these three genes were expressed in vivo in the murine 
pyelonephritis model. However, lyse, asd and dapA were also shown by TaqMan to be 
expressed at a significant level in vitro as compared to the pyelonephritis model. 
The role of aspartokinase II (lysC), aspartate semi aldehyde dehydrogenase (asd), and 
dihydrodipicolinate synthase (dapA) in infection, was investigated using three murine 
pathogenicity models. Strains defective in these enzymes were not found to be 
significantly attenuated in survival in these models. Therefore despite the apparent 
importance of these three lysine biosynthetic genes in, in vitro models mimicking 
infection, along with the fact that they are expressed in vivo, these genes do not have a 
significant function in these pathogenicity models. 
Interestingly, the lack of an important role of these three LBE genes was found to 
contradict reports published by both Mei et al. (1997) and Coulter et al. (1998). These 
reports describe the use of STM for the identification of S. aureus mutants with 
attenuated phenotypes in vivo. These studies identified asd as being important in a 
bacteremia model of infection, as well as lysA (diaminopimelate decarboxylase) and 
ykuQ (tetrahydrodipicolinate acetyltransferase) as being attenuated in both, abscess and 
bacteremia, models of infection. These results indicate an important role for lysine 
biosynthetic genes in infection particularly in bacteremia. Therefore from comparison 
with these results, it can be concluded that enzymes involved in the biosynthesis of 
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lysine do play an important role in vivo, and perhaps the pathogenicity models selected 
for this study were not suitable for the components tested. 
6.5 Concluding remarks 
Growth on serum, which potentially mimics the pathogenesis of S. aureus bacteremia, 
was used for the isolation and identification of preferentially expressed S. aureus genes 
(seg). This technique identified a number of genes, some of which may contribute to the 
establishment (surface proteins) and the persistence (biosynthetic genes, and an 
antimicrobial peptide) in the blood stream. The significance of this in vitro technique 
was confirmed by the discovery that some of the genes identified in this study have also 
been identified in other pathogenicity mimicking in vitro screens, as well as by STM. 
Therefore this simple in vitro approach has the potential to be both a cheap and 
effective method for the identification of genes important in the pathogenesis of S. 
aureus, in particular with respect to bacteremia. Finally, this in vitro model mimicking 
infection may be useful for the design of novel approaches for anti-staphylococcal 
therapies for the treatment of S. aureus infections. 
6.6 Future directions for the serum model and in vitro analysis of 
staphylococcal pathogenesis 
This study has described the development and use of an in vitro model for the analysis 
of staphylococcal pathogenesis. This investigation has lead to the identification of both 
known and unknown genes with a potential role in, in vivo growth. The role of these 
components can now be examined in detail, which will be facilitated greatly by the 
imminent completion of the S. aureus sequencing projects. Finally, conformation of the 
importance of the aspartate amino acid biosynthetic enzymes in bacteremia remains an 
important goal. 
The serum model once again showed the inherent usefulness of in vitro models for the 
identification of components potentially involved in the establishment of infection and 
in the causation of disease. These methods combined with the new generation of in vivo 
techniques will increase our knowledge of the pathogenicity of S. aureus. This is of 
increasing importance owing to the increasing prominence of antibiotic resistant strains. 
Therefore, new anti-staphylococcal therapies based on novel approaches are required, 
for which a greater understanding of the pathogenicity of S. aureus is essential. 
286 
REFERENCES 
Abdelnour A, Arvidson S, Bremell T, Ryden C, and Tarkowski A. (1993). Infect. 
Immun. 61, p3879-3885. 
Akerley BJ, Rubin EJ, Camilli A, Lampe OJ, Robertson HM, and Mekalanos 11. 
(1998). Proc. Natl. Acad. Sci. USA. 95, p8927-8932. 
Allaoui A, Sansonetti PJ, and Parsot C. (1992). J. Bacteriol. 174, p7661-7769. 
Arbuthnott JP, Coleman DC, and de Azavedo JS. (1990). 1. Appl. Bacteriol. plOl-107. 
Arvidson S. (1983). In Staphylococci and staphylococcal infections. p745-808. Easmon 
CSF, and Adlam C (Eds.). Academic press, London. 
Arvidson S, Janson L, and Lofdahl S. (1990). In Molecular Biology of the 
Staphylococci. p421-423. Novick RP (Ed.). VCH Publishers, Inc., New York. 
Atrih A, Zollner P, Allmaier G, and Foster SJ. (1996). J. Bacteriol. 178, p6173-6183. 
Bachmann BJ, and Low KB. (1980). Microbiol. Rev. 44, pI-56. 
Balaban N, and Novick RP. (1995). Proc. Natl. Acad. Sci. USA. 92, p1619-1623. 
Barber M, and Rozwadowska-Dowzenko M. (1948). Lancet. 255, p641-644. 
Bartlett ATM, White PJ. 1985. J. Gen. Microbiol. 131, p2145-2152. 
Bartlett ATM, White Pl 1986. J. Gen. Microbiol. 132, p3169-3177. 
Bayer MG, Heinrichs JH, and Cheung AL. (1996). J. Bacteriol. 178, p4563-4570. 
Behravan J, Chirakkal H, Masson A, and Moir A. (2000). J. Bacteriol. 182, pI987-
1994. 
Benov L, and Fridovich I. (1995). Arch. Biochem. Biophys. 332, p291-294. 
Bergdoll MS. (1989). In Bacterial food bourne pathogens. p464-523. Doyle MP (Ed.). 
Marcel Dekker. New York. 
287 
Bjorklind A and Arvidson S. (1980). FEMS Microbiol. Letters. 7, p203-206. 
Blevins 1, Gillaspy AF, Rechtin TM, Hurlburt BK, and Smeltzer MS. (1999). Mol. 
Microbiol. 33, p317-326. 
Bliska lB, Galan lE, and Falkow S. (1993). Cell. 73, p903-920. 
Bluhm G. (1985). Acta Medica Scandinavica. 699 (Suppl.). pl-62. 
Bondaryk RP, and Paulus H. (1985).1. BioI. Chern. 260, p585-591. 
Booth MC, Cheung AL, Hatter KL, lett BD, Callegan MC, and Gilmore MS. (1997). 
Infect. Immun. 65. p1550-1556. 
Bowe F, Lipps Cl, Tsolis RM, Groisman E, Heffron F, and Kusters lG. (1998). Infect. 
Immun. 66, p3373-3377. 
Boy E, and Patte lC. (1972). 1. Bacteriol. 112, p84-92. 
Boylan SA, Redfield AR, Brodie MS and Price CWo (1993).1. Bacteriol. 175, p7931-
7937. 
Brunskill EW, and Bayles KW. (1996). 1. Bacteriol. 178, p611-618. 
Brunskill EW. and Bayles KW. (1996). 1. Bacteriol. 178, p611-618. 
Bsat N, Herbig A, Casillas-Martinez L, Setlow P and HeImann lD. (1998). Mol. 
Microbiol. 29, pI89-198. 
Buchmeier NA, and Heffron F. (1990). Science. 248, p730-732. 
Camilli A, Beattie D, and Mekalanos 11. (1994). Proc. Natl. Acad. Sci. USA. 91, 
p2634-2638. 
Camilli A, and Mekalanos J. (1995). Mol. Microbiol. 18, p671-683. 
Camilli A, Mekalanos 11, and Portnoy DA. (1993). Mol. Microbiol. 8, p143-157. 
Camilli A, Portnoy DA, and Youngman P. (1990). 1. Bacteriol. 172, p3738-3744. 
288 
Casadaban MJ. (1976). J. Mol. BioI. 104, p541-555. 
Cassan M, Ronceray J, and Patte Je. (1983). Nucleic Acids Res. 11, p6l57-6l66. 
Cayouette M, Grismer L, Sucharczuk A, and Moores J. (1999). Strategies Newsletter. 
12, p89-92. 
Chan PF, and Foster SJ. (1998a). 1. Bacteriol. 180, p6232-6241. 
Chan PF, and Foster SJ. (1998b). Microbiol. 144, p2469-2479. 
Chan PF, Foster SJ, Ingham E, and Clements MO. (1998). 1. Bacteriol. 180, p6082-
6089. 
Chatterjee M, and White PJ. (1982). J. Gen. Microbiol. 128, pl073-l08l. 
Chein Y, and Cheung AL. (1998). J. BiolChern. 273, p2645-2652. 
Chen NY, Hu FM, and Paulus H. (1987).1. BioI. Chern. 262, p8787-8798. 
Chen NY, Jiang S, Klein DA, and Paulus H. (1993). 1. BioI. Chern. 268, p9448-9465. 
Chen NY, and Paulus H. (1988). J. BioI. Chern. 263, p9526-9532. 
Cheung AL, Bayer MG, and Heinrichs JH. (1997). J. Bacteriol. 179, p3963-3971. 
Cheung AL, Chein YT, and Bayer AS. (1999). J. Bacteriol. 67, p133l-1337. 
Cheung AL, Eberhardt KJ, Chung E, Yeaman MR, Sullarn PM, Ramos M, and Bayer 
AS. (1994). J. Clin. Invest. 94, pI815-1822. 
Cheung AL, Koomey JM, Butler CA, Projan SJ and Fischetti VA. (1992). Proc. Natl. 
Acad. Sci. USA. 89, p6462-6466. 
Cheung AL, Nast CC, and Bayer AS. (1998). Infect.lmmun. 66, p5988-5993. 
Cheung AL, and Projan SJ. (1994). J. Bacteriol. 176. p4168-4l72. 
289 
Cheung AL, Wolz C, Yeaman MR, and Bayer AS. (1995). 1. Bacteriol. 177, p3220-
3226. 
Cheung AL, and Ying P. (1994). 1. Bacteriol. 176, p580-585. 
Chiang SL, Mekalanos 11, and Holden OW. (1999). Ann. Rev. Microbiol. 53, p129-
154. 
Cirillo 10, Weisbrod TR, Pascopella L, Bloom BR, and lacobs WR. (1994). Mol. 
Microbiol. 11, p629-639. 
Clements MO. (1996). Ph.D. Thesis. University of Sheffield. 
Clements MO, and Foster Sl. (1998). Microbiol.144, p1755-1763. 
Clements MO, and Foster Sl. (1999). Trends in Microbiol. 7, p458-462. 
Clements MO, and Moir A. (1998). 1. Bacteriol. 180, p6729-6735. 
Clements MO, Watson SP, Poole RK, and Foster Sl. (1999a). 1. Bacteriol. 181, p50l-
507. 
Clements MO, Watson SP, and Foster Sl. (l999b). 1. Bacteriol. 181, p3898-3903. 
Cohen GN, and Saint-Girons I. (1987). In Escherichia coli and SaLmonella 
typhimurium: Cellular and Molecular Biology vol. 1. p429-444. Niedhardt FC, 
Ingraham lL, Low KB, Magasanik B, Schaechter M, and Umbarger HE (Eds.). ASM 
Washington, D.C. 
Cohen GN, Stanier RY, and LeBras G. (1969). 1. Bacteriol. 99, p791-801. 
Cormack BP, Valdivia RH, and Falkow S. (1996). Gene. 173, p33-38. 
Coulter SN, Schwan WR, Ng EYW, Langhorne MH, Ritchie HD, Westbrock-Wadman 
S, Hufnagle WQ, Folger KR, Bayer AS, and Stover CK. (1998). Mol. Microbiol. 30, 
p393-404. 
Courcol RJ, Trivier 0, Bissingger M-C, Martin GR, and Brown MRW. (1997). Infect. 
Immun. 65, p 1944-1948. 
290 
Cremer J, Eggeling L, and Sahm H. (1990). Mol. Gen. Genet. 224, p317 -324. 
Cremer J, Eggeling L, and Sahm H. (1991). Appl. Env Microbiol. 57, p1746-1752. 
Cremer J, Treptow C, Eggeling L, and Sahm H. (1988). J. Gen Microbiol. 134, p3221-
3229. 
De Saizieu A, Certa U, Warrington J, Gray C, Keck W, and Mous 1. (1998). Nature 
Biotectnol. 16, p45-48. 
Demerec M. (1948). 1. Bacteriol. 56, p63-74. 
Deora R, Tseng T, and Misra TK. (1997). J. Bacteriol. 179, p6355-6359. 
Devriese LA, Hajek V, Oeding P, Meyer SA, and Schleifer KH. (1978). Int. 1. Syst. 
Bacteriol. 28, p482-490. 
DiRita VJ, and Mekalanos n. (1989). Ann. Rev. Genet. 23, p455-482. 
Dukan S, and Nystrom T. (1998). Genes Devel. 12, p3431-3441. 
Fairhead H. (1999). Ph.D. Thesis. University of Sheffield. 
Ferrari E, Henner DJ, Yang MY. (1985). Biotechnology. 3, pi 003-1 007. 
Fitzgerald RH. (1989). Infect. Dis. Clines of North America. 3, p329-338. 
Follettie MT, Peoples OP, Agoropoulou C, and Sinskey. (1993). 1. Bacteriol. 175, 
p4096-4103. 
Foster TJ, and Hook M. (1998). Trends in Microbiol. 6, p484-488. 
Fridovich I. (1995). Ann. Rev. Biochem. 64, p97-112. 
Gillaspy AF, Patti, JM, and Smeltzer MS. (1997). Infect. Immun. 65, pI536-1540. 
Giraudo AT, Calzolari A, Cataldi AA, Bogni C, and Nagel R. (1999). FEMS Microbiol. 
Letters. 177, p15-22. 
291 
Giraudo AT, Cheung AL, and Nagel R. (1997). Arch. Microbiol. 168, p53-58. 
Giraudo AT, Rampone H, Calzolari A, and Nagel R. (1996). Can. J. Microbiol. 42, 
p120-123. 
Giraudo AT, Raspanti CG, Calzolari A, and Nagel R. (1994). Can. J. of Microbiol. 40, 
p677-681. 
Goerke C, Campana S, Bayer MG, Doring G, Botzenhart K, and Wolz C. (2000). 
Infect. Immun. 68, p 1304-1311. 
Graves LM, and Switzer RL. (1990). J. BioI. Chern. 265, pI4947-14955. 
Haight TH, and Finland M. (1952). Proc. Exp. BioI. Med. 81, p 183-188. 
Hajek V. (1976). Int. J. Syst. Bacteriol. 26, p401-408. 
Haldenwang W, and Losick R. (1980). Proc. Natl. Acad. Sci. USA. 77, p7000-7004. 
Hanahan D. (1983). J. Mol. BioI. 166, pI57-169. 
Handfield M, and Levesque RC. (1999). FEMS Microbiol. Rev. 23, p 69-91. 
Hani EK, and Chan VL. (1995). J. Bacteriol. 177, p2396-2402. 
Hart ME, Smeltzer MS, and Iandolo JJ. (1993). J. Bacteriol. 175, p7875-7879. 
Hartman BJ, and Tomasz A. (1984). J. Bacteriol. 158, p513-516. 
Haziza C, Stragier P, and Patte JC. (1982). EMBO 1. 1, p379-384. 
Hedges RW, and Jacob AB. (1974). Mol. Gen. Genet. 116, pI25-159. 
Heinrichs JH, Bayer MG, and Cheung AL. (1996). J. Bacteriol. 178, p418-423. 
Heithoff OM, Conner CP, Hanna PC, Julio SM, Hentschel U, and Mahan MJ (1997). 
Proc. Natl. Acad. Sci. USA. 94, p934-939. 
292 
Heithoff DM, Sinsheimer RL, Low DA, and Mahan MJ (1999). Science. 284, p967-
970. 
Hensel M, and Holden DW. (1996). Microbiol. 142, pl049-1058. 
Hensel M, Shea JE, Gleeson C, Jones MD, Dalton E, and Holden DW. (1995). Science. 
269, p400-403. 
Hensel M, Shea JE, Raupach B, Monack D, Falkow S, Gleeson C, Kubo T, and Holden 
DW. (1997). Mol. Microbiol. 24, p 155-167. 
Hiramatsu K, Aritaka N, Hanaki H, Kawasaki S, Hosoda Y, Hari S, Fukuchi Y, and 
Kobayashi Y. (1997). Lancet. 350, pI670-1673. 
Hols P, Defrenne C, Ferain T, Derzelle S, Delplace B, and Delcour 1. (1997). 1. 
Bacteriol. 179, p3804-3807. 
Hussain M, Hastings JGM, and White PJ. (1991). J. Med. Microbiol. 34, p143-147. 
Imlay KR, and Imlay JA. (1996). J. Bacteriol. 178, p2564-2571. 
Inaoka T, Matsumura Y, and Tsuchido T. (1998). J. Bacteriol. 180, p3697-3703. 
Ing MB, Baddour LM, and Bayer AS. (1997). In The Staphylococci in human disease. 
p331-353. Crossley KB, and Archer GL (Eds.). New York. Churchill Livingstone. 
Janzon L, Lofdahl S, and Arvidson S. (1989). Mol. Gen. Genet. 219, p480-485. 
Jevons, MP. (1961). Br. Med. J. I, pI24-125. 
Ji G, Beavis RC, and Novick RP. (1995). Proc. Natl. Acad. Sci. USA. 92, p12055-
12059. 
Ji G, Beavis RC, and Novick RP. (1997). Science. 276, p2027-2030. 
Kalcheva EO, Faiziev MM, Shanskaya VO, and Maluta SS. (1993). Can. J. Microbiol. 
40, p224-227. 
293 
Kavanaugh WM, and Williams LT. (1996). In Signal Transduction. p3-18. Heildin C-
H, and Purton M (Eds.). Chapman and Hall, London. 
Kemp EH, Sammons RL, Moir A, Sun 0, and Setlow P. (1991). J. Bacteriol. 173, 
p4646-4652. 
Keyer K, and Imlay JA. (1996). Proc. Natl. Acad. Sci. USA. 93, pI3635-13640. 
Kimura K, and Goto T. (1975). J. BioChem. 77, p4 I 5-420. 
Klaenhammer TR. (1993). FEMS Microbiol. Rev. 12,39-86. 
Klarsfeld AD, Goossens PL, and Cossart P. (1994). Mol. Microbiol. 13, p 585-597. 
Kleerebezem M, Quadri LEN, KuIpers 0, and de Vos WM. (1997). Mol. Microbiol. 24. 
p895-904. 
Kloos WE, and Bannerman TL. (1994). Clin. Microbiol. Rev. 7 pI17-140. 
Kloos WE, and Lambe OW. Jr. (1991). Manual of Clin. Microbiol. 5th Ed. p222-237. 
Balows et al., (Eds.). ASM, Washington D.C. 
Kochhar S, and Paulus H. (1996). Microbiol. 142, pI635-1639. 
Kornblum J, Kreiswirth BN, Projan SJ, Ross H, and Novick RP. (1990). In Molecular 
Biology of the Staphylococci. p421-423. Novick RP (Ed.). VCH Publishers, Inc., New 
York. 
Kreiswirth B, Lofdahl S, Bentley M, O'Reilly M, Schlievert P, Bergdoll M, and Novick 
RP. (1983). Nature. 305, p709-712. 
Kremery V, Trupl J, Drgona L, Lacka L, Kukuckova E, and Oravcova E. (1996). Eur. J. 
Clin. Microbiol. Infect. Dis. 15 p259-261. 
Krieg NR, and Hoffman PS. (1986). Ann. Rev. Microbiol. 40, p107-130. 
Kullik I, Giachino P, and Fuchs T. (l998a). J. Bacteriol. 180, p4818-4820. 
Kullik I, Jenni R, and BergerBachi B. (l998b). Gene. 219, p9-17. 
294 
Lammer A, Kruijt E, van de Kuijt C, Nuijten PJM, and Smith HE. (2000). Microbiol. 
146, p981-987. 
Le Y, He J and Vining LC. (1996). Microbiol. 142, p791-798. 
Lenter C. (1984). Geigy Scientific Tables. Vol 3. Ciba Geigy Ltd., Basel. 
Lilley PE, Stamford NP, Vasudevan SG, and Dixon NE. (1993). Gene. 129, p9-16. 
Lindsay JA, and Foster SJ. (1999). Mol. Gen. Genet. 262, p323-331. 
Lindsay JA, Riley TV, andMee BJ. (1995). Microbiol.141, p197-203. 
Lowe AM, Beattie DT, and Deresiewicz RL. (1998). Mol. Microbiol. 27, p967-976. 
Lu Y, Chen NY, and Paulus H. (1991). 1. Gen. Microbiol. 137, pl135-1143. 
Mahan MJ, Slauch JM, and Mekalanos JJ. (1993). Science. 259, p686-688. 
Mahan MJ, Tobias JW, Slauch JM, Hanna PC, Collier RJ, and Mekalanos J1. (1995). 
Proc. Natl. Acad. Sci. USA. 92, p669-673. 
Mallonee DH, Glatz BA, and Pattee PA. (1982). Appl. Env. Microbiol. 43, p397-402. 
Mani N, Tobin P, Jayaswal RK. (1993).1. Bacteriol.175, p1493-1499. 
Manna AC, Bayer MG, and Cheung AL. (1998). J. Bacteriol. 180, p3828-3836. 
McNamara PJ, and Iandolo J1. (1998). 1. Bacteriol. 180, p2609-2615. 
Mei J, Nourbakhsh F, Ford CW, and Holden DW. (1997). Mol. Microbiol. 26, p399-
407. 
Mekalanos JJ. (1992). J. Bacteriol. 174, pl-7. 
Mengaud J, dramsi S, Gouin E, Vazquez-Boland JA Milon G, and Cossart P. (1991). 
Mol. Microbiol. 5, p2273-2283. 
295 
Miller I, Maskell D, Hormaeche C, Johnson K, Pickard D, and Dougan G. (1989). 
Infect. Immun. 57, p2758-2763. 
Miller JH. (1972). Cold Spring Harbour Laboratory, Cold Spring Harbour. New York. 
Moir D, and Paulus H. (1977). J. BioI. Chern. 252, p4648-4654. 
Moran CPo Jr. (1993). In Bacillus subtiIis and other Gram-positive bacteria: 
Biochemistry, Physiology and Molecular Genetics. p237-267. Sonenshein AL, Hoch 
JA, Losick R (Eds.). ASM, Washington, D.C. 
Morfeldt E, Janzon L, Arvidson S, and Lofdahl S. (1988). Mol. Gen. Genet. 211, p435-
440. 
Morfeldt E, Panova-Sapundjievaa I, Gustafsson B and Arvidson S. (1996a). FEMS 
Microbiol. Letters. 143, p195-201. 
Morfeldt E, Tayler D, von Gabain A, and Arvidson S. (1995). EMBO J. 14, p4569-
4577. 
Morfeldt E, Tegmark K, and Arvidson S. (1996b). Mol. Microbiol. 21, p1227-1237. 
Neilands JB. (1972). Struct. Bond. 11, p145-170. 
Nicholas RO, Li T, McDevitt D, Marra A, Sucoloski S, Demarsh PL, and Gentry DR. 
(1999). Infect. Immun. 67, p3667-3669. 
Novick RP (1990). In Molecular Biology of the Staphylococci. p421-423. Novick RP 
(Ed.). VCH Publishers, Inc., New York. 
Novick RP, and Muir TW. (1999). Current opinion in Microbiol. 2, p40-45. 
Novick RP, Projan SJ, Kornblum J, Ross HF, Ji G, Kreiswirth B, Vandenesch F, and 
Moghazeh S. (1995). Mol. Gen. Genet. 248, p446-458. 
Novick RP, Ross HF, Projan SI, Kornblum 1, Kreiswirth B, and Moghazeh S. (1993). 
EMBO J. 12, p3967-3975. 
Novick RP. (1963). Virology. 33, pI55-156. 
296 
Novick RP. (1991). Methods Enzymol. 204, p587-636. 
Nystrom T, and Gustavsson N. (1998). Biochem. Biophys. Acta. 1365, p225-231. 
Ogawa SK, Yurberg ER, Hatcher VB, Levitt MA, and Lowy FD. (1985). Infect. Immun. 
50, p218-224. 
Ohlsen K, Koller KP, and Hacker J. (1997). Infect. Immun. 65, p3606-3614. 
Osbourne AE, Barber CE, and Danils MJ. (1987). EMBO J. 6, p23-28. 
Ozaki H, and Shiio. (1982).1. BioChem. 91, p1163-1171. 
Parkinson IS, and Kofoid EC. (1992). Annu. Rev. Genet. 26,71-112. 
Parsot C, and Cohen GN. (1988). J. BioI. Chern. 263, p14654-14660. 
Pattee PA, Lee H-C, Bannantine JP. (1990). In Molecular Biology of the Staphylococci. 
p41. Novick RP (Ed.). VCH Publishers, Inc., New York. 
Paulus H, (1993). In Bacillus subtilis and other Gram-positive bacteria: Biochemistry, 
Physiology and Molecular Genetics. p237-267. Sonenshein AL, Hoch JA, Losick R. 
(Eds.). ASM, Washington, D.C. 
Pavelka JR. MS, and Jacobs JR. WR. (1996).1. Bacteriol. 178, p6496-6507. 
Peacock Sl, Foster Tl, Cameron Bl, and Berendt AR. (1999). Microbiol. 145, p3477-
3486. 
Peng HL, Novick RP, Kreiswirth B, Kornblum J, and Schlievert P. (1988). 1. Bacteriol. 
170, p4365-4372. 
Perkin-Elmer Corperation (1999). Web site. www.pebio.com. 
Perkins JB, and Youngman PJ. (1986). Proc. Natl. Acad. Sci. USA. 83, pI40-144. 
Plum G, and Clarck-Curtiss IE. (1994). Infect. Immun. 62, p474-483. 
297 
Projan SI, and Novick RP. (1997). In The Staphylococci in human disease. p55-83. 
Crossley KB, and Archer GL (Eds.). New York. Churchill Livingstone. 
Rechtin TM, Gillaspy AF, Schumacher MA, Brennan RG, Smeltzer MS, and Hurlburt 
BK. (1999). Mol. Microbiol. 33, P307-316. 
Recsei P, Kreiswirth B, O'Reilly M, Schlievert P, Gruss A and Novick RP, (1986). 
Mol. Gen. Genet. 202, p58-61. 
Regassa LB, and Bentley MJ. (1993). Infect. Immun. 61, p1581-1585. 
Regassa LB, NovicK PR, and Bentley MJ. (1992). Infect. Immun 60, p3381-3388. 
Renzoni A, Cossart P, and Dramsi S. (1999). Mol. Microbiol. 34, p552-561. 
Richaud F, Phuc NH, Cassan M, and Patte Ie. (1980). 1. Bacteriol. 143, p513-515. 
Roos KL and Scheid WM. (1997). In The Staphylococci in human disease. p413-440. 
Crossley KB, and Archer GL (Eds.). New York. Churchill Livingstone. 
Roten CAH, Brandt C, and Karamata D. (1991). J. Gen. Microbiol. 137, p951-962. 
Rowbury RJ, and Woods DD, (1966). J. Gen. Microbiol. 42, p155-163. 
Sahl H-G, Jack RW, and Bierbaum G. (1995). Eur. J. Biochem. 230, p827-853. 
Saint-Girons I, Duchange N, Cohen GN, and Zakin MM. (1984). J. BioI. Chern. 259, 
p 14282-14286. 
Sambrook J, Fritsch EF, and Maniatis T. (1989). Molecular Cloning (a laboratory 
manual). Cold Spring Harbour Laboratory, Cold Spring Harbour. New York. 
Saravia-Otten P, Muller H-P, and Arvidson S. (1997). J. Bacteriol. 179, p5259-5263. 
Schlegel HG. (1992). Gen. Microbiol. Cambridge University Press. 
Schleiffer KH, and Kandler O. (1972), Bacteriol. Rev. 36, p407-477. 
298 
Schnell N, Entian K-D, Schneider U, Gotz F, Zahner H, Kellner R, and Jung G. (1988). 
Nature. 333, p276-278. 
Schrumpf B, Schwarzer A, Kalinowski J, Puhler A, Eggeling L, and Sahm H. (1991). J. 
Bacteriol. 173, p451 0-4516. 
Scully RE, McNeely BU, and Mark E1. (1986). New Eng 1. Med. 314 p39-49. 
Shea JE, Hensel M, Gleeson C, and Holden DW. (1996). Proc. Natl. Acad. Sci. USA. 
93, p2593-2597. 
Shiio I, and Miyajima R. (1969). 1. BioChem. 65, p849-859. 
Silhavy TJ, and Beckwith JR. (1985). Microbiol. Rev. 49, p398-418. 
Smeltzer MS, Gill SR, and Iandolo 11. (1992). J. Bacteriol. 174, p4000-4006. 
Smith QR, and Johanson CEo (1983). Am. J. Physiol. 249, p470-477. 
Spector MP, Park YK, Tirgari S, Gonzalez T, and Foster JW. (1988).1. Bacteriol. 170, 
p345-351. 
Staden R. (1990). Methods in Enzymology. 183, pI63-180. 
Stock JB, Ninfa AJ and Stock AM. (1989). Microbiol. Rev. 53, p450-490. 
Stragier P, Richaud F, Borne F, and Patte JC. (1983). J. Mol. BioI. 168, p307-320. 
Svensson B, Lubben M, and Hederstedt L. (1993). Mol. Microbiol. 10, p 193-20 1. 
Taylor RK, Miller VL, Furlong DB, and Mekalanos 11. (1987). Proc. Natl. Acad. Sci. 
USA. 84, p2833-2837. 
Theze J, Margarita D, Cohen GN, Borne F, and Patte Je. (1974). J Bacteriol. 117, 
pI33-143. 
Tipper DJ, and Strominger JL. (1968). J. BioI. Chern. 243, p3169-3179. 
Touati D. (1988). J. Bacteriol.l70, p2511-2520. 
299 
Tremaine M, Brockman DK, and Bentley MJ. (1993). Infect. Immun. 61, p356-359 
Trivier D, and Courcol RJ. (1995). FEMS Microbiol. Letters. 141, pl17-127. 
Tuomanen E. (1996). FEMS Microbiol. Rev. 18, p289-299 
Valdivia RH, and Falkow S. (1996). Mol. Microbiol. 22, p367-378. 
Valdivia RH, and Falkow S. (1997). Science. 277, p2007-2011. 
Van DijK G, Bottone AE, Strubbe JH, and Steffens AB. (1994). Brain Res. 660, p96-
103 
Van de Oost J, Von Wachenfield C, Hederstedt L, and Sarste M. (1991). Mol. 
Microbiol. 5, p2063-2072. 
Vandenesch F, Kornblum J, and Novick RP. (1991). J. Bacteriol. 173, p6312-6320. 
Villafane R, Bechhofer DH, Narayann CS, and Dubnau D. (1987). J. Bacteriol. 169, 
p4822-4829. 
Vriesema AJM, Beekhuizen H, Hamdi M, Soufan A, Lammers A, Willekens B, Bakker 
0, welten AGA, Veltrop MHAM, van de Gevel JS, Dankert J, and Zaat SAl (2000). 
Infect. Immun. 68, p 1765-1772. 
Wang J, Mushegian A, Lory S, and Jin S. (1996a). Proc. Natl. Acad. Sci. USA. 93, 
p10434-10439. 
Wang J, Lory S, Ramphal R, and Jin S. (1996b). Microbiol. 22, pl005-1012. 
Wanner BL. (1993). J. Cell. BioChem. 51, p47-54. 
Wasserman SA, Daub E, Grsafi P, Botstein D, and Walsh CT. (1984). BioChem. 23, 
p5182-5187. 
Watson SP. (1997). Ph.D. Thesis. University of Sheffield. 
Watson SP, Clements MO, and Foster SJ. (1998a). J. Bacteriol. 180, pI750-1758. 
300 
Watson SP, Antonio A, and Foster SJ. (1998b). Microbiol. 144, p3159-3169. 
Weinberger S, and Gilvarg C. (1970). J. Bacteriol. 101, p323-324. 
Wild J, Hennig J, Lobocka M, Walacsak W, and Klopotowski T. (1985). Mol. Gen. 
Genet. 198, p315-322 
Wilkinson BJ. (1997). In The Staphylococci in human disease. pl-38. Crossley KB, and 
Archer GL (Eds.). New York. Churchill Livingstone. 
Wiseman G.M. (1975). Bacteriol. Rev. 39, p317-344. 
Woese CR. (1987). Microbiol. Rev. 51 p221-271. 
Wu S, de Lencastre H, Tomasz A. (1996). J. Bacteriol. 178, p6036-6042. 
Xiong A,Singh VK, Cabrera G, and Jayaswal RK. (2000). Microbiol. 146, p659-668. 
Yamakuru F, Ikeda Y, Kimura K, and Sasakawa T. (1974). J. BioChem. 76, p611-621. 
Young GM, and Miller VL (1997). Mol. Microbiol. 25, p319-328. 
Youngman PJ. (1987). In Plasmids: a practical approach. Hardy K (Ed.). p79-103. IRL 
Press, Oxford. 
Youngman PJ. (1990). In Molecular Biology Methods for Bacillus. Harwood CR, and 
Cutting SM (Eds p221-226. John Wiley and Sons, New York. 
Yost FJ, and Fridovich I. (1973). J. BioI. Chern. 248, p4905-4908. 
Yugari Y, and Gilvarg C. (1965). J. BioI. Chern. 240, p4710-4716. 
Zakin MM, Greene RC, Dautry-Varsat A, Duchange N, Ferrara P, Py MC, Margarita D, 
and Cohen GN. (1982). Mol. Gen. Genet. 187, p101-106. 
Zhang J-J, Hu F-M, Chen N-Y, and Paulus H. (1990). J. Bacteriol. 172, p701-708. 
301 
APPENDIX 
A.I General 
A.1.1 Growth media 
Component Weight (g rl) Component Weieht (e rl) 
Calf brain infusion 12.5 Glucose 2.0 
solids 
Beef heart infusion 5.0 Sodium chloride 5.0 
solids 
Proteose peptone 10.0 Di-Sodium phosphate 2.5 
Table A.Ll 
List of ingredients of BHI (Oxoid) 
37g of BHI powder is made up to one litre with distilled water and autoclaved. I % agar is added prior to 
autoc1aving to produce BHI agar. 
Chemical Weight Chemical Weil!ht 
Solution 1 • Dissolved 
in 700 ml of distilled Il water adjusted to pH 
7.2 
Na2HP04.2H20 7 g L-Lvsine 100mg 
KH2P04 3g L-Leucine 150mg 
L-Aspartic Acid 150 mg L-Methionine 100mg 
L-Alanine 100 mg L-Phenvlalanine 100mg 
L-Arginine 100 mg L-Proline 150mg 
L-Cystine 50mg L-Serine 100mg 
Glycine 100 mg L-Threonine 150 mg 
L-Glutamic Acid 150mg L-Tryptophan 100mg 
L-Histidine 100mg L-Tvrosine 100mg 
L-Isoleucine )50mg L-Valine 150mg 
Solution 2 - Dissolved 
in 140 rril of distilled .... 11 
water. 
Biotin 0.02 mg Pyridoxal 0.8 mg 
Nicotinic acid 0.4 mg Pyridoxamine di 0.8 mg 
HC) 
D-Pantothenic acid 0.4 mg Riboflavin 0.4 mg 
Thiamine HCI 0.4 mg 
Solution 3 • Dissolved 
in 50 ml of 0.1 M HCI 
Adenine Sulphate 20mg Guanine HC) 20mg 
Solution 4 • Dissolved 
,~ 
in 10 ml of 0.1 M HCI 
CaCI2.6H2O lOmg (NH2)S04.FeS04·6H20 6mg 
Solution 5 • Dissolved 
in 100 ml of distilled 
water. 
Glucose 109 MgS04.7H2O 500mg 
Table A.l.2 
List of ingredients of CDM as devised by Hussain et al. ()991) 
Solutions I, 3 and 4 are mixed and autoc1aved together whereas solution 2 is filter sterili sed (0.2 11m 
pore size) and added after cooling. Solution 5 is autoc1aved separately and added after cooling. 
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Constituent Amount 
Chloride 12.-130 mM 
Albumin 0.295 g rl 
IgG 0.043 g rl 
Glucose 2.8-4.2 mM 
Protein : 
Lumbar 0.15-0.45 g rl 
Cisternal 0.15-0.25 g rl 
Ventricular 0.05-0.15 g rl 
Table A.1.3 
Values are for adults and refer to cerebrospinal fluid. 
Scully et al. (1986). 
Constituent Value 
Blood volumes 
(Mean adults) Blood volume 4.051 
Plasma volume 2.31 
Erythrocyte volume 1.75. I 
Physiochemical data 
Osmolarity 280-298 mmol kg' \ 
pH (arterial) 7.35-7.45 
Blood gases 
pC02 (arterial) 35-45 mmHg 
pO? (arterial) 75-100 mmHg 
Table A.l.4 
Blood volume, physiochemical and blood gas data. 
Scully et al. (1986). 
Constituent Amount 
Inorganic constituents 1-
Water 51.6-53 .0 mol r\ 
Sodium 134-147 mM 
Potassium 3.5-5.0 mM 
Chloride 96-106 mM 
Bicarbonate 21-30 mM 
Phosphate 0.7- 1.4 mM 
Sulphate 0.25-0.38 mM 
Calcium 2.1-2.7 mM 
MaJ!:nesium 0.7-\.3 mM 
Copper 12-30 IJ-M 
Zinc 12-241J-M 
Lead < 2.4IJ-M 
Iron 10-30~M 
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cont. 
Nitrogenous constituents 
Organic constituents 
Lipids (Fasting) 
Vitamins 
Proteins 
Clotting factors 
Table A.1.5 
Blood constituents 
Constituents 
Ammonia (NRt +) 
Urea 
Creatine 
Uric acid 
Amino acids (Free tota\)* 
-Glucose (fasting) 
Lactose 
Pyruvate 
Citrate 
Bilirbin (total) 
Triglyceride 
Cholesterol 
Phospholipids 
Fatty acids (total) 
Ascorbic ac id (C) 
Biotin 
Cholecalciferol (D3) 
Cobalamin (B 12) 
Folic acid 
Niacin (nicotinic acid) 
Pantothenic acid 
Retinol (A) 
Riboflavin (B2) 
Thiamine (B I ) 
a-Tocopherol (E) 
Total Protein 
Albumin 
Globulins (total) 
IgG 
Lipoprotein (HDL) 
Ceruloplasmin 
"~ 
Fibrinogem 
Plaminogen 
Prothrombin 
Values are for adults and refer to serum/plasma. 
Adapted from Scully et al. (1986). 
Amount 
12-60 uM 
2.5-7 .0 mM 
53-124 uM 
0.18-0.42 mM 
2.56-3 .95 mmol rl 
3.5-5 .5 mM 
0.6-1.8 mM 
0.03-0.1 I mM 
0.08-0.16 mM 
3-15 11M 
0.6-3.2 mM 
3.7-6.8 mM 
2.6-3 .2 mM 
0.2-0.8 mM 
20-100 11M 
2.5-5 .5 11M 
0.07 11M 
0.15-0.67 nM 
15-80 nM 
50uM 
1.3 11M 
0.3-2. 1 uM 
0.07-0.0 1 uM 
0.2-0.3 11M 
20-45 11M 
~ < c 
1-
60-84 g rl 
35-50 g rl 
23-35 g rl 
7- 15grl 
3-8 g rl 
0.2-0.4 g rl 
I 
2-4 g rl 
0.3 grl 
0.1 g rl 
* For more details on the amounts of amino acids in serum see Table A.I.6 and A.I .7 
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Adults JlI1101 rl 
Amino acids 38 Men 28 women 
Mean s Mean s 
Alanine 404 94 377 108 
Arginine 92 22 96 25 
Aspartic acid 21 5 20 5 
Citrulline 46 10 40 II 
Cystine / 2 109 18 107 23 
Glutamic acid 226 85 214 71 
Glycine 242 44 258 64 
Histidine 77 12 70 16 
Isoleucine 81 18 56 12 
Leucine 157 30 115 23 
Lysine 222 50 196 53 
Methionine 26 6 21 7 
Ornithine 85 24 67 19 
Phenylalanine 57 13 48 II 
Proline 274 62 218 63 
Serine 137 35 142 35 
Taurine 67 25 66 17 
Threonine 207 58 193 58 
Tyrosine 72 12 63 15 
Valine 274 53 214 41 
Table A.I.6 
Free amino acids in serum of adults 
Adapted from Lentner (1984). 
urnol rnrl 
Amino acids Pig Human 
Alanine 1125.1 1348.6 
Arginine 560.6 545.7 
Aspartic acid 368.6 260.6 
Cystine 146.9 101.1 
Glutamic acid 762.3 600.0 
Glycine 1719.4 1107.4 
Histidine 908.0 932.6 
Isoleucine 1042.3 518.3 
Leucine 2464.6 2270.3 
Lysine ,'. 87.4 254.9 
Methionine" ' ,.: 242.3 ' .. - 315.4 
Phenylalanine 1825.1 1982.9 
Proline 6984.0 6148.0 
Serine 1332.6 940.0 
Threonine 2657.7 2300 
Tyrosine 1565.1 1465.7 
Valine 2222.9 2044.0 
Table A.I.7 
Total amino acids content in pig and human serum (Sigma) as determined by HPLC analysis (Chapter 
2.27.2) 
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A.1.2 peR primers 
Primer Primer sequence Source/reference 
TnSI CTC ACA ATA GAG AGA TGT CAC CGT C Watson, 1997 
MDW9 TGT ATG CCA CTG ACC CAA GAC This study 
MDWlO AGA ACG TGC TGA TGA AAA TAA TAC This study 
SKB3 AAG TTA GCA GTT GTG GGT GC This study 
SKB4 CTA TCT TGA ACA GGC ACA CG This study 
MW3 AAA AAC AGT TAT TGA TTC TTG This study 
MW4 GTC CTT TTT CTT CTG CTA A This study 
MW41 GAG TAT ATG TCC AAG CAT G This study 
MW44 CCA GTC GTG CTG TAC AAT GTT CC This study 
OLI CGG GAT CCG GGC ATT GAT TCA TGT This study 
CCG 
OL2 GGA ATT CGC CAC ACC AGT AAC TGC This study 
OL3 GGA ATT CCC TTT CAT CCC TGA ACC This study 
OL4 GGA ATT CGC CAG TTC CTG CTA TGA This study 
CAG G 
OLP3 CAA GAT CTC GAG AAG CTT CTC CTG Horsburgh, 
CAT TAG GAA GCA GCC CAG unpublished 
RT-PCR Sequences not supplied SmithKline Beecham 
TaqMan Sequences not supplied SmithKline Beecham 
Table A.l.2.1 
Details of oligo nucleotide PCR primers used in this study 
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A.2 Sequence analysis 
A.2.t Sequence, translation and BLAST analysis of the DNA region 
flanking the Tn917 insertion site 
Figure A.2.ta 
segt 
ORl'l 
L K D S D F H Q ISM I LET L 
ATTAAAGGATAGTGATTTTCATCAAATTTCTATGATTCTTGAAACATTAA 50 
K N Q YEA LAY KIN E H Y V K 
AGAATCAATATGAAGCATTAGCTTATAAAATCAATGAGCATTATGTCAAA 100 
I S L I G S G M R D M S G V ASK 
ATTTCATTAATTGGCTCAGGCATGCGTGATATGTCAGGTGTGGCATCAAA 150 
seg14 
~ 
A F L T LIE N NIP F Y Q T T 
AGCATTTTTGACATTAATTGAAAATAATATACCTTTCTACCAAACAACAA 200 
Tn917 
~ 
T S E I SIS Y V I 
CATCTGAAATAAGTATTTCATACGTCATTGA 231 
5 best BLAST scores of ORFI 
Gene Heading 
Blast: lysC_helpy 
Blast: lysC_helpy 
Blast: lysC_bacsu 
Blast: lysC_bacsu 
Blast: lysC_bassp 
Amino acid alignment 
Accession No. 
4155744 
025827 
CAA99580.1 
P08495 
Q59229 
% Identity 
40% over 75 amino acids 
40% over 75 amino acids 
34% over 76 amino acids 
34% over 76 amino acids 
32% over 82 amino acids 
ORFI - 40% identity over 75 amino acids to LysC from H. pylori (lysC_helpy, 4155744). 
10 20 30 40 
ORF1 DSDFHQISMILETLKN-------QYEALAYKINEHYVKISLIGSGMRDMS 
D DF + +E K Q +++ Y +E+ K+S++G GM+ S 
lysC DLDFTIVKTQIEETKQALKPFLAQMDSIDY--DENIAKVSIVGVGMKSHS 
310 320 330 340 350 
50 60 70 
ORF1 GVASKAFLTLIENNIPFYQTTTSEISISYVID 
GVAS AF L ++NI +TSEI IS +ID 
lysC GVASIAFKALAKDNINIMMISTSEIKISVLID 
360 370 380 
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Figure A.2.th 
segS 
oU's 
R N V K Q I A T K S I I A I I S L 
GAAATGTTAAACAAATTGCTACAAAATCTATTATAGCTATTATTAGCTTA 50 
GIL T Y T T MIG S V LAD E I 
GGTATACTTACATATACAACAATGATTGGTAGCGTGTTGGCTGATGAGAT 100 
K Y P S A K F N Q PEA K D K T 
AAAATATCCATCAGCCAAATTTAATCAACCTGAAGCAAAAGATAAAACAG 150 
E L T T S I F D E K IKE N K A L 
AATTAACTACATCAATTTTTGATGAAAAGATAAAAGAGAATAAAGCGTTA 200 
Tn917 
~ 
ELL I F N Q 
GAGTTACTAATTTTTAATCAA 221 
5 best scores of ORF5 
No significant homology 
308 
Figure A.2.tc 
seg7 
ORP7 
Q K R L R MGT A S I I L G S L E 
GAAAAAAGATTACGAATGGGTACAGCATCTATCATTTTAGGTTCCCTAGA 50 
Y I GAD S Q Q v N A ATE D T 
GTACATAGGCGCAGACAGCCAACAAGTCAATGCGGCAACAGAAGATACGA 100 
NAT N I Q S T Q v S QAT S Q P 
ACGCAACTAATATTCAAAGCACACAAGTTTCTCAAGCAACATCACAACCA 150 
I N F Q v Q K D G SSE K S H M D 
ATTAATTTCCAAGTGCAAAAAGATGGCTCTTCAGAGAAGTCACACATGGA 200 
Tn917 
~ 
D Y 
TGACTATAT 209 
5 best BLAST scores of ORF7 
Gene Heading 
Blast: hypoth_staau 
Blast: sdrE_staau 
Blast: pls_staau 
Blast: CD44_bosta 
Blast: mst33a_drome 
Amino acid alignment 
Accession No. 
BAA86643.1 
CAA06652 
AAD09131.1 
Q294233 
CAB55437.1 
% Identity 
27% over 66 amino acids 
22% over 63 amino acids 
27% over 66 amino acids 
6% over 55 amino acids 
34% over 35 amino acids 
ORF7 - 27% identity over 66 amino acids to a hypothetical protein from S. aureus (hypoth_staau, 
BAA86643.1). 
10 20 30 40 50 
ORF7 KRLRMGTASIILGSLEYIGADSQQVNAATEDTNATNIQSTQVSQATSQPI 
+R +GTASI++G+ G + Q AA +T S+ S+ 
sahy RRFTVGTASILVGATLIFGVANDQAEAAENNTTQKQDDSSDASKVKG---
30 40 50 60 
60 
ORF7 NFQVQKDGSSEKSHMD 
N Q + S+ + D 
sahy NVQTIEQSSANSNESD 
70· 80 
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Figure A.2.1d 
segS 
GCACATTACTATATCCTTACTTACTGACTTTAATTGTGATAATTGTTCAG 50 
TAAGCATATTTACTTTTAATGCGTACTGAATAAGGTTATTTCAGCGATGG 100 
AATAACAAATAAAGGTGGTACCGCGAAACATAAGCTTTCGTCCTTTTTAT 150 
Tn917 
~ 
CCGATTCATTCGGGTACGAAGGACGGAAGCTTTTTTTATTTTTTCTTATA 200 
5 best BLAST scores of ORF8 
No significant homology 
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Figure A.2.1e 
seglO 
ORl'10 
S Q S K L Q S K L K P L GAD A 
AAAGTCAATCCAAGCTTCAATCCAAGCTAAAGCCCTTAGGGGCTGATGCA 50 
I M LIT P Y Y N K T N Q R G L V 
ATTATGTTAATTACGCCCTACTACAACAAAACGAACCAACGTGGTTTAGT 100 
K H F E A I A D A V K L P V V L 
CAAACACTTTGAAGCGATTGCAGATGCTGTGAAATTACCAGTCGTGCTGT 150 
Y N V P S R T N M TIE PET V E 
ACAATGTTCCTTCAAGAACGAACATGACAATTGAACCAGAAACTGTAGAA 200 
I L S Q H P Y I V A L K D A T N D 
ATATTAAGTCAACATCCTTATATAGTTGCTTTAAAAGATGCTACGAATGA 250 
Tn917 
~ 
FEY L 
TTTTGAGTATTTAG 264 
S best BLAST scores of ORFIO 
Gene Heading 
Blast: dapA_bacsu 
Blast: dapA_metja 
Blast: dapA_strco 
Blast: dapA_myctu 
Blast: dapA_corgJ 
Amino acid alignment 
Accession No. 
Q04796 
Q57695 
CAA20295 
CAA15549 
P19808 
% Identity 
52% over 73 amino acids 
55% over 69 amino acids 
54% over 72 amino acids 
50% over 71 amino acids 
47% over 71 amino acids 
ORFIO - 52% identity over 73 amino acids to DapA from B. subtilis (dapA_bacsu, Q04796). 
20 30 40 50 60 
ORF10 GADAIMLITPYYNKTNQRGLVKHFEAIADAVKLPVVLYNVPSRTNMTIEP 
G DA+ML+TPYYNK +Q G+ +HF+AIA LPV+LYNVP RT ++ P 
dapA GVDAVMLVTPYYNKPSQEGMYQHFKAlAAETSLPVMLYNVPGRTVASLAP 
100 110 120 130 140 
70 80 
ORF10 E-TVEILSQHPYIVALKDATNDFE 
E T+ + + P +VA+K+A+ D E 
dapA EITTRLAADIPNVVAIKEASGDLE 
150 160 
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Figure A.2.1f 
seg13 
ORl'13 
V I P L P D N Q L L T Q L F TEL 
GTTATCCCCCTACCTGACAATCAGCTACTTACCCAACTATTTACGGAACT 50 
E EGA V N V D MIS Q I V N L 
TGAAGAAGGTGCTGTAAATGTTGATATGATTTCACAAATCGTCAACTTGG 100 
D G L Q L S F T I K D S D F H Q I 
ATGGGCTACAACTATCCTTCACGATTAAAGATAGTGATTTTCATCAAATT 150 
S MIL E T L K N Q YEA LAY K 
TCTATGATTCTTGAAACATTAAAGAATCAATATGAAGCATTAGCTTATAA 200 
I N E H Y V K I S L I G S G M R 
AATCAATGAGCATTATGTCAAAATTTCATTAATTGGCTCAGGCATGCGTG 250 
Tn917 
~ 
D M S G V ASK A F L T L I 
ATATGTCAGGTGTGGCATCAAAAGCATTTTTGACATTAATT 291 
5 best BLAST scores of ORF13 
Gene Heading 
Blast: lysC_helpy 
Blast: AK_helpy 
Blast: lysC_bacsu 
Blast: lysC_bacsu 
Blast: AK2_bassp 
Amino acid alignment 
Accession No. 
4155744 
025827 
142524 
CAA99580.1 
P08495 
% Identity 
38% over 75 amino acids 
38% over 75 amino acids 
34% over 75 amino acids 
34% over 75 amino acids 
32% over 75 amino acids 
ORF13 - 38% identity over 75 amino acids to LysC from H. pylori (IysC_helpy, 4155744). 
30 40 50 60 70 
ORF13 VNVDMISQIVNLDG-LQLSFTIKDSDFHQISMILETLKNQYEALAYKINE 
+NVDMI Q + DG L FTI + + L+ Q +++ Y +E 
lysC INVDMIVQTIGRDGKTDLDFTIVKTQIEETKQALKPFLAQMDSIDY--DE 
300 310 320 330 
80 90 
ORF13 HYVKISLIGSGMRDMSGVASKAFLTL 
+ K+S++G GM+ SGVAS AF L 
lysC NIAKVSIVGVGMKSHSGVASIAFKAL 
340 350 360 
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Figure A.2.1g 
seg14 
TAGCAGTTATAATTTGTTGGACTTTTTGGTTAAGAGCTGAGAGTTTGTCA 50 
TTATTTAAAAATAATGGAGTGCATCACTTGTATATAGATTAAGAGCAAGT 100 
TCGCATTCCGAACTTGTTCTTTTTTTATTATTGTGTGCCCTTCCTNACNA 150 
OU14 
M V T R S V L K F G G S 
TTAGGAGGATTATATGGTAACAAGAAGTGTGTTGAAATTTGGCGGATCAT 200 
S V S D F T K I K R I A E M L K E 
CCGTCAGTGATTTTACAAAAATAAAAAGGATCGCTGAAATGTTAAAGGAG 250 
Tn917 
~ 
R V N Q D 
CGAGTCAATCAAGAT 265 
5 best BLAST scores of ORF14 
Gene Heading 
Blast: AK_mycsm 
Blast: lysC_thema 
Blast: AK_myctu 
Blast: AK_metja 
Blast: AKIH_ecoli 
Amino acid alignment 
Accession No. 
P41403 
AAD36585.1 
P97048 
Q57991 
POO56 1 
% Identity 
54% over 24 amino acids 
42% over 28 amino acids 
54% over 22 amino acids 
36% over 30 amino acids 
12% over 28 amino acids 
ORF14 - 54% identity over 24 amino acids to LysC from M. smegma tis (AK_mycsm. P41403). 
10 20 
ORF14 VLKFGGSSVSDFTKIKRIAEMLKE 
V+KFGG+++SD K++++AE + + 
lyse VQKYGGSSVADAERIRRVAERIVE 
10 20 
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Figure A.2.th 
seg2t 
ORl'21 
H K F V K L G W A TTl P S R L 
TTCACAAATTCGTCAAACTTGGATGGGCTACAACTATCCCTTCACGATTA 50 
K D S D F H Q ISM I LET L K N 
AAGGATAGTGATTTTCATCAAATTTCTATGATTCTTGAAACATTAAAGAA 100 
Q YEA LAY KIN E H Y V K I 
TCAATATGAAGCATTAGCTTATAAAATCAATGAGCATTATGTCAAAATTT 150 
S L I G S G M R D M S G V ASK A 
CATTAATTGGCTCAGGCATGCGTGATATGTCAGGTGTGGCATCAAAAGCA 200 
seg14 
~ 
F L T LIE N NIP F Y Q T T T S 
TTTTTGACATTAATTGAAAATAATATACCTTTCTACCAAACAACAACATC 250 
Tn917 
~ 
E I SIS Y V I 
TGAAATAAGTATTTCATACGTCATTGA 277 
5 best BLAST scores of ORF21 
Gene Heading 
Blast: lysC_bacsu 
Blast: lysC_ bacsu 
Blast: AK2_ bacsu 
Blast: AK2_ bacsp 
Blast: lysC_synsp 
Amino acid alignment 
Accession No. 
CAA99580.1 
142524 
P08495 
Q59229 
BAA18676 
% Identity 
34% over 82 amino acids 
34% over 82 amino acids 
34% over 82 amino acids 
32% over 82 amino acids 
36% over 74 amino acids 
ORF21 - X% identity over Y amino acids to LysC from B. subtilis (IysC_bacsu. CAA99580.1). 
10 20 30 40 50 
ORF21 TTIPSRLKDSDFHQISMILETLKNQYEALAYKINEHYVKISLIGSGMRDM 
T I +K D Q +LE K+ E + K+S++GSGM 
lysC TGISFSVKTEDADQTVAVLEEYKDALEFEKIETESKLAKVSIVGSGMVSN 
310 320 330 340 350 
60 70 80 90 
ORF21 SGVASKAFLTLIENNIPFYQTTTSEISISYVI 
GVA++ F L + NI +TSEI +S V+ 
lysC PGVAAEMFAVLAQKNILIKMVSTSEIKVSTVV 
360 370 380 
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Figure A.2.li 
seg22 
GGCGCATCAATCATGAGTAAAGTTTAGATTACTGTCTGCTAACAGCTAAA 50 
TTTGAAAGGGTGCGATGCCGAAGCAATTATAATAGCAGTTATAATTTGTT 100 
GGACTTTNTNGAAAAGAGCTGAGAGTTTGTCATTATTTAAAAATAATGGA 150 
GTGCATCACTTGTATATAGATTAAGAGCAAGTTCGCATTCCGAACTTGTT 200 
Tn917 
~ 
CTTTTTTTATTATT 214 
5 best BLAST scores of ORF22 
No significant similarity found 
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Figure A.2.1j 
seg24 
AACGTCATTGATGATTTTAATGGGCAACAAGCGGTAGAAAAACTATATGA 50 
ACGCATTTAACATTTAATGGTAAAATGATTGTTAAAATATTCTAAAAATT 100 
OJll'24 
M T K L A V V 
GGAAATTATTATAAAATGGAGTGACAAGTTATGACAAAGTTAGCAGTTGT 150 
GAT G L V G T K M LET L N R 
GGGTGCAACAGGATTAGTAGGTACAAAAATGTTGGAGACATTAAATCGTA 200 
K NIP F DEL V L F S S A R S A 
AAAATATTCCTTTCGATGAATTAGTATTATTTTCATCAGCACGTTCTGCA 250 
G Q EVE F Q G K T Y T V Q E L T 
GGGCAAGAAGTTGAATTTCAAGGAAAAACATATACAGTTCAAGAATTAAC 300 
Tn917 
~ 
DAR A S 
TGATGCTCGTGCAAGTG 317 
5 best BLAST scores of ORF24 
Gene Heading 
Blast: dhas3amje 
Blast: dhas_aquae 
Blast: asd_thema 
Blast: dhas_bascu 
Blast: asd_synsp 
Amino acid alignment 
Accession No. 
Q59291 
067716 
AAD36590.1 
Q04797 
S49978 
% Identity 
46% over 56 amino acids 
51 % over 54 amino acids 
50% over 56 amino acids 
57% over 52 amino acids 
27% over 59 amino acids 
ORF24 - 46% identity over 56 amino acids to Asd from C. jejuni (dhas3amje, Q59291). 
10 20 30 40 50 
ORF24 KLAVVGATGLVGTKMLETLNRKNIPFDELVLFSSARSAGQEVEFQGKTYT 
K+A+VGATG VG ++L L+ + P + ++ +SA+SAG ++EF+GK+YT 
asd KIAIVGATGAVGEELLNVLDELDFPVESILPLASAKSAGNQIEFRGKSYT 
10 20 30 40 50 
58 
ORF24 VQELTD 
++ELT+ 
asd IKELTE 
60 
316 
Figure A.2.1k 
seg2S 
OlUl'25 
C Q P G E Q Q T V S Y L S M V L 
TATTGCCAACCCGGAGAGCAACAAACTGTATCTTATTTATCAATGGTATT 50 
N DIG M N A K A M T G Y Q A G 
AAATGATATCGGTATGAATGCCAAAGCAATGACTGGCTATCAAGCGGGTA 100 
I K T I G H H L K SKI A Q I N P 
TTAAAACCATTGGCCATCATTTAAAAAGTAAAATTGCTCAAATTAATCCT 150 
Q T F E Q A F Q END I L V V A G 
CAAACATTTGAACAAGCCTTTCAAGAAAACGATATTTTAGTAGTTGCTGG 200 
F Q GIN E H Q E L TTL G R G 
ATTTCAAGGCATCAATGAACATCAGGAATTAACAACTTTAGGCAGAGGTG 250 
Tn917 
~ 
G S D T T A V A L A V S N Q I P C 
GTTCTGATACGACCGCTGTGGCACTTGCTGTTAGTAATCAAATACCTTGT 300 
5 best BLAST scores of ORF25 
Gene Heading 
Blast: lysC_thema 
Blast: AK2_ bacsp 
Blast: AK2_ bacsu 
Blast: lysC_ bacsp 
Blast: lysC_synsp 
Amino acid alignment 
Accession No. 
AAD36585.1 
Q59229 
P08495 
CAA99580.1 
BAA18676 
% Identity 
50% over 96 amino acids 
53% over 91 amino acids 
48% over 94 amino acids 
50% over 91 amino acids 
50% over 91 amino acids 
0RF25 - 50% identity over 96 amino acids to LysC from T. maritima (lysC_thema. AAD36585.1). 
10 20 30 40 50 
ORF25 GEQQTVSYLSMVLNDIGMNAKAMTGYQAGIKTIGHHLKSK1AQ1NPQTFE 
GEQ + + LSM L D+G+ AK++ +Q IKT HH ++1 1+ 
lysC GEQVSAALLSMALKDLGVKAKSLNAFQVKIKTTPHHTSARIVDIDDSVIR 
80 90 100 110 120 
60 70 80 90 100 
ORF25 QAFQENDILVVAGFQGINEHQELTTLGRGGSDTTAVALAVSNQIPC 
+ ++ D+LVV GFQG+NEH +LTTLGRGGSDT+AVALA ++PC 
lysC ENLKDYDVLVVTGFQGVNEHGDLTTLGRGGSDTSAVALAAKLRVPC 
130 140 150 160 
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Figure A.2.11 
seg26 
ORl'26 
V I D N S S Q W R MAE DID L I 
GTTATAGACAATTCAAGTCAATGGCGTATGGCAGAAGATATTGATTTAAT 50 
v P E V N E P T F T R G I I A N 
CGTTCCGGAAGTCAATGAACCTACATTTACAAGAGGTATCATTGCCAATC 100 
P N CST I Q S v v P L K V L Q D 
CAAACTGCTCTACGATTCAATCTGTTGTACCTCTAAAAGTATTGCAAGAT 150 
A Y G L K R V A Y TTY Q A V S G 
GCTTATGGTTTAAAACGAGTGGCATATACAACATATCAAGCTGTATCAGG 200 
S G M K G K K D L A E G V N G K 
TTCAGGGATGAAAGGTAAGAAAGATTTAGCTGAAGGTGTAAATGGTAAAG 250 
Tn917 
~ 
APE A Y P H PlY N N V L PHI 
CACCAGAAGCATATCCACATCCAATTTATAATAATGTGTTACCGCATATT 300 
5 best BLAST scores of ORF26 
Gene Heading 
Blast: dhas_aquae 
Blast: asd_thema 
Blast: dhas3amje 
Blast: asd_shevi 
Blast: dhas_legpn 
Amino acid alignment 
Accession No. 
067716 
AAD36590.1 
Q59291 
BAA08490.1 
031219 
% Identity 
58% over 100 amino acids 
48% over 100 amino acids 
50% over 100 amino acids 
52% over 100 amino acids 
52% over 100 amino acids 
ORF26 - 58% identity over 100 amino acids to Asd from A. aeolicus (dhas_aquae. 067716). 
10 20 30 40 
ORF26 VIDNSSQWRMAEDIDLIVPEVNEPTFT----RGIIANPNCSTIQSVVPLK 
VIDNSS WRM D+ L+VPEVN +GIIANPNCSTIQ VV LK 
asd VIDNSSAWRMDPDVPLVVPEVNPEDVKDFKKKGIIANPNCSTIQMVVALK 
100 110 120 130 140 
50 60 70 80 
ORF26 VLQDAYGLKRVAYTTYQAVSGSGMKGKKDL-------AEGVNGKAPEAYP 
+ D G+KR V +TYQAVSG+G K +DL EG + +P 
asd PIYDKAGIKRVVVSTYQAVSGAGAKAIEDLKNQTKAWCEGKEMPKAQKFP 
150 160 170 180 190 
90 100 
ORF26 HPIYNNVLPHI 
H I N LPHI 
asd HQIAFNALPHI 
200 
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Figure A.2.1m 
seg29 
ORF29 
V F G LIS P P P H H DIY S I E 
GTATTCGGTCTGATTTCACCACCCCCACATCATGATATTTATTCAATAGA 50 
D L A Q L I H D L K NAN K D A 
AGATTTAGCGCAACTGATACATGATTTGAAAAATGCGAATAAAGATGCAG 100 
D I A V K L V S K T G V G T I A S 
ATATCGCGGTAAAATTAGTTTCGAAAACAGGTGTTGGTACCATTGCATCT 150 
G V A K A FAD K I V I S G Y D G 
GGGGTGGCAAAAGCATTTGCAGATAAAATTGTCATCAGTGGTTACGATGG 200 
G T GAS P K T S I Q HAG V P 
TGGTACAGGGGCTTCACCCAAAACGAGTATTCAGCATGCCGGTGTTCCTT 250 
WEI G L A E T H Q T L K L N D L 
GGGAGATTGGTTTAGCAGAAACACATCAAACATTAAAACTAAATGACTTA 300 
R S R V K LET D G K L LTG K D 
AGAAGTCGTGTTAAGTTAGAAACAGACGGTAAGTTATTAACTGGTAAAGA 350 
Tn917 
~ 
v A 
TGTAGCG 357 
5 best BLAST scores of ORF29 
Gene Heading Accession No. % Identity 
Blast: gltb_bacsu P39812 84% over 116 amino acids 
Blast: gltb_syny3 P55037 77% over 117 amino acids 
Blast: gltb_plebo BAAI2741 77% over 116 amino acids 
Blast: gltb310ac AAD4I675.1 75% over 117 amino acids 
Blast: gltb_deira AAF09770.1 76% over 116 amino acids 
Amino acid alignment 
ORF29 - 84% identity over 116 amino acids to GtaB from B. subtilis (gltb_bacsu, P39812). 
10 20 30 40 50 
ORF29 GLISPPPHHDIYSIEDLAQLIHDLKNANKDADIAVKLVSKTGVGTIASGV 
GLISPPPHHDIYSIEDLAQLIHDLKNAN+DA I+VKLVSK GVGTIA+GV 
gltb GLISPPPHHDIYSIEDLAQLIHDLKNANRDARISVKLVSKAGVGTlAAGV 
980 990 1000 1010 1020 
60 70 80 90 100 
ORF29 AKAFADKIVISGYDGGTGASPKTSIQHAGVPWEIGLAETHQTLKLNDLRS 
AKA AD IVISGYDGGTGASPKTSI+H G+PWE+GLAE HQTL LN LR 
gltb AKATADVIVISGYDGGTGASPKTSIKHTGLPWELGLAEAHQTLMLNGLRD 
1030 1040 1050 1060 1070 
110 
ORF29 RVKLETDGKLLTGKDV 
RV LETDGKL+TG+DV 
gltb RVVLETDGKLMTGRDV 
1080 1090 
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Figure A.2.In 
seg30 
GATGAGGCGCATCAATCATGAGTAAAGTTTAGATTACTGTCTGCTAACAG 50 
CTAAATTTGAAAGGGTGCGATGCCGAAGCAATTATAATAGCAGTTATAAT 100 
TTGTTGGACTTTTTGGTTAAGAGCTGAGAGTTTGTCATTATTTAAAAATA 150 
ATGGAGTGCATCACTTGTATATAGATTAAGAGCAAGTTCGCATTCCGAAC 200 
Tn917 
~ 
TTGTTCTTTTTTTATTATT 219 
5 best BLAST scores of ORF30 
No significant similarity found 
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Figure A.2.10 
seg33 
CAATCATGAGTAAAGTTTAGATTACTGTCTGCTAACAGCTAAATTTGAAA 50 
GGGTGCGATGCCGAAGCAATTATAATAGCAGTTATAATTTGTTGGACTTT 100 
TTGGTTAAGAGCTGAGAGTTTGTCATTATTTAAAAATAATGGAGTGCATC 150 
ACTTGTATATAGATTAAGAGCAAGTTCGCATTCCGAACTTGTTCTTTTTT 200 
Tn917 
~ 
TATTATT 207 
5 best BLAST scores of ORF33 
No significant similarity found 
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Figure A.2.1p 
seg35 
TCTAACTTATGGAAGTTGACTGGCAAAACCCATACTGTTAAATTAATTCG 50 
GGTACGGGATTCTAAAGGAAACTAATCCTGGAGTATAACTGTTAGAAATA 100 
GAGGAAGTTAAACCCGAAATTTAAGAGTTAAACAAAAAATATTCACAACA 150 
TATTAAAAAAAGAAGTTACATTATTTGTTTAAACTAACAATAGTACCATA 200 
AAATTAATGACGATTTACAAATTAATAACAAATAATTATTATTAAATTCA 250 
TTGATTTATTGTGTGGTAATGATTAATATGACAATTGAAGTGGGTCTTAA 300 
CTTCAACTTTTAAATAGGGGGTTTTATCTTTGGAAAAAGTTCTTGATTTA 350 
Tn917 
~ 
GACGTGCAAGTT 362 
5 best BLAST scores of ORF35 
No significant similarity found 
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Figure A.2.1q 
seg37 
GATGCGTTAGGAAGTTCTTCTAATACAATTTATACAACGCCATTCCCTAC 50 
ACACTCTTATAAAAGAGATTCACGCGCGTCAATAAATTGTATTACATACT 100 
AACTAAAAAGCTTTTCTTAATCGTACTAACGAAGTTAGAGGTTCTTATGT 150 
GATTGGACAACTGTTCTCCCTACTAGACTTTTAGCATAGCTGGTTAAAAG 200 
TACTATTACAGATTGTTCAATTGTATGCCCCTTTCCTTTGAACGGAATAT 250 
Tn917 
~ 
TAAAAGCTATGTGCAGTAACTTTTAATAGGCATACCACTTTTGCATCAA 249 
5 best BLAST scores ofORF37 
No significant similarity found 
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Figure A.2.1r 
seg39 
AATACAATTAATACAACGCCATTCCCTACACACTCTTATAGTAGAGATTC 50 
ACGCGCGTCAATAAATTGTATTACATACTAACTGAAAAAGCTTTTGTTAA 100 
TCGTACTAACGAAGTTAGAGGTTCTTATGTGATTGGACAACTGTTCTCCC 150 
TACTAGACTTTTAGCATAGCTGGTTAAAAGTACTATTACAGATTGTTCAA 200 
TTGTATGCCCCTTTCCTTTGAACGGAATATTAAAAGCTATGTGCAGTAAC 250 
Tn917 
~ 
TTTTAATAGGCATACCACTTTTGCATCAA 279 
5 best BLAST scores of ORF39 
No significant similarity found 
324 
Figure A.2.1s 
seg40 
AAAGAGATTCCACGCGCGTCAATAAATTGTATTACATACTAACTAAGAAG 50 
CTTTTGTTAATCGTACTAACGAAGTTAGAGGTTCTTATGTGATTGGACAA 100 
CTGTTCTCCCTACTAGACTTTTAGCATAGCTGGTTAAAAGTACTATTACA 150 
GATTGTTCAATTGTATGCCCCTTTCCTTTGAACGGAATATTAAAAGCTAT 200 
Tn917 
~ 
GTGCAGTAACTTTTAATAGGCATACCACTTTTGCATCAA 239 
5 best BLAST scores ofORF40 
No significant similarity found 
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Figure A.2.tt 
seg43 
ORF43 
M V V N S A I V DNA L G V L I 
GGATGGTAGTGAATTCTGCCATTGTAGATAATGCGCTAGGAGTTCTTATT 50 
R Y P M GAR K G S D V N S Y L N 
CGTTATCCCATGGGAGCCAGAAAAGGCAGCGATGTTAACTCATACCTGAA 100 
P X L Y N E AND A N V R A F Y 
CCCTAGGTTATATAATGAAGCGAATGATGCAAATGTACGTGCGTTTTATG 150 
E F Y S Y L M E P W D G P T MIS 
AATTTTATAGTTATTTAATGGAACCGTGGGATGGTCCTACAATGATTTCG 200 
F C N G D K L GAL T D R N G L R 
TTCTGTAACGGTGACAAACTTGGCGCGCTTACAGATAGAAATGGATTACG 250 
P G R Y TIT K D N F I V F S S 
TCCAGGTCGTTATACGATTACTAAAGATAACTTTATTGTCTTTTCATCTG 300 
Tn917 
~ 
E v G V V D V PES 
AAGTGGGTGTTGTGGACGTACCTGAAAGT 329 
S best BLAST scores of ORF43 
Gene Heading 
Blast: gltb_bacsu 
Blast: gltb_medsa 
Blast: glsn_medsa 
Blast: gltb_strco 
Blast: gltb_orysa 
Amino acid alignment 
Accession No. 
P39812 
1066499 
Q03460 
CAB52861.1 
BAA35120.1 
% Idendty 
50% over 105 amino acids 
62% over 67 amino acids 
62% over 67 amino acids 
58% over 65 amino acids 
50% over 104 amino acids 
ORF43 - 50% identity over 105 amino acids to GtIB from B. subtilis (gltb_bacsu. P398l2). 
10 20 30 40 50 
ORF43 NSAIVDNALGVLIRYPMGARKGSDVNSYLNPXLYNEANDANV--RAFYEF 
+S+I+DNA + M RK + L P + E + RAFYE+ 
gltB DSSILDNAFEFFV---MAGRKPAHTAMMLIPEPWTENTHMSKEKRAFYEY 
300 310 320 330 
60 70 80 90 100 
ORF43 YSYLMEPWDGPTMISFCNGDKLGALTDRNGLRPGRYTITKDNFIVFSSEV 
+S LMEPWDGPT ISF +G ++GA+ DRNGLRP RY +TKD++I+FSSEV 
gtlB HSSLMEPWDGPTAISFTDGKQIGAILDRNGLRPARYYVTKDDYIIFSSEV 
340 350 360 370 380 
108 
ORF43 GVVDVPE 
GV++V + 
gltB GVIEVEQ 
390 
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Figure A.2.1u 
seg4S 
OO'4S 
G I K MIS V C M P K A M T G Y 
ATGGTATTAAAATGATATCGGTATGCATGCCAAAAGCAATGACTGGCTAT 50 
Q A G I K T I G H H L K SKI A Q 
CAAGCGGGTATTAAAACCATTGGCCATCATTTAAAAAGTAAAATTGCTCA 100 
I N P Q T F E Q A F Q END I L 
AATTAATCCTCAAACATTTGAACAAGCCTTTCAAGAAAACGATATTTTAG 150 
v V A G F Q GIN E H Q E L TTL 
TAGTTGCTGGATTTCAAGGCATCAATGAACATCAGGAATTAACAACTTTA 200 
G R G G S D T T A V A L A V S N Q 
GGCAGAGGTGGTTCTGATACGACCGCTGTGGCACTTGCTGTTAGTAATCA 250 
Tn917 
~ 
I P C 
AATACCTTGTG 261 
5 best BLAST scores ofORF45 
Gene Heading 
Blast: lysC_thema 
Blast: lysC_synsp 
Blast: AK2_bacsp 
Blast: AK2_bacst 
Blast: AK2_bacsu 
Amino acid alignment 
Accession No. 
AAD36585.1 
BAAl 8676 
Q59229 
P53553 
P08495 
% Identity 
50% over 76 amino acids 
54% over 70 amino acids 
55% over 68 amino acids 
51 % over 70 amino acids 
49% over 71 amino acids 
ORF45 - 50% identity over 76 amino acids to LysC from T. maritima (lysC_thema. AAD36585.1). 
20 30 40 50 60 
ORF45 KAMTGYQAG1KTIGHHLKSK1AQINPQTFEQAFQENDILVVAGFQGINEH 
K++ +Q 1KT HH ++1 I+ + ++ D+LVV GFQG+NEH 
lysC KSLNAFQVKIKTTPHHTSARIVDIDDSV1RENLKDYDVLVVTGFQGVNEH 
100 110 120 130 140 
70 80 
ORF45 QELTTLGRGGSDTTAVALAVSNQIPC 
+LTTLGRGGSDT+AVALA ++PC 
lysC GDLTTLGRGGSDTSAVALAAKLRVPC 
150 160 
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Figure A.2.t v 
seg48 
ORFU 
H Q N N K E L ALL L T T G E Q 
GCACCAAAACAACAAGGAACTGGCATTATTATTGACAACCGGAGAGCAAC 50 
Q T V S Y L S M V L N DIG M N A 
AAACTGTATCTTATTTATCAATGGTATTAAATGATATCGGTATGAATGCC 100 
K A M T G Y Q A G I K T I G H H L 
AAAGCAATGACTGGCTATCAAGCGGGTATTAAAACCATTGGCCATCATTT 150 
K SKI A Q I N P Q T F E Q A F 
AAAAAGTAAAATTGCTCAAATTAATCCTCAAACATTTGAACAAGCCTTTC 200 
Q END I L V V A G F Q GIN E H 
AAGAAAACGATATTTTAGTAGTTGCTGGATTTCAAGGCATCAATGAACAT 250 
Q E L TTL G R G G S D T T A V A 
CAGGAATTAACAACTTTAGGCAGAGGTGGTTCTGATACGACCGCTGTGGC 300 
Tn917 
~ 
L A V S N Q I P C 
ACTTGCTGTTAGTAATCAAATACCTTGTG 329 
5 best BLAST scores of ORF48 
Gene Heading 
Blast: lysC_therna 
Blast: AK2_bacsp 
Blast: AK2_bacsu 
Blast: lysc_bacsu 
Blast: AK2_bacst 
Amino acid alignment 
Accession No. 
AA036585.1 
Q59229 
P08495 
CAA99580.1 
P53553 
% Identity 
49% over 107 amino acids 
52% over 104 amino acids 
47% over 105 amino acids 
49% over 102 amino acids 
47% over 104 amino acids 
ORF48 - 49% identity over 107 amino acids to LysC from T. maritima (lysC_therna, AA036585.1). 
10 20 30 40 50 
ORF48 NNKELALLLTTGEQQTVSYLSMVLNDIGMNAKAMTGYQAGIKTIGHHLKS 
+++EL +LL TGEQ + + LSM L D+G+ AK++ +Q IKT HH + 
lyse DSRELDMLLATGEQVSAALLSMALKDLGVKAKSLNAFQVKIKTTPHHTSA 
70 80 90 100 110 
60 70 80 90 100 
ORF48 KIAQINPQTFEQAFQENDILVVAGFQGINEHQELTTLGRGGSDTTAVALA 
+I I+ + ++ D+LVV GFQG+NEH +LTTLGRGGSDT+AVALA 
lyse RIVDIDDSVIRENLKDYDVLVVTGFQGVNEHGDLTTLGRGGSDTSAVALA 
120 130 140 150 160 
109 
ORF48 VSNQIPC 
++PC 
lyse AKLRVPC 
168 
328 
Figure A.2.1w 
seg50 
ORl'SO 
S K Q T V S Y L S M V L N DIG 
AGAGCAAACAAACTGTATCTTATTTATCAATGGTATTAAATGATATCGGT 50 
M N A K A M T G Y Q A G I K T I G 
ATGAATGCCAAAGCAATGACTGGCTATCAAGCGGGTATTAAAACCATTGG 100 
H H L K SKI A Q I N P Q T F E 
CCATCATTTAAAAAGTAAAATTGCTCAAATTAATCCTCAAACATTTGAAC 150 
Q A F Q END I L V V A G F Q G I 
AAGCCTTTCAAGAAAACGATATTTTAGTAGTTGCTGGATTTCAAGGCATC 200 
N E H Q E L TTL G R G G S D T T 
AATGAACATCAGGAATTAACAACTTTAGGCAGAGGTGGTTCTGATACGAC 250 
Tn917 
~ 
A V A L A V S N Q I P C 
CGCTGTGGCACTTGCTGTTAGTAATCAAATACCTTGT 287 
5 best BLAST scores of ORFSO 
Gene Heading 
Blast: lysC_thema 
Blast: AK2_bacsp 
Blast: AK2_bacsu 
Blast: lysc_myctu 
Blast: AK_myctu 
Amino acid alignment 
Accession No. 
AA036585.1 
Q59229 
P08495 
1899205 
P97048 
% Identity 
48% over 92 amino acids 
52% over 87 amino acids 
47% over 90 amino acids 
44% over 83 amino acids 
44% over 83 amino acids 
ORF50 - 48% identity over 92 amino acids to LysC from T. maritima (lysC_thema. AAD36585.1). 
10 20 30 40 50 
ORF50 TVSYLSMVLNDIGMNAKAMTGYQAGIKTIGHHLKSKIAQINPQTFEQAFQ 
+ + LSM L D+G+ AK++ +Q IKT HH ++1 1+ + + 
lysC SAALLSMALKDLGVKAKSLNAFQVKIKTTPHHTSAR1VD1DDSVIRENLK 
80 90 100 110 120 
60 70 80 90 
ORF50 ENDILVVAGFQGINEHQELTTLGRGGSDTTAVALAVSNQ1PC 
+ D+LVV GFQG+NEH +LTTLGRGGSDT+AVALA ++PC 
lysC DYDVLVVTGFQGVNEHGDLTTLGRGGSDTSAVALAAKLRVPC 
130 140 150 160 
329 
Figure A.2.1a-w 
Sequence, translation and BLAST analysis of the DNA region flanking the Tn917 
insertion site 
The best 5 scores and amino acid alignments, of predicted ORFs were the product of a 
BLAST database search. 
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A.2.2 
Figure A.2.2a 
seg5 
Further sequence analysis of seg 
AGTTGCATCCTTAGCATTATTAATCGCAATCACATTGTTTGTTAGAAAAAAATCTAAAGG 60 
ORl'5 
M R N V K Q I A T K S I I A I I 
CAATGTGGAATAATGAGAAATGTTAAACAAATTGCTACAAAATCTATTATAGCTATTATT 120 
S L GIL T Y T T MIG S V LAD ElK 
AGCTTAGGTATACTTACATATACAACAATGATTGGTAGCGTGTTGGCTGATGAGATAAAA 180 
Y P S A K F N Q PEA K 0 K TEL T T S 
TATCCATCAGCCAAATTTAATCAACCTGAAGCAAAAGATAAAACAGAATTAACTACATCA 240 
•• g5 
V 
I FOE K IKE N K ALE L L I F N Q E 
ATTTTTGATGAAAAGATAAAAGAGAATAAAGCGTTAGAGTTACTAATTTTTAATCAAGAA 300 
N K N V TEE Q Q L V 0 E K A Q LIS 0 
AATAAAAATGTAACTGAGGAACAACAACTAGTTGACGAAAAGGCGCAATTGATTTCAGAT 360 
M T G K I Y L Q v K L K G Q I 0 K 0 Q R 
ATGACTGGTAAAATTTACTTGCAAGTAAAGCTAAAAGGTCAAATAGATAAAGACCAACGT 420 
V F Q N 0 K NEE F P L V I K 0 E K 0 0 
GTTTTTCAAAATGACAAAAATGAAGAATTTCCTTTGGTAATAAAAGATGAAAAGGATGAC 480 
T I V R I LIE Q HMO KIN M H V K T 
ACAATAGTAAGAATTTTAATTGAACAGCATATGGATAAAATCAATATGCATGTTAAAACG 540 
L A E K K N L D N K E M V Y S I H F K E 
TTGGCTGAAAAGAAAAATCTAGATAACAAAGAAATGGTGTATTCTATTCATTTTAAAGAG 600 
K K V Q H D D A K E V P S K H Q N Q E N 
AAAAAAGTACAACATGATGATGCAAAAGAAGTGCCTTCAAAACATCAAAATCAAGAAAAT 660 
N Q 0 Q L K K DID D K K D S Q K SOT 
AATCAAGATCAGCTTAAAAAAGATATTGATGACAAAAAAGATAGTCAAAAATCAGATACT 720 
K ERR T S L F T E K G L N DIP v Q K 
AAGGAAAGACGTACTAGCCTTTTTACTGAAAAAGGATTAAATGATATTCCTGTACAAAAA 780 
D K V Q Q 0 S N K K lEN E R P K A S G 
GATAAAGTGCAACAAGACAGTAATAAAAAGATTGAAAATGAGCGACCTAAAGCATCAGGT 820 
T L K V ENS P P T I K K V E N N H K E 
ACATTAAAAGTTGAAAATAGCCCTCCAACAATAAAAAAGGTTGAAAATAATCACAAAGAG 900 
Q P K H K D E K S K K E KKK V V EKE 
CAACCGAAACATAAAGATGAAAAATCAAAAAAGGAAAAGAAAAAAGTAGTTGAAAAAGAA 960 
K ALP A F N ROD 0 S K N S S Q L S S 
AAAGCGTTACCAGCTTTTAATAGAGATGATGATAGCAAGAATAGTAGTCAATTATCTAGT 1020 
o IKE L 0 E P N H K K Q Y M L F A A G 
GATATTAAAGAACTTGATGAACCAAATCATAAAAAGCAATATATGTTATTTGCAGCTGGC 1080 
I V L A TIL LIS A H L Y S R K R G N 
ATTGTGTTAGCAACTATTTTACTTATTTCGGCACATTTATACAGCAGAAAGAGAGGTAAC 1140 
Q v * 
CAAGTTTGAGAATCATAAAGTATTTAACCATTTTAGTGATAAGCGTCGTTATCTTAACCA 1200 
5 best Blast scores of ORF5 
No significant homology found 
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Figure A.2.2b 
seg8 
GTACCGCGAAACATAAGCTTTCGTCCTTTTTATCCGATTCATTCGGGTACGAAGGACGGA 60 
•• ga ORrS 
V MKDTQLAQ 
AGCTTTTTTTATTTTTTCTTATAGGAGGGTCTTAATATOAAGGATACACAGTTAGCCCAA 120 
I T LTD D S T G A I A N P I H L S T A 
ATCACATTAACCGATGATTCAACCGGTGCTATAGCGAATCCAATCCATTTATCTACTGCC 180 
Y K H P K L G Q S T G F D Y T R T K N P 
TACAAGCATCCAAAACTAGGACAATCGACAGGTTTTGATTATACACGTACTAAAAATCCT 240 
T R S T F ETC F A K L E H G I A S F A 
ACACGCTCAACATTTGAAACCTGTTTTGCCAAACTTGAGCATGGTATTGCATCATTCGCT 300 
T SSG M S A I Q L I C N L F K PHD E 
ACATCAAGTGGAATGTCAGCCATTCAATTAATATGTAATCTATTTAAACCTCATGATGAA 360 
I L V S F D L Y G G T F R L F E F Y E Q 
ATTTTAGTTTCATTCGATTTATATGGTGGCACATTTAGATTATTTGAATTTTACGAGCAA 420 
Q Y D I K F K Y V D F T DYE Q v EKE 
CAATACGATATCAAATTTAAGTACGTTGATTTTACAGATTATGAACAAGTTGAAAAAGAA 480 
lTD K T V A L FIE PIS N P Q M I A 
ATCACTGATAAAACAGTTGCATTATTCATTGAACCAATATCTAACCCACAAATGATTGCT 540 
I D V K P Y Y Q L C K A K G L LSI I D 
ATTGATGTAAAGCCATACTATCAACTTTGTAAAGCTAAAGGCTTATTGTCAATTATCGAC 600 
N T F L T P Y L S T P L A EGA D I V L 
AATACTTTTTTAACACCTTATCTTTCAACACCACTAGCAGAAGGTGCTGATATAGTCTTA 660 
H SAT K Y I G G H N D V LAG V v T V 
CATTCAGCCACGAAATATATTGGCGGACATAACGATGTACTAGCAGGTGTCGTAACCGTC 720 
K DES L A Q Q L F D F H N M T GAT L 
AAAGATGAATCACTCGCGCAACAGTTGTTTGATTTTCACAACATGACTGGCGCAACACTT 780 
S P IDS Y L L L R G L K T L H L R I E 
TCACCAATAGATAGTTATTTGTTGTTACGTGGACTTAAAACTTTGCATTTACGCATTGAG 840 
R A Q S N ARK L A K K C Q S L Q A I D 
CGTGCGCAATCAAACGCTAGAAAACTTGCTAAAAAATGTCAGTCACTTCAAGCAATTGAC 900 
E V L Y S G Q T G M L S L R L N KAY S 
GAAGTACTATATAGCGGGCAAACTGGCATGCTTAGTTTAAGACTTAACAAGGCCTATAGC 960 
V A K L LEN L D I C I F A E S L G G T 
GTCGCTAAATTATTAGAAAATTTAGACATTTGCATTTTTGCAGAAAGTTTAGGAGGTACT 1020 
S best BLAST scores of ORF8 
Gene Heading Accession No. % Identity 
Blast: yjci_ bacsu A69847 49% over 324 amino acids 
Blast: metb_haein P44502 46% over 328 amino acids 
Blast: metb_ haein 064047 46% over 328 amino acids 
Blast: metc_Iacla AFF14693.1 37% over 329 amino acids 
Blast: metc_Iacla AFF14695.1 38% over 329 amino acids 
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Amino acid alignment 
ORF8 - 49% identity over 324 amino acids to YjcI from B. subtilis (yjci_bacsu, 
A69847). 
ORF8: 104 DTQLAQI-TLTDDSTGAIANPIHLSTAYKHPKLGQSTGFDYTRTKNPTRSTFETCFAKLE 283 
+T+LAQI +D+ TG ++ PI+LSTAY+H +G+STGFDY RTKNPTR E A LE 
yjcI: 6 ETKLAQIGNRSDEVTGTVSAPIYLSTAYRHRGIGESTGFDYVRTKNPTRQLVEDAIANLE 65 
ORF8: 284 HGIASFATSSGMSAIQLICNLFKPHDEILVSFDLYGGTFRLFEFYEQQYDIKFKYVDFTD 463 
+G A SSGM+AIQ I LFK DE++VS DLYGGT+RLFE ++Y + F Y DF+D 
yjcI: 66 NGARGLAFSSGMAAIQTlMALFKSGDELIVSSDLYGGTYRLFENEWKKYGLTFHYDDFSD 125 
ORF8: 464 YEQVEKEITDKTVALFIEPISNPQMIAIDVKPYYQLCKAKGLLSIIDNTFLTPYLSTPLA 643 
+ + +IT T A+F+E +NP M D++ ++ K GLL I+DNTF TP L PL 
yjcI: 126 EDCLRSKITPNTKAVFVETPTNPLMQEADIEHIARITKEHGLLLIVDNTFYTPVLQRPLE 185 
ORF8: 644 EGADIVLHSATKYIGGHNDVLAGVVTVKDESLAQQLFDFHNMTGATLSPIDSYLLLRGLK 823 
GADIV+HSATKY+GGHND+LAG+V VKDE L +++F N GA L P DS+LL+RG+K 
yjcI: 186 LGADIVIHSATKYLGGHNDLLAGLVVVKDERLGEEMFQHQNAIGAVLPPFDSWLLMRGMK 245 
ORF8: 824 TLHLRIERAQSNARKLAKKCQSLQAIDEVLYSGQTGMLSLRLNKAYSVAKLLENLDICIF 1003 
TL LR+ + Q+NA++LA + + I +VLY G+ GMLS RL K V L+ L F 
yjcI: 246 TLSLRMRQHQANAQELAAFLEEQEEISDVLYPGKGGMLSFRLQKEEWVNPFLKALKTICF 305 
ORF8:1004 AESLGGTETLVTFPYTQTHVDMPD 1175 
AESLGG E+ +T+P TQTH+D+P+ 
yjcI: 306 AESLGGVESFITYPATQTHMDIPE 329 
333 
Figure A.2.2c 
seg22 (seg30, seg33) 
ATGGAGTGCATCACTTGTATATAGATTAAGAGCAAGTTCGCATTCCGAACTTGTTCTTTT 60 
•• g22 (30,33) ly.C (a aubunit) 
V M V T R S V L 
TTTATTATTGTGTGCCCTTCCTAACAATTAGGAGGATTATATGGTAACAAGAAGTGTGTT 120 
K F G G S S V S D F T K I K R I A E M L 
GAAATTTGGCGGATCATCCGTCAGTGATTTTACAAAAATAAAAAGGATCGCTGAAATGTT 180 
•• g14 
V 
K E R V N Q D E Q L I V V V SAM G N T 
AAAGGAGCGAGTCAATCAAGATGAACAATTAATTGTCGTTGTAAGTGCTATGGGTAACAC 240 
T D Q L M T N V S T L T K A P K Q Q E L 
AACAGATCAATTAATGACGAATGTATCAACCTTGACTAAAGCACCAAAACAACAAGAACT 300 
Diagram showing the location of the Tn917 insertions in seg22 (seg30, seg33) 
The transposon insertion sites are shown in relation to the start codon (ATG) of lyse (n 
subunit) and the Tn917 insertion in seg14. 
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Figure A.2.2d 
seg35 
ORF35 
G V L S L E K V 
ACAATTGAAGTGGGTCTTAACTTCAACTTTTAAATAGGGGGTTTTATCTTTGGAAAAAGT 60 
•• g35 
V 
L D L D V Q v K G N N N T N D SAG D E 
TCTTGATTTAGACGTGCAAGTTAAAGGAAATAACAACACTAATGATTCAGCGGGTGACGA 120 
R ITS H L F C S F G C E K T G S F N S 
AAGAATAACTAGCCATCTTTTTTGTAGCTTTGGTTGTGAAAAGACGGGTAGTTTTAACAG 1BO 
FCC * 
CTTCTGTTGTTAAGGATACAGCAAATAGAGCCTGAAAGGGCTCTATTTGTCTTTTTAAAT 240 
ATATTAAGTGCTAAAAAACGGAAACAGTTTATTAATCGCCAGGTATTTTTATAATTAGCC 300 
5 best BLAST scores of ORF35 
Gene Heading Accession No. 0/0 Identity 
Blast: lang_staga P21838 51 % over 45 amino acids 
Blast: lane_staep P08136 50% over 44 amino acids 
Blast: mutA_strmu AAC18827.1 56% over 25 amino acids 
Blast: lanm_strmu P80666 76% over 17 amino acids 
Blast: epid_ staep CAA30690.1 59% over 22 amino acids 
Amino acid alignment 
ORF35 - 51 % identity over 45 amino acids to lantibiotic galliderrnin precursor (GdmA) from S. 
gallinarum (lan~staga, P21838). 
ORF35: 2B KVLDLDVQVKGNNNTNDSAGDERITSHLFCSFGCEKTGSFNSFCC 190 
++ DLDV+V + NDS + RI S C+ GC KTGSFNS+CC 
gdhM : 9 ELFDLDVKVNAKES-NDSGAEPRIASKFLCTPGCAKTGSFNSYCC 52 
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Figure A.2.2e 
seg37 (seg39, seg40) 
OllF37 (39,40) 
H K A DYE K 0 G N K Y I A 0 L E K L N 
ACATAAAGCAGATTATGAAAAGCAAGGTAACAAATACATTGCTCAATTGGAAAAATTAAA 60 
N D S K D K F N DIP K E 0 RAM ITS 
TAATGACAGTAAAGACAAATTTAATGACATTCCAAAAGAACAACGTGCCATGATTACAAG 120 
EGA F K Y F S K 0 Y G I T P G Y I W E 
TGAAGGTGCCTTCAAGTACTTCTCAAAACAATACGGTATTACACCAGGTTATATTTGGGA 180 
I N T E K 0 G T P E 0 M R 0 A I E F V K 
AATTAACACTGAAAAACAAGGTACACCTGAACAAATGAGACAAGCTATTGAGTTTGTTAA 240 
K H K L K H L L VET S V D K K A M E S 
AAAGCACAAATTAAAACACTTATTAGTAGAAACAAGTGTTGATAAGAAAGCAATGGAAAG 300 
L SEE T K K D I F G E V Y T D S I G K 
TTTATCTGAAGAAACGAAGAAAGATATCTTTGGTGAAGTGTACACAGATTCAATCGGTAA 360 
E G T K G D S Y Y K M M K S N lET V H 
AGAAGGCACTAAAGGTGACTCTTACTACAAAATGATGAAATCAAATATTGAAACTGTACA 420 
G S M K * C N 
CGGAAGCATGAAATAACACGCTGTGTTTTAATGAAGTAAGATGAATTGATGTTGATGCAA 480 
L K Y W Y L Q Y F R PHI NIT K S K A 
Q S R R 
CCTAAAATATTGGTATCTCCAATATTTTAGGCCACACATCAACATAACAAAGTCGAAGGC 540 
N S PIS C V K Y I L P S Y * Y I Y R S 
L I V P Y R A L N I Y Y P PIN I Y T V 
TAATAGTCCCATATCGTGCGTTAAATATATATTACCCTCCTATTAATATATATACCGTTC 600 
R S H D M V V L ELL FER K R K A R S 
P D R T I W W Y * 
CCGATCGCACGATATGGTGGTATTAGAACTTCTCTTTGAACGAAAGAGAAAAGCTAGAAG 660 
S Y A V L I K L * 
TTCTTATGCAGTTTTAATTAAACTGTAAACATTTGTCACTCTTTAAATCAAAGAGTAAAG 720 
TTAAAAGCTTTATGTGGTTTTGATTAAACTGCGAACAGCTGCTTCTCTTTGAACGAAAGA 780 
GAAAAGCTAGAAGTTCTTATGCAGTTTTAATTAAACTGTAAACATTTATCACTCTTTAAA 840 
L N CEQ L L L 
TCAAAGAGTAAAGTTAAAAGCTTTATGTGGTTTTGATTAAACTGCGAACAGCTGCTTCTC 900 
FER E R K A R S S Y A V L I K L S F P 
T V V P 
TTTGAACGAGAGAGAAAAGCTAGAAGTTCTTATGCAGTTTTAATTAAACTGTCGTTCCCT 960 
S S L L T T E M R * 
P Q R C V R S S S N T I Y T T P 
F I S F N H R D ALE V L L I Q F I Q R 
TCATCTCTTTTAACCACAGAGATGCGTTAGAAGTTCTTCTAATACAATTTATACAACGCC 1020 
F P T H S Y K R D S R A SIN CIT Y * 
H S L H T L IKE I H A R Q * 
ATTCCCTACACACTCTTATAAAAGAGATTCACGCGCGTCAATAAATTGTATTACATACTA lOBO 
ACTAAAAAGCTTTTCTTAATCGTACTAACGAAGTTAGAGGTTCTTATGTGATTGGACAAC 1140 
TGTTCTCCCTACTAGACTTTTAGCATAGCTGGTTAAAAGTACTATTACAGATTGTTCAAT 1200 
TGTATGCCCCTTTCCTTTGAACGGAATATTAAAAGCTATGTGCAGTAACTTTTAATAGGC 1260 
•• g37 (39,40) 
V 
ATACCACTTTTGCATCAAGCTATAAATAATCGCATACTTTGATATTTAATCTGGCCTATC 1320 
AAAGTAAACATCTATGGTTTCCTCCCCCCATAGATCCTTAAGCCACACTCATCCGATGTC 1380 
ATATGAGTGTGGCTATTTTTTGTGAATACACTTAACTTCACCTTTAAATGACTTCGCTTA 1440 
ATCTATCTCCTCCAATTTTTAAAACTTATTTCAATTAAATCTCAAATATTAATAATTCGT 1500 
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5 best BLAST scores of ORF37 (39/40) 
Gene Heading 
Blast: lipo_staep 
Blast: psaA_strmi 
Blast: psaA_strpn 
Blast: psaA_ strpn 
Blast: ensp3ntfa 
Amino acid alignment 
Accession No. 
CAA67571.1 
AFF055088 
AAD09975.1 
ABB09440.1 
AAA70056.1 
% Identity 
76% over 143 amino acids 
48% over 139 amino acids 
48% over 139 amino acids 
48% over 139 amino acids 
47% over 143 amino acids 
ORF37 (39/40) - 76% identity over 143 amino acids to a lipoprotein from S. epidermidis (lipo_staep. 
CAA67571.1). 
ORF37 : 2 KADYEKQGNKYIAQLEKLNNDSKDKFNDIPKEQRAMITSEGAFKYFSKQYGITPGYlWEI 61 
K+ YEKQGN YI++LE+LN DSK+KF+DIPK QRAM+TSEGAFKYF++Q+ + PGYlWEI 
lipo : 167 KSTYEKQGNAYISKLEELNKDSKNKFDDIPKNQRAMMTSEGAFKYFAQQFDVKPGYlWEI 226 
ORF37: 62 NTEKQGTPEQMRQAIEFVKKHKLKHLLVETSVDKKAMESLSEETKKDIFGEVYTDSIGKE 121 
NTEKQGTP QM+QAI+FVK + LKHLLVETSVDKKAM+SLSEETKKDI+GEV+TDSIGKE 
lipo : 227 NTEKQGTPGQMKQAIKFVKDNHLKHLLVETSVDKKAMQSLSEETKKDIYGEVFTDSIGKE 286 
ORF37: 122 GTKGDSYYKMMKSNIETVHGSMK 144 
GTKGDSYYKMMKSNI+T+HGSMK 
lipo : 287 GTKGDSYYKMMKSNIDTIHGSMK 309 
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Figure A.2.2a-e 
Further sequence analysis of seg 
seg5 (a), seg8 (b), seg22 (seg30, seg33) (c), seg35 (d), and seg37 (seg39, seg40) (e), 
were all analysed further by searching S. aureus databases for contigs with homology to 
the seg sequences. These contigs were then analysed to determine the identity of the 
sera expressed gene. 
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